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Factors influencing the development of a tissue engineered bone to bone
ligament
by Uchena N. G. Wudebwe
This thesis aimed to quantify the effect of anabolic agents ascorbic acid (AA)/ proline
(P) on the rates of contraction of the fibrin hydrogel scaffold as well as develop a
process for increasing construct collagen content, tensile strength and widths.
Supplementation with AA/ P, in combination or individually, revealed contrasting
effects on the rates of fibrin gel contraction dependent on concentration and culture
duration. There appeared to be strong correlations between the extents of contraction
and construct collagen content.
Enhancing the stiffness of the fibrin hydrogel augmented widths of the constructs but
did not improve construct collagen content or tensile strength. The results further
demonstrated that increasing the volume fraction of fibrin fibres present, either by
increasing the total volume of reagents or by adjusting the ratio of thrombin to
fibrinogen used could be utilised to modify sinew widths.
Constructs prepared using a stiffer fibrin gel formulation, supplemented with AA+P,
resulted in enhanced collagen content, sinew tensile strength and improved interface
tensile attachment.
The results also demonstrated variation in fibrin gel contraction rates and collagen
production due to different cell sources, growth medium employed or the use of metal
ion cofactors Zn2+/ Mn2+, thereby suggesting areas that could be investigated further
and optimized.
Dedicated to my Mother
And
In loving memory of my Grandmother
Acknowledgements
First and foremost, I would like to thank my supervisor Professor Liam Grover for
the opportunity to join his research group and develop academically. I am grateful for
his support and guidance throughout my PhD. I would also like to thank Dr Jennifer
Paxton, for training me in cell culture methods and her friendship during my PhD.
My gratitude to Dr Alan Smith, who trained me in practical rheology techniques and
his warm welcome when I visited his group at the University of Huddersfield.
Thank you to Dr James Bowen who offered me much assistance in troubleshooting
equipment and agreeing to trial AFM and flow based cell detachment methods with
me.
To Mr Paul Stanley and Mrs Theresa Morris from the Centre of Electron of Mi-
croscopy, who trained me in SEM techniques, thank you for your patience. Theresa,
prepared my samples in Chapter 4 for SEM and TEM, for which I am very grateful.
Further thanks are extended to Dr Dick Shelton and Ms Michelle Holder from the
School of Dentistry for allowing me to use their facilities. Michelle designed the
primers used in this work and trained me in RT-PCR.
Thank you to Dr Alex Robinson and Dr David Cheneler for their assistance and the
work they began on fabricating micropost arrays.
I would also like to thank all my colleagues in my research group, department and
throughout the university.
I could not have done this PhD without the support and encouragement of my mother.
Thank you mum, for your love and the confidence you have in me. Many thanks also
go to my close friends and family who continue to believe me.




List of Figures ix
List of Tables xiii
Abbreviations xv
1 Introduction 1
1.1 Thesis objectives . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
2 Background 5
2.1 Ligament and tendon structure . . . . . . . . . . . . . . . . . . . . . 5
2.2 Damage to ligaments and tendons and their repair . . . . . . . . . . . 8
2.3 Biological aspects of Tissue Engineering . . . . . . . . . . . . . . . . 11
2.3.1 Cells and their function . . . . . . . . . . . . . . . . . . . . . 13
2.3.1.1 Cell proliferation . . . . . . . . . . . . . . . . . . . . 15
2.3.1.2 Cell adhesion . . . . . . . . . . . . . . . . . . . . . . 17
2.3.1.3 Migration . . . . . . . . . . . . . . . . . . . . . . . . 19
2.3.1.4 Cell signalling . . . . . . . . . . . . . . . . . . . . . . 21
2.3.2 Tissue morphogenesis and wound healing . . . . . . . . . . . . 21
2.3.2.1 The Extracellular Matrix . . . . . . . . . . . . . . . 24
2.3.2.2 Fibrin . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.3.2.3 Collagen . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.3.2.4 Matrix metalloproteinases . . . . . . . . . . . . . . . 31
2.3.2.5 Hydrogels . . . . . . . . . . . . . . . . . . . . . . . . 33
2.4 Current ligament and tendon tissue engineering strategies . . . . . . . 34
2.4.1 Growth factors . . . . . . . . . . . . . . . . . . . . . . . . . . 35
2.4.2 Cell source . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.4.3 Interface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
2.4.3.1 Use of bone mimetics . . . . . . . . . . . . . . . . . . 37
2.4.4 Mechanical loading . . . . . . . . . . . . . . . . . . . . . . . . 38
2.4.5 Scaffolds and scaffold design . . . . . . . . . . . . . . . . . . . 39
2.4.5.1 Synthetic . . . . . . . . . . . . . . . . . . . . . . . . 40
2.4.5.2 Natural . . . . . . . . . . . . . . . . . . . . . . . . . 42
Contents ii
2.4.5.3 Use of MMP inhibitors or TIMPs . . . . . . . . . . . 43
2.5 Opening Remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3 General Methods and Materials 45
3.1 Cell Culture . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.1.1 Supplemented medium . . . . . . . . . . . . . . . . . . . . . . 45
3.1.2 Supplemented F12 Ham . . . . . . . . . . . . . . . . . . . . . 45
3.1.3 Cell thawing . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.1.4 Cell culture . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.2 Tissue engineering ligament/tendon . . . . . . . . . . . . . . . . . . . 46
3.2.1 Preparation of stock solutions . . . . . . . . . . . . . . . . . . 46
3.2.1.1 3.5M Ortho-phosphoric acid with 50mM Citric Acid 46
3.2.1.2 Thrombin . . . . . . . . . . . . . . . . . . . . . . . . 47
3.2.1.3 Fibrinogen . . . . . . . . . . . . . . . . . . . . . . . 47
3.2.1.4 Phosphate Buffered Saline solution . . . . . . . . . . 47
3.2.1.5 Ascorbic Acid and Proline solutions . . . . . . . . . . 47
3.2.2 Sylgarded petri-dishes/ well plates . . . . . . . . . . . . . . . 48
3.2.3 Brushite cement anchors . . . . . . . . . . . . . . . . . . . . . 48
3.2.4 Fibrin hydrogel preparation . . . . . . . . . . . . . . . . . . . 48
3.2.5 Cell dissociation from flasks . . . . . . . . . . . . . . . . . . . 49
3.2.6 Cell counting . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3.2.6.1 Using Trypan Blue . . . . . . . . . . . . . . . . . . . 50
3.2.7 Construct formation - cell seeding . . . . . . . . . . . . . . . . 50
3.2.8 Changing growth medium . . . . . . . . . . . . . . . . . . . . 51
3.3 Contraction Imaging and Quantification . . . . . . . . . . . . . . . . 51
3.4 Collagen quantification . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.4.1 Preparation of Reagents . . . . . . . . . . . . . . . . . . . . . 53
3.4.1.1 Aldehyde-perchloric acid reagent . . . . . . . . . . . 53
3.4.1.2 Chloramine-T Solution . . . . . . . . . . . . . . . . . 53
3.4.1.3 Hydroxyproline Buffer . . . . . . . . . . . . . . . . . 53
3.4.2 Method . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
3.5 Mechanical Testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.5.1 Rheology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.5.1.1 Strain and Frequency Sweeps . . . . . . . . . . . . . 55
3.5.1.2 Time Sweeps . . . . . . . . . . . . . . . . . . . . . . 56
3.5.2 Tensile Testing . . . . . . . . . . . . . . . . . . . . . . . . . . 57
3.5.2.1 Equipment set-up . . . . . . . . . . . . . . . . . . . . 57
3.5.2.2 Sample preparation . . . . . . . . . . . . . . . . . . . 58
3.6 Construct cell quantification . . . . . . . . . . . . . . . . . . . . . . . 58
3.6.1 Reagents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.6.1.1 TESCA Buffer . . . . . . . . . . . . . . . . . . . . . 58
3.6.1.2 Collagenase I Solution . . . . . . . . . . . . . . . . . 59
Contents iii
3.6.1.3 Calcein-AM Solution Preparation . . . . . . . . . . . 59
3.6.2 Cell dissociation from constructs . . . . . . . . . . . . . . . . 59
3.6.3 Quantification using calcein-AM . . . . . . . . . . . . . . . . . 59
3.6.4 Cell viability in reagents . . . . . . . . . . . . . . . . . . . . . 60
3.7 Fluorescence Microscopy . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.7.1 DAPI staining . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.7.2 Calcein-AM stained contraction impeded gels . . . . . . . . . 61
3.8 Electron Microscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.8.1 Scanning Electron Microscopy . . . . . . . . . . . . . . . . . . 62
3.8.1.1 Karnovsky’s Fixative . . . . . . . . . . . . . . . . . . 62
3.8.1.2 Sample dehydration . . . . . . . . . . . . . . . . . . 62
3.8.1.3 Critical point CO2 drying . . . . . . . . . . . . . . . 63
3.8.2 Cryo-Scanning Electron Microscopy . . . . . . . . . . . . . . . 63
3.9 Histology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
3.9.1 Construct preparation . . . . . . . . . . . . . . . . . . . . . . 64
3.9.2 Hematoxylin and Eosin staining . . . . . . . . . . . . . . . . . 64
3.9.3 Masson’s Trichrome Staining . . . . . . . . . . . . . . . . . . . 65
3.10 Reverse Transcription Polymerase Chain Reaction . . . . . . . . . . . 65
3.11 Statistical Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4 Contraction of ascorbic acid and proline supplemented constructs 67
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
4.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 69
4.2.1 Construct preparation . . . . . . . . . . . . . . . . . . . . . . 69
4.2.2 Supplementation . . . . . . . . . . . . . . . . . . . . . . . . . 69
4.2.2.1 Ascorbic acid and proline . . . . . . . . . . . . . . . 69
4.2.2.2 Varying concentration of either ascorbic acid or proline 69
4.2.2.3 Collagen inhibition with DMOG . . . . . . . . . . . 69
4.2.3 Collagen quantification . . . . . . . . . . . . . . . . . . . . . . 69
4.2.4 Microscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
4.2.4.1 Scanning Electron Microscopy . . . . . . . . . . . . . 70
4.2.4.2 Transmission Electron Microscopy . . . . . . . . . . 70
4.2.5 Histology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
4.2.6 Reverse transcription polymerase chain reaction . . . . . . . . 70
4.2.7 Statistical Analysis . . . . . . . . . . . . . . . . . . . . . . . . 71
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
4.3.1 Effect of ascorbic acid and proline on fibrin gel contraction . . 71
4.3.1.1 Fibrin percentage gel areas . . . . . . . . . . . . . . 73
4.3.1.2 Maximum and minimum widths . . . . . . . . . . . . 75
4.3.2 Scanning electron microscopy . . . . . . . . . . . . . . . . . . 77
4.3.2.1 Control and ascorbic acid + proline construct longi-
tudinal sections . . . . . . . . . . . . . . . . . . . . . 77
Contents iv
4.3.2.2 Control construct cross-sections . . . . . . . . . . . . 77
4.3.2.3 Ascorbic acid + proline construct cross-sections . . . 77
4.3.3 Histology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
4.3.3.1 Hematoxylin and Eosin . . . . . . . . . . . . . . . . 80
4.3.3.2 Masson’s Trichrome . . . . . . . . . . . . . . . . . . 83
4.3.4 Transmission electron microscopy . . . . . . . . . . . . . . . . 85
4.3.4.1 Control construct longitudinal sections . . . . . . . . 85
4.3.4.2 Ascorbic acid + proline construct longitudinal sections 87
4.3.4.3 Control construct cross-sections . . . . . . . . . . . . 89
4.3.4.4 Ascorbic acid + proline construct cross-sections . . . 91
4.3.5 Effect of varying ascorbic acid and proline concentrations on
fibrin contraction . . . . . . . . . . . . . . . . . . . . . . . . . 93
4.3.5.1 Fibrin percentage gel areas and max/min widths . . 93
4.3.6 Collagen content of supplemented constructs . . . . . . . . . . 97
4.3.7 Effect of collagen synthesis inhibition on contraction . . . . . . 97
4.3.8 RT-PCR detection of transcripted mRNAs . . . . . . . . . . . 99
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
4.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
5 Influence of fibrin gel formulation on contraction 111
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
5.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 112
5.2.1 Supplementation of acellular gels with AA+P . . . . . . . . . 112
5.2.2 Fibrin gel rheology . . . . . . . . . . . . . . . . . . . . . . . . 113
5.2.3 Construct preparation . . . . . . . . . . . . . . . . . . . . . . 113
5.2.3.1 Altering fibrinogen volume . . . . . . . . . . . . . . . 113
5.2.3.2 Altering total fibrin volume . . . . . . . . . . . . . . 113
5.2.3.3 Altering fibrin gel stiffness . . . . . . . . . . . . . . . 114
5.2.4 Calcein-AM staining . . . . . . . . . . . . . . . . . . . . . . . 114
5.2.5 Cell proliferation . . . . . . . . . . . . . . . . . . . . . . . . . 115
5.2.6 Fibrin fibre diameter and pore sizes . . . . . . . . . . . . . . . 115
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
5.3.1 Supplementation of acellular gels with ascorbic acid + proline 115
5.3.2 Altering fibrinogen volume . . . . . . . . . . . . . . . . . . . . 116
5.3.2.1 Fibrin percentage gel areas . . . . . . . . . . . . . . 117
5.3.2.2 Construct widths . . . . . . . . . . . . . . . . . . . . 120
5.3.3 Altering total fibrin volume at a constant thrombin to fibrino-
gen ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
5.3.3.1 Fibrin percentage gel areas . . . . . . . . . . . . . . 122
5.3.3.2 Construct widths . . . . . . . . . . . . . . . . . . . . 123
5.3.3.3 Strain sweeps of gels of varying volume/ thickness . . 125
5.3.3.4 Frequency sweeps of gels of varying volume/ thickness 127
Contents v
5.3.4 Altering fibrin gel stiffness (thrombin to fibrinogen ratio) whilst
maintaining a constant volume . . . . . . . . . . . . . . . . . 128
5.3.4.1 Fibrin percentage gel areas . . . . . . . . . . . . . . 130
5.3.4.2 Construct widths . . . . . . . . . . . . . . . . . . . . 130
5.3.4.3 Fibrin fibre diameters and pore sizes . . . . . . . . . 132
5.3.4.4 Gelling kinetics of fibrin gels of varying thrombin to
fibrinogen ratio . . . . . . . . . . . . . . . . . . . . . 136
5.3.4.5 Mechanical behaviour of acellular fibrin gels of vary-
ing thrombin to fibrinogen ratios . . . . . . . . . . . 138
5.3.4.6 Effect of cell presence on fibrin gel rheological response139
5.3.4.7 Cell morphology on fibrin gels . . . . . . . . . . . . . 139
5.3.4.8 Cell proliferation within constructs . . . . . . . . . . 144
5.3.4.9 Histological morphology of constructs . . . . . . . . . 145
5.3.4.10 Construct collagen content . . . . . . . . . . . . . . . 145
5.3.4.11 Construct tensile strength . . . . . . . . . . . . . . . 147
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
5.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 160
6 Optimisation of ascorbic acid + proline treated constructs 161
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
6.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 162
6.2.1 Construct preparation . . . . . . . . . . . . . . . . . . . . . . 162
6.2.2 Construct supplementation . . . . . . . . . . . . . . . . . . . . 162
6.2.2.1 Combined AH and AP treatment . . . . . . . . . . . 162
6.2.2.2 Supplementation with AH, AP or EDTA . . . . . . . 163
6.2.2.3 Supplementation with ZnSO4 and MnSO4 . . . . . . 163
6.2.3 Collagen quantification . . . . . . . . . . . . . . . . . . . . . . 163
6.2.4 Histology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 163
6.2.5 Confocal microscopy . . . . . . . . . . . . . . . . . . . . . . . 163
6.2.6 RT-PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
6.2.7 Interface strength testing . . . . . . . . . . . . . . . . . . . . . 164
6.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
6.3.1 Use of MMP inhibitors to reduce rates of matrix degradation . 164
6.3.1.1 Supplementation with both AH and AP . . . . . . . 165
6.3.1.2 Supplementation with AH, AP or EDTA . . . . . . . 165
6.3.2 Effect of collagen cross-linkers on contraction and collagen syn-
thesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
6.3.2.1 Fibrin percentage gel areas and widths . . . . . . . . 169
6.3.2.2 Construct collagen content and tensile strength . . . 169
6.3.2.3 Construct morphology . . . . . . . . . . . . . . . . . 172
6.3.3 Effect of Ascorbic Acid + Proline treatment on constructs pre-
pared on stiffest gel formulation . . . . . . . . . . . . . . . . . 172
Contents vi
6.3.3.1 Tensile strength and collagen content . . . . . . . . . 172
6.3.3.2 Construct morphology . . . . . . . . . . . . . . . . . 173
6.3.3.3 Confocal microscopy . . . . . . . . . . . . . . . . . . 176
6.3.3.4 RT-PCR detection of transcripted mRNAs . . . . . . 176
6.3.3.5 Interface mechanical strength . . . . . . . . . . . . . 178
6.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
6.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
7 Influence of cell properties on sinew formation 187
7.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 187
7.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 189
7.2.1 Construct preparation . . . . . . . . . . . . . . . . . . . . . . 189
7.2.1.1 Varying passage number . . . . . . . . . . . . . . . . 189
7.2.1.2 Cell seeding density . . . . . . . . . . . . . . . . . . 189
7.2.1.3 Cell type for construct formation . . . . . . . . . . . 190
7.2.2 Supplementation . . . . . . . . . . . . . . . . . . . . . . . . . 190
7.2.2.1 Determining effect of ascorbic acid + proline on con-
structs seeded with rat tail tendon fibroblasts . . . . 190
7.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190
7.3.1 Effect of passage number on rates and extent of fibrin gel con-
traction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 190
7.3.2 Effect of cell seeding density on fibrin contraction . . . . . . . 192
7.3.3 Suitability of different cell sources for TE L/T . . . . . . . . . 197
7.3.4 Effect of ascorbic acid and proline on contraction of PFB seeded
constructs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201
7.3.5 Effect of ascorbic acid + proline on chick and rat fibroblast cell
proliferation . . . . . . . . . . . . . . . . . . . . . . . . . . . . 204
7.3.6 Morphology of rat tail PFB cells on fibrin gels . . . . . . . . . 205
7.3.7 Construct collagen content and tensile strength . . . . . . . . 207
7.3.7.1 Comparison of CTF and PFB construct collagen con-
tent . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
7.3.7.2 Comparison of CTF and PFB construct tensile strength208
7.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 210
7.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
8 Conclusions and Future Work 215
8.1 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215
8.2 Recommendations for future work . . . . . . . . . . . . . . . . . . . . 218
8.2.1 Increasing fibrin fibre volume fraction . . . . . . . . . . . . . . 218
8.2.2 Optimising fibrin gel stiffness with AA+P supplementation . . 218
8.2.3 Cross-linking fibrin . . . . . . . . . . . . . . . . . . . . . . . . 220
8.2.4 Quantifying degraded fibrin . . . . . . . . . . . . . . . . . . . 220
Contents vii
8.2.5 Interface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221
8.2.6 Mechanical loading . . . . . . . . . . . . . . . . . . . . . . . . 221
8.2.7 RT-PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221
8.2.8 Studying contraction . . . . . . . . . . . . . . . . . . . . . . . 222
8.2.9 Supplementation . . . . . . . . . . . . . . . . . . . . . . . . . 222
8.2.10 Cell proliferation . . . . . . . . . . . . . . . . . . . . . . . . . 223
A Example calculations 225
A.1 Determining UT/mgF of control gels . . . . . . . . . . . . . . . . . . 225
A.2 Estimating fibrin gel thickness . . . . . . . . . . . . . . . . . . . . . . 226
A.3 Estimating fibrin fibre volume fraction . . . . . . . . . . . . . . . . . 226
A.4 Quantifying collagen from standard curve . . . . . . . . . . . . . . . . 228
B Construct uniformity and anchor parameters 231
B.1 Determining construct length to width (aspect) ratios . . . . . . . . . 232
B.2 Construct anchor area measurements . . . . . . . . . . . . . . . . . . 232
B.3 Ratio of maximum to minimum widths . . . . . . . . . . . . . . . . . 233
B.4 Aspect ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233
B.5 Effect of anchor planar surface area . . . . . . . . . . . . . . . . . . . 235
C Influence of extrinsic factors on fibrin gel contraction 237
C.1 Effect of fibrin reagents and preparation methods . . . . . . . . . . . 238
C.1.1 Fibrin gel contraction . . . . . . . . . . . . . . . . . . . . . . . 238
C.1.2 Rheology of fibrin gels due to FT cycles and UV sterilisation . 239
C.1.2.1 Fibrin gel mechanical response due to FT cycles or
UV sterilisation . . . . . . . . . . . . . . . . . . . . . 239
C.1.2.2 Thrombin . . . . . . . . . . . . . . . . . . . . . . . . 243
C.2 Effect of culture medium type . . . . . . . . . . . . . . . . . . . . . . 243
C.2.1 Fibrin gel contraction . . . . . . . . . . . . . . . . . . . . . . . 245
C.2.1.1 Fibrin percentage gel areas . . . . . . . . . . . . . . 245
C.2.1.2 Maximum and minimum widths . . . . . . . . . . . . 245
C.2.2 Sinew collagen content and mechanical strength . . . . . . . . 245
C.2.3 Rheology of fibrin gels prepared using different media . . . . . 247
C.2.4 DMEM and Ham’s F12 media composition . . . . . . . . . . . 248
C.2.5 Evaluation of media used during chick fibroblast cell culture . 250
C.2.6 Composition of different types of media used for chick fibroblast
cell culture . . . . . . . . . . . . . . . . . . . . . . . . . . . . 251
C.3 Serum sensitivity of CTF cells and effects on fibrin gel contraction . . 251
C.3.0.1 Fibrin percentage gel areas . . . . . . . . . . . . . . 251
C.3.0.2 Maximum and minimum widths . . . . . . . . . . . . 251
C.4 Effect of temperature . . . . . . . . . . . . . . . . . . . . . . . . . . . 254
Contents viii
C.5 Effect of culture duration on construct mechanical strength . . . . . . 254
D Publication 257
D.1 Monitoring Sinew Contraction During Formation of Tissue-Engineered
Fibrin-Based Ligament Constructs . . . . . . . . . . . . . . . . . . . 257
References 270
List of Figures
2.1 Tendon Structure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2.2 Ligament stress strain curve. . . . . . . . . . . . . . . . . . . . . . . . 7
2.3 Zones of the ligament/tendon-bone interface. . . . . . . . . . . . . . . 8
2.4 Anatomy of left knee. . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.5 Tissue Engineering Process . . . . . . . . . . . . . . . . . . . . . . . . 12
2.6 The typical cell cycle. . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.7 Cell migration. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.8 Cell-cell and cell-matrix adhesion complexes. . . . . . . . . . . . . . . 22
2.9 Fibrin fibril formation. . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.10 Collagen synthesis process. . . . . . . . . . . . . . . . . . . . . . . . . 30
3.1 General method for TE L/T construct formation. . . . . . . . . . . . 49
3.2 Quantification of fibrin percentage gel area and max/min widths using
ImageJ. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.3 Hydroxyproline caliberation curve. . . . . . . . . . . . . . . . . . . . 54
3.4 Equipment and sample loading for rheological experiments. . . . . . . 56
3.5 Equipment and sample loading for construct tensile testing. . . . . . 57
3.6 Standard curves used to quantify construct cell proliferation using
calcein-AM. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
3.7 Viability of CTF cells in reagents used for dissociation. . . . . . . . . 61
3.8 Preparation of contraction impeded constructs. . . . . . . . . . . . . 62
3.9 Equipment used for scanning electron microscopy. . . . . . . . . . . . 63
4.1 Images showing contraction of AA/ P/ AA+P supplemented constructs. 72
4.2 Quantification of fibrin gel areas of constructs treated with AA/P or
AA+P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
4.3 Construct maximum and minimum widths . . . . . . . . . . . . . . . 76
4.4 Longitudinal SEM images of control (NT) and AA+P treated sinews. 78
4.5 Cross-sectional electron microscopy images of control (NT) sinews. . . 79
4.6 Cross-sectional electron microscopy images of AA+P treated sinews. . 81
4.7 H&E stained sections of control and AA+P treated constructs. . . . 82
4.8 Control and AA+P sections stained for collagen using Massons Trichrome.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
List of Figures x
4.9 Longitudinal transmission electron micrographs (TEM) of control con-
structs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
4.10 Longitudinal transmission electron micrographs (TEM) of AA+P con-
structs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
4.11 Cross-section TEM images of control (NT) constructs. . . . . . . . . 90
4.12 Cross-section TEM images of AA+P constructs. . . . . . . . . . . . 92
4.13 Contraction images showing effect of varying AA concentration or P
concentration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
4.14 Rate of contraction and widths due to varying AA/P concentrations . 96
4.15 Effect of varying AA/P concentration on collagen content . . . . . . . 97
4.16 Effect of collagen synthesis inhibitor on construct contraction . . . . . 98
4.17 RT-PCR results of mRNAs expressed by Control and AA+P treated
constructs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
4.18 Formation of collagen fibrils as shown by Christiansen et al. (2000). . 103
4.19 Fusion of the tips of collagen fibril to form rings as shown by Graham
et al. (2000). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
4.20 Structures of α-ketoglutaric acid and its analogue DMOG. . . . . . . 106
4.21 Tensioned and free floating constructs. . . . . . . . . . . . . . . . . . 108
5.1 Frequency sweeps of acellular fibrin gels. . . . . . . . . . . . . . . . . 116
5.2 Images of constructs prepared with varying volumes of fibrinogen. . . 118
5.3 Effect of changing fibrinogen volume. . . . . . . . . . . . . . . . . . . 119
5.4 Effect of fibrinogen volume on construct maximum and minimum widths.121
5.5 Effect of varying fibrin volume at a constant thrombin to fibrinogen
ratio (1.25UT/mgF). . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
5.6 Strain sweeps of gels of differing total fibrin volume. . . . . . . . . . . 126
5.7 Frequency sweeps of gels of differing total fibrin volume. . . . . . . . 127
5.8 Effect of varying fibrin gel stiffness whilst maintaining a constant fibrin
volume. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
5.9 Fibrin gel percentage areas of constructs of prepared from fibrin gels
of varying stiffness. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131
5.10 Effect of fibrin gel stiffness on sinew maximum and minimum widths. 133
5.11 Analysis of fibrin fibre diameters. . . . . . . . . . . . . . . . . . . . . 134
5.12 Analysis of fibrin pore sizes. . . . . . . . . . . . . . . . . . . . . . . . 135
5.13 Time sweeps of gels. . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
5.14 Strain stiffening behaviour at low % strain. . . . . . . . . . . . . . . . 138
5.15 Strain sweeps of gels. . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
5.16 Frequency sweeps of gels of varying thrombin to fibrinogen ratios. . . 141
5.17 Frequency sweeps of gels of varying stiffness seeded with cells. . . . . 142
5.18 CTF cell proliferation on contraction inhibited fibrin gels on day 3. . 143
5.19 Proliferation of CTF cells seeded on gels of varying stiffness. . . . . . 144
5.20 Histology of 0.313UT/mgF and control (1.25UT/mgF) constructs. . . 146
List of Figures xi
5.21 Collagen content of constructs. . . . . . . . . . . . . . . . . . . . . . . 147
5.22 Tensile test results. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.23 Young’s Modulus of constructs due to scaffold stiffness. . . . . . . . . 150
5.24 Visualized effect of increasing fibrin volume on diffusion distances. . . 152
5.25 Comparison of percentage fibrin gel areas, maximum and minimum
widths of experimental groups. . . . . . . . . . . . . . . . . . . . . . . 154
6.1 Method for tensile testing construct interface strength. . . . . . . . . 165
6.2 Contraction inhibition using AP and AH in combination. . . . . . . . 166
6.3 Effects of MMP inhibitors on contraction and sinew mechanics. . . . 167
6.4 Images of constructs treated with combinations of ZnSO4, MnSO4 and
AA+P on Day 35. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 168
6.5 Effects of ZnSO4 and MnSO4 on fibrin contraction and construct me-
chanical properties. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 170
6.6 Histological staining of constructs treated with ZnSO4 and MnSO4. . 171
6.7 AA+P supplementation of constructs prepared using the stiffest gel
formulation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 174
6.8 Histological staining of construct cross-sections prepared using the
stiffest gel formulationand treated with AA+P. . . . . . . . . . . . . . 175
6.9 Histological staining of construct long-sections prepared using the stiffest
gel formulation and treated with AA+P. . . . . . . . . . . . . . . . . 177
6.10 Actin staining of constructs treated with AA+P. . . . . . . . . . . . . 178
6.11 RT-PCR results showing mRNA expressions of constructs treated with
AA+P. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
6.12 Interface tensile strength of AA+P treated constructs. . . . . . . . . 180
6.13 Effect of galardin on inhibiting contraction in matrices of differing
stiffness or employing different cell types. . . . . . . . . . . . . . . . . 182
7.1 Images of constructs prepared using cells at differing passage stages. . 191
7.2 Effect of CTF cell passage number on fibrin gel contraction. . . . . . 193
7.3 Effect of CTF cell passage number on sinew maximum and minimum
widths. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 194
7.4 Effect of cell seeding density on fibrin gel contraction. . . . . . . . . . 195
7.5 Contraction of fibrin gels due to cell seeding density. . . . . . . . . . . 196
7.6 Effect of cell seeding density on maximum and minimum widths. . . . 198
7.7 Images showing contraction of fibrin due to different cell types. . . . . 199
7.8 Rate of fibrin contraction dependent on cell type. . . . . . . . . . . . 200
7.9 Maximum and minimum widths of constructs of varying cell type. . . 202
7.10 Contraction of PFB seeded constructs due to AA/P treatment. . . . . 203
7.11 Digestion of fibrin matrix due to AA treatment. . . . . . . . . . . . . 204
7.12 Proliferation of constructs supplemented with AA/P. . . . . . . . . . 205
7.13 Variation in cell proliferation between CTF and PFB cells over 7 days. 206
7.14 Collagen content of constructs due to cell properties. . . . . . . . . . 207
List of Figures xii
7.15 Construct tensile test results. . . . . . . . . . . . . . . . . . . . . . . 209
8.1 Multiple factor comparison of percentage gel areas. . . . . . . . . . . 219
8.2 Effect of fibrin UT:mgF ratio and supplementation on maximizing con-
struct properties. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 220
8.3 Optimizing AA+P concentrations. . . . . . . . . . . . . . . . . . . . . 224
A.1 A CTF construct hydroxyproline caliberation curve. . . . . . . . . . . 229
B.1 Dimensions measured for aspect ratio. . . . . . . . . . . . . . . . . . 232
B.2 Determining anchor surface area at visible plane. . . . . . . . . . . . 233
B.3 Comparison of construct dimensions. . . . . . . . . . . . . . . . . . . 234
B.4 Comparison of average anchor surface areas at visible plane. . . . . . 235
C.1 Effect of fibrinogen powder dissolution time, sterilisation method and
freeze-thaw cycles on fibrin gel contraction. . . . . . . . . . . . . . . . 240
C.2 Rheology of fibrin gels of differing freeze thaw cycles and UV sterili-
sation times. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 242
C.3 Effect of thrombin FT on fibrin gel mechanical strength. . . . . . . . 244
C.4 Effect of medium. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 246
C.5 Effect of medium type on construct collagen content and maximum
loads. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 247
C.6 Effect of medium - mechanical performance of gels. . . . . . . . . . . 248
C.7 Serum type effects on contraction. . . . . . . . . . . . . . . . . . . . . 253
C.8 Effect of temperature fluctuations of fibrin gel mechanics. . . . . . . . 254
C.9 Effect of culture time on construct mechanics. . . . . . . . . . . . . . 255
List of Tables
2.1 Examples of MMPs and some of their substrates. . . . . . . . . . . . 32
3.1 Chick primers used for PCR. . . . . . . . . . . . . . . . . . . . . . . . 66
5.1 Approximate fibrin gel thickness at increasing total volume of reagents
in 35mm petri-dish. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
5.2 Determining UT/mgF from fibrinogen and thrombin volumes. . . . . 114
5.3 Approximate thickness of fibrin gels based on total volume of reagents
in 35mm petri-dish. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122
5.4 G’ of gels of various volumes at different strain percentages. . . . . . 125
5.5 G’ of gels of various volumes at different frequencies. . . . . . . . . . 127
5.6 G’ of gels of varying thrombin to fibrinogen ratio at t=3600s. . . . . . 136
5.7 Estimated fibrin fibre volume fraction in experimental groups. . . . . 155
A.1 mg Fibrinogen in increasing fibrinogen volumes. . . . . . . . . . . . . 227
A.2 mg Fibrinogen in UT/mgF. . . . . . . . . . . . . . . . . . . . . . . . 227
A.3 Fibre volume fractions (φf ) of fibrin gels of increasing fibrinogen vol-
umes or of varying UT/mgF. . . . . . . . . . . . . . . . . . . . . . . . 227
C.1 G’ values at low strain and low frequency. . . . . . . . . . . . . . . . 241
C.2 DMEM and F12 Ham media composition. . . . . . . . . . . . . . . . 249
C.3 Media used during culture of embryonic chick cells. . . . . . . . . . . 250
C.4 Comparison of media used during culture of chick embryo cells. . . . 252





AA+P Ascorbic acid and Proline
ACL Anterior Cruciate Ligament
ASC Adipose derived Stem Cells
β beta
BMP Bone Morphogenic Protein
BMSCs Bone marrrow Mesenchymal Stem Cells
cDNA ccomplementary DNA
CG Collagen-Glycosaminoglycan
CHO Chines Hamster Ovary
CTF Chick Tendon Fibroblasts




DOE Design Of Experiments
ECM ExtraCellular Matrix
EGF Epidermal Growth Factor
EMEM Eagle’s Minimal Essential Medium
ER Endoplasmic Reticulum / Endoplasmic Reticula
ERK Extracellular signal-Regulated Kinases
Abbreviations xvi
ESEM Environmental Scanning Electron Microscope
F Fibre / Fibrils / Fibrillar
FGF Fibroblast Growth Factor
FDA Food and Drug Administration
FT Freeze-Thaw
GAG GlycosAminoGlycan
GDF Growth Differentiation Factor
HA HydroxyApatite
H&E Hematoxylin and Eosin
hESCs human Embryonic Stem Cells
IGF Insulin-like Growth Factor
iPSCs induced Pluripotent Stem Cells
L Ligament(s)
LCL Lateral Collateral Ligament
L/T Ligaments/Tendons
LVR Linear Viscoelastic Region
M Matrix
MAPK Mitogen Activated Protein Kinase
MCDB Molecular Cellular & Developmental Biology
MCL Medial Collateral Ligament
MMPs Matrix MetalloProteinases
mRNA messenger RNA
MSCs Mesenchymal Stem Cells
N Nucleus / Nuclei
NT No Treatment / Non-Treated
P Proline











ROS Reactive Oxygen Species
RPMI Roswell Park Memorial Institute
RT-PCR Reverse Transcription–Polymerase Chain Reaction
sDMEM supplemented DMEM
SEM Scanning Electron Microscopy
T Tendon(s)
TE Tissue Engineering or Tissue Engineered
TEM Transmission Electron Microscopy
TGF-β Transforming Growth Factor-Beta
TIMP Tissue Inhibitor of MetalloProteinase
UHMWPE Ultra High Molecular Weight Polyethylene
UV Ultra Violet
V Transport Vesicles




Ligaments and tendons (L/T) are composed of high quantities of collagen, which
provide them with their mechanical strength (Rumian et al., 2007). Fibroblasts are
involved in wound healing where they remodel fibrin and deposit de novo collagen
matrix (Wang et al., 2007). They are also the main cell type found in L/T and
throughout the body. Consequently, the model used in this thesis was developed
from this basis, seeding a fibrin hydrogel scaffold with chick tendon fibroblast cells.
Due to the structural role of collagen and its high quantity in ligaments and tendons,
a natural aim of L/T tissue engineering is to enhance construct collagen content and
thereby mechanical strength. From a clinical perspective, tissue engineered ligaments
and tendons (TE L/T) must be robust enough to handle, be surgically implantable
and be able to withstand mechanical loads imposed on them in vivo (Hutmacher,
2000). Although synthetic scaffolds offer the flexibility of tailorable mechanical prop-
erties, it is advantageous to use a natural scaffold such as fibrin, which could poten-
tially be sourced from the patient thereby reducing the risk of disease transmission
or immune rejection (Ahmed et al., 2008).
Supplementation of TE L/T with ascorbic acid (AA), a cofactor for the enzymes
that synthesize collagen, and proline (P), an amino acid that stabilizes the collagen
molecule resulted in significant increases in collagen compared to those receiving no
treatment (Paxton et al., 2012). However, it was observed that AA+P treatment
also produced sinews that were much smaller in width than non-treated constructs.
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Excessive contraction and rapid depletion of the TE scaffold is generally undesirable
(Sung et al., 2004). Most mammalian cells are adherent, which is why a scaffold is
employed and if it is rapidly degraded the cells lose their support structure leading to
cell apoptosis (Frame and Hu, 1988). Further, the way in which fibroblasts deposit
collagen matrix during wound healing, requires the initial presence of fibrin into which
collagen is deposited (Young and McNaught, 2011). The fibrin is then gradually
remodelled and eventually completely replaced with collagen. Controlling the rates
of contraction and remodelling of the fibrin hydrogel are therefore crucial factors in
enhancing TE L/T collagen content. In addition, L/T vary in their size, shape and
mechanical strength throughout the body (Kannus, 2000). As a result, processes
whereby these parameters can be controlled need to be developed. The ability to
control or stimulate construct collagen content and contraction of the fibrin hydrogel
scaffold could potentially offer a means of predictably producing bespoke tissue.
1.1 Thesis objectives
This thesis has sought to quantify the differences observed between non-treated and
AA+P supplemented constructs during culture and elucidate the mechanism behind
AA+P action on fibrin gel contraction and construct collagen synthesis. The me-
chanical properties of the fibrin hydrogel matrix were also altered to determine the
effects of scaffold stiffness on contraction rates and construct widths.
Factors that may lead to variability and affect construct development were also inves-
tigated such as the effects of cell type, preparation of the fibrin reagents and medium
selection, with a focus on general process improvement.
The aims of each of the results chapters in this thesis are briefly described below:
Chapter 4
This chapter aimed to quantify fibrin gel contraction rates due to supplementation.
Following prolonged contraction, differences in size observed between constructs were
only the widths, therefore construct widths were also quantified. Morphological differ-
ences between control and supplemented constructs were also evaluated using various
techniques.
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Chapter 5
Properties of the fibrin hydrogel were modified to determine their influence on con-
traction. In addition, it was of interest to characterise the fibrin gels used.
Chapter 6
Based on results from previous chapters, this chapter sought to optimize construct
collagen content and widths.
Chapter 7
Quantifiable cell properties and their effects on fibrin gel contraction were evaluated.
It was also of interest to determine if TE L/T sinews could be developed using




2.1 Ligament and tendon structure
Ligaments and tendons (L/T) play a crucial role in holding the body together and
permitting movement. When damage through injury or pathologies arise it can often
be debilitating. L/T impart and guide movement in the vertebral column, in the
limbs such as those used in walking and running to L/T found in the jaw involved in
talking and chewing.
Whilst ligaments are responsible for connecting bone to bone, tendons connect muscle
to bone (Tozer and Duprez, 2005). Although L/T vary in their function, their biolog-
ical structure and composition are fairly similar (Rumian et al., 2007). Tendons act
by transmitting the force from muscles by pulling on the bone to enable movement
(Kannus, 2000). In order to function effectively tendons need to be able to withstand
high tensile uniaxial forces whilst restricting extension (Rumian et al., 2007). On the
other hand, ligaments function to limit excessive or abnormal movement of the joints
(Solomonow, 2004) and therefore must cope with high tensile forces. Depending on
the joint, forces experienced by ligaments may take on various directions (multi-axial)
(Weiss et al., 2002). In addition, L/T are viscoelastic, which allows them to store a
certain amount of energy when deformed permitting them to recoil to their original
position once the load is removed, depending on the time scale of application (Proven-
zano et al., 2001). This capability to withstand high tensile forces, store energy and
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the functional difference between ligaments and tendons are due to variations in their
anatomical location and molecular arrangement in the extracellular matrix (ECM).
The most common cell type found in connective tissues are fibroblasts and they
are responsible for synthesizing ECM proteins such as collagen as well as regula-
tory growth factors involved in maintenance and repair (Calve et al., 2004). Both
ligaments and tendons contain up to 90% collagen in dry weight, elastin as well as
ground substance made up of glycoproteins, proteoglycans and water (Rumian et al.,
2007; Van Eijk et al., 2004). Human tendons contain slightly lower levels of elastin,
approximately 2% (dry weight), whereas in ligaments the elastin content can range
from 5%, 7.3% to up to 47% elastin (dry weight) as in the human anterior cruciate
ligament (ACL), posterior longitudinal ligament (PLL) and ligaments of the spine,
respectively (Kuo et al., 2010). Pyridinoline, a crosslinker present in mature collagen
is also approximately 34% greater in tendons than in ligaments (Kuo et al., 2010).
Collagen fibrils in the tendon are aligned parallel to each other along the axis of the
tendon (Figure 2.1) but in ligaments the fibrils are not uniformly aligned to allow
function in multiple directions (Rumian et al., 2007).
Figure 2.1: Tendon Structure. Collagen fibrils are arranged into fibres and con-
sequently larger bundles that form the tendon. Internal bundles of fibres are sepa-
rated by an endotenon connective tissue and the whole tendon itself is surrounded
by a fibrous sheath or epitenon. From Kannus (2000), with permission.
Water makes up to 65-75% of tendon wet weight and in combination with proteo-
glycans (PGs), they are responsible for lubrication and spacing and thereby permit
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collagen fibrils to glide past each other (Benjamin and Ralphs, 1997). Ligaments
have a higher content of ground substance in comparison to tendons due to greater
shearing actions experienced between fibres.








Figure 2.2: Ligament stress strain curve. Adapted from Woo et al. (2000).
The mechanical attributes of L/T owing to their macromolecular arrangements are
best demonstrated by tensile tests. In experimental studies, ligament and tendon
mechanical response to strain results in non-linear load-extension or stress-strain
curves, which are characterized by three stages (Laurencin and Freeman, 2005). The
first is where stress does not change much in relation to strain; this is known as
the toe region (Figure 2.2). The toe region corresponds to straightening of crimps
that are present in collagen fibres (Laurencin and Freeman, 2005). The crimps are
responsible for absorbing the initial loading during extension in both ligaments and
tendons and they spring back when tissues return to their original position (Franchi
et al., 2010). Following this is the linear region where stress increases with strain
in a linear manner. Damage is characterised by a decline in stress when strain is
applied, after which failure occurs and consequently this is called the failure region
(Laurencin and Freeman, 2005).
The L/T–bone interface or enthesis experiences large stresses and is thus very vulner-
able to injury because there is a change in structure from soft to hard tissue (Clark
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Figure 2.3: Zones of the ligament/tendon-bone interface.
and Stechschulte, 1998). However, this change in structure at the interface is gradu-
ated, a functional design aimed at minimizing excessive stress concentrations at the
region (Benjamin et al., 2006). As a result, injury or failure tends to occur close to
the interface – within the ligament itself or at the bone (Hashimoto et al., 2007).
The interface gradient is made up of four distinct zones, namely, ligament/tendon,
fibrocartilage, mineralized fibrocartilage and bone (Benjamin and McGonagle, 2009;
Thomopoulos et al., 2010). At these regions, the cell types differ in relation to the
material/ ECM synthesis required. Generally, fibroblasts at the soft tissue and fi-
brocartilage zones express collagen type I, whilst chondrocytes at the fibrocartilage
and mineralized fibrocartilage zones express collagen type II and type X, respec-
tively (Thomopoulos et al., 2010). The bone is formed, maintained and repaired by
osteoblastic cells (Mutsuzaki et al., 2004).
At the interface both tensile and compressive loads are experienced and in L/T
fibrocartilage is an adaptation to compressive loads that occur during a change in
direction (Benjamin and Ralphs, 1998). In addition, the thickness of the mineralized
fibrocartilage zone maybe related to the ultimate strength of the L/T (Benjamin
et al., 2006).
2.2 Damage to ligaments and tendons and their
repair
Injuries to ligament and tendon soft-connective tissue are increasingly common, espe-
cially amongst young active people (Adirim and Cheng, 2003). The anterior cruciate
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ligament (ACL) is one of the most commonly injured ligaments during sporting ac-
tivities, occurring at a frequency of 30 ACL injuries out of every 100,000 people in
the UK (NHS-Choices, 2012). A human ACL is about 27–32mm in length (Vunjak-
Novakovic et al., 2004) and as mentioned earlier, its role is to stabilize the knee joint
and it is therefore subject to extreme loads (Rodrigues et al., 2013). Ligaments can
withstand maximum loads of up to 1730N and have a stiffness measure of 182N/mm
(Vunjak-Novakovic et al., 2004). However, pivoting movements that occur during


















Figure 2.4: Anatomy of the left knee. A) Schematic depicting ligaments of the
left knee. B) Human ACL of the left knee, adapted from (Zantop et al., 2006),
with permission.
Ligament characteristics also vary with anatomic location, age and the presence of
disease or injury (Vunjak-Novakovic et al., 2004). The rate of ACL injury is higher in
female athletes than in males, resulting even during non-contact activities and that
females also sustain their injuries at a younger age (Ireland, 1999; Lohmander et al.,
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2004). The cause for the greater occurrence of ligament injuries in females has been
attributed to anatomical, hormonal and problems associated with muscles, nerves
and proprioception (Hewett et al., 2005). Menstrual hormones such as oestrogen and
progesterone are linked to increased risk for ACL damage and have been respectively
shown to enhance and decrease the presence of collagenase, a collagen degrading
enzyme (Slauterbeck et al., 2002). Anatomical factors due to females having larger
’q’ (knee valgus) angles are responsible for putting additional loads on the knee (Ford
et al., 2003).
Natural healing of most L/T follows the phases of wound healing, however, this is
slow and poor due to low cellularity and limited blood supply (Laurencin and Free-
man, 2005). The medial collateral ligament (MCL) is located outside the joint and
able to heal without the need for grafting (Leong et al., 2013). However, ruptured
or torn ACLs are treated surgically using autografts, allografts and xenografts (Chen
et al., 2009). Autografts are taken from the person’s own body – such as the mid-
dle portion of the patellar tendon along with its bony attachments (Bone-Patellar
Tendon-Bone (BPTB) Graft) or two of the four hamstring (gracilis and semitendi-
nosus) tendons (Vunjak-Novakovic et al., 2004). Unfortunately, donor site morbidity
is often reported and long healing times are required due to the invasiveness of the
procedure (Kartus et al., 2001; Yasuda et al., 1995). Allografts from donor patients
are in short supply (Robertson et al., 2006), they usually illicit an immune response
as exact tissue matches are difficult to obtain and there is also the potential to trans-
mit disease (Laurencin and Freeman, 2005). Xenografts from synthetic or natural
polymers or from animals, such as bovine ligaments, have also been employed (Chen
et al., 2009). Rehabilitative exercises are normally recommended immediately after
grafting operations in order to return the range of motion, weight bearing ability and
to improve general knee stability (Kvist, 2004). Stability of the knee is dependent
on several factors such as muscle strength and general proprioceptive ability, con-
sequently, neuromuscular training leads to reduced frequency of ACL injury (Kvist,
2004).
Integration and remodelling of foreign tissue in the body is difficult, especially when
xenografts are used, and there is a high occurrence of graft failure (Ventura et al.,
2010). In females, ACL graft ruptures occur more frequently, with greater laxity
reported after both hamstring and BPTB grafts due to the influence of hormones in
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ligament remodelling (Slauterbeck et al., 2002). Not many long-term post-grafting
studies have been conducted, however, it is claimed that ACL injury, with or with-
out reconstruction, leads to the development of osteoarthritis, with 50% of patients
developing the condition 15 - 20 years after injury (Øiestad et al., 2009).
The achilles tendon is the largest tendon in the body, involved in acceleration and
deceleration movements (Trobisch et al., 2010) such as during jumping, running and
sprinting and can withstand loads in excess of 12.5 times the body weight (Gajhede-
Knudsen et al., 2013). Achilles tendon injuries can make up 90% of reported sporting
injuries (Sharma and Maffulli, 2006) and is mostly seen in men aged above 40 years
(Hess, 2010). Similarly, quadriceps tendon injury and rupture occur 6 to 8 fold more
frequently in men over 60 years of age, normally trying to prevent a fall ((Trobisch
et al., 2010) and is often linked to degenerative conditions such as gout, chronic re-
nal failure and others (Ellanti et al., 2012). Due to the strength of tendon, injuries
due to over-loading result in ruptures at either the musculotendinous junction or to
the osteotendinous junction (Lin et al., 2004). Tendon tears and ruptures are often
treated surgically using sutures (Rawson et al., 2013) although allografts from cadav-
ers as well as bovine xenografts have also been used (Magnussen et al., 2011). 70 -
90 % of athletes are reported to return to their sporting activities after achilles ten-
don surgery, however, 20% require successive operations and around 5% permanently
suspend their sporting careers (Kvist, 1994).
As a result of all these factors, methods that will improve ligament and tendon
healing are being developed. Tissue engineering of ligament and tendons promises to
overcome problems arising due to L/T poor natural healing capacities and the use of
grafts.
2.3 Biological aspects of Tissue Engineering
The demand for engineered tissue is rising steadily due to organ donor shortages and
the population’s increased life expectancy (Atala, 2007). Tissue Engineering (TE),
a multi-disciplinary field which is a part of regenerative medicine, aims to provide a
means to assist in the regeneration of damaged or diseased tissue and organs (Bonas-
sar and Vacanti, 1998). There are several methods by which this can be achieved,
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ideally using autogenic cells from the patient although allogenic and xenogenic sources
can also be used (Ikada, 2006). The basic principle involves removing a small amount
of tissue, expanding the cells in culture and re-implanting them into the site of in-
jury or disease on a supportive scaffold, leading to eventual integration with native
tissue (Fuchs et al., 2001) (Figure 2.5). If the cells are obtained from the patient,
this circumvents problems such as immune response rejection and the transmission
of infections that can occur with allografts and xenografts.
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Figure 2.5: Tissue Engineering Process
The success of TE depends on understanding the roles of various types of cells,
the processes involved in tissue morphogenesis and how cells behave and interact
with each other and their environment (Ikada, 2006; Tuan, 2013). The supportive
scaffold plays a pivotal role in allowing the migration and proliferation of the cells and
guiding the development of the tissue through extracellular matrix deposition and
remodelling processes. As a result, scaffold properties and their design have received
much attention (O’Brien, 2011). In addition, cells are highly specific and the use
of the ’correct’ cells, in combination or cells that can be guided down a particular
lineage, as with mesenchymal stem cells, is crucial in engineering tissues that resemble
native tissue that will lead to functional regeneration (Ge et al., 2005). There should
be an emphasis on ’functional’ as it is important that the tissues and organs not
only appear as found in the body but that the engineered tissues work on a par with
or will lead to function that closely matches local tissue (Breidenbach et al., 2013;
Butler et al., 2008; Guilak et al., 2001). Due to the complexity and numerous factors
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required to engineer functional tissues, which may vary from to tissue to tissue, TE
is frequently subdivided into categories relating to the area of application (Saltzman,
2004; Horch, 2006). In recent years, successful applications have been achieved in
areas such as bone, cartilage, skin (Horch, 2006) and trachea (Gonfiotti et al., 2014)
regeneration.
The following sections will discuss biological aspects relavant to this thesis. Cell
functions and their interactions with the matrix are particularly important in un-
derstanding the formation of tissues and organs and how to this knowledge can be
translated into tissue engineering processes in vitro.
2.3.1 Cells and their function
To understand how cells are involved in the development of tissue and organs their
behaviors in morphogenesis and wound healing are being studied (Ulloa and Briscoe,
2007). Organs and tissue such as the heart, kidneys, liver, ligaments and tendons, to
name a few, all differ in their functions owing to the different properties or special-
ization of their cells and organization of the extracellular matrix. The cell type used
in TE of a specific organ or tissue must therefore match the phenotype and function
required or be able to be induced to such a type (Ikada, 2006). Primary or differen-
tiated cells are adult and specialized in nature and can be taken from living tissue to
be expanded in vitro. The use of primary cells is particularly beneficial in autogenic
engineering of tissues as they can be sourced from the individual, reducing the risk
of rejection and infection (Ikada, 2006). Unfortunately, this is not always productive
as some cell types do not proliferate well ex vivo and some cells de-differentiate as
seen with articular cartilage cells that form fibrocartilage instead of hyaline cartilage
(Polak and Bishop, 2006).
Stem cells have gained much attention due to their potential to form any tissue or
organ (potency) and their ability to self-replicate (Ulloa and Briscoe, 2007). There
are two main types of stem cells, namely, embryonic and adult stem cells. Embry-
onic stem cells are concerned with embryonic and foetal development, whilst adult
stem cells are responsible for growth, maintenance and the regeneration and repair
of damaged or diseased tissue (Jukes et al., 2008). The ability for self-renewal could
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potentially provide large cell stores of undifferentiated cells for use in tissue engineer-
ing (Lanza et al., 2011). Stem cell self-renewal occurs due to the two forms of cell
division, symmetric and asymmetric, that can take place. In symmetric division, a
stem cell will divide to form two daughter cells that are identical, that will remain
either undifferentiated or will both differentiate. Asymmetric division results in one
daughter cell remaining as a stem cell and the other differentiating into a progenitor
cell, which can only divide a limited number of times and is more specific than a stem
cell (Knoblich, 2008). The mechanism for the two forms of division are not yet fully
understood but one theory is that the balance between the two modes is determined
by developmental and environmental signals (Morrison and Kimble, 2006). The po-
tency of a stem cell is also of importance as it determines the number of cell types it
can differentiate into. Current research is largely focused on the use of pluripotent
and multipotent stem cells. Embryonic stem cells are pluripotent and can form all
three germ layers, ectoderm, mesoderm, and endoderm, which lead to the formation
of tissues and organs (Rossi et al., 2010), whereas mesenchymal stem cells (MSCs)
are multipotent and can form multiple tissue types such as cartilage, bone and fat
(Jukes et al., 2008).
According to Nindl Waite and Waite (2007), differences in cell function are due gene
expressions that vary with time and intensity. For example, genome analyses have
identified a 99% similarity between the genome of humans and chimpanzees, however
it is not the number of genes and their similarity that determine the characteristics of
an organism but rather the expression of those genes into mRNAs and proteins and
consequently, this provides a similar explanation for differences between cell types in
one person or organism (Nindl Waite and Waite, 2007).
Cell communication between individual and neighbouring cells is an important aspect
of differentiated cell specialization and in order for cells to function as a unit they
need to be able to proliferate, migrate and attach to each other as well as to their
supporting extracellular matrix (Friedl and Gilmour, 2009). Almost all mammalian
cells are by nature adherent cells that need a surface to attach to and cannot be
in suspension, as is the case with blood cells (Cooper and Hausman, 2000). The
signals received from cell-cell contacts and cell-matrix adhesion result in the expres-
sion of various genes and their translation into mRNA and proteins. This results in
regulatory cascades with feed-back and feed-forward loops.
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2.3.1.1 Cell proliferation
Cell proliferation has briefly been touched upon in the previous section and will
only be shortly expanded on. Most tissues do not contain proliferating cells as fully
differentiated cells do not divide, however, cells needed for tissue repair proliferate
and normally these are stem cells and progenitor cells (Cooper and Hausman, 2000;
Malumbres and Barbacid, 2001). Cell proliferation is an important part of growth;
usually, as tissues expand and increase in size, cell number also increases (Saltzman,
2004). However, cell proliferation must be regulated as excess cell growth leads to
cancers (Evan and Vousden, 2001) and the balance between cell proliferation and cell
death (apoptosis) is achieved by the correct function of the cell cycle (Malumbres
and Barbacid, 2009).
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Figure 2.6: The typical cell cycle. Stages G1, S and G2 can last 16-24 hours,
whilst M may be just an hour or two. There are several checkpoints in the cycle
that monitor availability of nutrients and growth factors as well as the accuracy of
DNA synthesis and replication before mitosis can go ahead (Cooper and Hausman,
2000; Nussbaum et al., 2007).
S is the synthesis stage where DNA is segregated, M is mitosis where DNA is packaged
and chromosomes are split, leading to cell division, G1 is a gap stage between M
and S and G2 is is a gap stage between stages S and M (Tyson and Novak, 2001;
Cooper and Hausman, 2000). For cell division to occur DNA needs to be replicated
and segregation of the sister chromatids needs to occur to result in two genetically
identical daughter cells (Tyson and Novak, 2001). Before DNA can be replicated,
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activation of the DNA synthesis enzymes, a family of protein kinases called cyclin
dependent kinases (Cdk) that produce nucleotides, must happen (Tyson and Novak,
2001; Hyland, 2007). To function or initiate/stop the cell cycle, Cdk forms a complex
with a protein (cyclin), which becomes phosphorylated or dephosphorylated thereby
turning it on or off (Csikász-Nagy et al., 2006). This process occurs in the late stages
of G1. The production of DNA synthesis proteins for cell division depends on the
availability of growth factors and nutrients in the extracellular matrix. Quiescent
cells in G0/G1 require growth factors to enter the growth phase (Brooks, 1976)
and it is only in the G1 stage that cells are sensitive to signals from the ECM
(Hyland, 2007). Growth factor signals are needed until the late G1 phase, which
is called the restriction point. In order for the cycle to progress from early G1 to late
G1, transcription cyclin E must be synthesized and this requires the growth factor
E2F. If this step is inhibited by a protein called Rb (retinoblastoma) binding to
E2F, proliferation does not occur (Harbour and Dean, 2000). Essentially, Rb works
as a arrestor or controller on the proliferation process and proliferation will only
resume if Rb is phosphorylated, causing it to release from E2F (Weinberg, 1995).
Other proteins can inhibit proliferation by directly binding to Cdk and preventing
the enzymatic protein kinase activity. In addition, mitogens or chemical molecules
that lead to signal transduction pathways such as cytokines, hormones or growth
factors can also be involved in mitosis and act as switches that can turn the cycle
from an inactive to active state or vice-versa (Saltzman, 2004). Mitogens activate
protein kinases known as Mitogen Activated Protein Kinases (MAPK) to initiate
the Ras/Raf/MEK/ERK signaling cascade (Chambard et al., 2007). There are four
mammalian MAPK pathways, namely: (i) ERK pathway is activated by cell surface
receptors, (ii) p38, (iii) ERK5 and (iv) JNK are activated by growth factors and stress
(Roberts and Der, 2007) as well as certain mitogens (Zhang and Liu, 2002). Several
studies have shown that ascorbic acid activates the ERK pathway (Park et al., 2005;
Mimori et al., 2007; Temu et al., 2010).
A great challenge in tissue engineering is obtaining the required size and shape of
TE constructs. Amongst other factors, engineering functional tissue and maintain-
ing their size could be achieved by maintaining a balance between the rate of cell
proliferation and apoptosis as well as control of the rates of matrix degradation and
remodelling. This necessitates in-depth knowledge of how cells interact with their
matrix through cell-matrix adhesion complexes.
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2.3.1.2 Cell adhesion
As most mammalian cells are anchorage dependent adhesion to a solid surface or
extracellular matrix is crucial for cell survival (Frame and Hu, 1988). The cell mem-
brane consists of a phospholipid bilayer engulfed by a polysaccharide layer called
glycocalyx, which is ionizable resulting in a net negative charge on the cell surface
(Saltzman, 2004). Tissue culture surfaces such as petri dishes are normally coated
with Poly-L-lysine, whose amine groups are positively charged (Mazia et al., 1975;
Saltzman, 2004). This allows non-specific adhesion of various types of cells to the
solid surface through weakly attractive electrostatic Van der Waals forces (Saltzman,
2004). Cell adhesion plays an important part in tissue engineering and regenera-
tion as the strength of adhesion can affect rates of cell migration, kinetics of cell-cell
attachment or result in resistance to diffusion (Saltzman, 2004).
Cells need to function as a unit and respond to their environment in order to migrate,
grow, proliferate, differentiate and ultimately form, maintain and repair tissue (Al-
berts, 2000). In order to do this they have to be able to communicate with each other
and gain information about their environment. For cell-cell adhesion to occur and
with cells being negatively charged, receptor-ligand interactions are necessary, which
can lead to signal transduction pathways such as described in Section 2.3.1.1. Cell-
cell adhesion can occur through three modes: (i) a cell membrane receptor attaching
to ligands on another cell, (ii) receptor of two cells attached to the same ligand or
(iii) cell surface receptors binding to similar receptors on other cells (Alberts, 2000;
Saltzman, 2004). Similarly, for cell-matrix adhesion, cells are able to interact with
the ECM using cell surface receptors that bind to specific ligands present in the ECM.
In developed tissue, stabilization of cell-cell or cell-matrix contacts are enhanced
through the formation of adhesion junctions, namely, tight, anchoring and communi-
cating cell adhesion junctions (Saltzman, 2004). In tight junctions, cells are tightly
connected to each other, with little or no space between them (Saltzman, 2004). This
allows the cells to act as a protective barrier and gives control over the diffusion of
molecules in and out of the cells, for example by only allowing molecules of a specific
charge or size to pass through (Hartsock and Nelson, 2008). Anchoring junctions
confer mechanical stability and are a result of the associations of intracellular actin
filaments, which connect the cytoskeleton to the membrane i.e. the cell membrane
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and cell surface receptors that form links to ligands on the membrane of a neighbour-
ing cell or the matrix (Saltzman, 2004). Adhesion contacts that consist of several
cells are responsible for contractile and folding movements generated during tissue
morphogenesis and wound healing (Friedl and Gilmour, 2009). The end points of
actin filament bundles present on the cell membrane act as focal adhesion sites that
link the cell to the ECM (Wozniak et al., 2004). Focal adhesion points act as me-
chanical anchors and also transmit signals from the ECM to the cytoskeleton (Ren
et al., 2000).
The cell surface receptors involved in cell-cell adhesion are cadherins, whilst those
responsible for cell-matrix adhesions are integrins (Weber et al., 2011).
Cadherins
Cadherins are transmembrane proteins responsible for cell-cell adhesion that is Ca2+
dependent (Alberts, 2000). These are found in adhesion junctions where they form
linkages with actin filaments in the cell cytoskeleton. Vital to the function of cad-
herins are cytoplasmic proteins called catenins. α, β and γ catenins form complexes
with cadherins, which allows the cadherins to function fully as cell adhesives and
improves cadherin-cadherin affinity (Kemler, 1993; Saltzman, 2004). α-catenins are
responsible for linking cadherins to actin filaments and other transmembrane proteins
(Weis and Nelson, 2006).
Integrins
Cell-matrix adhesion requires the participation of cell surface glycoproteins called
integrins (Berrier and Yamada, 2007). Integrin molecules contain 1-18 α and 1-8
β subunits arranged in different combinations (van der Flier and Sonnenberg, 2001;
Berrier and Yamada, 2007). Many integrins bind to the same ligands on ECM com-
ponents that contain the amino acid sequence Arg-Gly-Asp commonly known as
RGD (Saltzman, 2004). Typical ECM components that have the RGD sequence are
vitronectin, fibronectin and tenascin though on collagen and laminin these are more
obscure (van der Flier and Sonnenberg, 2001). Fibroblasts do not spread on synthetic
polymers that do not contain the RGD sequence (Kourouklis et al., 2014). Integrins
also play a role in cell-cell adhesion such as with non-adherent blood cells (Alberts,
2000). Adhesion of cells to the matrix results in the activation of signaling pathways
that drive cell growth, proliferation, differentiation and apoptosis (Chen et al., 1994).
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Fibroblasts express integrins with subunit arrangement α1β1 and α2β1 that bind to
collagen simultaneously, however, α2β1 has been found to have a greater affinity for
Collagen type I (Heino, 2000). In three dimensional collagen matrices, cells defi-
cient in α1β1 receptors showed decreased growth whereas presence of α2β1 enhanced
the expression of collagen degrading enzymes MMP1- and MMP-13 (Heino, 2000;
White et al., 2004). The two integrins appear to have different roles in how they
relate to the matrix; during wound healing α2β1 expression is upregulated by fibrob-
lasts whilst that of α1β1 is downregulated (Heino, 2000). Endothelial cells proliferate
during wound healing and they possess αV β3 as their most prominent integrin (Hall
et al., 2001). In addition, dermal endothelial cells cultured in fibronectin or fibrin gels
expressed higher mRNA levels of αV β3 than when cultured in collagen gels. As a re-
sult, αV β3 is an integrin implicated in cell-fibrin adhesion. Cell-cell adhesion can also
be mediated by fibrinogen though binding of αIIbβ3 and αXβ1 on fibrinogen motifs
Lys-Gln-Ala-Gly-Asp-Val (KQAGDV) and Gly-Pro-Arg-Pro (GPRP), respectively
(Hynes, 1992).
2.3.1.3 Migration
The movement of cells from one location to another is termed cell migration. This
occurs in response to physical or chemical cues in their environment such as during
wound healing, angiogenesis, immunogenic response and preferred matrix stiffness
(Lo et al., 2000). Migration due to chemical or molecular substances is called chemo-
taxis (Saltzman, 2004). The term durotaxis is given to the migration of cells in
response to the stiffness of the matrix (Lo et al., 2000). Cell-matrix adhesion is an
important part of cell migration and different types of cells prefer matrices of differ-
ing stiffness (Hadjipanayi et al., 2009) as this can affect their function and ability to
mobilize (Reinhart-King et al., 2008). If the matrix is too soft, cells cannot establish
adequate adhesion required for motility and if the matrix is too rigid, strong adhesion
results and cell migration is impaired. Migrating cells can do so independently or in
unison, depending on the cell type, the cytoskeletal arrangement and adhesion to the
ECM.
Cells have a definitive front and rear end or cell polarity (Berrier and Yamada, 2007).
From the main body of the cell, the front end has protruding lamella and several
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lamellipodia extending in the direction of movement (Raftopoulou and Hall, 2004).
The rear end of the cell acts as a retractable tail. To propel the cell, the front
or leading edge lamellipodia detach and extend forward to establish new adhesive
connections, as the new adhesive connections are established, the main body is pulled
forward and the rear end detaches, retracts and adheres to the matrix again at a new
position (Raftopoulou and Hall, 2004) (Figure 2.7).
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Figure 2.7: Cell migration. Migrating cell develops actin cytoskeletal protrusions
(lamellopodia), which extend forward, adhering to the matrix. The rear of the cell
retracts propelling the main body forward as the cell arrives at its new position.
Note: The green colour represents the actin cytoskeletal filaments.
These steps require the assembly, disassembly and reorganisation of the actin cy-
toskeleton as the forward extension of the lamellipodium is due to growth of actin
filaments and attachment/detachment involves controlling cell-matrix adhesive con-
tacts (Ballestrem et al., 2000; Raftopoulou and Hall, 2004).
Fibroblasts have highly organized skeletal structures and adhere strongly to the ECM,
resulting in slow migration rates. In contrast, immune cells need to act rapidly and
consequently have fast amoebic-like migration patterns as they lack highly ordered
cytoskeleton and have weak cell-matrix interactions. Some diseases occur due to the
migration of cells to the wrong place. Rheumatoid arthritis is the result of inflam-
matory cells migrating to the joints and degrading the structures leading to disease.
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Cancer spreading or metastasizing is the migration of tumor cells to neighboring and
distant tissues, which causes secondary tumors.
2.3.1.4 Cell signalling
The development of cell-matrix adhesion contacts is crucial for anchoring the cells and
migration but also for creating signal transduction pathways involved in cell growth,
proliferation and synthesis or degradation of ECM components. Focal adhesion sites
are rich in enzymes such as Focal Adhesion Kinases (FAK), which phosphorylate
or dephosphorylate other proteins, thereby acting as on or off switches for various
processes. Cell-cell as well as cell-matrix adhesion leads to the activation of Ras and
Rho regulated signal transduction pathways. The signalling molecules Ras and Rho
belong to the GTPase superfamily. Rho determines, focal adhesion and actin stress
fibre formation (Saltzman, 2004), gene transcription, cell cycle regulation and apop-
tosis (Moon and Zheng, 2003). Ras is also involved in mitogenesis and cyctoskeletal
rearrangement as well as vesicle traffic and nuclear transport (Macara et al., 1996).
Myofibroblasts have a specialised contractile function useful in remodelling and con-
tracting granular tissue during wound healing. The expression of alpha-smooth mus-
cle actin, required to generate contractile forces and their expression of Collagen Type
I is regulated by TGF-β1, a growth factor cytokine (Tomasek et al., 2002; Wang et al.,
2007). Contractile function of myofibrasts can be short-lived or sustained. The short-
lived pathway is Ca2+ dependent whereas sustained contraction, which appears to be
the main pathway, is led by the Rho kinase activity (Tomasek et al., 2002). Tension
in the ECM as well as RhoA dependent/mediated cell cytoskeletal tension have been
shown to lead to greater expression of the ECM protein Tenascin-C, suggesting that
mechanical tension is necessary for ligament and tendon repair (Sarasa-Renedo and
Chiquet, 2005; Wang et al., 2007).
2.3.2 Tissue morphogenesis and wound healing
“Morphogenesis is the process by which a population of cells rearranges into the
distinctive shape and form of a tissue” (Nelson, 2009). Most tissues such as the
heart, liver and kidneys are complex in nature and comprised of more than one
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Figure 2.8: Cell-cell and cell-matrix adhesion complexes. The interactions ini-
tiate signal transduction pathways that result in cell proliferation, migration or
stress fibre generation. Image from (Weber et al., 2011), used with permission.
cell type, necessary for tissue development, homeostasis and repair capabilities. For
example, the liver tissue is a complex three dimensional arrangement of liver hepatic
cells, vascularisation system and bile canaliculi and ducts. One of the challenges
in tissue engineering the liver has been that primary hepatocytes do not proliferate
well and rapidly deteriorate in function when in vitro (Hammond et al., 2006). It
has been found that co-culturing hepatocytes with 3T3 fibroblasts leads to increased
proliferation and maintained hepatic function (Bhandari et al., 2001; Lu et al., 2005;
Seo et al., 2006; Stevens et al., 2013). Since cell-cell communication is vital for
determining correct tissue morphology and consequently function, studies including
more than one cell type in co-culture are required to understand the formation of
complex three dimensional tissue and how to engineer them (Hendriks et al., 2007;
Stevens et al., 2013). Aggregate formation is a tool that with further development will
allow for better understanding of tissue formation including cell-cell communication
(Saltzman, 2004). Some intermingling cell aggregates made up of two or more cell
types sort or rearrange themselves into distinct layers or regions. This phenomena is
akin to that seen in immiscible liquids, where the liquids separate out into phases due
to differences in surface tension (Lecuit and Lenne, 2007). Cell sorting is slightly more
complicated than immiscible liquids as rearrangement depends not only on cell surface
tension or adhesion molecules but also cell shape (Lecuit and Lenne, 2007; Nelson,
2009). In addition, formation into tissue/organs depends on the (bio)chemical cues or
morphogens being present as well as signals from the ECM, particularly the geometry
surrounding the cells and mechanical tensile and compressive forces (Nelson, 2009).
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When a cut or trauma that causes disruption and exposure of the tissue or organ
contents occurs, the wound healing process initiates in order to repair the injured site.
Many aspects of wound healing are being studied in order to mimic the processes
and use them as models in tissue engineering and regeneration. During the wound
healing process, cells migrate to the injured location resulting in cell proliferation,
formation of new blood vessels, the deposition of new ECM, formation of scar tissue
and its remodelling (Enoch and Leaper, 2008). These processes are regulated by
cytokine and growth factor signalling proteins, matrix metalloproteinases (MMPs)
and tissue inhibitors of metalloproteinases (TIMPs) and the presence of platelets
and inflammation cells (Enoch and Leaper, 2008).
The first stage in wound healing is to minimize loss of blood or haemostasis by
constricting blood vessels and arteries and forming a clot to plug the wound. Clot
formation is achieved through three possible mechanisms: (i) damage to the endothe-
lial exposes inner tissue cells to blood, leading to a cascade activation of factor X
which converts pro-thrombin to thrombin causing fibrinogen to be polymerized to a
fibrin clot, (ii) an extrinsic pathway where factor VII is activated eventually result-
ing in thrombin activation and (iii) activated platelets clump together attaching to
collagen to form a clump, which is strengthened by platelet myosin and actin fibres,
the von Willebrand factor and the formation of fibrin (Young and McNaught, 2011).
Inflammation is the second stage and its occurrence is usually undesirable as it sug-
gests the presence of an infection. If bacteria or debris are present at the wound,
neutrophil and macrophage inflammatory cells migrate to the site in response to sig-
nalling chemokines to ’fight’ the infection by engulfing the foreign contaminant or
releasing toxins to destroy it until the infection is cleared (van Blitterswijk, 2008).
Macrophages contain large stores of TGFβ and Epidermal Growth Factor (EGF)
required for angiogenesis, which are necessary for nutrient transport to the site of
repair. At later stages of inflammation, T-lymphocytes locate to the wound and
are responsible for regulating the production of an extracellular matrix scaffold and
remodelling of collagen (Young and McNaught, 2011). Platelets express Vascular
Endothelial Growth Factor (VEGF) and angiogenesis begins once haemostasis and
inflammatory are stabillized (Young and McNaught, 2011). Expression of Platelet
Derived Growth Factor (PDGF), Epidermal Growth Factor (EGF), TGF-β and Fi-
broblast Growth Factor (FGF) results in fibroblasts migrating and proliferating into
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the wound to synthesize extracellular proteins such as fibronectin, collagen and pro-
teoglycans (Enoch and Leaper, 2008).
The final stage of wound healing is remodelling. The new ECM is organized and scar
tissue is removed.
2.3.2.1 The Extracellular Matrix
As mentioned in previous sections of this thesis, the ECM is the three dimensional
space that surrounds cells in a tissue or organ and functions as an adhesive and sup-
portive structure. Thus far, the ECM has been referred to without going into detail
regarding its composition. The ECM is made up of proteins, glycosaminoglycans
(GAGs) and proteoglycans that provide mechanical strength as well as offering cues
required for differentiation, migration, growth, proliferation and gene expression of
certain functional proteins (Juliano and Haskill, 1993). As a result, the ECM is con-
stantly undergoing change, responding to environmental stimulus such as mechanical
loading and hypoxia (van Blitterswijk, 2008). Fibroblast connective tissue cells and
their specialized subfamilies of chondrocyte and osteoblasts are responsible for secret-
ing ECM molecules and proteins in the form of pre-cursors (pro-α-chains) (Ivanova
and Krivchenko, 2012). Composition, concentration and spatial arrangement of ECM
components varies between tissue and organ types, determining its function (Alberts,
2000). Soft connective tissue are high in structural fibrillar proteins such as collagen
types I and II, cartilage obtains its shock absorbing properties from high concentra-
tions of hyaluronan and proteoglycan aggrecans and the rigidity of bone is a function
of calcium phosphate present in the fibrillar collagen matrix (Watt and Huck, 2013).
GAGs are linear polysaccharide chains, which are usually highly sulfated and nega-
tively charged (Rudd et al., 2010). Sulfated GAGs include chondroitins, dermatan
and keratans whereas heparan, a basement membrane GAG and hyaluronan are un-
sulfated (Gandhi and Mancera, 2008). GAGs have extensive interaction with proteins
such as growth factors, chemokines and cytokines (Taylor and Gallo, 2006) and the
GAG long chains shield the proteins from proteolysis (Antonio and Iozzo, 2001).
Connective tissues have high quantities of hyaluronan (hyaluronic acid), which aids
cell migration and proliferation and maintains tissue hydration (Kogan et al., 2007).
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The long chains are not very flexible though highly soluble in water and assume con-
formations that can trap large volumes of aqueous medium to form hydrated gels,
a property that gives cartilage its resistance to compressive stress (Saltzman, 2004).
Apart from cartilage, synovial fluid also has a significant hyaluronic acid content to
lubricate the joints (Kogan et al., 2007).
Proteoglycans are GAGs that are covalently bonded to a protein and as with GAGs,
proteoglycans offer a platform for signal transduction and provide additional struc-
tural support to tissues (Linhardt and Toida, 2004). Aggrecan, versican, neurocan
and brevican known as lecticans are members of the chondroitin sulfate proteoglycan
family that offer resilience to compressive force (Yamaguchi, 2000). Other small-
proteoglycans whose proteins have leucine-rich repeat structures (SLRPs), form u-
shaped structures suitable for protein-protein interactions (Kresse and Schönherr,
2001). Members of the SLRP family are decorin, biglycan, bromodulin, lumican, and
keratoca. Decorin is present in connective tissue and along with other SLRPs, con-
tributes to collagen fibril assembly and its regulation (Kresse and Schönherr, 2001).
A study by Matuszewski et al. (2012) with the human supraspinatus tendon, located
in the upper back, showed that aggregan and biglycan distribution varied throughout
the tendon with highest concentration being in the anterior and posterior regions that
experience higher compressive stress and are prone to injury; decorin concentration
was high throughout the tendon as expected in areas of high tensile strength. Pro-
teoglycans that contain heparan sulfate play a crucial role in cell growth as growth
factors and signalling receptors have a high affinity for heparan sulfate and form
complexes with it (Saltzman, 2004).
Fibronectin, a glycoprotein, is the second most prevalent protein found in the ECM
next to collagen that has RGD ligands, which are important in integrin mediated
cell adhesion. It is found in fibrous connective tissue and basement membranes
(Yamada and Kleinman, 1992). The fibronectin molecule is dimeric, consisting of
two polypetides joined together by a disulfide bond at the carboxyl termin and folded
into several globular domains. These globular domains allow fibronectin to form
simultaneous attachments to collagen, other ECM components and cells (Singh et al.,
2010; Kadler et al., 2008). Apart from RGD, fibronectin also has a secondary binding
region to which neural and lymphocytes can adhere but not fibroblasts (Saltzman,
2004).
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Elastin is a nonglycosylated protein that provides elasticity and resilience to tissues,
especially those subject to repeated stretching (Mithieux and Weiss, 2005; Saltzman,
2004). Water is paramount for elastin function as elastin is only elastic when hy-
drated (Debelle and Tamburro, 1999). Elastin content in ligaments is low, except
for ligaments found in the cervical column and intervertebrally (Culav et al., 1999).
Tenascin is a glycoprotein whose expression increases during embryonic development
(Chiquet-Ehrismann et al., 1986) and the initial inflammation stages during wound
healing (Midwood and Orend, 2009). Tenascin is also an elastic protein and is seen
in tendons as tenascin-C, regarded as a general tendon marker, which is expressed in
response to mechanical stress. Fibronectin adhesion properties have been shown to
be affected by tenascin, resulting in cell shape changes and consequently detachment
from the ECM or inability to attach to the ECM (Chiquet-Ehrismann et al., 1988).
Mehr et al. (2000) suggest that tenascin expression in tendons is a cellular adapta-
tion to compression requirements. Thrombospondin is a gylcoprotein released from
platelets that interacts with fibronectin and has a role in cell growth. During wound
healing, thrombospondin-1 is expressed and Crawford et al. (1998) have shown that
thrombospondin-1 leads to activation of TGF-β1 in vivo.
Other noteworthy proteins of the ECM are laminin and vitronectin. The ability of
basement membranes to hold cells and tissues together is largely attributed to their
high content of laminin. In embryonic development, laminin is crucial for vascular
development and maintenance (van Blitterswijk, 2008) and allows interaction between
plasma membrane cells and the basement membrane (Aumailley, 2013). Vitronectin
is found in blood and the ECM where it is usually associated with fibronectin. Many
cell types are able to adhere to vitronectin and its name reflects its ability to bind to
cells as well as glass beads (Hayman et al., 1983). Vitronectin is very susceptible to
protease degradation and enzymes present during wound healing such as thrombin,
elastase and plasmin, which have been shown to cleave vitronectin (Schvartz et al.,
1999).
2.3.2.2 Fibrin
Fibrin is a major component of blood clots that acts as a plug and matrix to which
cells can attach during wound healing (see section 2.3.2 on wound healing). Fibrin is
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formed through thrombin mediated cleavage of fibrinogen. Fibrinogen is a glycopro-
tein composed of two Aα-Bβ-γ chains linked together by disulfide bonds (Mosesson,
2005). A and B are cleaved off the Aα-Bβ-γ chains, located in the middle of the
fibrinogen molecule, by the enzyme thrombin. Fibrinopeptides A are cleaved more
readily than fibrinopeptides B. Cleavage of A and B fibrinopeptides exposes knobs A
and B that fit into complementary holes ’a’ and ’b’ located on the γ chains (Janmey
et al., 2009b). As proposed by Ferry (1952), joining of the protofibrils at A-a is im-
portant in creating a half-staggered arrangement whereas B-b interactions promote












Figure 2.9: Fibrin fibril formation. Thrombin cleaves fibrinopeptides A & B to
produce staggered fibrils with lateral connections. Adapted from Janmey et al.
(2009a).
The resulting fibrin monomers lengthen and form double stranded fibrin protofibrils,
which aggregate to form fibrin fibrils. Limits to fibrin fibril diameters formed via
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lateral connections are due to the increasing amounts of energy required to stretch
and link A-a and B-b interactions of the twisted double stranded protofibrils as the
diameter increases (Janmey et al., 2009b). When thick fibrils cannot be formed,
thinner fibrils ensue with a greater degree of branching. Branching is important
for forming a gel network and the extent of branching varies and depends on several
factors, three being the concentrations of thrombin, fibrinogen and the pH (Mosesson,
2005). Low levels of thrombin result in thicker fibres with larger pores and high
thrombin volumes lead to small diameter fibrin fibres (Standeven et al., 2005; Janmey
et al., 2009a).
Fibrin is known to be viscoelastic, possessing both elastic and viscous properties and
the mechanical properties of fibrin can also be influenced by the diameters of the
fibres, quantity of branching and fibrin concentration (Standeven et al., 2005). In
vivo, an enzyme, transglutaminase (Factor XIIIa), covalently crosslinks the γ chains
to stabilize fibrin and reduce sensitivity to proteolysis (Ahmed et al., 2008). Plasmin
inhibitors are cross-linked together with fibrin and simultaneously the generation of
fibrin activates the the fibrinolytic system, creating a balance between fibrin forma-
tion and degradation, however, only fibrin and not fibrinogen initiates enzymatic
digestion, a mechanism that localizes the process (Standeven et al., 2005).
2.3.2.3 Collagen
Collagen is the most abundant protein found in the body. There are over 20 different
types, which play different roles - varying in size, function and distribution. Collagen
types span several groups, including fibril forming (I, II, XI), fibril associated (IX,
XII, XIV), transmembrane (XIII, XVII), network forming (VI, VII, X), anchoring,
basement membrane (IV) and unique function collagens although most types fall in
the fibril forming category (Gelse et al., 2003).
In connective tissue such as ligaments and tendons, Collagen I is most prevalent,
constituting up to 90%, respectively, and will be focused on here. Collagen type I
is a structural protein with a triple helical conformation made up of two α1 chains
and one α2 chain, that offers load bearing tissue sufficient mechanical strength to
withstand unixial and multiaxial loads (Gelse et al., 2003). The folding of the triple
helix is due to glycine (Gly) recurring as third residue in the Gly-X-Y amino acid
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sequence, where X and Y are most commonly the amino acids proline and hydrox-
yproline, to give Gly-Pro-Hyp (Ramshaw et al., 1998). It is the close packing of the
three stands, hydrogen bonding and the high concentration of amino acids proline
and hydroxyproline stabilizes the triple helix (Ramshaw et al., 1998). Gly is hidden
in the centre of the structure whereas residues X and Y are highly exposed, giving
the amino acid sequence both structural integrity and allowing for intermolecular
interactions (Ramshaw et al., 1998). The amino acids proline and 4-hydroxyproline
are also referred to as imino acids (Ramshaw et al., 1998; Wu et al., 2011) as they
have one hydrogen atom attached to the nitrogen atom and when this is in use, there
are no free hydrogen atoms available for hydrogen bonding. As a result, the presence
of proline/hydroxyproline in the collagen molecule provides the twists and turns re-
quired to form the helical conformation for stability. When X and Y residues are not
imino acids, they allow collagen fibril formation through attachment to other colla-
gen molecules, integrins or ECM molecules (Brodsky and Ramshaw, 1997; Ramshaw
et al., 1998). It has been determined that hydroxyproline has a greater stabilizing
role than proline due to its ability to trap water through a water network with a
Gly residue in the same sequence or a Hyp in an adjacent one and this is depen-
dent on Hyp always being present in the Y position (Brodsky and Ramshaw, 1997;
Bhattacharjee and Bansal, 2005). Further stabilization of the collagen triple helix is
achieved through binding of individual helices (tropocollagens) into collagen fibrils
(Bhattacharjee and Bansal, 2005). These fibrils can also join to form bundles and
cross-link for enhanced stability (Bhattacharjee and Bansal, 2005).
Synthesis of collagen happens in stages, intracellularly and extracellularly and begins
with collagen gene transcription, which depends on the cell types and is instigated by
several growth factors and cytokines. In bone, TGFβ and insulin-like-growth factors
are responsible but in other tissues FGFs are more important (Gelse et al., 2003).
Once transcription has occurred, the mRNA containing a signal recognition domain,
enters the cytoplasm where it is recognised by a signaling molecule on the endoplas-
mic reticulum and is translated to preprocollagen. After removal of the signal protein,
preprocollagen becomes procollagen through further post-translational steps: (i) hy-
droxylation of the proline and lysine domains happens and is catalysed by enzymes
prolyl 3-hydroxylase, prolyl 4-hydroxylase, and lysyl hydroxylase, whose function re-
quires ferrous ions, 2-oxoglutarate (α-ketoglutarate), molecular oxygen and ascorbate
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Figure 2.10: Collagen synthesis process. Synthesis begins intracellularly and
assembly into fibrils and fibres occurs within the ECM. Image from (McKleroy
et al., 2013).
as cofactors and (ii) glycosylation through the addition of glucosyl- and galactosyl-
to the hydroxylysine (Gelse et al., 2003). Formation and folding of three procollagen
molecules occurs through addition of intermolecular disulfide bonds and is medi-
ated by several enzymes, in particular protein disulfide polymerase (PDI) and PPI
(peptidyl-prolyl cis-trans-isomerase) (Schönbrunner and Schmid, 1992). The pro-
collagen triplet is then transferred to the golgi apparatus where it is packaged into
secretory vesicles. Outside the cell, the terminal C and N peptides on the procol-
lagen are cleaved by Zn+2 dependent metalloproteinases, resulting in tropocollagen.
Tropocollagens are only weakly stabilized and at this stage tropocollagens can eas-
ily be modified by other molecules, temperature and ionic strength leading to the
formation of non-cylindrical fibrils (Ottani et al., 2002).
Collagen fibril formation occurs via extracellular self-assembly of tropocollagens. Fib-
rillar collagens such as Collagen type I have a distinctive staggered arrangement of
monomers called a D-period that is about 63-70nm (Gelse et al., 2003), 67nm on av-
erage (Saltzman, 2004; Kadler et al., 1996), and fibril diameter can vary widely from
0 to 500nm to more (Ottani et al., 2001). Fibril stabilization due to cross-links form
when telopeptide lysine residues are hydroxylized by the catalytic enzyme lysyl oxi-
dase, which is copper dependent. Thereafter, subsequent spontaneous cross-links can
occur. The extent of the hydroxylation of these residues varies from tissue to tissue,
Chapter 2. Background 31
complete hydroxylation being seen in cartilage and almost no hydroxylation occuring
in skin (Gelse et al., 2003). Orientation of fibrils in the ECM is closely related to
function and varies between tissues and organs (Ottani et al., 2001). In ligaments
and tendons, fibrils are aligned in parallel and form bundles or fibres. According to
Ottani et al. (2001), the parallel arrangement of fibres correlates with the function of
the tissue being orientation dependent, as seen in tendons, fibre orientation matches
stress direction and loading of tendon fibres at right angles nullifies strength. The
arrangement in ligaments is less parallel than in tendons as they need to respond to
multi-directional forces (Culav et al., 1999).
2.3.2.4 Matrix metalloproteinases
The role of MMPs has briefly been touched upon in section 2.3.2. MMPs are
zinc dependent enzymes involved in maintaining and remodelling the ECM (Ma-
trisian, 1990). Several groups of MMPs have been identified including collagenases,
stromelysin, gelatinases and those located on cell membranes (Tang et al., 2009).
MMPs are usually secreted in inactive forms into the ECM where they are activated
under the correct conditions such as chemical signals or response to cell–cell or cell–
matrix interactions. TIMPs are able to deactivate MMPs into their latent form where
they can reside in the ECM until required. According to Matrisian (1990) both MMP
and TIMP expression can be regulated by growth factors and TGF-β has been shown
to block expression of MMPs and thereby prevent degradation of the ECM. Alterna-
tively, growth factors and cytokines bound within the ECM can be released by the
action of MMPs when required by the cells (McCawley and Matrisian, 2001). The
role of TGF-β has been described in sections 2.3.1.4, 2.3.2 and 2.3.2.1. MMPs impli-
cated in TGF-β release and activation include MMP-2, MMP-3, MMP-9, MMP-13
and MMP-14/ MT1-MMP (Mott and Werb, 2004).
Fibroblasts are the main cell type found in L/T and are responsible for wound healing
as well as the development of diseases of the joints (Wang et al., 2007). Clegg
et al. (2007) investigated differences between healthy and diseased tendon MMP
expression and found that damaged tendons expressed lower levels of MMP-3 than
normal tendons. In addition, ruptured tendons had elevated levels of MMP-1 and
MMP-9 expression and decreased expression of MMP-3 and MMP-7.
Chapter 2. Background 32
Table 2.1: Examples of MMPs and some of their substrates. Adapted from
(McCawley and Matrisian, 2001).
Collagenase Gelatinase Stromelysin Minimal Domain Membrane Type
MMP-1, MMP-8 MMP-2, MMP-9 MMP-3, MMP-10, MMP-7, MMP-26 MMP-14, -15, -16, -17
MMP-13 MMP-11 MMP-24, -25,
 MMP-12, MMP-19
Collagen I, II, Collagen I, IV, V, Fibrin, Fibrinogen, Fibrin, Fibrinogen, Fibrin, Fibrinogen, 
III, VII, X,  VII, X, XI, gelatin, Tenascin, Collagen III, Tenascin Collagen, Gelatin






Tang et al. (2009) found differences in the MMP expression of damaged human ACL
and MCLs sourced from amputees. They found that higher levels of MMPs were
expressed in the damaged ACLs than in MCLs and that type of MMPs and TIMPs
expressed varied with time. Interestingly, MMP-1 expression increased by 276%,
MMP-2 by 429%, MMP-7 by 746% and MMP-14 by 667% in ACLs and were signif-
icantly greater than expressed by MCL cells.
Degradation of fibrin gels due to MMP activity can be prevented by the use of galardin
(GM6001) or aprotinin as was shown by (Ahmed et al., 2007) where chondrogenic cells
expressed MMP-2 and MMP-3 to breakdown fibrin hydrogels. Research on MMPs is
advancing due to their involvement in adhesion, migration and proliferation of cells,
which when not regulated properly result in disease and cancers. Ehrbar et al. (2011)
showed that cell migration is dependent on the stiffness of the scaffold matrix and
MMP activity, as cell migration was prevented by treatment with an MMP inhibitor
(Galardin/ GM6001) on stiff gels.
The use of synthetic MMP inhibitors and TIMPs have been investigated as potential
treatments for disease and cancers. As a result, these inhibitors can also be used
during tissue engineering in vitro in combination with other methods such as tailoring
the mechanical properties of their scaffold in order to control its degradation rates
and guide the formation of tissue.
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2.3.2.5 Hydrogels
Tissue and organ ECM generally contains less than 1% solid matter and is a gel
composed of interconnected fibrils and fibres that provide resistance to tensile stress
and a hydrated network of GAGs supplying resistance to compressive stress (Lutolf
and Hubbell, 2005). The low quantity of solid matter and high water content make
it a hydrogel. According to Peppas et al. (2000), hydrogels are hydrophillic, poly-
meric networks capable of trapping large volumes of water or biological fluids and
may have covalent bonds or physical cross-links such as entanglements or crystal-
lites. Hydrogels can further be classified according to the charges on their building
blocks or based on their physical structure (amorphous, supramolecular or hydrocol-
loidal) (Van Vlierberghe et al., 2011). Physiologically active hydrogels have polymer
complexes can be broken down or exhibit swelling, depending on environmental fac-
tors such as temperature, pH, ionic strength and electromagnetic radiation (Peppas
et al., 2000). Hydrogel scaffold mechanical properties can be tailored by controlling
elasticity, viscoelastic properties, tensile and compressive strength and failure strain
(Drury and Mooney, 2003). Additional crosslinking can further stabilize hydrogel
scaffolds and retard degradation, which can occur through proteolysis, dissolution or
hydrolysis (Drury and Mooney, 2003).
Hydrogels can be either synthetic or naturally derived materials. Synthetic hydrogels
include poyl(ethylene oxide) (PEO), poly(acrylic acid) (PAA)(Drury and Mooney,
2003) as well as composites with PLGs. However, PLGs are hydrophobic and gelling
them with encapsulated cells is difficult and the process tends to be cytotoxic due
the use of UV irradiation during their processing. To overcome this encapsulation
problem, it is possible to first gel the PLA polymer and then seed the cells on top.
This leads to a 2D layer, which does not resemble in vivo conditions. The advantage
of hydrogels is that cells can be encapsulated within the gel to form 3D constructs
(Tibbitt and Anseth, 2009), whose size and shape is mainly limited by nutrient and
waste diffusion requirements. Synthetic hydrogels lack cell adhesive properties and
peptides containing RGD sequence need to be incorporated.
Naturally derived polypeptides can form hydrogels and are employed as TE scaffolds
and vehicles for cell delivery (Hunt and Grover, 2010). Examples of such naturally
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derived hydrogels are agarose, gelatin, alginate used in TE of bone, neural, car-
tilage, adipose and dermal tissue (Kemençe and Bölgen, 2013; Tseng et al., 2013;
Kim et al., 2012); chitosan for its wound healing attributes and preferential adhe-
sion of osteoblasts over fibroblasts (Croisier and Jérôme, 2013; Douglas et al., 2013);
collagen for various tissues due to its ubiquitous presence, elastin for blood vessels
and ligament TE (Daamen et al., 2007) and fibrin as a scaffold for adipose tissue,
bone, cardiac tissue, cartilage, liver, nervous tissue, ocular tissue, skin, tendons, and
ligaments (Ahmed et al., 2008; Paxton et al., 2012). Hydrogels comprised of ECM
biopolymers such as collagen and fibrin can regulate cell adhesion, migration, prolifer-
ation and differentiation better than synthetic polymers (Balakrishnan and Banerjee,
2011). Major drawbacks of natural biopolymer hydrogels are their low mechanical
strength, poor reproducibility due to donor variability and rapid degradation.
2.4 Current ligament and tendon tissue engineer-
ing strategies
The structure of L/T have been described in above sections as were cell processes
and their role in synthesizing the ECM and forming tissue. In recent years, a number
of studies on L/T tissue engineering research have focused on scaffold development,
the use of MSCs and the L/T attachment sites (entheses). Composite or hybrid
scaffolds that aim to improve scaffold mechanical properties, promote growth factor
release and/or enhance cell adhesion and proliferation have been employed by several
researchers (Vaquette et al., 2010; Kuo et al., 2010; Tamayol et al., 2013). The
use of composite materials allows the balancing of scaffold mechanical properties
with biological requirements for cell processes and ultimately tissue formation (van
Blitterswijk, 2008). Electrospun fibres are attractive as spinnable fibres tend to be
fairly robust and alignment of the fibres can be achieved, which can direct tissue
growth (Teh et al., 2013). As collagen is the greatest component of ligaments and
tendons, its use provides cells with a L/T matrix-like environment (Kew et al., 2011).
Embryonic stem cells (ESCs) are highly attractive due to their potential to form any
of the three germ layers and the less mature differentiated cells may offer greater
efficacy for TE applications (Cohen et al., 2010; van Blitterswijk, 2008). Often these
approaches have been used in combination to maximise the potential of optimising
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the engineered L/T. In the following sections, several selections of the individual
strategies used in TE L/T will be outlined.
2.4.1 Growth factors
Several growth factors including but not limited to BMP-12, BMP-13 (Haddad-Weber
et al., 2010; Heisterbach et al., 2012), GDF5 (James et al., 2011; Park et al., 2010),
IGF, FGF, PDGF (Cummings et al., 2012) and TGF-β1 have been used in L/T TE
(Hsu et al., 2010; Steinert et al., 2011; Wang et al., 2012; Leong et al., 2013; Gross
and Hoffmann, 2013).
Sahoo et al. (2010), were the first to show growth factor enhanced mechanical strength
of in vitro TE ligament/tendon constructs. They developed a silk/PLGA electro-
spun scaffold capable of sustained release of the growth factor bFGF for L/T TE,
using BMSCs, which resulted in the enhanced proliferation of cells and expression of
tenogenic proteins collagen I, collagen III, biglycan and fibronectin. In addition, the
mechanical properties of the constructs with bFGF were also greater than the cell
and/or growth factor negative groups. Their design was based on several advantages
and challenges: that MSCs proliferate faster and produce more collagen than liga-
ment fibroblasts; silk degrades slowly and has suitable mechanical properties; PLGA
provides a temporary scaffold, which in combination with silk provided better cell
attachment, proliferation and ECM deposition; and for a stem cell based L/T TE
approach, the scaffold had to provide signalling molecules.
Recombinant human platelet-derived growth factor-BB (rhPDGF-BB) has been shown
to increase ligament and tendon healing through enhanced cell recruitment and pro-
liferation to the injured site as well as greater ECM synthesis (Hee et al., 2012).
Hagerty et al. (2012) investigated the effect of growth factors TGFβ, IGF-1, GDF-7
at varying concentrations and combinations over 7 -10 days. Using fibroblasts isolated
from a human ACL in a fibrin hydrogel matrix, collagen synthesis was enhanced 5.2
fold and the maximum tensile load 5.7 fold when supplemented with TGFβ, IGF-
1, GDF-7 and 200µM ascorbic acid. In contrast, EGF resulted in constructs with
decreased collagen content and consequently lower mechanical load capacity. These
Chapter 2. Background 36
studies emphasise how growth factor expression and requirements differ depending
on cell type and other environmental factors.
A recent demonstration of how gene expression varies depending on cell type or
anatomical origin and cell age is that by Brown et al. (2014). They showed that
supplementation with growth factors to stimulate gene expression could have little
or no effect or even adverse effects unless the cells were at the correct development
stage or originated from a particular location. For example, using mouse embryonic
cells at different stages of growth and taken from either the limbs or trunk, Brown
et al. (2014) observed that expression of scleraxis, collagen type I, tenomodulin and
elastin varied. Attempting to stimulate gene expression with growth factor FGF-4
significantly upregulated collagen type I in limb cells but not cells sourced from the
trunk of the body. In addition, gene regulation by FGF-4 appeared to depend on cell
development stage as not all limb cells upregulated collagen. Conversely, TGF-β2
upregulated scleraxis at all developmental stages regardless of cell anatomical location
(Brown et al., 2014). Their findings were interesting as both FGF-4 (Edom-Vovard
et al., 2002) and TGF-β2 growth factors (Edom-Vovard and Duprez, 2004) have been
implicated in scleraxis expression, the marker for tendons (Schweitzer et al., 2001).
2.4.2 Cell source
Due to the limited potential of adult derived MSCs, Chen et al. (2010) investigated
the use of MSCs derived from hESCs (hESC-MSCs) both in and ex vivo for tendon
tissue engineering. hESC-MSCs seeded on a knitted silk-collagen scaffold differenti-
ated into a tenogenic lineage upon dynamic mechanical loading and expressed tendon
related gene markers for collagen type I, collagen type III and scleraxis as well as cell
adhesion markers for integrins α1, α2 and β1 and myosin stress fibres.
Adipose derived stem cells (ASCs) have been explored as an alternative to MSCs or
bone-marrow stem cells, for L/T TE by several researchers due to their multipotency
and proliferative efficiency (Eagan et al., 2012; Little et al., 2010; James et al., 2011;
Park et al., 2010; Uysal et al., 2012). The study by Uysal et al. (2012) treating a
severed rabbit achilles tendon using ASCs and platelet-rich-plasma (PRP) revealed a
doubling in tensile strength and 70% increase in collagen quantity of the treated group
in comparison to the ASC cell negative control group. They evaluated the presence
Chapter 2. Background 37
of TGFβ-1,-2,-3, VEGF and FGF growth factors and found high levels of FGF and
VEGF and collagen type I in the ASC treatment group, however, TGFβ-1,-2,-3 were
significantly lower than with the control.
2.4.3 Interface
The L/T–bone interface is the location of high stress concentration and although
the transitional zones allow the gradual transmission of loads from L/T to bone,
the site is frequently injured during sporting activities or is afflicted by disease (Ho
et al., 2010). The current challenge in tissue engineering the L/T–bone interface is
reproducing the gradation, which does not regenerate following graft therapy and is
the site prone to failure post-surgery (Thomopoulos et al., 2010).
MSCs with high viral-mediated expression of smad8ca and BMP-2 were investigated
for their potential to spontaneously form interfaces in subcutaneous and intramus-
cular sites of mouse (Shahab-Osterloh et al., 2010). The researchers found that
intramuscular murine MSC implantation resulted in the formation of bony tissue
with tenogenic-like and cartilage-like insertions; human MSCs however, formed bony
structures but not the interface and from their observations TGF-β and FGF showed
greater efficacy in hMSCs chondrogenic expression than BMP-2 (Shahab-Osterloh
et al., 2010). Other researchers have investigated the co-culture of osteoblast and
fibroblast cells or tri-culture with MSCs, for the formation of the enthesis and some
studies have included mechanical loading and/or growth factor treatments such as
BMP-2 or TGF-β (He et al., 2012; Sahoo, 2011).
2.4.3.1 Use of bone mimetics
Up to 65% of bone tissue is composed of carbonated hydroxyapatite the rest being
mainly collagen and water (Vallet-Regi and González-Calbet, 2004). Osteoblasts and
osteoclasts are the main cell type present, responsible for synthesis and remodelling
of bone, respectively. Hydroxyapatite (HA) cements show good biocompatibility and
are frequently used in bone tissue engineering (Paxton et al., 2008). However, the
resorption of the scaffold and integration with native tissue are also important factors
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for bone mimetics (Hutmacher, 2000). Brushite is synthesised at a lower pH than
HA and is more readily resorbed by the body at a pH of 7.4 (Klammert et al., 2010).
Tissue engineered bone–L/T–bone constructs show great promise in forming soft
tissues with an intact interface. Ma et al. (2011) developed a three-dimensional
bone–ligament–bone construct consisting of tissue engineered bone and ligament-like
tissue produced by BMSCs. When these constructs were placed side by side, they
fused together to form constructs that were broader in dimension, which were then
implanted into a sheep as an ACL graft. After 6 months in vivo, the ligament-like
structure had a defined interface, resembled the native ACL in morphology and with
closely matching tensile strength (Ma et al., 2011).
Using a similar bone-ligament-bone model to Ma et al. (2011), Paxton et al. (2008) de-
veloped bone mimetic anchors from RGD functionalised Poly(ethylene glycol) (PEG)
hydrogels containing HA and found that the PEG HA and PEG HA RGD gels signifi-
cantly promoted PFB cell proliferation and the anchors remained attached for longer
than anchors that did not contain HA and that attachment duration was dependent
on HA concentration. Following this work, (Paxton et al., 2010a) went on further to
develop brushite cement anchors where they found that brushite cement composition
and anchor shape were factors that determined duration of interface attachment and
strength.
2.4.4 Mechanical loading
Mechanical loading has been shown to increase fibroblast cell alignment and stimulate
collagen production by cells (Riehl et al., 2012; Xu et al., 2014). Aligned silk fibroin
hybrid scaffolds coupled with dynamic loading increased rabbit BMSC cell prolifera-
tion, collagen synthesis and resulted in greater expression of ligament/tendon related
proteins such as collagen type I and tenascin-C in comparison to statically cultured
construct with aligned and random fibres or dynamic cultured random fibre con-
structs (Teh et al., 2013). Similarly Subramony et al. (2013) investigated the effects
of a poly(lactide-co-glycolide) scaffold fibre alignment with or without mechanical
loading on human MSC differentiation into fibroblasts and determined that load-
ing did not increase collagen type I expression although other matrix proteins such
as collagen type III, tenascin-C and fibronectin were upregulated; cell proliferation
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and expression of adhesion integrins was also upregulated in both aligned/ unaligned
constructs by loading.
Collagen synthesis due to mechanical loading has been attributed to the activation
of MAPK pathways (ERK and p38) (Lee et al., 2000), due to increased TGF-β,
which has been shown to increase after exercise (Klein-Nulend et al., 1995; Hayashida
et al., 1999). Paxton et al. (2011) used ERK1/2 expression to optimise cyclic loading
duration and as expected enhanced ERK 1/2 correlated positively with increased
construct collagen type I content. The MAPK signal transduction pathways are also
linked to many other cells processes such as growth, proliferation, gene expression, cell
metabolism and apoptosis (Cowan and Storey, 2003). In the recent study by Brown
et al. (2014) discussed in section 2.4.1, mechanical loading affected tendon progenitor
cells differently depending on their site of origin in the body and development stage
as following mechanical loading, TFG-β2 was down-regulated in both limb and trunk
tendon lineage cells and scleraxis was upregulated in limbs and not axial skeletal cells.
2.4.5 Scaffolds and scaffold design
The scaffold plays a pivotal role in tissue engineering as most mammalian cells are
adherent and will not survive long in floatation. As a result, cells are combined
with a suitable scaffold or matrix to form a construct that facilitates cell adhesion,
migration, growth and differentiation (van Blitterswijk, 2008). Numerous complex
factors need to be considered when selecting a suitable scaffold that depend on the
cell type(s) and function of the engineered tissue. Among these considerations are
scaffold biocompatibility, bioresorptability and its mechanical properties. Biocom-
patible scaffolds allow the adhesion, proliferation and migration of cells and do not
illicit an immune response once implanted in the body; bioresorbable scaffolds will
degrade and allow cell remodelling, ideally at a controlled rate; mechanical properties
of the scaffold should closely match those of native tissue and be robust enough to
withstand implantation and any forces it is subjected to in vivo (Hutmacher, 2000).
One of the main challenges in TE scaffold design is ensuring adequate mechanical
stiffness of the scaffold and that the scaffold will breakdown or is resorbed at a rate
that matches cell de novo ECM synthesis.
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A significant amount of research has been conducted using two dimensional (2D)
scaffolds in vitro. However, it is now apparent that these 2D scaffolds do not accu-
rately represent the natural cell environment. Researchers are now focusing on three
dimensional in vitro studies, which pose challenges in ensuring that the scaffolds pos-
sess the correct porosity and mechanical attributes to allow cell processes to occur
as well as facilitate nutrient mass transport. Mass transfer and tissue development
needs mean that scaffolds have low volume fractions. Increasing the porosity must be
in balance with the overall mechanical strength of solid scaffolds, which is dependent
on the density of the material that constitutes the pore walls or edges (van Blitter-
swijk, 2008). Several methods can be utilized to prepare 3D porous scaffolds such
as gas foaming, phase separation, freeze-drying and porogen leaching (Chen et al.,
2002). Cell invasive fibre scaffolds have the advantage of having high surface areas,
they can be aligned in a specific direction to guide cell growth and generally allow
permeability between fibres. The fibres can by fabricated using non-woven extrusion
methods for micron diameter fibres or electro-spinning for submicron to micron di-
ameter fibres (van Blitterswijk, 2008). Individual fibres can be bundled into larger
scaffolds with greater pore interconnectivity, through braiding and weaving. Other
methods developed or being used to fabricate TE scaffolds and are solid free-form
fabrication, laser and UV based fabrication techniques and 3D printing.
Both synthetic and biological polymers are being investigated for their use as tissue
engineering scaffolds. Common materials include ceramics, polyhydroxyesters and
collagen. In ligament and tendon tissue engineering, the most often used natural
polymers are collagen and silk fibroin.
2.4.5.1 Synthetic
The surface adhesiveness of synthetic polymers determines cell spreading, average
cell height and rate of cell growth (Saltzman, 2004). Most synthetic polymers do not
contain the biological motifs required for cell adhesion and are often functionalised
by coating with RGD peptide containing proteins such as fibronectin, vitronectin
or laminin (Shin et al., 2003). Alternative methods that modify the surface to be
positively charged to allow weak cell adhesion may also be used. Synthetic polymers
can be non-degradable or biodegradable. Biodegradable polymers are generally more
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desirable as they can partake in the healing or regeneration process by permitting
cell infiltration and scaffold remodelling. Common biodegradable synthetic polymers
that are US Food and Drug Administration (FDA) approved are polyesters such as
poly(glycolic acid) (PGA), poly(lactic acid) (PLA) and their copolymer poly[lactic-
co-(glycolic acid)] (PLGA) (Chen et al., 2002). Biodegradable synthetic polymers are
attractive due to the tailorability of their mechanical properties, their reproducibility
porosity, tendency to be functionalised and biodegradability, however, biodegradation
does not suggest complete elimination from the body but rather that the polymer
can be biologically attacked and break into fragments that may or may not persist
(Hutmacher, 2000).
Several synthetic materials have been used to replace ruptured ligaments. Among
these are FDA approved non-degradable synthetic ligaments or ligament augmenters
such as Leeds-Keio Ligament (polyethylene terephthalate), Kennedy Ligament Aug-
mentation Device (polypropylene) and Gore-Tex (Vunjak-Novakovic et al., 2004; Lau-
rencin et al., 1999; Ge et al., 2006). Carbon fibres and silastic sheets have also been
used for the repair of functional tendons (Calve et al., 2004). Advantages of these
are their high strength as they adequately provide the support lacking due to the in-
jured ligament. However, these synthetic replacements fail over time as they cannot
replicate the mechanical complexity of the native tissue. Extension gradually results
in permanent deformation of the prostheses, wear on sharp bone edges at the point
of fixation cause debris that lead to inflammation and poor tissue ingrowth has also
been noted (Vunjak-Novakovic et al., 2004; Laurencin et al., 1999; Ge et al., 2006).
A PLLA twist-braid scaffold with similar stress-strain behaviour to natural ligament
was developed by Freeman et al. (2007) and a composite of the PLLA twist-braided
scaffold with a polyethylene glycol diacrylate (PEGDA) hydrogel, increased scaffold
viscoelastic properties as well as maintaining fibroblast cell proliferation over 4 weeks.
Twisting of fibres is frequently used in the yarn industry to improve fibre tensile
strength and braiding supplies reinforcement for axial loads. Recent work by Bach
et al. (2013) studied the use of acellular twist-braided PVA for use as a prosthetic
device for ACL replacement and determined its viscoelastic nature and ultimate
tensile strength of 2000N to be similar to native ACL. Combining PVA with ultrahigh
molecular weight polyethylene (UHMWPE) further enhanced mechanical strength.
Due to the synthetic nature, this material will not favour natural remodelling and
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interface integration; the authors state that further in vitro and in vivo work will
need to be conducted.
2.4.5.2 Natural
Mammalian tissue from humans, bovine, porcine and equine has been employed as
biological tissue engineering scaffolds (Longo et al., 2012). The tissue is first cleaned
and treated to remove non-collagen cellular components such as DNA and lipids as
these would illicit an immune response leaving a scaffold comprised mainly of collagen
type I. However, the decellularization process can be harsh and lead to damage of
the required ECM (Gilbert et al., 2006; Crapo et al., 2011). Collagen structure
can be compromised by decellularization leading to an ECM with significantly lower
mechanical strength (Badylak et al., 2009). Tischer et al. (2007) demonstrated the
use of decellularized rabbit tendon in maintaining tissue strength and permitting
successful seeding of cells. A review of decellularization methods for orthopeadic
tissue engineering purposes was recently conducted by Cheng et al. (2014) detailing
physical, chemical and enzymatic methods.
An alternative method of using biological polymers is to use enzymes or chemicals to
synthesize the biopolymers in vitro. This method is currently preferred as potentially,
the enzymes/ primary reagents can be isolated from the patient thus eliminating
exogenic transplantation. Cells can then be seeded onto these polymers and secrete
their own ECM components to form tissue that closely resembles that found in the
body. Advantages of using natural ECM polymers include presence of receptors
necessary for cell attachment and that cells are able to remodel and proteolytically
degrade the scaffold (Lutolf and Hubbell, 2005). Challenges of this method are that
the mechanical and biochemical properties of the scaffold must be ideal to provide
the required signals to induce such action within the cells. Biochemical stimulants
are frequently required in combination with tailoring scaffold properties.
Porous collagen-glycosaminoglycan (CG) scaffolds were developed by Caliari et al.
(2011) as an alternative to fibrous electrospun scaffolds for tendon tissue engineering.
The CG scaffolds have a low density, anisotropic core surrounded by a CG membrane
shell with tunable shell elasticity and thickness. Cross-linking and aligning the pore
structure improved tensile mechanical properties and the shell did not limit nutrient
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transport and cell viability was not adversely affected. The rationale behind their
design was that TE scaffolds often require porosities >90%, which result in scaffolds
being too soft for tendon tissue engineering and although mechanical loading can
be used to enhance mechanical properties, they often do not reach those of native
tendon. They stated that composite core-shell designs are found in nature, such
as plant stems that have an osmotic core and shell with suitable tensile, bending
stiffness (Caliari et al., 2011). Further work has shown that increasing anisotropic
density improves cell attachment, expression of tenascin-c and scleraxis, including
decreased cell-mediated contraction of the scaffolds and decreased MMP-1 / -13 ex-
pression (Caliari and Harley, 2011). Use of multiple growth factors and their use in
sequestration rather than as soluble factors maintained tenocyte phenotype and cell
proliferation and other bioactivity, crucial for tissue regeneration (Caliari and Harley,
2013).
2.4.5.3 Use of MMP inhibitors or TIMPs
The use of growth factors for L/T TE has been detailed in section 2.4.1. However,
growth factor use although generally successful has been shown to have limitations
particularly due to variations in inherent cell programming. A current review by
Lo et al. (2014) suggests that since growth factors have the potential to illicit im-
mune response and the high costs associated with their commercial production, the
focus of tissue engineering for musculoskeletal purposes should be on small bioactive
molecules such as MMP inhibitors or TIMPs, in the case of ligament tissue engineer-
ing. The studies by Lui et al. (2013a,b) as cited by Lo et al. (2014) using alendronate
showed great efficacy in promoting ligament healing by reducing MMP-1 and MMP-3
expression.
As mentioned in section 2.3.2.4, Galardin and Aprotinin are two MMP inhibitors that
successfully attenuated fibrin matrix degradation, however, thorough understanding
of which MMPs are up- or downregulated and when, are necessary in order to design
successful MMP inhibition paradigms. MMP expression in natural tissue undergoing
healing showed that MMPs 9 and 13 were upregulated between the first and second
week, whereas MMPs 2, 3 and 14 (MT1-MMP) were upregulated throughout a 4 week
investigative period and as result, the findings suggested that MMP-9 and MMP-13
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were responsible for collagen degradation and MMP-2 -3 and -14 degraded as well as
remodelled the matrix (Yang et al., 2013).
2.5 Opening Remarks
This chapter has highlighted the importance of ligaments and tendons and has re-
ported tissue engineering methods relevant to their regeneration. This thesis has
aimed to build upon current ligament and tendon tissue engineering strategies based
on the function of the supportive fibrin scaffold and the roles of ascorbic acid and
proline in cell collagen synthesis.
Chapter 3
General Methods and Materials
3.1 Cell Culture
3.1.1 Supplemented medium
500mL of DMEM (D6546, Sigma-Aldrich, UK) was supplemented to contain 10% v/v
FBS (A15-105, PAA UK), 2.4% v/v L-Glutamine (G7513, Sigma-Aldrich UK), 2.4%
v/v Hepes Buffer (H0887, Sigma-Aldrich UK) and 1% v/v Penicillin/Streptomycin
(P4333, Sigma-Aldrich UK). This supplemented DMEM is referred to as sDMEM
throughout this thesis and was the standard medium for Chick Tendon Fibroblasts
(CTFs) cells unless stated otherwise. Where DMEM (D5796, Sigma-Aldrich UK)
was used, no L-Glutamine was added.
3.1.2 Supplemented F12 Ham
F12 Ham medium (N4888, Sigma-Aldrich UK) for Rat Tendon Primary Fibrob-
lasts (PFBs) was supplemented with 20% v/v FBS, 1% v/v Antiobiotic/Antimycotic
(ABAM) (A45955, Sigma-Aldrich UK) and 0.5% v/v 1mM L-Glutamine. This was
used for PFB cell culture unless otherwise stated.
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3.1.3 Cell thawing
A 1mL vial of CTFs or PFB cells stored in Liquid Nitrogen at -196◦C was quickly
thawed in a waterbath (JB Aqua 12, Grant Instruments) at 37◦C. The 1mL cell
suspension was transferred to a 50mL tube, to which 9mL of sDMEM was added.
The 10mL cell suspension was pipetted up and down several times before centrifuging
(MSE Mistral 2000) for 3 minutes at 1000rpm. The supernatant was aspirated off
and the cells were resuspended in fresh 10mL of sDMEM. The cell suspension was
then transferred into a T-75cm2 flask for expansion in a humidity controlled incubator
(InCusaFe MCO-15AC, Sanyo) at 5% CO2 and 37
◦C.
3.1.4 Cell culture
Cells in T-75cm2 flasks were cultured until ≈70% confluency and then passaged into
T-175cm2 flasks. The growth medium (sDMEM) was changed every 2 to 3 days. Cells
between passages 2-5 were used for TE L/T or were split before reaching confluency.
3.2 Tissue engineering ligament/tendon
3.2.1 Preparation of stock solutions
3.2.1.1 3.5M Ortho-phosphoric acid with 50mM Citric Acid
Orthophosphoric acid (H3PO4) (Fisher, UK) was supplied as 85% v/v in water, a
concentration of 15.2M. To prepare 100mL of 3.5M acid, 77mL of distilled water
was added to 23.03mL orthophosphoric acid. 96mg of Citric Acid, molecular weight
192g/mol, was added to the acid, to obtain 50mM Citric Acid in 3.5M orthophos-
phoric acid.
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3.2.1.2 Thrombin
1% w/v BSA in F12K was prepared by adding 1mg BSA powder (A9418, Sigma-
Aldrich UK) per mL of Ham’s F12K (Kaighn’s) medium (21127022, Invitrogen UK).
5mL of the BSA/F12K medium was added to each 1000 Units Thrombin (UT)
vial (605157-1KU, Calbiochem UK or BT 1002 a, Enzyme Research Laboratories,
Swansea UK) resulting in a stock of 200UT/mL. Solutions of 200UT/mL were trans-
ferred into Bijou tubes and frozen at -20◦C.
3.2.1.3 Fibrinogen
Fibrinogen solutions were prepared by dissolving 20mg of fibrinogen (F8630 Sigma-
Aldrich UK) per mL of Ham’s F12K (Kaighn’s) medium (21127022, Invitrogen UK)
in a waterbath at 37◦C for a period of 4 hours. The 20mg/mL fibrinogen solution
was gently swirled every hour to ensure dissolution of the fibrinogen powder. There-
after, the fibrinogen was sterile filtered using 0.22µm syringe filters. Alternatively,
fibrinogen was sterilised by leaving under UV light in the laminar flow hoods (BSB,
Gelaire Inc Biomedicals) overnight.
3.2.1.4 Phosphate Buffered Saline solution
Two PBS tablets (P4417, Sigma-Aldrich UK) were dissolved in 400mL of distilled wa-
ter to yield 0.01M phosphate buffer, 0.0027M potassium chloride and 0.137M sodium
chloride. Alternatively, 4 PBS-Dulbecco A tablets (BR0014G, OXOID UK) were dis-
solved in 400mL of distilled water. The PBS solutions were sterilised by autoclaving
at 115◦C for 15 minutes.
3.2.1.5 Ascorbic Acid and Proline solutions
L-ascorbic acid 2-phophate sesquimagnesium salt hydrate (A8960, Sigma-Aldrich
UK) was dissolved in phosphate buffer saline (PBS) by dissolving 0.869g in 12mL of
PBS. The final solution had a concentration of 250mM and was syringe filtered to
sterilise.
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50mM L-Proline solutions were prepared by dissolving 69mg of L-Proline (P5607,
Sigma-Aldrich UK) in 12mL of PBS. The solutions were sterilised by syringe filtering.
3.2.2 Sylgarded petri-dishes/ well plates
Sylgard polymer solution was prepared by mixing the base to catalyst at a ratio of
10:1 (Sylgard 184 Silicone Elastomer Kit, Dow). Approximately 1.5mL of the polymer
solution was added to 35mm diameter petri-dishes or well plates. Where smaller or
large diameter dishes were used, the polymer volume was adjusted accordingly. The
polymer filled dishes/ plates were left to polymerise at room temperature for 3 – 4
days.
3.2.3 Brushite cement anchors
Brushite cement anchors were prepared from a reaction between β-TCP and ortho-
phosphoric acid (Equation 3.1). The paste was prepared using 3.5g β-TCP per 1mL
of ortho-phosphoric acid (Figure 3.1-1). The paste was rapidly mixed on a vibrating
platform and then spread onto anchor molds. Stainless steel minutien pins, 0.20mm
in diameter (Austerlitz) were inserted through the cement paste prior to hardening.
The cement filled molds were left in an incubator (LEEC, UK) at 37◦C to harden
overnight.
Ca3(PO4)2(s) +H3PO4(l) + 6H2O(l) −→ 3CaHPO4 · 2H2O(s) (3.1)
3.2.4 Fibrin hydrogel preparation
200mM 6-Aminohexanoic Acid (AH) (A7260, Sigma Aldrich) and 10mg/mL Apro-
tinin (10981532001, Roche UK) were each added to sDMEM at a volume of 2µL per
mL of sDMEM (Figure 3.1-2). 50µL of 200UT/mL Thrombin were also added per
mL of sDMEM. 500µL of sDMEM containing thrombin, AH and AP was added to
each 35mm petri-dish or well and spread to evenly cover the surface. 200µL of a
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β-Tricalcium phosphate powder ortho-phosphoric acid DMEM + Thrombin + Aprotinin + Aminohexanoic
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Figure 3.1: General method for TE L/T construct formation. 1) Brushite cement
anchor formation. 2) Thrombin, AH and AP are added to sDMEM, of which 500µL
is then evenly spread onto petri-dishes, followed by 200µL fibrinogen. 3) Seeding
at 100,000cells/mL and 4) Cells contract the gel about the anchors and remodel
the matrix.
20mg/mL Fibrinogen solution was then evenly distributed onto each dish/ well and
gently mixed by rotating. The dishes/plates were placed in an incubator at 37◦C and
left to polymerise for 1 hour.
3.2.5 Cell dissociation from flasks
Spent medium was aspirated off and the cells were washed in PBS. Once PBS was
removed, 1mL of TrypLE Select 1X solution (12563-029, Invitrogen UK) was added to
a T-75cm2 flask and incubated for 1-3 minutes at 37◦C. To aid cell detachment from
the flask, the flasks were tapped gently to assist the dissociation process. TrypLE
was deactivated by adding 9mL of sDMEM. Where T-175cm2 flasks were used, 2mL
of TrypLE was added, which was deactivated using 8mL of sDMEM.
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3.2.6 Cell counting
12µL of a cell suspension was loaded onto a haemocytometer and cells in the 5 squares
were counted. The total cell count in the 5 squares was multiplied by 2000 to give
the cell count in 1mL of sDMEM. This was then multiplied by the total volume of
cell suspension present. At least two counts were taken and the average count was
taken.
3.2.6.1 Using Trypan Blue
Trypan Blue stains dead cells a dark blue colour thereby allowing an estimate of
live/dead cells in the suspension (Strober, 2001). 500µL of Trypan Blue was added to
500µL cell suspension in an eppendorf tube and gently pipetted using a 1mL pipette.
12µL of the cell suspension was loaded on a haemocytometer and the number of live
and dead cells was determined as above. (Note: the haemocytometer counts using
the trypan blue method represented the cell density in 500µL of the suspension.
Therefore to obtain the density in 1mL, the count was multiplied by 2 and then by
2000).
3.2.7 Construct formation - cell seeding
Cell suspensions for seeding fibrin gels were prepared at a density of 100,000 cells
per mL of sDMEM (Figure 3.1-3). The cell seeding density of 100,000cells/mL was
obtained by resuspending the total cell count, acquired using the method in section
3.2.6, in an appropriate volume of medium (Equation 3.2). Where the volume of
medium required for resuspension was too great, the cell suspension was concentrated
by a factor, for example by X10 or X100. The cell seeding density was then obtained
by dividing the concentrated suspension by its concentration factor and adding that
volume of cell suspension to acellular sDMEM (Equations 3.3 and 3.4).
Cell seeding density (100,000cells/mL) =
Total cell count
Appropriate volume of medium (mL)
(3.2)
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Conc. cell suspension for seeding =
Total volume of cell suspension required for seeding
Concentration factor
Cell seeding suspension = Volume of medium required + Conc. cell suspension for seeding
(3.3)
For example, to prepare a total volume of 25mL cell suspension for seeding, using a
X10 concentrated cell suspension:




Cell seeding suspension = 22.5mL of medium + 2.5mL conc. cell suspension for seeding
(3.4)
1mL of the cell seeding suspension was then evenly distributed on top of the poly-
merised fibrin hydrogels and left to incubate at 37◦C for 3 days before changing the
medium. Where constructs were supplemented with AA+P, the supplements were
added directly to the cell suspension at 1µL supplement per mL of sDMEM before
seeding.
3.2.8 Changing growth medium
After the initial 3 day incubation, medium was changed every 2 to 3 days. Generally,
6 constructs were set up per group and cultured for a period 5 weeks unless shown
otherwise.
3.3 Contraction Imaging and Quantification
Generally, images of constructs were taken every day for the first 14 days using a
compact digital camera (Canon PowerShot A3100 IS00), under a laminar flow hood.
A black cloth was used as dark backing and the digital camera was mounted on a
metal stand. The cloth, camera and stand were all sprayed with 70% v/v ethanol
prior to placement in a sterilised hood to prevent contamination. Images were taken
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with open petri-dish/ well plate lids and a ruler was placed next to the samples during
imaging for calibration. No flash was used.
ImageJ software (NIH) was used to determine the percentage fibrin gel areas as well
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Figure 3.2: Quantification of fibrin percentage gel area and max/min widths
using ImageJ.
The imaged ruler was used to set the scale in mm. To measure area, the perimeter
around the construct was traced and the software computed the corresponding area
based on the set scale. Anchor surface areas at measured plane were quantified on Day
0 for each construct and subtracted from the computed area so that the measurements
reflected only the area of the fibrin hydrogel. The maximum and minimum widths
were taken as the broadest and narrowest dimension, respectively, perpendicular to
the construct lengths and in-between the anchors.
3.4 Collagen quantification
Generally, the amount of collagen in the constructs was determined using an hydrox-
yproline assay (Acid Hydrolysis Method) modified from Neuman (1950), by Paxton
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et al. (2010b, 2012). As the hydroxyproline assay is destructive, quantification was
generally performed after 5 weeks of TE L/T development.
3.4.1 Preparation of Reagents
3.4.1.1 Aldehyde-perchloric acid reagent
10mL of the reagent was made by dissolving 1.5g of para-dimethylaminobenzaldehyde
in 6mL of iso-propanol, followed by 2.6mL of perchloric acid (70%) and topped up
to the required volume using distilled water.
3.4.1.2 Chloramine-T Solution
141mg of Chloramine-T was dissolved in 10mL distilled water before use and kept
away from bright light.
3.4.1.3 Hydroxyproline Buffer
500mL of the buffer at pH 6.0 – 6.5 were made from a mixture of 4mL acetic acid,
16.6g citric acid, 40g sodium acetate and 11.4g sodium hydroxide in distilled water.
A small amount of toluene (0.25mL) was added as a preservative and the solution
was stored in the dark.
3.4.2 Method
Dry L/T samples were weighed in eppendorfs tubes before being hydrolysed in 200µL
of 6N hydrochloric acid for 3 hours at 130◦C under closed lids in a fume cupboard.
Thereafter the eppendorf lids were opened and liquid was allowed to evaporate off for
30–45 minutes. The resulting dark residue of the samples was then resuspended in
200µL of hydroxyproline buffer. Standards with known quantities were prepared by
dissolving hydroxyproline powder (Sigma Aldrich UK) in hydroxyproline buffer. Each
of the samples was then diluted in hydroxyproline buffer at a ratio of 1:3. 150µL of
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Chloramine-T was added to the diluted samples and the standards. After vortexing,
the samples and standards were left at room temperature for 20 minutes. 150µL
of the aldehyde-perchloric acid reagent was then added to each of the samples and
standards. They were then vortexed and incubated at 60◦C with the eppendorf lids
closed for 15 minutes. The samples and standards were then transferred into clear
96-well plates and the absorbance at 550nm measured using a micro plate reader
(Glomax Multidetection System, Promega). The standards of known hydroxyproline
concentration were used to plot a calibration curve.



























Figure 3.3: Hydroxyproline caliberation curve. This is one of the curves obtained
during collagen quantification experiments in this thesis. A standard curve was
obtained for each experiment conducted.
From Neuman and Logan, hydroxyproline is estimated to constitute 13.4% of the
total collagen present in the tissue. Using this basis, the quantity of collagen present
in the samples as a percentage of the construct dry weight was calculated using the
following equation:





An example calculation is shown in Appendix A.
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3.5 Mechanical Testing
3.5.1 Rheology
Oscillatory dynamic shear tests were conducted on pre-formed gels, which were pre-
pared as described in section 3.2.4. Viscoelastic materials exhibit both viscous (liquid-
like) and elastic (solid-like) behavior described by the equation:
G∗ = G′ + jG′′ (3.6)
G′ is the storage modulus, which describes the elastic part of the equation and is a
measure of the energy stored during deformation and G′′ is the loss modulus, which
represents the viscous part, the energy lost as heat when the material is deformed
(Gunasekaran and Ak, 2000). Materials that behave more like a solid have a G′
greater than G′′ and conversely, the more liquid-like the material, G′′ exceeds G′
(Yan and Pochan, 2010). The stress response of the elastic and viscous parts of a
viscoelastic material respond differently to an applied strain and are out-of-phase
with each other. For an oscillatory sinusoidal strain, the strain is time dependent
and related to angular frequency:
γ(t) = γ0 sin(ωt) (3.7)
and the corresponging sinusoidal stress response is:
σ = γ0(G
′(ω) sinωt +G′′(ω) cos(ωt)) (3.8)
and both G’ and G” are functions of angular frequency (Weitz et al., 2007).
3.5.1.1 Strain and Frequency Sweeps
Where the stiffness of pre-formed fibrin gels was measured, the gels were placed
between two 40mm stainless steel sandblasted parallel plates (993244 and AC20-3
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Cover Plate, TA Instruments). The fibrin gels were prepared such that the diameter
of the gels matched the diameter of the geometry (Figure 3.4). Sandblasted bottom
and top plates were used to prevent the gels from slipping. To determine the Linear
Viscoelastic Region (LVR) of the gels, where stress is independent of strain, the
frequency was kept constant at 1 rad/s, at a temperature of 37◦C. The strain range
was set at either 0.1 – 100% or 0.1 – 150%. The robustness of the gels within the
LVR, was measured by adjusting the frequency from 0.1 – 50rad/s, at a set strain of
either 0.5% or 1% strain and constant temperature of 37◦C.
A B C D
Figure 3.4: Equipment and sample loading for rheological experiments. A) Rheo-
logical properties were characterised using an ARG2 Rheometer (TA Instruments).
B) Samples were robust enough to handle. C) Sample diameter matched that of
geometry. D) Sample between parallel plates, top plate was lowered enough so that
normal force was maintained positive and close to zero.
3.5.1.2 Time Sweeps
Time sweeps investigated the change in stiffness with time during gelation. Thrombin,
AP and AH were added to sDMEM as previously described and 500µL of this was
added to an eppendorf tube, followed by 200µL of Fibrinogen. The mixture was gently
pipetted one or twice, using a 1000µL hand pipette, and loaded onto the centre of
the rheometer bottom plate. A 40mm stainless steel cone geometry (992493, TA,
Instruments) was used, which was quickly lowered before starting the test. The test
was set to run for 1 hour, as cells are normally seeded on top of the gels following 1
hour gelation in the incubator.
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3.5.2 Tensile Testing
3.5.2.1 Equipment set-up
The mechanical testing apparatus was set up as shown in Figure 3.5-1). First, the
10N load cell was fitted onto the machine (Instron 5800 series) before assembling the
water bath. Once the water bath was fully connected, it was filled with 1.2L PBS
solution and the pump was started to heat and recirculate the PBS to 37◦C. The
load cell was then calibrated using the Bluehill software program before connecting
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Figure 3.5: Equipment and sample loading for construct tensile testing. 1) Set-
up of Environmental Microtester (Instron 5800) with 10N load cell, water bath and
sample grips. 2) Construct gripped between two pieces of sandpaper. 3) Sample
loaded on to machine before starting test. 4) Test stopped on rupture of construct
in the mid-section.
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3.5.2.2 Sample preparation
To test the soft TE L/T, the anchors were gently pealed away from the constructs.
Both ends of the constructs were then glued between two pieces of sandpaper, they
were imaged using a compact digital camera and the gauge length between the two
pieces of sandpaper was measured using callipers. One end of the constructs was
then connected to the top grip, ensuring that the edge of the sandpaper, towards
the tissue, was aligned with the edge of the grip, to ensure accuracy of the measure
gauge length. The gripped construct was then lowered to the bottom grip inside the
water bath, and gripped in a similar manner as the top grip, so that only the tissue
was visible between the grips. The pump was stopped during the running of each
test to prevent water currents influencing the results. The test was started manually
and stopped manually on complete rupture of the tissue. The pump was immediately
restarted after each test to maintain the water bath temperature.
3.6 Construct cell quantification
To determine whether AA+P supplementation affect cell proliferation, cells were
detached from constructs to allow quantification. Constructs were scaled down and
grown in 12-well plates, to improve the efficiency of cell dissociation from the matrix.
3.6.1 Reagents
3.6.1.1 TESCA Buffer
TESCA buffer was prepared as a solvent for Collagenase I (C0130, Sigma-Aldrich).
The buffer was composed of 50 mM TES (T5691, Sigma-Aldrich) and 0.36 mM
Calcium chloride (C3881, Sigma-Aldrich) in distilled water. The buffer solution was
sterile filtered using a bottle top system (10211321 , Fisher UK).
Chapter 3. General Methods and Materials 59
3.6.1.2 Collagenase I Solution
Collagenase is activated by Ca2+ and therefore it is recommended that the powder
be reconstituted in TESCA buffer (Sigma). Stock solutions were prepared at a con-
centration of 10mg/mL and the aliquotes were frozen at -20◦C. When used during
construct matrix digestion, the collagenase stock was diluted to 1mg/mL.
3.6.1.3 Calcein-AM Solution Preparation
50µg vials of Calcein-AM (C3100MP, Invitrogen) was dissolved in 950µL DMSO
(dimethlyl sulfoxide).
3.6.2 Cell dissociation from constructs
A series of enzymatic digestion stages were used to digest the fibrin and collagen
matrices in order to release the cells. First, under a sterile laminar flow hood, spent
sDMEM was removed from the constructs and constructs were then washed in PBS.
Once the PBS was removed, constructs were cut into smaller pieces using an ethanol
sterilised scalpel. 500µL of TrypLE was added to each well and incubated at 5%
CO2 and 37
◦C for 15 minutes. Then 1mg/mL collagenase I in tesca buffer was added
to each well at a volume of 500µL and the constructs were transferred to a shaker
incubator (Innova 4000, New Brunswick Scientific) at 37◦C and 100rpm for 1.5 hour.
The constructs were taken out of the shaker incubator and pipetted up and down
before returning for another 1.5 hour. Thereafter, 500µL of 0.25% EDTA Trypsin
was added and construct were returned to the shaker incubator for 5-10 minutes.
500µL of DMEM was then added to the constructs and they were pipetted up and
down again ensuring any small fragments were disrupted.
3.6.3 Quantification using calcein-AM
The cell suspension was then transferred into 1mL eppendorfs and centrifuged for 3
minutes at 1000 rpm. The supernatant was removed and replaced with 1mL PBS
per tube. 10µL of Calcein-AM was added to each tube and incubated for 40 minutes.
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The cell suspensions were then loaded on to 96-well black bottom plates and the
fluorescence was read at 490nm using a Spectrophotometer (Glomax Multi Detection
System, Promega). Standard curves were use to quantify construct cell number. The
standard curves were obtained by seeding known quantities of Calcein-AM treated
cells on a 96-well black bottom plate and correlating the fluorescence to the seeded
cell number. Figure 3.6 shows two such standard curves.
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Figure 3.6: Standard curves used to quantify construct cell proliferation using
calcein-AM. A) CTF standard curve. B) PFB standard curve.
3.6.4 Cell viability in reagents
Viability of cells in reagents used for dissociation was determined. A calibration
curve using known quantities of CTF cells was prepared as above. A cell suspension
of CTF cells at a density of 5,000cells/mL was prepared and seeded on 96-well black
bottom plates. Cells were left to attach for 4 hours in a 5% CO2 incubator at 37
◦C.
The media was then replaced with either TrypLE, Collagenase I, Trypsin or left in
DMEM (control) and returned to the incubator.
Every hour over a period of 3 hours, individual plates were stained with Calcien-
AM and the calibration curve was used to quantify cell number and consequently
viability. The results showed that cells survived well in TrypLE, Collagenase I and
DMEM. However, leaving cells in Trypsin for a prolonged period was detrimental to
cell viability.

























Figure 3.7: Viability of CTF cells in reagents used for dissociation.
3.7 Fluorescence Microscopy
3.7.1 DAPI staining
Constructs were washed in PBS before adding 300µL of 300nM DAPI stain and
incubating for 20–30 minutes. No fixation or permeabilization was done for DAPI
only staining. The DAPI stain was brought to 300nM by adding 3µL of the 10.9mM
stock solution to 50mL of PBS solution. Constructs were imaged in a dark room
using a confocal microscope (DM 2500, Leica).
3.7.2 Calcein-AM stained contraction impeded gels
Thin rings of filter paper were cut and pinned onto sylgard coated 35mm petri-dishes
(Figure 3.8). The dishes with filter paper were sterilised with 70% ethanol under a
laminar flow hood before gelling fibrin on top of the paper. The volume of fibrin was
doubled due to the absorption of liquid reagents by the filter paper prior to gelation.
Due to the strong adhesion of the gel to the paper, over 7 days the cells were unable to
laterally contract the gel. Constructs were either supplemented or unsupplemented
or the stiffness of the gel was adjusted. They were fed every 2 to 3 days as standard.
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Figure 3.8: Preparation of contraction impeded constructs.
Constructs were stained with Calcein-AM and Propidium Iodide to observe cell via-
bility and proliferation. Constructs were visualized and imaged using a fluorescence
microscope.
3.8 Electron Microscopy
3.8.1 Scanning Electron Microscopy
3.8.1.1 Karnovsky’s Fixative
A 0.2M sodium cacodylate buffer solution was prepared by dissolving 8.56g sodium
cabodylate trihydrate (C0250, Sigma-Aldrich UK), 33g of dihydrous calcium chloride
(C3881, Sigma-Aldrich), 2.5mL 0.2N hydrochloric acid (Fisher) in 200mL distilled
water. 100mL stock of Karnovsky’s fixative contained 8% v/v Formaldehyde, 50%
Glutaraldehyde and 40mL sodium cacodylate buffer. The fixative was stored in 15mL
tubes at -20◦C until use.
Constructs or fibrin gels were fixed in Karnovsky’s fixative for 3 hours or 1 hour,
respectively, before dehydrating in ethanol (fixative was not was not diluted).
3.8.1.2 Sample dehydration
Samples were dehydrated in a series of ascending ethanol grades for 15 minutes in
each. The ethanol solutions used were 15%, 20%, 30%, 50%, 70%, 80%, 90%, 95%,
100% and 100%.
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3.8.1.3 Critical point CO2 drying
Care was taken to ensure that the samples did not air dry by keeping them immersed
in 100% ethanol. Samples were placed in individual metallic baskets in a sample
boat, they were flooded with ethanol and then placed in the critical CO2 chamber
(Figure 3.9A). The chamber was filled with liquid CO2 at a pressure of 800lb/in
2 and
then the ethanol was completely flushed out.








Figure 3.9: Equipment used for scanning electron microscopy.
Once all the ethanol was flushed, all the valves were closed at the samples left in
liquid CO2 for 10 - 20 minutes. The liquid CO2 was then drained to a level just
above the sample and vaporised by turning on the hot water tap. When a pressure of
1600 lb/in2 and temperature of 38◦C was reached, the hot water tap was closed and
the CO2 chamber pressure was let down/ vented. Dried samples were removed from
the chamber and stored or sputter coated in gold (Figure 3.9B) and imaged using
ESEM (XL30 ESEM FEG, Philips) (Figure 3.9C).
3.8.2 Cryo-Scanning Electron Microscopy
Samples were rapidly frozen in liquid nitrogen before being transferred into the ESEM
machine’s prep-chamber (Figure 3.9D). The samples were etched for 20 minutes at
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-90◦C. Once etched the temperature was reduced to -176◦C and samples were sputter
coated in gold. The samples were then moved into the imaging chamber.
3.9 Histology
3.9.1 Construct preparation
Constructs were fixed in 4% formaldehyde (Sigma) in PBS overnight. The constructs
were then dehydrated in an ascending series of ethanol washes, 30%, 50%, 70%, 80%,
90%, 95% and twice in 100%, for 15–20 minutes in each solution. Dehydrated samples
were cleared in Histoclear (HS-200, National Diagnostics) for 20–30minutes. Samples
were placed in embedding cassettes and embedded in wax for 30 minutes to 1 hour,
depending on the size and robustness of the sample, at 60◦C (Wax Embedder, Leica
EG 1160). The wax infiltrated samples were left to harden on the cold plate for 1
hour. 5-8µm sections were cut using a microtome (Leica RM 2035). Sections were
collected in a water bath set at 45◦C (Klinipath Good(s) in Pathology, WB28040).
Sections were transferred onto slides (J2800AMNZ, Thermo Scientific), which were
left to dry on a hot plate at 65◦C. After drying, the slides were cleared in Histoclear
for 15 minutes and rinsed in 100% then 70% ethanol, followed by a rinse in distilled
water.
3.9.2 Hematoxylin and Eosin staining
The protocol supplied by Sigma-Aldrich with the reagents was used as a guide for
staining. Slides were stained in hematoxylin (HHS16, Sigma-Aldrich UK) for 2.5
minutes, rinsed in running tap water followed by 10s in the differentiating solution.
Slides were then blued in Scotts Tap Water for 2 minutes and in 95% ethanol for 2
minutes before staining in Eosin (HT-110116, Sigma-Aldrich) for 1 minute. Stained
slides were dehydrated in 70% - 100% ethanol and cleared in Histoclear for 10mins.
Slides were then mounted (Histomount, HS-103, National Diagnostics) and imaged
using a light microscope (CETI) with an in-built camera (CETI, Si-3000).
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3.9.3 Masson’s Trichrome Staining
Constructs were prepared for masson’s staining (HT15, Sigma Aldrich) as above and
the slides were complexed with Bouins solution at 55◦C under a fume hood for 20
minutes. Moderately remaining Bouin’s was washed off the slides under running
tap water until clear (prior washes were disposed off using special measures due to
the fixative’s harmful effects). The slides were then stained in Weigert’s Working
Hematoxylin solution for 10 minutes and rinsed in distilled water. This was followed
by Biebrich scarlet acid fuchsin solution for 5 minutes, a rinse in distilled water and
then Phosphomolybdic phosphotungstic acid solution for 15 minutes. The sections
were then placed in Aniline Blue for 10 minutes, rinsed in distilled water followed by
a rinse in 1% acetic acid. Sections were then dehydrated in 70%, 80%, 90%, 95% and
100% ethanol and mounted. Samples were imaged using a light microscope.
3.10 Reverse Transcription Polymerase Chain Re-
action
Constructs at weeks 2, 3 and 4 were used. Cells were dissociated from the fibrin
matrix using enzyme digestion as described in section 3.6.2. The cell suspensions
were centrifuged at 1000 rpm for 3 minutes, washed in PBS and centrifuged again
into pellets. Thereafter, the protocols supplied with the RNeasy Mini Kit (74104,
Qiagen) were followed from Appendix D (pages 69–70) and the Handbook (pages
25 –30). The cell pellets were disrupted to extract DNA by adding 350µL of Buffer
RW1 and centrifuging at 10,000 rpm for 30s followed by the addition of 80µL of the
DNase I incubation mix (72954, Qiagen). The samples were then left to stand at
room temperature for 15 minutes. Because RNA is more sensitive to degradation
than DNA, RNA was extracted once all samples were collected. The DNA samples
were stored at -20◦C until required.
To extract RNA, 500µL of buffer RPE was added to each sample. They were then
centrifuged at 10,000 rpm for 15 seconds and the flow through discarded. Buffer RPE
was added again at 500µL per sample and centrifuged at 10,000 rpm for 2 minutes.
30–50µL of RNase free water was then added to each sample before centrifuging for
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1 minute at 10,000 rpm. Samples were stored in a freezer at -80◦C prior to reverse
transcription and PCR.
Total RNA in each of the samples was determined using the Eppendorf Biophotome-
ter Plus. The Tetro cDNA Synthesis Kit (BIO-65042, Bioline) protocol was then
followed. Solutions of forward and reverse primers in Biomix Red (BIO-25005, Bio-
line) were prepared for GAPDH as well as for 9 target mRNAs (primers are shown
below in Table 3.1). mRNAs regulate genes that encode for proteins, which control
cell function. The mRNAs investigated are referred to according to the genes they
regulate and/or the proteins encoded for by those genes.
GAPDH was normalised first before PCR for the targets was conducted. Generally
for each sample, 2µL of sample was added to 23µL of the primer mix to prepare
cDNA and amplified by thermocycling for 23 – 35 cycles (RT-PCR). 1.5% agarose
gels with 3µL Ethidium Bromide were prepared and loaded with the samples and
ladder (11300, Norgen). The gels were run at 120 volts for 20 minutes. The gels
were then placed in a PCR cabinet (Geneflow) and results were quantified relative
to GAPDH using GeneSnap (Geneflow).
Table 3.1: Chick primers used for PCR.
Primer Full Name Species Sequence Annealing temp Size bps
GAPDH GAPDH 60 565
F - TTCGCAGTGTAGCTGAAGCA  R - TGCACATCTCCACCAAGACC 60 624
MMP2 MMP2 60 429
MMP9 MMP9 60 644
COL1A1 collagen - type I alpha 1 60 230
MMP3 MMP3 60 519
60 466
TenC 60 442
ACTA2 alpha smooth muscle actin F- ACTCTGCTGACTGAAGCACC   R- CTGTCTGCAATGCCTGGGTA 60 629
SCX scleraxis F - TCAAAGCCGGCAAGAGGAG   R - TCCTGTCGCGGTCTTTACTC 60 402
3.11 Statistical Analysis
Results are quoted as mean± standard deviation. Statistical variance was determined
using ANOVA (SPSS v 21, IBM). Significance was set a p ≤ 0.05 and generally
pair-wise comparison between group means was evaluated using Tukey’s post hoc.
However, where groups sample sizes varied, Games-Howell post hoc was used instead.
Chapter 4
Contraction of ascorbic acid and
proline supplemented constructs
4.1 Introduction
Improving the mechanical strength of tissue engineered ligaments and tendons (L/T)
and ensuring they exhibit the histological morphology of native tissue is the focus of
many studies (Marturano et al., 2013; Teh et al., 2013; Herchenhan et al., 2013; Leong
et al., 2013). Due to the structural supportive role of L/T, mechanical properties of
tissue engineered analogues must closely match those of native tissue in order to
withstand imposed forces once in vivo and to facilitate the regeneration process.
The synthesis of collagen, which is a structural protein and the predominant compo-
nent of L/T tissues, has long been known to require ascorbic acid (AA) as a cofactor
for the synthesizing enzymes (Peterkofsky, 1972; Murad et al., 1981). Consequently,
AA is frequently employed as a supplement during cell culture (Osiecki et al., 2010).
This is also likely due to its anti-oxidative properties (Arrigoni and De Tullio, 2002),
which have implications on fertility (Luck et al., 1995), MSC differentiation (Otsuka
et al., 1999; Franceschi, 1992) and cancer treatment (Padayatty et al., 2006).
The amino acid proline (P) is responsible for the helical conformation and stability
of the collagen molecule (Vitagliano et al., 2001) and is involved in several metabolic
pathways (Phang et al., 2008; Wu et al., 2011). In vivo, proline is hydroxylated after
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synthesis of the collagen precursor peptide into hydroxyproline, however, soluble
hydroxyproline is poorly incorporated into collagen whereas proline shows better
efficacy (Prockop and Juva, 1965). Nevertheless, the effects these supplements have
on the depletion of the tissue engineering scaffold and construct final dimensions have
not been widely reported.
Using the methodology employed in this thesis, supplementation of constructs with
50µM AA and 50µM P from the 7th day in culture, over a period of 5 weeks, resulted
in TE sinews with a higher collagen quantity of 8.34 ± 0.37% when compared to
the unsupplemented control group 1.34 ± 0.2% (Paxton et al., 2010a). In addition,
the anchor-TE ligament interface strength and sinew modulus increased 3-fold and
18-fold, respectively, over the control group. Part of the published work featured in
this thesis reports further enhanced sinew collagen content to 15.45 ± 0.49% after 5
weeks in culture when supplementation concentration was increased to 250µM AA
in combination with 50µM P (Paxton et al. (2012), Appendix D). Yet, constructs
treated with these concentrations of AA+P were visibly thinner than non-treated
constructs. OCT imaging further revealed that cross-sectional areas of AA+P sinews
were significantly smaller than control sinew cross-sections (Paxton et al., 2012).
Excessive contraction of the supportive TE scaffold is generally undesirable as it does
not allow sufficient time for tissue formation with adequate mechanical integrity. As
most mammalian cells are adherent, rapid depletion of the scaffold also leads to cell
apoptosis (Chiarugi and Giannoni, 2008). Consequently, the ideal scaffold has a
degradation rate that resembles the rate of new matrix deposition by the cells (Sung
et al., 2004).
Studies were set-up to determine the effect of AA+P supplementation on cell medi-
ated contraction of the fibrin hydrogel scaffold and to quantify the rates of contrac-
tion. The aim of the studies was to supply data, which would be useful in producing
alternative supplementary regimes or other methods to further optimise collagen con-
tent whilst controlling the extent of contraction.
Biological characterisation of the TE L/T was conducted utilising microscopy and
histological techniques to compare non-treated control constructs with those where
AA+P was administered during culture.
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4.2 Materials and Methods
4.2.1 Construct preparation
Constructs were prepared as described in Chapter 3 section 3.2.
4.2.2 Supplementation
4.2.2.1 Ascorbic acid and proline
On seeding day, groups were fed with either sDMEM only for the controls or sDMEM
supplemented with AA, P or AA+P. Thereafter, constructs were fed every two to
three days.
4.2.2.2 Varying concentration of either ascorbic acid or proline
Where AA or P concentrations were varied, during combined AA+P supplementa-
tion, either AA was kept constant at a concentration of 250µM or P was maintained
at 50µM. When varied, concentrations of the varied group were 50µM, 250µM and
500µM.
4.2.2.3 Collagen inhibition with DMOG
To inhibit collagen formation, constructs were fed with sDMEM supplemented with
either 25µM or 100µM DMOG (D3659, Sigma-Aldrich UK).
4.2.3 Collagen quantification
Collagen was quantified as described in Chapter 3 section 3.4.
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4.2.4 Microscopy
4.2.4.1 Scanning Electron Microscopy
Samples were fixed in 2.5% Glutaraldehyde in 0.1M Phosphate buffer for 1 hour.
This was followed by a series of dehydration washes at 50%, 70%, 90% and 100%
ethanol, twice for 15 minutes in each. The ethanol in the samples was replaced with
liquid CO2, followed by critical point drying. Samples were then mounted and sputter
coated in gold. Images were taken using the XL30 ESEM FEG (Philips).
4.2.4.2 Transmission Electron Microscopy
Primary fixation and dehydration were conducted in a similar manner as for SEM.
TEM included a secondary fixation step in 1% Osmium Tetroxide for 1 hour prior
to dehydration. After dehydration, samples were infiltrated with a 1:1 mixture of
Propylene Oxide and Resin for 45 minutes, followed by 1 hour in 100% Resin. The
samples were embedded beneath the surface of the resin in embedding moulds and
left under vacuum for 30 minutes before returning samples to atmospheric pressure.
The resin was left to polymerize at 60◦C for ≥ 16 hours. The samples were cut into
semi-thin sections of about 1µm, which were mounted on slides and stained with
toluidine blue. Ultra-thin sectioned were prepared from the semi-thin sections. The
sections were collected on Formvar/carbon coat TEM grids and stained with uranyl
acetate and lead citrate. Samples were imaged on the JEOL 1200EX TEM.
4.2.5 Histology
Samples were prepared for histology as decribed in Chapter 3 section 3.9.
4.2.6 Reverse transcription polymerase chain reaction
RT-PCR was conducted as described in Chapter 3 section 3.10.
Chapter 4. Contraction of AA+P supplemented constructs 71
4.2.7 Statistical Analysis
Results are quoted as means ± standard deviation. Measurements of constructs
treated with AA, P or receiving no treatment, were statistically compared to the
AA+P group using independent t-tests on a day by day basis, based on the priori that
AA+P supplemented groups would differ from other groups. For overall comparisons
over the course of the study, all measurements were compared using one-way analysis
of variance (ANOVA) and Tukey’s test of significance. All other experiments were
compared using one-way analysis of variance (ANOVA) and Tukey’s post-hoc on a
day by day basis. p<0.05 was considered significant. (IBM SPSS Statistics v. 21)
4.3 Results
4.3.1 Effect of ascorbic acid and proline on fibrin gel con-
traction
Constructs in this section were either non-treated (NT) controls or were supplemented
with ascorbic acid only (AA), proline only (P) or both ascorbic acid and proline
(AA+P).
All constructs, supplemented and non-treated, contracted to less than half the original
fibrin gel surface area by day 3 and continued to contract significantly over the
duration of the 52 day study (Figure 4.1). Differences in construct dimensions were
not visibly apparent in the first week, however, by day 22 constructs treated with
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Figure 4.1: Images showing contraction of AA/ P/ AA+P supplemented constructs. No obvious differences observed in the
first 3 days. AA and AA+P treated constructs appear denser than those treated with P only and control (NT) constructs on
day 10. By day 22, AA+P supplemented noticeably thinner in width than other constructs, becoming even more apparent on
day 52. n=7
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4.3.1.1 Fibrin percentage gel areas
Fibrin gel percentage areas were measured daily in the first two weeks and then
periodically over the 52 day study. This was conducted to determine if a particular
trend due to treatment with AA, P or AA+P could be established.
Quantification of fibrin gel surface area changes supported visual representations.
The greatest decline in gel area was observed on day 1, where all group areas de-
creased by over 50% (Figure 4.2). Supplementation with AA only on seeding day
resulted in the greatest reduction in fibrin gel area to 38.69 ± 9.86% by day 1, which
differed significantly (p<0.05) from P (46.40 ± 12.80%) and AA+P (45.52 ± 12.99%)
supplemented groups. The difference between AA and the control group gel area of
40.83 ± 11.03% was not significant (p=0.823).
The general trend from day 4 to day 13 was that AA only treated constructs con-
tracted the most, P only gels the least and the control and AA+P fibrin gel areas
fell in between the two.
However, no statistically significant differences in fibrin gel area were observed until
day 36 where AA+P showed the greatest decrease in fibrin gel area to 3.41 ± 1.24%
in comparison to AA at 4.0 ± 0.68% (p=0.010), P at 4.27 ± 1.68% (p=0.011) and
the control (NT) group, which was at 3.97 ± 1.13% (p=0.008).
By day 52 of the study, AA+P group had the lowest fibrin percentage gel area
remaining of 2.73 ± 0.28%, which differed significantly from AA percentage gel area
of 2.85 ± 1.96% (p=0.036) and P percentage gel area 3.81 ± 0.91% (p=0.018) but
not from non-treated control group 3.41 ± 1.24% (p=0.179).
Comparisons of the overall rates of contraction over the 52 day period indicated that
there were significant differences between the groups although AA only supplemen-
tation did not differ from the rate of contraction of the control group (p=0.324) and


























































































































































Figure 4.2: Quantification of fibrin gel areas of constructs treated with AA/P or AA+P. (A) is an overview of the overall rates
of fibrin contraction. (B) Contraction over the first 7 days; the control and AA groups exhibited the fastest rate of contraction
and P the slowest. (C) Control, AA and AA+P rates fairly similar, though extent of contraction of P less. (D) Statistically
significant differences in percentage gel areas observed between AA+P and other treatment groups.
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4.3.1.2 Maximum and minimum widths
Both maximum and minimum widths were measured because it was observed that
constructs did not form uniformly. Although the average width could be quoted, this
would not adequately represent limits on contraction. For example, it was considered
that the maximum width could be dependent on the anchors, whilst the minimum
width reflected continued contraction due to the supplements. However, irregular
remodelling within the constructs due to the supplements, nature of the fibrin gel
or other factors could not be discounted. As a result, both maximum and minimum
widths are quoted throughout this thesis.
For all groups, no statistically significant differences were observed between the max-
imum and minimum widths during the first four weeks (Figure 4.3).
However, by the fifth week of culture, the maximum widths of AA+P group were
thinner than the control and proline treated groups. On day 33, AA+P had a max-
imum width of 2.12 ± 1.05mm, which differed significantly from the control (NT)
group 3.46 ± 0.59mm (p=0.016). AA+P minimum widths were also smaller in com-
parison to control constructs, with final dimensions of 1.48 ± 0.15mm and 2.41 ±
0.48mm, respectively (p=0.016). After the 5th week, minimum widths of AA+P
treated constructs were relatively constant at about 0.91mm, shown in Figure 4.3.
Minimum widths of AA+P treated constructs differed significantly from control and























































































































































































































































































































Maximum and minimum widths within groups 
begin to differ significantly from each other
Figure 4.3: Construct maximum and minimum widths. There were variations in construct maximum and minimum widths,
significant differences between AA+P and other groups becoming apparent after 5 weeks in culture. Significant difference from
AA+P max width denoted by * and significant difference from minimum width by #.
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4.3.2 Scanning electron microscopy
4.3.2.1 Control and ascorbic acid + proline construct longitudinal sec-
tions
Scanning electron microscopy was used to examine the longitudinal and cross-sectional
morphology of control and AA+P treated constructs (Figures 4.4, 4.5 and 4.6). The
outer surface of the control sinews had a high concentration of cells, which appeared
to have raised cell bodies (Figure 4.4A and B). The cells also appeared to be aligned
along very thin fibres (≈ 0.2µm) shown in Figure 4.4C. In contrast, AA+P treated
sinews had a flat sheath-like cover, composed of flat cells (Figure 4.4D and E). Under
the external sheath-like layer, a densely populated cell layer, similar to those of the
control group were seen, however, these also appeared slightly flatter than those of
the control group Figure 4.4 G and H. AA+P treated sinews also exhibited cell align-
ment parallel to the construct length (Figure 4.4F) surrounded by the thin similarly
aligned fibres. The fibres were harder to identify than in the control constructs as
AA+P sinews were more densely compacted.
4.3.2.2 Control construct cross-sections
Cross-section images of control constructs showed multiple folds within that resem-
bled folded sheets (Figures 4.5A and B). The fibres that make up the constructs were
distinguishable, particularly on the outer layers of the construct (Figure 4.5D). Apart
from the sheet-like arrangement across the constructs (Figure 4.5E), the “sheets” also
appeared to have perpendicularly aligned fibres connecting them together (Figures
4.5F and G).
4.3.2.3 Ascorbic acid + proline construct cross-sections
In AA+P treated constructs, distinct folds were visible along with the sheet-like
arrangement across the sinews (Figures 4.6A and D). AA+P treatment appeared to
result in greater compaction of the tissue (Figures 4.6B and C). In addition to the
enhanced compaction, the “sheets” were connected by thin and densely matted fibres











Figure 4.4: Longitudinal SEM images of control (NT) and AA+P treated sinews.
Cells on the outer layer of control contructs were aligned in the direction of tension
and appeared to have raised cell bodies (A–C). On the surface of AA+P treated
cells appeared much broader and flatter in comparison to the controls (E–H).











Figure 4.5: Cross-sectional electron microscopy images of control (NT) sinews.
Contraction folds were visible within the sinew (A–C). Individual fibres were
aligned in a parallel direction to each other (D). Thicker sheets were layered across
the cross-section (E & F) and joined by fibres running perpendicular to them (G).
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(Figure 4.6F and G), which differed in appearance from those of the control group
(Figure 4.5F and G).
4.3.3 Histology
4.3.3.1 Hematoxylin and Eosin
H&E staining of longitudinal control constructs showed cell alignment in the mid
portion of the constructs, with higher cell densities present on the periphery of the
sinew (Figure 4.7a). AA+P supplemented constructs exhibited a similar morphology
though the mid-portion appeared to be composed of a thicker fibrillar arrangement
and generally, the cell densities throughout the AA+P sinews were lower than for the
controls (Figure 4.7d). In native tissue, cells appear uniformly aligned along collagen
fibres as in the rat tail tendon shown in Figure 4.7g.
Cross-sectional staining of the control constructs showed multiple folds within the
constructs with one larger central fold (Figure 4.7b and c). In contrast, AA+P cross-
sections, indicated a rolling formation of the sinews from the outside-in (Figure 4.7e
and f). On the periphery of control and AA+P constructs, a fibrillar arrangement
running across the sinew cross-sections was observed (Figures 4.7c and f), similar to
the “sheet” arrangement seen with SEM (Figures 4.5 and 4.6).










Figure 4.6: Cross-sectional electron microscopy images of AA+P treated sinews.
AA+P constructs appeared denser although the folds (A–C) and sheets across (D–
G) were also visible. The sheets were joined by largely matted fibres (F & G),































Figure 4.7: H&E stained sections of control and AA+P treated constructs. Longitudinal sections showed cells were aligned
along the direction of tension in the mid-portion of a) control constructs and d) AA+P constructs. g) rat tail tendon indicating
the morphology of native tissue. Cells were present throughout the cross-sections (b, c, e & f) of the constructs. e) & f) AA+P
rolling formation was apparent.
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4.3.3.2 Masson’s Trichrome
Masson’s Trichrome was used due to its ability to stain collagen blue/green and fibrin
pink/red (Isenberg et al., 2006; Lanza et al., 2011). Control cross-sections revealed a
darker red staining of fibrin around the outer portion of the constructs and within the
folds whereas toward the centre of the construct fibrin stained a lighter pink (Figure
4.8a). At higher magnification the control constructs appeared to be flooded with
blue specs (Figure 4.8b), which were distinguishably smaller than cell nuclei (Figure
4.8c).
The periphery of AA+P treated constructs stained blue for collagen to a greater
extent than control constructs and the fibrin tissue also predominantly stained a
darker red colour (Figure 4.8d and f). Patches of blue were found throughout the































Figure 4.8: Control and AA+P sections stained for collagen using Massons Trichrome. a) cross-section of control construct.
b) Blue specks were darted throughout the control cross-sections, which were identified as collagen and were significantly smaller
than cell nuclei (c). AA+P cross-sections (d) stained darker and collagen was mostly situated on the periphery of the constructs
(e) although collagen was also present within the construct (f). Scale bar is 200µm for all images.
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4.3.4 Transmission electron microscopy
4.3.4.1 Control construct longitudinal sections
The constructs were characterized further at the submicroscopic level using TEM.
Within the control constructs elongated cells as well as dark patches (P) were aligned
along the length of the constructs (Figures 4.9a and b). Throughout the constructs
needle- and speck-like structures were present. On the outer edge of the construct
cells were densely packed, as shown with SEM, followed by an organised fibrillar
arrangement (F), after which the needle-like and speck-like morphology appeared
towards the middle (Figure 4.9c and d). Towards, the middle of the control con-
structs, there were areas free of the needle-like morphology along which only cells
were aligned (Figure 4.9e). In addition, collagen (C) was identified and appeared to
be aligned in both transverse and longitudinal directions. At higher magnification
(Figure 4.9h), the banding pattern present in collagen was clearly apparent. Collagen
fibres were also present within some of the dark patches and branched structures (S)
(Figures 4.9f and g). The cells also contained large and numerous transport vesicles
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Figure 4.9: Longitudinal transmission electron micrographs (TEM) of control constructs. a) Dark patches (P) were aligned
along the direction of tension along with cells. b) The patches were surrounded by needle-like structures. c) & d) Greater fibril
(F) arrangement and general organisation was observed from the outside in. e)– h) The cells had large transport vesicles (V)
and collagen (C) fibrils were arranged haphazardly within the construct.
Chapter 4. Contraction of AA+P supplemented constructs 87
4.3.4.2 Ascorbic acid + proline construct longitudinal sections
On the outer edges of AA+P constructs, cells were highly populated and aligned
along fibres (F) whereas towards the middle of the constructs, dense matrix (M)
was present with fewer cells (Figures 4.10a, b and c). Cells on the edge of AA+P
treated constructs had prominent endoplasmic reticula (ER), as shown in Figure
4.10a. Strands of collagen (C) were present in dark patches within the constructs
and in close proximity to the cells (Figure 4.10d and e). Within the dense matrix
there were areas of aligned cells (Figure 4.10f) and the cells appeared thinner and
more elongated than control cells in Figure 4.9. A large number of transport vesicles
(V) were also present within the cells (Figure 4.10g and h). Some cells were very
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Figure 4.10: Longitudinal transmission electron micrographs (TEM) of AA+P constructs. a) Construct edge had numerous
cells with visible endoplasmic reticula (ER) and b) the matrix (M) was extremely dense. c) Some form of fibril (F) arrangement
was visible and d) collagen (C) was present. e) Cells were aligned along the construct, varied in nuclei (N) size and f) contained
numerous transport vesicles (V).
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4.3.4.3 Control construct cross-sections
Cross sectional images also showed a larger number of cells on the periphery of
the constructs (Figure 4.11a). Collagen fibrils and the needle-like morphology were
present throughout the central portion of the constructs (Figure 4.11b). The dark
patches observed in the longitudinal sections (Figure 4.9) were also visible in the
cross-sections and were bounded by strands of collagen fibrils that appeared to be in
the process of joining to form rings (Figure 4.11c). The collagen fibrils also appeared
in close proximity to the cells (Figure 4.11d and e). Collagen was identified by the






























Figure 4.11: Cross-section TEM images of control (NT) constructs. a) A large number of cells were found on the edge of
the constructs. b)–c) Collagen fibres surrounded the dark patches and were local to the cells d) & e). The collagen fibres were
identified by the banding patten (f).
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4.3.4.4 Ascorbic acid + proline construct cross-sections
The cross-sectional edge of AA+P constructs had a high cell number, as was prevalent
in all other sections, however, a greater amount of collagen strands were observed on
the periphery of the AA+P cross-sections (Figure 4.12a). The cells on the periphery
also exhibited prominent endoplasmic reticula (Figure 4.12b). Some of the collagen
fibrils formed rings, in the centre of which were numerous cross-sections of collagen
fibrils (Figures 4.12c and d). Towards the center of the constructs, the matrix (M)
was dense and fewer cells were visible (Figure 4.12c and e). Dark patches within the
matrix (M), were identified as bundles of collagen fibrils were present throughout the
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Figure 4.12: Cross-section TEM images of AA+P constructs. a) The construct edge had a higher cell density. b) Endoplasmic
reticula (ER) were visible. c)–f) collagen fibres and arranged bundles were visible. g) Secretion of collagen was also local to
cells.
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4.3.5 Effect of varying ascorbic acid and proline concentra-
tions on fibrin contraction
The effects of varying AA or P concentrations whilst maintaining one of the two
supplements constant during AA+P supplementation were assessed. This was done
to establish if increasing or reducing either AA or P would attenuate the extensive
contraction seen at the combined 250µM AA + 50µM P concentrations. Varying
the concentration of either AA or P would also shed some light as to which of the
supplements was responsible for enhancing extent of contraction.
Constructs supplemented with differing concentrations of AA along with the control
constructs displayed no noticeable contraction in the first two days. However, by day
3 constructs in all groups had contracted, although those in the proline varied groups
appeared more translucent than those in the AA treatment varied groups (Figure
4.13 and 4.14A).
4.3.5.1 Fibrin percentage gel areas and max/min widths
Day 3 results showed that the control group had contracted to 21.4 ± 7.85% (Fig-
ure 4.14A). Increasing AA concentrations resulted in increased extents of the fibrin
gel contraction to 34.34 ± 13.70%, 28.03 ± 12.34% and 20.47 ± 6.05%, for 50AA,
250AA and 500AA, respectively. Conversely, increasing concentrations of P showed
a decreased rate of fibrin gel contraction with 50P contracting to 30.09 ± 6.25%,
250P to 38.81 ± 7.21% and 500P to 36.40 ± 9.73%. Generally, when compared to
the control group, supplementation reduced initial rates of contraction.
The case was different when supplemented groups were compared to each other.
Percentage gel areas of the 250AA group were significantly lower than 50AA, 250P
and 500P, whilst 500AA had significantly less fibrin percentage gel area than 250P
and 500P on day 3 (p<0.05). This indicated that AA and P had opposing effects
on contraction. The lowest maximum and minimum widths were observed in the
control group at 11.97 ± 2.71mm and 8.29 ± 2.23mm (Figure 4.14D). Maximum
and minimum widths of AA treatment varied constructs were higher with decreasing
concentrations of AA. However, there was no clear trend for P supplement varied
constructs, although maximum widths of the control and AA treatment varied groups
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Figure 4.13: Contraction images showing effect of varying AA concentration or
P concentration. In the first three days constructs treated with varying concen-
trations of P appear more translucent in comparison to those were AA is varied.
By day 7, P treated constructs appear greater in width, though by the end of the
study this difference is visually less apparent.
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differed significantly from 250P, which expressed the greatest maximum width of all
groups at 20.97 ± 2.67mm (p<0.05).
A similar trend was observed for day 7 percentage gel areas and maximum/ minimum
widths (Figure 4.14B and D). Again, increasing concentrations of AA appeared to in-
crease the rate of fibrin gel contraction 7.39 ± 1.53% (50AA), 6.39 ± 1.69% (250AA)
and 4.68 ± 1.13% (500AA). Increasing concentrations of P showed no discernible
trend as the lowest concentration 50P (7.82 ± 0.85%) was not dissimilar from the
highest concentration of 500P (7.95 ± 0.84%), however, the median concentration
had a higher fibrin percentage gel area (8.75 ± 0.73%). Statistically significant dif-
ferences were largely between the 500AA group and all the P treatment varied groups
(p<0.05). Day 7 500AA maximum widths also differed significantly from all P varied
groups and 50AA, whereas the minimum widths of AA supplement varied constructs
differed significantly from P treatment varied constructs. Essentially, during the first
two weeks, increasing AA had a greater effect on contraction than increasing P.
From day 12 to day 33/34, construct percentage gel areas did not differ significantly
from each other, however, there were statistically significant differences between the
maximum and minimum widths from day 20. By day 34, control maximum widths
were the largest of all groups at 1.20 ± 0.17mm. Varying AA supplement concen-
tration resulted in constructs widths being lowest with increasing AA concentration,
1.38 ± 0.43mm (50AA), 1.19 ± 0.09mm (250AA) and 1.13 ± 0.16mm (500AA). Min-
imum widths of AA treatment varied groups exhibited a comparable trend although
smaller in effect with 50AA= 0.98 ± 0.28mm, 250AA =0.88 ± 0.15 and 500AA=0.83
± 0.26mm. The control group max width differed significantly from 250AA and
500AA (p=0.017 and p=0.002, respectively), with no statistically significant differ-
ences between individual AA groups.
Interestingly, at this point the trend for P supplement varied groups also resembled
AA treatment groups in that increasing P concentrations reduced maximum and
minimum widths. For 50P, 250P and 500P max widths were 1.61 ± 0.18mm, 1.32 ±
0.15mm and 1.14 ± 0.08mm, whilst the minimum widths were 1.09 ± 0.16mm, 1.02
± 0.13mm and 0.95 ± 0.07mm, in the order of supplementation. Only the maximum
widths of the 50P group displayed statistically significant differences from 250AA
(p=0.012) and 500AA (p=0.002). Whilst only the minimum widths of 250P differed
from 500AA only (p=0.024).


























AA+ P 50uM AA+P 250uM AA+P 500uM
Control 50uM AA+ P 250uM AA + P
500uM AA + P
Day Control 50uM AA+P 250uM AA+P 500uM AA +P AA+P 50uM AA+P 2 50uM AA+P 500 uM
0 35.00 35.00 35.00 35.00 35.00 35.00 35.00
3 11.97 ± 2.71 14.43 ± 5.43 13.42 ± 3.71 12.02 ± 2.71 16.18 ± 3.10 20.97 ± 2.67 16.71 ± 3.04
7 4.22 ± 0.62 5.10 ± 1.05 4.75 ± 0.73 3.70 ± 0.54 5.36 ± 0.70 5.95 ± 0.35 5.16 ± 0.46
20 1.85 ± 0.25 1.57 ± 0.43 1.48 ± 0.10 1.45 ± 0.30 2.01 ± 0.23 2.03 ± 0.29 1.66 ± 0.18
22 1.87 ± 0.32 1.44 ± 0.34 1.38 ± 0.17 1.31 ± 0.28 1.96 ± 0.23 1.91 ± 0.27 1.87 ± 0.20
33 1.61 ± 0.22 1.38 ± 0.43 1.19 ± 0.09 1.13 ± 0.16 1.61 ± 0.18 1.32 ± 0.15 1.14 ± 0.08
Day Control 50uM AA+P 250uM AA+P 500uM AA +P AA+P 50uM AA+P 2 50uM AA+P 500 uM
0 33.00 33.00 33.00 33.00 33.00 33.00 33.00
3 8.29 ± 2.23 12.12 ± 5.64 10.08 ± 3.03 8.60 ± 1.49 13.76 ± 3.65 15.50 ± 4.38 14.69 ± 2.53
7 3.15 ± 0.55 3.43 ± 0.55 3.24 ± 0.45 2.13 ± 0.41 4.73 ± 0.80 4.60 ± 0.62 4.39 ± 0.48
20 1.39 ± 0.10 1.20 ± 0.20 1.18 ± 0.17 1.15 ± 0.15 1.34 ± 0.20 1.52 ± 0.14 1.33 ± 0.10
22 1.34 ± 0.17 1.18 ± 0.21 1.15 ± 0.17 1.05 ± 0.25 1.39 ± 0.22 1.43 ± 0.14 1.26 ± 0.22
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Figure 4.14: Rate of contraction and widths due to varying AA/P concentrations.
A) Delayed contraction seen in AA treated constructs in the first two days. B) From
day 7, statistically significant differences seen between fibrin percentage gel areas
of control and 250P, 50AA and 500AA, 250AA and 250P, 500AA and 50AA/all
P treated constructs. C) No significant differences observed except on day 22,
between the control and 500AA & 500P. D) Significant differences in maximum and
minimum widths, variations largely being between AA supplemented constructs
and the P treated group or control. * denotes statistically significant differences
referred to in the text.
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4.3.6 Collagen content of supplemented constructs
The effect of varying AA+P concentrations on resultant sinew collagen content was
evaluated. Control sinews had an average collagen content of 6.92 ± 4.01%, which
was significantly less than 50AA with 39.18 ± 15.05% (p=0.018) and 500AA, 43.10
± 32.07% (p=0.000). Apart from the control, the 500AA group’s collagen content
was also significantly higher than all P treated groups where 50P contained 10.91 ±





Figure 4.15: Effect of varying AA/P concentration on collagen content. Supple-
mentation enhanced sinew collagen content, increases in AA concentration having a
greater effect on collagen content than increases in P. (p<0.05 for 500AA compared
to all P groups & control and 50AA compared to control & 50P.)
4.3.7 Effect of collagen synthesis inhibition on contraction
To determine the effect of collagen synthesis on fibrin gel contraction rates and sinew
widths, constructs were supplemented with either 25µM DMOG or 100µM DMOG
to inhibit collagen synthesis.





































































Group Day 4 Day 5 Day 6 Day 7
Control 7.60 ± 1.14 6.61 ± 0.50 5.79 ± 0.25 5.07 ± 0.39
25µM DMOG 7.32 ± 0.47 6.44 ± 0.43 5.63 ± 0.45 5.18 ± 0.55
100µM DMOG 8.86 ± 2.13 7.43 ± 0.62 6.90 ± 0.83 6.03 ± 0.76
Group Day 4 Day 5 Day 6 Day 7
Control 6.01 ± 1.39 4.52 ± 0.54 3.81 ± 0.45 3.36 ± 0.49
25µM DMOG 6.3 ± 0.43 5.76 ± 0.40 4.79 ± 0.28 3.97 ± 0.49







Figure 4.16: Effect of collagen synthesis inhibitor on construct contraction. In-
creasing concentrations of DMOG had a significant effect in slowing down the rate
of fibrin gel contraction.
No statistically significant differences in the rate of fibrin gel contraction were ob-
served in the first three days although the presence of DMOG supplements appeared
to slightly enhance initial contraction (Figure 4.16B).
However, there was a sudden decrease in contraction from day 4. On day 5, fibrin
gel areas of treated constructs were 10.36 ± 0.57% for the 25µM group and 11.41
± 0.63% for 100µM. These differed significantly from control group (p<0.05), which
had a gel area of 8.67 ± 1.10% (Figure 4.16).
The maximum width of 100µM supplemented constructs were also broader and dif-
fered significantly from both the control and 25µM groups. The minimum widths of
both the 25µM and 100µM groups of 5.76 ± 0.40mm and 5.80 ± 0.77mm, differed
significantly from the control group of 4.52 ± 0.54mm, suggesting the continued
contraction of the control constructs.
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Control fibrin gel areas continued to be the lowest and by day 7 had reduced to 7.37
± 0.75% compared to 25µM at 7.81 ± 0.93% and 100µM at 9.54 ± 1.06%. The gel
area of the 100µM group differed significantly from control and 25µM groups. The
maximum (6.03 ± 0.76mm) and minimum widths (4.76 ± 0.50mm) of the 100µM
group were broadest compared to the other groups and showed statistical significance
(p<0.05).
4.3.8 RT-PCR detection of transcripted mRNAs
Reverse-transcription polymerase chain reaction (RT-PCR) was used to evaluate dif-
ferences in the expression of specific messenger ribonucleic acids (mRNAs). Collagen
type I expression was investigated to determine whether it varied between control
and AA+P constructs or if differences were due to collagen downstream processing
events. Although results in sections 4.3.1 and 4.3.5 indicated AA+P constructs to be
highly contractile, this needed to be confirmed and separated from fibrin and possibly
collagen matrix degradation. Consequently, the expression of MMP-1, -2, -3 and -9
were also evaluated due to their implication in collagen and fibrin degradation (see
Chapter 2 sections 2.3.2.4 and 2.4.5.3 on MMPs).
At weeks 2 and 3 none of the targeted mRNAs were detected and these results are
for constructs at week 4. The expression of the targeted mRNAs in control and
AA+P treated constructs were compared, relative to GAPDH. In control constructs
RhoA and MMP-2 expression were upregulated by 42% and 25%, respectively. There
was an increase in the number of targeted mRNAs upregulated as result of AA+P
supplementation.
RhoA was 144% greater in AA+P constructs than in the control group. COL1A1,
MMP-2 and ACTA-2 were also upregulated by 69%, 65% and 436%, compared to the
control group. In addition, the expression of Ten-C in AA+P treated constructs was
over 5-fold greater than for control constructs. The expression of MMP-1 was greater
for control constructs than for AA+P treated constructs. No significant differences
were observed in MMP-3 and MMP-9 expression between the control and AA+P
groups.

































Figure 4.17: RT- PCR results of mRNA expressed by Control and AA+P treated
constructs. Expression of COL1A1, Tenascin-C, RhoA, MMP-2 and ACTA2 were
upregulated in AA+P treated constructs compared to the controls. However, ex-
pression of MMP-1 was downregulated.
4.4 Discussion
Proline reduced rates of fibrin contraction
As expected, supplementation with AA, P or AA+P resulted in subtle yet significant
variations in the rates of contraction of the fibrin hydrogel scaffold and statistically
significant differences in the rate of fibrin gel contraction due to AA+P were observed
around Week 5 of the study (Figure 4.2). Comparisons of the overall reduction in fib-
rin gel areas between treated and non-treated groups, indicated that the contraction
profile for AA+P constructs closely correlated with that of the proline treated group
whereas response to AA treatment was related to the control group. This is likely
because the presence of proline attenuated initial rates of contraction in both AA+P
and P only groups. As a result, these correlations suggested that treatment with AA
had the general effect similar to no treatment and therefore AA had no direct effect
on the gross rate of fibrin gel contraction. Since the overall effects of proline contrac-
tion were not statistically different from AA+P treatment, this appeared to suggest
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that proline supplementation was the governing factor in fibrin gel contraction rates
but not necessarily the extent of contraction.
Nonetheless, these contraction measurements did not explain the difference in widths
observed as AA+P constructs were visibly thinner in width in comparison to the
other groups, especially when compared to proline only supplementation. An expla-
nation for this may be due to contraction and depletion of the fibrin gel being two
separate phenomena, which are implemented during remodelling of the TE sinew.
Consequently, the maximum and minimum widths of the constructs were quantified
to determine how the TE sinews developed in between the anchor points.
AA+P supplementation significantly reduces construct widths
Similar to fibrin percentage area results, differences in maximum and minimum
widths of the AA+P treated groups were only significant after 5 weeks in culture
(Figure 4.3). By day 52, maximum widths of AA+P were significantly larger than
AA group, although the minimum widths were not. However, there were significant
differences between the minimum widths of AA+P constructs, which were signifi-
cantly smaller than P treated constructs and the control group. This indicated that
AA+P treatment resulted in constructs with overall widths amid those supplemented
with AA only or P only, suggesting a combined effect due to AA and P supplemen-
tation. This further suggested that altering the concentrations of either AA or P,
during combined supplementation, would increase or decrease the maximum or min-
imum widths achieved as well as maintain enhanced collagen production.
Supplementation of constructs with AA+P affects morphology of cells,
construct internal structure and collagen formation
Figures 4.4B and E showed that the outer surface of the constructs had a high cell
density, however, SEM also indicated differences in the morphology of AA+P supple-
mented constructs when compared to the controls that received no treatment. AA+P
cells appeared much flatter, possibly due to a higher concentration of contractile actin
stress fibres, as spread cells have been shown to contain greater actin (Dalby et al.,
2004).
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Cross-sectional images indicated a greater extent of fibrin remodelling in AA+P con-
structs than the controls as individual fibres (possibly fibrin) were still distinguishable
in the controls (Figure 4.5) but in AA+P constructs, they appeared more intercon-
nected and matted (Figure 4.6). Collagen staining using Masson’s Trichrome con-
firmed the enhanced presence of collagen in AA+P sinews compared to control con-
structs (Figure 4.8). What was interesting was that control sinews were flooded with
“specks” that were smaller in dimension than cell nuclei; blue staining by Masson’s
Trichrome suggested they were collagen (Figure 4.8b). TEM images also showed the
presence of needle- and speck-like structures throughout the longitudinal and cross-
sections of control constructs (Figures 4.9 and 4.11). Comparison of these images
with those shown by Christiansen et al. (2000), confirmed that these “needles” and
“specks” were indeed collagen subunits. In particular, Figure 4.11f closely resem-
bled observations by Christiansen et al. (2000) shown in Figure 4.18 of collagen fibril
formation.
In contrast, these collagen subunits were harder to identify in the longitudinal sections
of AA+P treated constructs as the matrix was significantly denser, although areas
of dark patches were observed (Figure 4.10). Cross-sections of AA+P did however,
show the “specks” or cross-sections of collagen subunits to be present throughout
the matrix (Figure 4.12e) and bundles of these collagen units (Figure 4.12f). In
AA+P treated constructs, collagen fibrils appeared to form rings in proximity to
cross-sections of collagen fibril bundles (Figure 4.12b and c). Fusion of collagen at
the tips has been shown by Graham et al. (2000), where collagen fibrils in suspension
fused at their tips to form rings following 16 hours of swirling (Figure 4.19). It was
not clear however, whether swirling or shear stress could be the only cause of collagen
fibril fusion. If so, contractile forces may have contributed to ring formation.
AA+P construct cells at the periphery also exhibited more prominent ER, however,
numerous and large transport vesicles were seen in both control and non-treated
constructs. The cell organelles and collagen were identified using various studies
such as those by Canty and Kadler (2002); Silver et al. (2003); Calve et al. (2004);
Bayer et al. (2010).
Increasing either AA or P concentrations, increased rates of fibrin gel
contraction
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Figure 4.18: Formation of collagen fibrils as shown by Christiansen et al. (2000).
The TEM images show formation of collagen fibrils at different temperatures and
pH. Used with permission (Elsevier).
Figure 4.19: Fusion of the tips of collagen fibril to form rings as shown by
Graham et al. (2000). The TEM images show full length fibrils, that fused at the
tips following swirling. Used with permission (Elsevier).
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Varying AA+P concentrations by altering the concentration of one component whilst
maintaining the other one constant was evaluated to determine its effects on the
rate of fibrin gel contraction and construct widths (Section 4.3.5). Previously, the
control and constructs treated with AA/ P or AA+P all contracted the fibrin gel
by day 1 (Figure 4.2B). In these experiments no contraction was observed in the
control and those treated with varying concentrations of AA in the first two days
(Figure 4.14). Constructs treated with varying concentrations of P also appeared
more translucent in the first few days in comparison to those where AA was varied
(Figure 4.13). Reasons for this could be due differences in cell metabolism of AA
/ P or other factors such as minor variances in cell seeding density or the fibrin
hydrogel properties. After day 3, the effect of supplementation behaved as expected
in that increasing AA concentration increased the extent of fibrin gel contraction
whereas increasing P concentration decreased the extent of contraction. Statistical
assessment, supported this analysis as construct gel percentages of the 250AA group
differed significantly from the lowest AA treatment group (50AA) and the higher P
treatment groups, 250P and 500P. The 500AA treatment group also differed from the
250P and 500P, further indicating the polar effects of the treatments. As expected
the percentage gel areas of the 250AA and 50P groups were not statistically different,
as they were in fact the same group.
There was a correlation between the maximum and minimum widths and fibrin per-
centage gel areas of constructs supplemented with varying concentrations of AA.
However, widths were similar for the lowest 50P and the highest 500P group and
250P resulted in constructs with the lowest widths, showing no clear trend due to
P treatment. Possible causes for this may be due to the fact that proline requires
ascorbic acid for its hydroxylation and there may be an optimum AA:P ratio required
by the enzymes.
Towards the end of the study, AA supplemented constructs were generally smaller
in width than non-treated constructs, with 250AA and 500AA groups showing sig-
nificant differences from the control widths. Proline max/min widths were not sig-
nificantly smaller than the control group, falling somewhere in between the effects of
the higher 250AA and 500AA treatments and no supplementation. Why construct
dimensions with increasing P treatment fell towards the 5 week period was not clear
but could be due to increasing collagen production and its effect on the remodelling
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of the fibrin gel scaffold. As high concentrations of P reduced construct maximum
widths, this supplementation regime was deemed unsuitable for the purpose of en-
hancing construct widths.
There is a correlation between construct collagen content and extent of
contraction
Collagen content of the TE sinews was quantified in an attempt to identify its re-
lationship with the concentrations of AA+P supplements, the rate of contraction of
the fibrin gel and sinew maximum and minimum widths. Non-treated constructs
expressed the least amount of collagen of only 6.92 ± 4.01%. This was lower and
differed significantly from the supplemented groups, except for the 250AA group,
though this lack of statistical significance could be attributed to experimental error.
Increasing concentrations of both AA and P appeared to increase collagen content,
with the effect being greater as a result of AA treatment.
Collagen synthesis inhibition did not impede contraction but gradually
reduced rates of fibrin gel contraction
To further investigate the correlation between collagen synthesis, gel contraction
and sinew width, constructs were treated with DMOG (dimethyloxalylglycine), an
inhibitor of collagen synthesis (Thoms and Murphy, 2010). Iron, ascorbic acid
and α-ketoglutaric acid are cofactors required for proline hydroxylation by prolyl-
4-hydroxylase enzymes (Trackman, 2005). DMOG is an α-ketoglutaric acid analogue
(Thoms and Murphy, 2010) and acts by competing for the active site on the hydrox-
ylase enzyme preventing collagen triple helix formation (GCinzler and Weidmann,
1997).
It was unexpected that supplementation with DMOG would actually increase the
initial rates of contraction, which occurred in the first 3 days. Interestingly, by day 5,
the presence of DMOG significantly slowed down fibrin contraction, with the 100µM
group having a greater effect than 25µM. The maximum and minimum widths of
the 100µM group also differed significantly from both the control and the 25µM
treated group. This behaviour continued and was similarly observed on day 7 of the
study, supporting the hypothesis that collagen synthesis affects the rate of the fibrin















Figure 4.20: Structures of α-ketoglutaric acid and its analogue DMOG.
gel contraction and consequently the maximum and minimum widths of the sinews,
possibly due to remodelling phenomena.
AA+P treatment upregulates COL1A1, RhoA, ACTA2 expression, MMP-
2 and Tenascin-C
The preliminary RT-PCR results showed that COL1A1 expression was significantly
greater in AA+P supplemented constructs than in the controls (Figure 4.17), thereby
supporting collagen content results shown in section 4.3.6. In addition, AA+P in-
creased cell mediated contraction as indicated by upregulated RhoA and ACTA2
expression. RhoA has been implicated in the control of α-sma contractility in non-
muscle cells (Yee Jr et al., 2001; Wheeler and Ridley, 2004). Alpha-smooth muscle
actin has been shown to drive contraction and generation of tensile forces in myofi-
broblasts, (Hinz et al., 2001; Hinz and Gabbiani, 2003a). The roles of RhoA and
α-sma have been discussed in Chapter 2 section 2.3.1.4. The results in this chapter
indicating upregulation of COL1A1, RhoA and ACTA2 help explain the increased
collagen content, extensive contraction of the fibrin matrix and smaller widths ob-
served in AA+P treated constructs in comparison to the non-treated controls.
RT-PCR results also indicated an upregulation of MMP-2 due to AA+P treatment.
MMP-2 is secreted extracellularly as pro-MMP2, which is activated by MT1-MMP
(Kinoh et al., 1996; Haas et al., 1998) and MT1-MMP (MMP-14) has been impli-
cated in the enzymatic degradation of both Collagen Type I and fibrin (Hotary et al.,
2002; Werb, 1997). These results suggested that AA+P increased the rate of fibrin
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remodelling through MMP action and although collagen synthesis was upregulated,
the upregulation of MMP-2 may also have resulted in remodelling and perhaps degra-
dation of newly formed collagen type I. Ahmed et al. (2007) showed the expression
of MMP-2, MMP-3 and MMP-9 in fibrin matrices and that fibrin gel degradation
was reduced by the use of Aprotinin, a serine proteinase inhibitor. Similarly, Collen
et al. (2003) identified the presence of MMP1, MMP2 and MT1-MMP (MMP-14)
expression in cells cultured in collagen-fibrin matrices and Clark (2001) suggested
that MMPs 1, 2 and 3 expressed by fibroblasts were capable of degrading fibrin clots
during wound healing.
Constructs did not form uniformly, though small variations in anchor dis-
tance or size were not responsible for observed differences in supplemented
groups
The above results indicated differences in fibrin gel contraction and maximum and
minimum widths. To fully attribute the difference in contraction to the supplements,
potential sources of error had to be eliminated.
The ratio of maximum to minimum width was determined to better illustrate non-
uniformity of the constructs and to determine if construct irregularity varied signif-
icantly in certain experimental groups and how this difference in construct width
differed with culture duration. Surprisingly, supplementation with AA, P or AA+P
appeared to result in constructs with a ratio closer to 1, when compared to the control
constructs (Appendix B). This was possibly an indication of remodelling or matrix
arrangement process that occurred within. Additionally, anchor positioning is neces-
sary to provide tension required for the formation of TE sinew, as without them, the
extensive contraction and depletion of the fibrin gel occurs resulting in the formation
of small spherical ball (Figure 4.21).
However, anchor distance was not the only factor that could have affected construct
fibrin gel area and maximum/minimum width measurements. Fibrin percentage gel
area measurements were conducted such that the area of the anchors at the measure-
ment plane were subtracted from the total area, to give only the area of the fibrin
gel. As a result, differences in anchor areas could have potentially been the cause
of observed differences between supplemented groups rather than the supplements
themselves (Appendix B).







Figure 4.21: Tensioned and free floating constructs. (A) Image of tensioned and
(B) free floating construct in petri dish after 3 weeks in culture. Confocal images of
a DAPI stained tensioned construct (C) and a free floating construct (D), showing
high proliferation of cells. (E) Cell alignment seen towards anchor edge of tensioned
construct. (F) Almost no cells visible inside the free floating construct. Greatest
cell proliferation is on periphery of tensioned and free floating constructs (E & F).
No significant differences were observed between anchor distances or aspect ratios.
Within individual experiments, no statistical differences were observed between the
visible anchor total surface areas and as a result these were not contributing factors
for the observed differences in the rate of fibrin gel contraction.
4.5 Conclusion
The above results suggested that AA and P had significant effects on the rate of
contraction of the fibrin hydrogel. There were distinct differences between the mor-
phology of control and AA+P supplemented TE sinews. SEM and TEM images re-
vealed that AA+P supplementation affected construct formation in terms of collagen
morphology and the expressed quantity. RT-PCR also confirmed the upregulation
of Collagen type I in AA+P supplemented constructs as well as RhoA, Actin stress
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fibres and MMPs involved in matrix degradation. What was unclear from the results
was whether AA+P also directly impacted fibrin matrix compliance. If AA+P soft-
ened or stiffened the matrix, then it was possible that altering fibrin gel mechanical
properties could replicate the results obtained without supplementation.

Chapter 5
Influence of fibrin gel formulation
on contraction
5.1 Introduction
Chapter 4 showed that AA+P supplementation resulted in overall greater extents
of contraction of the fibrin hydrogel and that this was likely due to upregulated
expression of contraction mediating proteins and proteolytic enzymes. However, it
was unclear what effect supplementation had on fibrin gel compliance.
Scaffold properties are crucial to tissue engineering as cells have been shown to re-
spond to their extracellular environment (Discher et al., 2005; Shapira-Schweitzer
and Seliktar, 2007; Hadjipanayi et al., 2009; Dado and Levenberg, 2009). Optimum
conditions of the scaffold can vary from tissue to tissue and for the cell type utilized
(Dado and Levenberg, 2009). Strategies to improve the mechanical properties of TE
scaffolds include altering the composition of the reagents and cross-linking (Dado and
Levenberg, 2009; Shen et al., 1974; Wolberg and Campbell, 2008). Tissue morpho-
genesis depends not only on intra- and extracellular chemical signals but also on the
spatial arrangement of the matrix (Vogel and Sheetz, 2006) and its stiffness (Discher
et al., 2005), which are sensed through forces generated by cell-matrix adhesion com-
plexes described in Chapter 2 section 2.3.1.2. Researchers have proposed that cell
response to scaffold stiffness is independent from the response to scaffold thickness
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at certain length scales and that further work is required in this area to elucidate the
mechanisms (Buxboim et al., 2010; Lin et al., 2010).
Challenges of producing engineered tissue of the correct size and shape affect several
branches of tissue engineering. For example, cartilage is said to vary in thickness
from 500µm – 7.1mm and tissue engineered constructs should be able to fill defects
of varying shapes and thickness, whilst maintaining cell viability (Bryant and Anseth,
2001; Chen et al., 2003). Ligament and tendon sizes and shape also vary depending
on their location and how they are attached to the bone, which may be wide and
flat, cylindrical, fan or ribbon shaped (Kannus, 2000).
The following experiments were conducted to further help elucidate the mechanism
behind AA+P treatment on construct development by investigating if the mode of
AA+P action was on fibrin gel stiffness. Furthermore, experiments were conducted to
determine if properties of the fibrin hydrogel such as volume and stiffness affected the
rate of contraction of the fibrin gel and the extent to which the gel would contract,
in terms of sinew maximum and minimum widths. If AA+P acted by softening
or stiffening the gel then evaluating contraction without AA+P supplementation at
fibrin gel stiffnesses below or above the standard (control) gel stiffness would result
in constructs with similar geometries and collagen content. Additionally, because
ligaments and tendons vary in size and shape throughout the human body, if fibrin
gel properties affected construct geometry and mechanical strength, then gel stiffness
or thickness could be used to control the rates of contraction and sinew widths whilst
modulating TE sinew collagen content/ tensile strength.
5.2 Materials and Methods
5.2.1 Supplementation of acellular gels with AA+P
Fibrin gels were prepared as previously described (Chapter 3 section 3.2.4). Groups
were divided such that gels were either supplemented with 250µM AA and 50µM P
or non-treated. The gels were left in an incubator at 37◦C for a period of 5 or 7 days.
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5.2.2 Fibrin gel rheology
Gels were prepared for rheology as described in Chapter 3 section 3.5.1.1. Gels of
varying UT/mgF (method described in 5.2.3.3) were either cell seeded or acellular.
Briefly, dynamic oscillatory shear stress (G’/G”) was determined from frequency
sweeps conducted at 1% strain, over 0.1–50 rad/s and at 37◦C. A 40mm SS sand
blasted parallel plate geometry was used on the ARG2 Rheometer (TA Instruments).
For time sweeps, a 40mm truncated geometry was used, set to observe change in G’
during gelation over 1 hour (3600s). Following gelation, in situ strain and frequency
sweeps were conducted.
5.2.3 Construct preparation
5.2.3.1 Altering fibrinogen volume
500µL of sDMEM containing 25µL of thrombin was added to each petri-dish and
spread evenly. Groups were divided such that they contained differing volumes of
fibrinogen: 100µL, 200µL, 500µL and 800µL, which were then left to polymerize for
≈1 hour in an incubator at 37◦C and 5% CO2. Thereafter, cells were seeded at a
density of 100,000cells/mL as described in Chapter 3 section 3.2.
Increasing or lowering the volume of fibrinogen altered the total volume present in
the petri-dish and consequently the thickness of the fibrin gel (Table 5.1). The
standard protocol utilizes a total volume of 700µL of reagents (made up of 500µL
sDMEM with thrombin plus 200µL fibrinogen) to produce fibrin gels of approximately
0.73mm in thickness. The thrombin in sDMEM volume was kept constant at 500µL.
Lowering the volume of fibrinogen added to 100µL decreased the thickness of the gels
to 0.62mm. Additions of 500µL and 800µL fibrinogen resulted in gels of 1.04mm and
1.35mm thick, respectively. An example calculation is shown in Appendix A.
5.2.3.2 Altering total fibrin volume
The sDMEM with thrombin to fibrinogen ratio was kept constant as per standard
formulation (see Chapter 3 section 3.2.4) at 5:2 (from 500µL sDMEM (with thrombin)
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Table 5.1: Approximate fibrin gel thickness at increasing total volume of reagents
in 35mm petri-dish.
Total volume ( µL) 700 600 1000 1300
Fibrin gel thickness (mm) 0.73 0.62 1.04 1.35
to 200µL fibrinogen). Group total volumes were set at 500µL, 700µL, 1000µL and
1500µL total volume. For example, the 500µL total volume group was made up
of 357µL thrombin + 143µL fibrinogen - a ratio of 2.5:1 or 5:2. Gels were left to
polymerize for 1 hour and CTF cells were seeded on top at a density of 100,000
cells/mL, as per standard protocol (Chapter 3 section 3.2.7).
5.2.3.3 Altering fibrin gel stiffness
Relationships of thrombin to fibrinogen used in method 5.2.3.1 were converted to
UT/mgF, which allowed the volumes to be kept constant (Table 5.2).
Table 5.2: Determining UT/mgF from fibrinogen and thrombin volumes.
Fibrinogen stock =  20mg/mL
Thrombin stock = 200UT/mL, added as 50µL per mL of DMEM = 200*0.050 = 10UT/mL sDMEM
Group (µL fibrinogen) 100µL 200µL 500µL 800µL
Milligrams Fibrinogen (mgF) in well 2 4 10 16
Units thrombin (UT) in 500µL Thombin in sDMEM in well 5 5 5 5
Equivalent groups (UT/mgF) 2.50 1.25 0.50 0.313
An example calculation demonstrating how the ratios were determined is available
in Appendix A.
5.2.4 Calcein-AM staining
Gels were stained with calcein-AM and imaged as detailed in Chapter 3 section 3.7.2.
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5.2.5 Cell proliferation
Cells were dissociated from fibrin gels and quantified as described in Chapter 3 section
3.6.
5.2.6 Fibrin fibre diameter and pore sizes
Fibrin fibre diameters were measured from +75 points on SEM images for each group.
Pore sizes of fibrin gels of varying thrombin to fibrinogen ratio, were determined from
cryo-SEM images. 60-65 pore areas were measured per image/ group.
SEM methods were detailed in Chapter 3 section 3.8.1. ImageJ was calibrated using
the scale-bar on the images.
5.3 Results
5.3.1 Supplementation of acellular gels with ascorbic acid +
proline
To determine if AA+P directly affected the stiffness of the fibrin hydrogel, the stiff-
ness of acellular gels, with or without AA+P supplementation on days 0, 5 and 7
were compared to determine if AA+P resulted in softening or stiffening of the fibrin
gel through a direct action on the gel.
Figure 5.1 showed that the gels were robust and linear up to 50rad/s. The experiment
was initially conducted employing a 5 day incubation period. Day 0 gels had an initial
G’ of 51.45 ± 1.65Pa and on day 5, G’ for both the control and AA+P treated gels
had reduced to 40.22 ± 9.45Pa and 45.76 ± 3.08Pa, respectively, at a frequency of
1 rad/s. At the range of frequencies investigated, the groups showed no statistically
significant differences in stiffness from each other.
To determine if longer incubation was required, AA+P treated and non-treated acel-
lular gels were incubated for 7 days. Day 0 control gels had a G’ of 14.54 ± 4.74Pa.
Chapter 5. Fibrin gel formulation 116
A
B
Figure 5.1: Frequency sweeps of acellular fibrin gels. The dynamic shear modulus
of the fibrin gels was measured on day 0 and A) on day 5 and in an independent
experiment on B) day 7 following supplementation with AA+P. Day 5 and 7 control
and AA+P gels did not differ significantly from each other.
By day 7, G’ of the control group had risen to 27.70 ± 3.33Pa, whilst G’ of AA+P
acellular gels had increased to 22.70 ± 9.80Pa. The increase may have been due to
slowed gelation on day 0.
5.3.2 Altering fibrinogen volume
Here, constructs were set up using fibrin gels where the stiffness was adjusted by
increasing or decreasing the volume of fibrinogen used, whilst maintaining the volume
of thrombin in sDMEM constant.
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Fibrin gels prepared using the lowest volume of fibrinogen (100µL) contracted to
the greatest extent by day 3 and those of the highest fibrinogen volume (800µL)
contracted the least (Figure 5.2), indicating that increase in fibrinogen volume and
consequently stiffness reduced extent of fibrin gel contraction.
5.3.2.1 Fibrin percentage gel areas
Measuring fibrin percentage gel areas revealed differences in contraction between the
two lower and two higher fibrinogen volume groups.
On day 3, there were no significant differences in the percentage fibrin gel areas be-
tween the 100µL (10.89 ± 2.50%) and 200µL (13.31 ± 2.56%) groups (p=0.968) (Fig-
ure 5.3A). However, both these groups differed significantly from the 500µL (61.66
± 18.30%) and 800µL (90.19 ± 6.41%) groups, which also differed significantly from
each other (p=0.000 for all instances).
By day 7, the 100µL group had contracted to 2.86 ± 0.22% of the original fibrin
gel area and the 200µL group had reduced to 4.25 ± 0.78% (Figure 5.3B). For the
higher volumes, the percentage gel area for the 500µL group was 21.55 ± 15.80% and
21.23 ± 5.47% for the 800µL group. Differences between the extent of contraction
of the 100µL gel and the 800µL gel were close to 7.5 fold. The trend seen on day 7
continued to the end of the study on day 34, with the two lower fibrinogen volumes
not differing significantly from each other and similarly the two higher volume groups
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Figure 5.2: Images of constructs prepared with varying volumes of fibrinogen. Increasing volume of fibrinogen and conse-
quently stiffness of fibrin delayed contraction of the fibrin gel.
































































































100uL Fibrinogen 200uL Fibrinogen
500uL Fibrinogen 800uL Fibrinogen
Figure 5.3: Effect of changing fibrinogen volume. Fibrin percentage gel areas
between: A) days 0–7, B) days 7–21 and C) days 22–34. Lower fibrinogen vol-
umes of 100µL and 200µL resulted in the fastest rates of fibrin gel contraction in
comparison to higher volumes of 500µL and 800µL.
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5.3.2.2 Construct widths
Throughout the study, it was visibly apparent that increasing the volume of fibrinogen
resulted in increased construct sinew widths (Figure 5.2). Day 3 maximum and
minimum widths of constructs in the 500µL group were 26.15 ± 5.84mm and 20.78
± 9.42mm respectively, differed significantly from those of the 800µL group 33.73 ±
2.07mm and 31.55 ± 2.30mm (Figure 5.4). 100µL and 200µL groups respectively had
maximum widths of 8.14 ± 2.53mm and 8.20 ± 1.40mm and minimum widths of 6.00
± 1.27mm and 6.98 ± 1.05mm, respectively (p >0.05). Although the maximum and
minimum widths of the 100µL and 200µL groups did not differ significantly from each
other, differences were statistically significant when compared to 500µL and 800µL
groups (p=0.000, when 100µL or 200µL was compared to either 500µL or 800µL).
By day 7, maximum and minimum widths of the 500µL and 800µL groups continued
to be significantly greater than those of the lower fibrinogen groups (100µL and
200µL) although they no longer exhibited major differences between each other at
11.03 ± 6.23mm and 12.78 ± 2.76mm for the maximum and 7.45 ± 3.92mm and
9.01 ± 3.31mm for the minimum, respectively. The maximum widths of the 500µL
and 800µL groups were between 3.4 to 4.5 fold greater than those of group 100µL at
2.81 ± 0.45mm and group 200µL at 3.23 ± 0.68mm. Minimum widths of the 100LµL
group were 1.60 ± 0.35mm and 2.67 ± 0.50mm for the 200µL group, which were 4.66
to 8.5 times lower than those of groups 500µL and 800µL. This trend continued for










































































































































































































































Figure 5.4: Effect of fibrinogen volume on construct maximum and minimum widths. On day 3, widths of 500µL and
800µL fibrinogen constructs differed significantly from each other. Throughout the study, both 500µL and 800µL constructs
had significantly greater widths than constructs containing lower volumes of fibrinogen. * denotes p <0.05 compared to other
groups, ** p <0.05 compared to each other.
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5.3.3 Altering total fibrin volume at a constant thrombin to
fibrinogen ratio
The method used in Section 5.3.2 varied both the volume and the stiffness of the
fibrin gel. Consequently it was difficult to come to any firm conclusions about which
property, stiffness or volume was responsible for the observations. The effects of fibrin
volume and fibrin stiffness needed to be decoupled. Keeping the ratio of reagents
constant, only the total volume used to prepare the fibrin gels was altered.
Naturally, increasing the total volume of reagents using a petri-dish of constant di-
ameter, increased the thickness of the fibrin hydrogels (Table 5.3).




Petri dish diameter (mm)
0.73 1.49 2.48 3.71
60606035
0.7 (1X) 4.2 (6X) 7.0 (10X) 10.5  (15X)
5.3.3.1 Fibrin percentage gel areas
At the lowest volume of 500µL, constructs showed a visibly higher extent of contrac-
tion (Figure 5.5A), at 18.01 ± 4.49% on day 3 (Figure 5.5B). The percentage gel area
of the 500µL group was half the value of the 700µL of 37 ± 5.06%, 3.35 times lower
than the 1000µL group of 60.32 ± 6.60% and 4.31 times less than the 1500µL group
of 77.58 ± 8.44%. As such, fibrin gel contraction was appeared to proportional to
fibrin volume.
Comparison of day 3 fibrin gel percentage areas, indicated that all groups had statis-
tically significant differences from each other (p<0.05). This was the general trend
over the course of the 22 day study although on days 4, 7 and 12 no statistically
significant differences were observed between the 500µL and 700µL groups (p=0.529,
p=0.074 and p=0.121, respectively).
On day 12, the 1000µL (10.53 ± 1.39%) group only differed significantly from the
500µL (3.87 ± 0.52%) and the 1500µL (14.47 ± 2.37%) groups whereas the 1500µL
Chapter 5. Fibrin gel formulation 123
differed from all groups (Figure 5.5C). Throughout the study, fibrin gel percentages
were higher with increasing volumes of fibrin. By day 22 fibrin gel percentage areas
had reduced to 2.78% ± 0.25% for 500µL, 3.42 ± 0.13% for 700µ, 4.41 ± 0.29% for
1000µL and 6.10 ± 0.42% for 1500µL (p<0.05 for all group comparisons).
5.3.3.2 Construct widths
Day 7 maximum widths of 500µL constructs (3.84 ± 0.54mm) did not differ signifi-
cantly from those of the 700µL group (4.79 ± 0.42mm) whereas constructs made of
higher initial fibrin gel volumes of 1000µL and 1500µL were much broader and dif-
fered significantly from each other as well as all other groups at 6.12 ± 0.68mm and
9.14 ± 0.72mm, respectively (Figure 5.5D). Minimum widths of all groups differed
significantly from each other at 2.63 ± 0.42mm, 3.92 ± 0.67mm, 5.06 ± 0.47mm and
5.50 ± 0.47mm for 500µL, 700µL, 1000µL and 1500µL, respectively. This trend was
similar on day 12, however on day 22, maximum widths of groups 500µL, 700µL and
1000µL showed no significant differences from each other at 1.82 ± 0.27mm, 2.24 ±
0.25mm and 2.71 ± 0.16mm. Only the maximum widths of the 1500µL group of 4.22
± 0.48mm differed significantly from all other groups. Minimum widths on day 22
were 1.35 ± 0.28mm, 1.74 ± 0.03mm, 2.26 ± 0.23mm and 3.37 ± 0.39mm for groups
500µL, 700µL, 1000µL and 1500µL, in that order (p<0.05, for 1500µL min width








































































































































































































































































































p<0.05, § when compared to 500µL and 700µL on day 7; * compared to 700µL, 
** compared to 500µL and 700µL on day 12, # compared to all other groups.
*p<0.05 maximum width
# p<0.05 minimum width





Figure 5.5: Effect of varying fibrin volume at a constant thrombin to fibrinogen ratio (1.25UT/mgF). A) Images of constructs
prepared using varying volumes of fibrin gel. B) Fibrin percentage gel areas in the first week showing significant differences on
contraction rates between all groups on day 3. C) After the first week, percentage gel areas of the two lowest volume groups
differed significantly from the two highest groups. D) Maximum and minimum widths of the constructs also differed.
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5.3.3.3 Strain sweeps of gels of varying volume/ thickness
Strain sweeps were conducted to determine the linear viscoelastic region (LVR) of
the gels.
Figure 5.6A shows strain sweeps of gels of varying volumes. At low strains (<5%) 6X
and 10X gels exhibited a linear G’ of approximately 7.5 Pa and 10.5 Pa respectively,
whereas 15X gels were linear over a very short period between 0.1% - 0.3% strain
(Figure 5.6B).
The linear viscoelastic region was therefore taken to be below 5% strain as thereafter
the G’ of gels began to decline steadily and the exact critical strain was difficult to
pinpoint. Total disruption of gel structure was taken to be where G” exceeded G’ and
these were at strain of >121.7% for 6X, at 79.84% for 10X and 31.83% for 15X, with
corresponding G’/G” of 0.75Pa/0.60Pa, 0.65Pa/0.74Pa and 1.01Pa/1.02Pa (Figures
5.6 C, D & E).





1% strain 3% strain 10% strain 65% strain
0.29 ± 0.37
10.22 ± 6.92 9.22 ± 6.65 1.01 ± 0.75




7.25 ±1.56 6.59 ± 1.60 3.28 ± 0.89
Average G' ± SD  (Pa)
# *
# and * denote significant difference compared to 15X and 10X /15X, respectively.
Within the LVR region at 1% strain, the stiffness of 6X gels was significantly lower
than 15X gels at 7.4 ± 1.57% (Table 5.4). The strain of the 15X group of 16.36 ±
4.48% was double the value of the 6X gels.
Conversely, at higher strains, it can be seen that 6X remained more robust, with G’
higher than both 10X (1.01 ± 0.75Pa) and 15X (0.29 ± 0.37Pa) gels at 3.28 ± 0.89Pa
(Table 5.4). No significant differences were observed between the 10X and 15X gels
over the range of strains investigated.




Figure 5.6: Strain sweeps of gels of differing total fibrin volume. A) Strain profiles
over the investigated range, 0.1 –120% at 1 rad/s, B) At low strains, gel response
was linear and C) – E) show individual strain curves for gels of volumes 6X, 10X
and 15X. (n=3)
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5.3.3.4 Frequency sweeps of gels of varying volume/ thickness
At constant strains of 1% (within the LVR), gels appeared to stiffen at low angular
frequencies <10rad/s until a plateau was reached, which remained fairly stable over
10rad/s - 50rad/s (Figure 5.7A and B).





11.49 ± 4.29 12.39 ± 4.72 15.64 ± 6.08 17.17 ± 4.96
17.52 ± 2.69 17.95 ± 2.17 21.19 ± 1.79 23.65 ± 1.85
Average G' ± SD  (Pa)
0.5 rad/s 1.0 rad/s 10 rad/s 50 rad/s
7.20 ± 1.25 7.85 ± 1.32 10.36 ± 1.53 9.18 ± 1.05
# significant difference compared to 15X 
*  represents significant difference from both 10X & 15X.
# # # *
A 
B C 
Figure 5.7: Frequency sweeps of gels of differing total fibrin volume. A) Gel
response over the range 0.1 –50rad/s. B) Profiles suggested a slight frequency
dependency at <10rad/s although this was not significant C). Overall, the G’ of
the low volume gel 6X was significantly lower than the highest volume gel 15X.
(n=3)
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G’ of 6X differed significantly from the 15X group at angular frequencies <10rad/s
(Table 5.5), indicating that increasing volume increased stiffness of the gels as they
resisted small deformations. However, in Figure 5.7C, it can be seen that for each
curve, G’ of successive points at <1rad/s do not differ significantly from each other
in magnitude. As a result, the gels were taken to be frequency independent.
5.3.4 Altering fibrin gel stiffness (thrombin to fibrinogen ra-
tio) whilst maintaining a constant volume
To determine the effect of fibrin gel stiffness on contraction the ratios of thrombin to
fibrinogen were altered whilst maintaining a constant fibrin volume of 700µL. It was
observed that with decreasing thrombin to fibrinogen ratios, the extent of contraction
of the fibrin gel decreased. By day 7 and throughout the rest of the study, 2.5UT/mgF
























Figure 5.8: Effect of varying fibrin gel stiffness whilst maintaining a constant fibrin volume. Gel formulations were such that
the higher the thrombin:fibrinogen ratio was then the softer the gel. By day 35 constructs of the softest gel had contracted the
gel the most and were thinnest whereas constructs of the stiffest gel were broadest.
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5.3.4.1 Fibrin percentage gel areas
On day 3, the percentage fibrin gel area of 2.5UT/mgF was lowest (25.21 ± 8.70%)
and differed significantly from 0.5UT/mgF (58.96 ± 9.11%) and 0.313UT/mgF (77.68
± 20.09%) but not from 1.25UT/mgF controls (40.65 ± 6.28%) (Figure 5.9A).
The 1.25UT/mgF (control) group only differed significantly from the 0.313UT/mgF
group.
By day 7, percentage gel areas of all groups had decreased to approximately 20%
of day 3 percentage gel areas and were greater with increasing stiffness/ decreasing
UT/mgF. Percentage gel areas were 5.18 ± 0.64%, 8.59 ± 0.96%, 14.64 ± 2.19%
and 17.50 ± 4.63% for 2.5UT/mgF, 1.25UT/mgF, 0.5UT/mgF and 0.313UT/mgF,
respectively (Figures 5.9A & B). Groups 0.5UT/mgF and 0.313UT/mgF differed
significantly from 1.25UT/mgF and 2.5UT/mgF, though not from each other.
Changes between days 14 and 21 were very small although the stiffer the fibrin gels
were the greater the change in fibrin percentage gel area was. For groups 2.5UT/mgF,
1.25UT/mgF, 0.5UT/mgF and 0.313UT/mgF the reduction in fibrin percentage gel
areas from day 14 to 21 were 0.46 ± 0.11%, 0.41 ± 0.08%, 0.9 ± 0.42% and 1.32 ±
0.22%, respectively (p<0.05 between all groups) (Figure 5.9B & C). Percentage of
original fibrin gel areas on day 21 were 2.76 ± 0.20%, 3.83 ± 0.46%, 5.45 ± 0.30%
and 6.16 ± 0.25% (group ratios descending; all groups differed significantly from each
other (p<0.05)).
Day 35 percentage gel areas had further reduced to 1.68 ± 0.30%, 2.13 ± 0.36%, 3.07
± 0.42% and 3.52 ± 0.41% (p<0.05 between groups 2.5UT/mgF, 1.25UT/mgF and
0.5UT/mgF, 0.313UT/mgF). Decrease in percentage gel areas between days 21 and
35 were 0.61, 0.56, 0.56 and 0.57 fold for 2.5UT/mgF, 1.25UT/mgF, 0.5UT/mgF and
0.313UT/mgF, respectively.
5.3.4.2 Construct widths
The trend shown by the maximum and minimum widths on day 3 differed slightly
from percentage gel areas shown above in that significant differences in width were



































































































Figure 5.9: Fibrin gel percentage areas of constructs of prepared from fibrin gels
of varying stiffness. A) shows fibrin percentage gel areas between days 0–7, B)
between days 7–21 and C) days 21–35. Decreased thrombin to fibrinogen ratios
(UT/mgF) reduced the rates and extent of contraction.
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observed between constructs of the softest (2.5UT/mgF) and stiffest (0.313UT/mgF)
gel formulations, which also differed from the other two groups (Figure 5.10A).
Increased rates of contraction in the 1.25UT/mgF (control) and 0.313UT/mgF groups
led to comparable max/min widths between the 2.5UT/mgF and 1.25UT/mgF and
between 0.5UT/mgF and 0.313UT/mgF on day 7 (Figure 5.10B).
All maximum widths differed significantly from each other on day 14. However,
the minimum widths of both the 2.5UT/mgF and 1.25UT/mgF constructs differed
significantly from groups 0.5UT/mgF and 0.313UT/mgF but not from each other.
Interestingly, on day 21 all minimum widths differed from each other. The maximum
widths differed of groups 2.5UT/mgF and 1.25UT/mgF differed from each other as
well as from both 0.5UT/mgF and 0.313UT/mgF. This was perhaps indicative of
limits on maximum widths posed by the anchors, not present in minimum widths
thereby allowing them to contract further.
After 5 weeks in culture, maximum widths of 0.313UT/mgF constructs were signifi-
cantly broader than of both 1.25UT/mgF and 2.5UT/mgF (day 35). This was likely
due to contraction still occurring in 0.313UT/mgF maximum widths but due the
higher stiffness of the fibrin matrix, constructs were still wider than constructs of
softer fibrin gel formulations. Again, all minimum widths differed significantly from
each other, perhaps as no restrictions were posed on minimum widths by the anchors.
5.3.4.3 Fibrin fibre diameters and pore sizes
SEM images were used to quantify fibrin fibre diameters (Figure 5.11b, c and d).
Measurements of average fibre diameter showed large variations in the 2.5UT/mgF
group of 0.13 ± 0.078µm (Figure 5.11). Average fibre diameters of the 1.25UT/mgF,
0.5UT/mgF and 0.313UT/mgF groups were 0.092 ± 0.015µm, 0.090 ± 0.038µm and
0.074 ± 0.016µm, respectively, (p>0.05). This was surprising, as stiffer fibrin gels
produced from lower thrombin volumes are said to result in thicker fibrin fibres.
Images showing the cryo-fractured structure of the gels suggested porosity decreased
with decreasing UT/mgF ratios, with a greater extent of pore variation occurring
in the 0.313UT/mgF group (Figure 5.12). Pore size analysis indicated statistically





























































































































































































































































































































































































































































Figure 5.10: Effect of fibrin gel stiffness on sinew maximum and minimum widths.
On day 3 maximum and minimum widths of the 2.5UT/mgF group differed sig-
nificantly from all other groups, as did the 0.313UT/mgF. Over the 5 week study,
widths continued to vary although differences mainly occurred between either just
the maximum or the minimum widths. p<0.05 for * max width, ** min width and
# compared to all group max widths.



























Figure 5.11: Analysis of fibrin fibre diameters. a) No statistically significant
differences were observed between fibre diameters. SEM images of a) Control
(1.25UT/mgF) gels , b) 2.5UT/mgF gels and c) 0.313UT/mgF gels. Scale bar is
2µm for b & c and 1µm for d.
relevant variances between the 0.313UT/mgF and 1.25UT/mgF control (p=0.000)
and 2.5UT/mgF (p=0.031) groups. 0.313UT/mgF had an average pore size of 195
± 223µm2 (p<0.05), whilst that of 1.25UT/mgF control was 66 ± 58 µm2 and
2.5UT/mgF was 127 ± 223µm2 (Figure 5.12). Differences between the control and
the 2.5UT/mgF group were not statistically significant (p=0.064). However, because
the number of pore sizes above 400µm2 increased in the stiffer gels of decreasing
thrombin, this was in line with the literature, which report that stiffer gels are more
porous.







Figure 5.12: Analysis of fibrin pore sizes. Images of cryo-fractured fibrin gels were
used to measure scaffold pore sizes: A) Control 1.25UT/mgF gels, B) 2.5UT/mgF
gels and C) 0.313UT/mgF gels. Increase in fibrin gel stiffness resulted in a number
of pore sizes above 400µm2.
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5.3.4.4 Gelling kinetics of fibrin gels of varying thrombin to fibrinogen
ratio
Gelling kinetics of fibrin gels where quantities of thrombin and fibrinogen were altered
were investigated. This was done to observe differences in stiffness during polymeri-
sation and completion of gelation at the 1 hour time point, which is the about the
time when cells are seeded on the gels during construct formation.
It was observed that gelation began to occur almost instantaneously upon mixing
as G’ was higher than G” at time t=13s (Figure 5.13). For all gels, there appeared
to be an increase in G’ until an initial stable plateau was reached, which was fol-
lowed by a second steady increase in storage modulus. This phenomenon was more
readily noticeable in 1.25UT/mgF and 0.313UT/mgF gels. The points at which
these plateau were reached were at approximately 12Pa, 14Pa and 18Pa for gels
2.5UT/mgF, 1.25UT/mgF and 0.313UT/mgF, respectively, at times 2500s, 2900s
and 2300s, in aforementioned order. Referring to the review by Weisel (2004), this
is likely the gel point, which is reached when at least 10% of the fibrinogen has
polymerized, followed by further branching to increase the stiffness of the gel. After
an hour, the storage modulus of 0.313UT/mgF was higher than for 2.5UT/mgF
and 1.25UT/mgF gels (Table 5.6). No significant differences were seen between
2.5UT/mgF and 1.25UT/mgF.
Table 5.6: G’ of gels of varying thrombin to fibrinogen ratio at t=3600s.
Group 2.5UT/mgF 1.25UT/mgF 0.313UT/mgF























≈  2500s 
≈ 14Pa 
≈  2900s ≈ 18Pa 
≈  2300s 
A B 
C D 
Figure 5.13: Time sweeps of gels. A) Gelation profiles of prepared using varying thrombin to fibrinogen ratios. An initial
peak was reached, followed by further increase in stiffness. This occurred at close time points. Individual gelation curves are
shown from B to D. (n=3)
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In-situ strain sweeps of gels (following time sweep), showed gels had strain-dependent
stiffening behaviour at very low strain <0.5% (Figure 5.14). This LVR was lower than




Figure 5.14: Strain stiffening behaviour at low % strain. A) In-situ strain sweeps
following gelation. The strain stiffening behaviour is more apparent in the separate
plots B) to D).
5.3.4.5 Mechanical behaviour of acellular fibrin gels of varying thrombin
to fibrinogen ratios
Rheology tests were conducted on fibrin gels of varying thrombin to fibrinogen ratios,
which were gelled in an incubator.
Strain sweeps
Response of acellular fibrin gels to deformations of increasing amplitude indicated
that 2.5UT/mgF and 1.25UT/mgF gels were linear at strains<5% although 0.313UT/mgF
appeared to almost immediately slowly deform (Figure 5.15).
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At 1% strain, G’ for gels were 20.27 ± 4.41Pa, 50.90 ± 1.74Pa and 121.67 ±
10.46Pa for gels 2.5UT/mgF, 1.25UT/mgF and 0.313UT/mgF respectively. The
G’ for 0.313UT/mgF gels was over 2-fold greater than that of the control gels
(1.25UT/mgF).
Corresponding G” were 2.02 ± 0.66Pa, 5.16 ± 1.74Pa and 14.64 ± 2.28Pa. Cross
over of G’ and G” occurred at about 65% strain for 2.5UT/mgF and 1.25UT/mgF
gels and 50% strain for 0.313UT/mgF gels. G’ at these points were 1.73 ± 1.03Pa
(2.5UT/mgF), 6.71 ± 2.46Pa (1.25UT/mgF) and 13.96 ± 1.03Pa (0.313UT/mgF).
Frequency sweeps
There were no interactions between G’ spectra of all groups depicting statistically
significant differences. The response was linear, further emphasising the robustness
of the gels to deformation (1% strain). However, G” response to increasing angular
frequency for 2.5UT/mgF and 1.25UT/mgF gels were almost identical whereas G”
for 0.313UT/mgF gels was significantly higher than for other groups.
5.3.4.6 Effect of cell presence on fibrin gel rheological response
To determine whether the presence of CTF cells altered fibrin gel response either
by stiffening or softening the gels, possibly due to the secretion of MMPs, frequency
sweeps were conducted on gels 5 days post cell seeding. Similar to gels in the previous
section, the gels were relatively frequency independent. The presence of cells on the
fibrin gels did not affect the stiffness of the gel in the first 5 days as G’ of cell seeded
and acellular 1.25UT/mgF gels did not differ in magnitude (Figure 5.17).
5.3.4.7 Cell morphology on fibrin gels
Fibrin gels of varying thrombin to fibrinogen ratios, fixed in place to prevent contrac-
tion of the gel, were seeded with CTF cells and left to incubate for 3 days, to evaluate
the effect of gel mechanics on cell morphology and proliferation. Light microscopy
images of the gels at 4X magnification suggested proliferation was highest in gels
of highest thrombin to fibrinogen ratio (2.5UT/mgF) and lowest in the stiffest gels
(0.313UT/mgF) (Figure 5.18). At higher magnification (10X), cells on 2.5UT/mgF





Figure 5.15: Strain sweeps of gels of varying thrombin to fibrinogen ratios. A)
At zero shear, G’ of gels differed significantly. Behaviour of all gels B) – C) was
non-linear at high strains and linear only at very low strains <5% (E). (n=3)
Chapter 5. Fibrin gel formulation 141
A 
B C 
Figure 5.16: Frequency sweeps of gels of varying thrombin to fibrinogen ratios.
A) Gels were fairly robust over the frequency range at a low strain of 1% and the
results confirmed that lowering UT/mgF significantly increased gel stiffness. B)
Frequency independence at high frequency as well as (C) low frequency (<1rad/s).
(n=3)
appeared elongated or more spindle shaped. On the 1.25UT/mgF and 0.313UT/mgF
fibrin gels, cells possessed slight dendritic extensions though some cells on the stiffest
gels also appeared smaller and rounded. Using live/dead staining, contrasting re-
sults were seen, with 2.5UT/mgF showing the least amount of proliferation, however,
cell morphology was in agreement with that seen using light microscopy. Live/dead
staining of cells on 0.313UT/mgF gels, showed a mixture of rounded and elongated
cells as well as directional alignment. Cell viability was high in all gel groups and no
significant amount of dead (red) cells were seen.
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A 
B C 
Figure 5.17: Frequency sweeps of gels of varying stiffness seeded with cells.
A) Frequency sweeps of gels seeded with CTF cells following 5 days of incuba-
tion. B) No differences were observed between acellular and cell seeded control/























Figure 5.18: CTF cell proliferation on contraction inhibited fibrin gels on day 3. A) Light microscopy images of cell. B) Images
taken using light microscopy with phase contrast showed greater proliferation in softer gels than stiffer gels. C) Conversely,
confocal images of calcein-AM and propidium iodide (live/dead) stained gels indicated greater proliferation in stiffer matrices.
Scale bars are 250µm, 100µm and 150µm for 4X, PH10X and 20X, respectively.
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5.3.4.8 Cell proliferation within constructs
Due to the contrasting results seen in section 5.3.4.7 regarding cell proliferation, it was
necessary to detach the cells from gels/ constructs. To determine how cells proliferate
on gels of varying stiffness during TE L/T formation, constructs were allowed to form
TE sinews by permitting contraction of the fibrin hydrogel. Day 3 results showed the
number of live cells on 2.5UT/mgF gels to be lowest at 2.6× 105 ± 5.1× 104 cells and
significantly different (p<0.05) when compared to groups 1.25UT/mgF (3.6× 105 ±
1.0× 105 cells), 0.5UT/mgF (3.0× 105 ± 1.6× 105 cells) and 0.313UT/mgF (4.1× 105















































































































Figure 5.19: Proliferation of CTF cells seeded on gels of varying stiffness. Gen-
erally, cell proliferation increased with increasing gel stiffness.
Proliferation was highest for the stiffer gels 0.5 & 0.313 UT/mgF on day 7, with
live cell numbers of 8.3× 105 ± 1.5× 105 cells and 8.6× 105 ± 2.7× 105 cells,
respectively. These cell numbers were approximately 250% greater than those of
1.25UT/mgF (control) constructs (3.4× 105 ± 1.3× 105 cells) and approximately
700% higher than live cell numbers of the softest gel 2.5UT/mgF (1.2× 105 ±
4.8× 104 cells) (p<0.05).
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Day 14 saw a decline in live cell numbers in the 0.5UT/mgF and 0.313UT/mgF by
17% and 12%, to 6.9× 105 ± 1.0× 105 cells and 7.6× 105 ± 1.9× 105 cells, in that or-
der. Live cell numbers on the softer gels increased by 53% for 1.25UT/mgF (5.2× 105
± 8.8× 104 cells) and by and 281% for 2.5UT/mgF (4.6× 105 ± 1.2× 105 cells). Dif-
ferences in live cell number on day 14 between 2.5UT/mgF and both 0.5UT/mgF and
0.313UT/mgF were statistically significant as were differences between 1.25UT/mgF
and 0.313UT/mgF (p<0.05). Generally, a stiffer gel formulation promoted cell pro-
liferation in the early stages of contraction, but after prolonged culture attenuated
growth.
5.3.4.9 Histological morphology of constructs
Figures 5.20A and B show longitudinal sections of 0.313UT/mgF and 1.25UT/mgF
(control) constructs, respectively, stained with H&E. Similar to constructs in chapter
4, a larger number of cells were present on the periphery of the constructs (nuclei
stained dark blue). Cells appeared to be aligned in the central portion of the con-
trol constructs, along the direction of tension (Figure 5.20B). At the pinned end of
a control construct, it can be seen that the cells aligned themselves following the
curvature of where the pin was placed (Figure 5.20D). Upon closer magnification of
0.313UT/mgF constructs, cells also appeared to align themselves in the direction of
tension although the constructs were less densely packed with cells; in addition, the
greatest alignment and density of cells occurred within the folds of the 0.313UT/mgF
constructs, indicating that the increase in fibrin gel stiffness had not impacted cell
migration and proliferation (Figure 5.20C). Cross-sectional images (Figures 5.20E to
H) also revealed constructs to be surrounded by a thin layer rich in cells. Fibrilla-
tion was present within the constructs although perhaps this may have been a result
of processing artefacts or due to the folding nature of formation (Figure 5.20G and
H). The rolling mechanism that occurs during TE L/E formation was particularly
prominent in 0.313UT/mgF constructs (Figure 5.20E).
5.3.4.10 Construct collagen content
Chapter 4 results suggested there was a relationship between construct collagen con-
tent and fibrin gel contraction. To determine whether fibrin gel stiffness played a role








Figure 5.20: Histology of 0.313UT/mgF and control (1.25UT/mgF) constructs.
A) Longitudinal section of 0.313UT/mgF construct. Cells were aligned in the
mid-substance along the direction of tension (C) and cross-sections (E) revealed
the presence of the rolling mechanism seen during formation resulting in a central
fold (G). Cells were observed throughout the construct. Control (1.25UT/mgF)
longitudinal section (B) showed the presence of aligned cells. Where pins were
used, cells aligned around the pin edge (D). Cross-sections of control constructs
(F) and (H) showed folds within the sinew and cell presence.
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in cell collagen synthesis, collagen content of week 5 sinews was evaluated. No statis-
tically significant differences were found between the collagen contents of all groups,
which had collagen contents of 17.89± 7.54% (1.25UT/mF / control), 22.38± 13.65%
























Figure 5.21: Collagen content of constructs.
5.3.4.11 Construct tensile strength
Figure 5.22 shows the load vs. extension curves of constructs prepared using fibrin
gels of varying stiffness. The stiffest constructs had the highest maximum load of 201
± 32mN, which showed statistical variation from the maximum load of constructs of
the softest fibrin gel of 136 ± 30mN (Figure 5.22C). No significant differences were
observed when compared to the control group (1.25UT/mgF) whose maximum load
was 182 ± 26mN or compared to 0.5UT/mgF at 188 ± 37mN.
As the constructs varied in dimensions (maximum and minimum widths), these were
taken to be a factor that would affect maximum/ minimum stresses withstood by the
constructs (see section 5.3.4 on construct max/min widths). 2.5UT/mgF constructs
being smallest in width had the highest maximum and minimum tensile stresses
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of 122.05 ± 25.13kPa and 80.71 ± 27.94kPa (Figure 5.22B). Maximum stresses of
groups 1.25UT/mgF, 0.5UT/mgF and 0.313UT/mgF were 73.96 ± 5.83kPa, 59.89 ±
13.39kPa and 75.23 ± 12.18kPa, whilst the minimum stresses were 37.75 ± 16.00kPa,
33.59 ± 14.74kPa and 60.12 ± 11.87kPa, in stated group order. The maximum stress
of the 2.5UT/mgF group differed significantly from all other maximum stresses, whilst
its minimum stress varied significantly only from 1.25UT/mgF and 0.5UT/mgF min-
imum stresses. Strain at ultimate load/ stress showed a slight decrease with in-
creasing fibrin gel stiffness although differences were only significant between groups
1.25UT/mgF (1.29 ± 0.51) and 0.313UT/mgF (0.34 ± 0.19).
The Young’s (elastic) modulus of the constructs was calculated from the initial linear
portion of the stress/strain curves (Figure 5.23). Group 1.25UT/mgF appeared to
have the lowest elastic modulus (based on the minimum stress profile, which would be
the limiting case) of 132 ± 106kPa. Elastic modulus values for groups 2.5UT/mgF,
0.5UT/mgF and 0.313UT/mgF were 281 ± 84kPa, 200 ± 110kPa and 335 ± 196kPa,
respectively. Due to the large standard deviations in these results, no statistically



















































































Figure 5.22: Tensile test results. A) Load vs extension curves of constructs. B) Stresses are dependent to geometry of
constructs whereas maximum loads (C) can be quoted irrespective of construct maximum or minimum widths. D) 0.313UT/mgF
had lower strains and significantly differed from the controls. * represents significant difference at p<0.05.
























Figure 5.23: Young’s Modulus of constructs due to scaffold stiffness. Increasing
fibrin gel stiffness did not increase stiffness of constructs after 5 weeks of culture.
5.4 Discussion
AA+P supplementation of acellular gels did not affect gel stiffness
Rheological tests suggested that AA+P had no effect on the stiffness of acellular fibrin
gels. This suggested that differences observed between AA+P treated constructs and
the control where largely due to cell mediated processes. In Chapter 4 it was shown
that AA+P treated constructs contracted the fibrin hydrogel to a greater extent and
contained significantly higher quantities of collagen than non-treated control con-
structs. The relationship between ascorbic acid and fibrin(ogen) needs to be further
studied as AA has been shown to polymerise fibrinogen without thrombin (Marx and
Chevion, 1985). Studies are also available, which show that AA enhances fibrinolysis,
but these were in the presence of endothelial cells (Kojima et al., 1986). As a result,
since AA+P supplementation showed no direct effects on fibrin mechanical strength,
further evaluation into the influence of other cell variables with or without AA+P
was required.
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Increasing fibrinogen volume and stiffness did not limit TE ligament for-
mation
Degradation rates of TE scaffolds are known to be crucial to providing cells with suf-
ficient time for new extracellular matrix deposition (Wu and Ding, 2004). Increasing
the volume of fibrinogen used to prepare constructs resulted in considerable differ-
ences in the rates of contraction of the fibrin hydrogel, particularly between the gel of
the lowest fibrinogen volume (100µL) and the highest volume (800µL) (Section 5.3.2,
Figure 5.3). The widths of the lowest volume constructs visibly resembled constructs
treated with AA+P, however, they were not significantly different from the controls
(Figure 5.4). Surprisingly, at almost double the total volume of reagents used in
the standard protocol (700µL) at 1300µL and a fibrin gel thickness of 1.35mm, cells
were still able to contract and form a ligament-like sinew between the anchors. This
suggested that the increase in fibrinogen volume to 800µL was not limiting to the
formation of TE ligaments although correct biological morphology was not assessed
at this point. It was visualized that since cells were seeded on top of the fibrin gels
rather than entrapped within the gels, nutrient diffusion distances would be lower
than for the latter case and still provide adequate mass transfer, additionally due to
the replenishment of medium every two to three days (Figure 5.24). The assump-
tion was: if the cells were able to migrate to a certain distance within the gel, then
nutrient transfer would also be possible to/from that location.
The data suggested that increasing stiffness had a greater effect on con-
traction than increasing volume
In order to uncouple the effects of changing volumes and stiffness, constructs were
prepared at constant ratios of thrombin to fibrinogen as per standard protocol but
with changing total volumes. The results indicated that fibrin volume alone could be
used to control the rate of fibrin depletion and consequently construct dimensions.
When compared with results from section 5.3.2 on day 3, the percentage gel area
of the 800µL fibrinogen group was 8.28 times larger than the 100µL group (Figure
5.3). However, where only the volume was altered the increase in percentage gel
areas between lowest and highest volume was only 4.31 fold. This suggested that
stiffness played a greater role on fibrin gel contraction rates, especially considering
that the 800µL group had a higher average fibrin percentage gel area of 90.19 ±
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A
Distance x between cells remains constant despite increase fibrin volume.
Initial diffusion distance y  between  medium and cells also remains constant.
Volume 1 Volume 2 Volume 3
B
Entrapment of cells within fibrin gels leades to greater distances between cells, if cell number is kept constant.
Diffusion distance y also increases to a greatly limiting extent.
Volume 1 Volume 2 Volume 3
  
                               
  
                               







Figure 5.24: Visualized effect of increasing fibrin volume on diffusion distances.
6.41% yet a lower total fibrin volume of 1300µL when compared to the 1500µL group
where only the total volume was altered at constant stiffness. Day 22 showed similar
relationships between the effect of volume and stiffness due to changing fibrinogen
volume. The difference in percentage gel areas between the highest volume of 1500µL
was only 2.19 times greater in percentage gel area than the lowest volume group
(500µL), however, when compared with changing fibrinogen groups, the percentage
gel area of 800µL fibrinogen (of total volume 1300µL) was 6 fold greater than that
of the 100µL fibrinogen group (total volume 600µL), again suggesting that at the
particular stiffnesses and volumes used, stiffness had an additional effect on rates of
contraction at those high volumes.
When the stiffness of the gels was altered whilst maintaining a constant volume (using
similar ratios of thrombin to fibrinogen as in section 5.3.2, where fibrinogen volume
was increased), no differences were seen between the percentage gel areas of the two
softest gel groups compared to the two stiffest gels in the first week, suggesting that
differences in the stiffnesses of groups 2.5UT/mgF and 1.25UT/mgF had no effect of
the rate of contraction (see section 5.3.4). However, as expected, the result showed
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that increasing the stiffness of the gel slowed the rate of fibrin gel contraction and
consequently increased the final maximum and minimum widths of the constructs, at
stiffnesses above 0.5UT/mgF. Final average maximum widths of the experiment were
fibrinogen volumes (and stiffness) were increased, were 41.4% larger at 4.37mm ±
0.55mm for 800µL fibrinogen (Figure 5.4) than those were stiffness alone was altered
at constant volume, 3.09mm ± 0.38mm for 0.313UT/mgF. Minimum widths of the
800µL group were also larger than for 0.313UT/mgF, though only by 29%. These
results further suggested that although the 800µL group was at nearly double the
volume of the 0.313T/mgF group, the effect of volume alone on construct maximum
and minimum widths was smaller.
Although the data was not shown, it is important to note that at higher stiffness
the 500µL and 800µL, were thicker than standard constructs prepared at total fibrin
volumes of 700µL and of a more rectangular shape rather than circular. As such,
there was a dimension neglected, in order to preserve sterility during tissue culture.
Comparison of contraction data further suggested that increasing total fib-
rin volume or increasing stiffness (lowering thrombin to fibrinogen ratios)
have the same effect
Figure 5.25 compared results of all the contraction experiments in this chapter and
it appeared to indicate that generally, increasing fibrinogen volume had the same
effect as increasing volume at constant stiffness, which in turn had the same effect
as increasing stiffness at constant volume. The red highlighted groups were the
control groups, all at similar stiffness and volume, and as their percentage fibrin gel
areas and maximum/minimum widths, seem to vary from one experiment to another,
made it difficult to form definitive conclusions about variations between experiments,
although differences between groups within each experiments were very clear.
Extent of contraction is proportional to total quantity of fibrinogen
Within experimental groups, increasing the volume of fibrin or increasing stiffness or
both would naturally increase the amount of fibrin matter present, which would result
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Altering fibrinogen volume (and stiffness) Altering volume at constant stiffness Stiffness at constant volume
100µL fibrinogen 500µL volume 2.5UT/mgF 
200µL fibrinogen 700µL volume 1.25UT/mgF  
500µL fibrinogen 1000µL volume 0.5UT/mgF 
800µL fibrinogen 1500µL volume 0.313UT/mgF  
10.89%  ± 2.50% 18.01%  ± 4.49% 25.21%  ± 8.70%
13.31%  ± 2.56% 37.00%  ± 5.06% 40.65%  ± 6.28%
61.66%  ± 18.30% 60.32%  ± 6.62% 58.96%  ± 9.11%
90.19%  ± 6.41% 77.58%  ± 8.44% 77.68%  ± 20.09%
1.22% ± 0.17%  2.78%  ± 0.25% 2.76%  ± 0.20%
2.24% ± 0.45%  3.42%  ± 0.13%  2.83%  ± 0.46%
7.68% ± 4.01%  4.41%  ± 0.29%  5.45%  ± 0.30%
7.38% ± 0.54%  6.10%  ± 0.42% 6.16%  ± 0.25%
1.10% ± 0.10% 1.68% ± 0.30%
2.09% ± 0.38% 2.13% ± 0.36%
7.36% ± 4.98% 3.07% ± 0.42
6.63% ± 0.58% 3.52% ± 0.41%
Altering fibrinogen volume (and stiffness) Altering volume at constant stiffness Stiffness at constant volume
8.14mm  ± 2.53mm 9.40mm ± 2.00mm 12.24mm ± 2.37mm
8.20mm  ± 1.40mm 17.35mm  ± 2.94mm 17.40mm  ± 2.17mm
26.15mm  ± 5.84mm 23.56mm ± 1.80mm 21.00mm  ± 2.84mm
33.73mm  ± 2.07mm 35mm  ± 0.00mm 32.21mm  ± 4.42mm
1.14mm ± 0.04mm  1.82mm ± 0.27mm 2.01mm  ± 0.22mm
1.68mm ± 0.20mm  2.24mm  ± 0.25mm  2.83mm ± 0.35mm
5.28mm ± 2.26mm 2.71mm ± 0.16mm  3.61mm  ± 0.33mm
5.19mm ± 0.35mm  4.22mm  ± 0.48mm 3.87mm  ± 0.23mm
0.98mm ± 0.08mm 1.81mm ± 0.35mm
1.51mm ± 0.21mm 2.54mm ± 0.30mm
4.33mm ± 2.59mm 2.72mm ± 0.28mm
4.37mm ± 0.55mm 3.09mm ± 0.38mm
Altering fibrinogen volume (and stiffness) Altering volume at constant stiffness Stiffness at constant volume
6.00mm  ± 1.27mm 7.42mm  ± 1.67mm 8.96mm  ± 1.50mm
6.98mm  ± 1.05mm 12.70mm ± 1.92mm 15.40mm  ± 1.81mm
20.78mm ± 9.42mm 21.74mm  ± 2.20mm 19.98mm  ± 2.81mm
31.55mm ± 2.30mm 33.00  ± 0.00mm 30.33mm ± 4.43mm
0.69mm ± 0.09mm  1.35mm  ± 0.28mm 1.25mm ± 0.12mm
1.42mm ± 0.19mm  1.74mm ± 0.03mm  1.98mm  ± 0.14mm
3.66mm ± 1.41  2.26mm  ± 0.23mm 2.58mm  ± 0.12mm
3.84mm ± 0.26mm  3.37mm  ± 0.39mm 3.11mm  ± 0.54mm
0.64mm ± 0.14mm 1.19mm ± 0.14mm
1.19mm ± 0.22 1.58mm  ± 0.13mm
3.51mm ± 1.70mm 2.05mm ± 0.19mm














Figure 5.25: Comparison of percentage fibrin gel areas, maximum and minimum
widths of experimental groups. The control groups are shown in red.
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in the constructs taking longer to contract. However, cell processes such as prolifer-
ation, cell mediated contraction and cell enzymatic digestion, which could increase
or decrease in response to scaffold and other extracellular environment signals could
not be predicted, making these experiments necessary. By quantifying the actual mg
of fibrinogen present and using equations from Wufsus et al. (2013) (equations 5.1
and 5.2) to determine the overall fibrin fibre volume fraction φf , it was found that
there were correlations between the rates and extents of contraction with the total
mg of fibrinogen used to prepare the fibrin gels (Table 5.7, an example calculation is
shown in Appendix A).
Φint = 0.015ln(cFbg) + 0.13





where cFbg is fibrinogen concentration, ρm is fibrinogen density
(5.2)
Table 5.7: Estimated fibrin fibre volume fraction in experimental groups. The
control groups are shown in red.
Fibrinogen vol Fibrinogen (mg) Vf (фf) (%) Fibrin volume Fibrinogen (mg) Vf (фf) (%) Stiffness Fibrinogen (mg) Vf (фf) (%)
100µL 2.00 1.61 500µL 2.86 2.62 2.5UT/mgF 2.34 1.61
200µL 4.00 2.61 700µL 4.00 2.61 1.25UT/mgF 4.00 2.61
500µL 10.00 4.34 1000µL 5.72 2.62 0.5UT/mgF 7.00 4.34
800µL 16.00 5.24 1500µL 8.58 2.62 0.313UT/mgF 8.62 5.25
Experiment 1 Experiment 2 Experiment 3
The increase in φf of experiment 1 and constant φf of experiment 2, explain why, dra-
matic differences in percentage gel areas/ widths were observed between the 800µL
and 100µL fibrinogen groups and more moderate variances occurred between the
1500µL and 500µL fibrin volume groups. The stiffest groups (800µL and 0.313UT/mgF)
had twice the fibrin fibre volume fraction of the controls (shown as red). Consider-
able increases in fibrinogen content and consequently φf , were more readily achieved
by increasing stiffness (i.e. lowering thrombin to fibrinogen ratio) than by increas-
ing fibrinogen volume – the former also potentially reduces the amounts of reagents
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used. This suggested that mechanical strength and dimensions of TE tissues could
be tailored to a certain extent by altering the stiffness of fibrin scaffold or increas-
ing the fibre volume fraction by modulating only the stock concentrations, whilst
maintaining the thrombin to fibrinogen ratio. This could potentially be applicable
to various branches of tissue engineering. For example, if larger/ broader tissues are
desired then only the total volume would need to be altered at a specific thrombin to
fibrinogen ratio/ fibrinogen concentration, provided the volumes are not limiting to
cell survival. Alternatively, gel stiffness could be increased by adjusting thrombin to
fibrinogen ratios or increasing the concentrations of both stock solutions to increase
the fibrin fibre volume fraction as shown in Table 5.7. Possibly culture periods could
also be adjusted to control sinew mechanics and dimensions.
Gel mechanical characteristics
Gels possess very low LVRs (<5%) and are frequency independent
Cells have been shown to respond to the stiffness of the matrix or scaffold resulting in
variations of cell shape, gene expression and myosin dependent contractility (Discher
et al., 2005; Solon et al., 2007). As a result, the stiffness of the matrix was of interest
here as it not only determined the rates and extension of contraction by the cells
but also the morphology of the TE ligaments/tendons (sections 5.3.4.7 and 5.3.4.9).
Fibroblasts have been shown to achieve maximal spreading on stiffer surfaces around
10kPa (Solon et al., 2007). To determine if the increasing volumes of fibrin gels
at constant thrombin to fibrinogen ratio (or stiffness) used to prepare constructs in
section 5.3.3, were in fact at constant stiffness, the storage (G’) and loss (G”) moduli
were rheologically measured.
According to Shen et al. (1974), elastic modulus as a measure of fibrin gel stiffness
due to molecular networks and as a determinant of the extent of branch points in the
network was developed by Ferry et al. (1951). Dynamic measurements of viscoelastic
moduli revealed that gel storage modulus G’ increased with increasing volume, most
likely due to the higher total fibrin fibre quantity. Again this supported findings
that adjusting volume or stiffness perhaps had the same effect. However, the highest
volume gel (15X) was weaker as it began to deform at very low strains of >0.3%
strain (Figure 5.6B). The gels also exhibited frequency independence and paralleled
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other studies, which have shown frequency independent behavior of fibrin gels (Shah
and Janmey, 1997; Wen et al., 2007; Weisel, 2007). Frequency independence of G’
indicates that mechanical energy is not lost or stored as a result of molecular motions
during the test (Janmey et al., 1991), in addition, it signifies interconnectedness of
the fibrin fibres (Shah and Janmey, 1997).
Where the ratios of thrombin to fibrinogen were altered, time sweep studies showed
that stiffness increased with decreasing thrombin amounts, as expected. The G’ for
gels was lower than expected <35Pa at 3600s (1 hour), though G’ for 0.313UT/mgF
gels was double that of 1.25UT/mgF. The gelation profile also showed that gels
reached a plateau at between 2300s and 2900s, however, thereafter a second increase
in gel stiffness was observed. It was not clear, whether this was due to further net-
works and branching forming within the gel or drying out of the gel on the machine
as very low sample volumes were used (700µL) at 37◦C. Following, the time sweeps,
in-situ strain sweeps revealed the strain stiffening behavior of the fibrin gels noted by
researchers such as Shah and Janmey (1997), which occurred at strains <5%. Such
strain stiffening behaviour was not observed in pre-formed gels, gelled in the incu-
bator. This suggested that how the gels are prepared affects response to oscillatory
shear and measured G’ values.
Strain sweeps of gels of changing thrombin to fibrinogen ratios (Figure 5.15) that
were gelled in an incubator prior to analysis, showed a similar response to increasing
deformations as with gels of varying volume and thickness (Figure 5.6), with an
LVR below 5% strain. It was expected that increasing the stiffness by decreasing
thrombin concentrations used would improve the robustness of the gels and the stiffer
0.313UT/mgF had an initial G’ twice that of the control 1.25UT/mgF gels.
Presence of cells, incubated over a period of 5 days, did not appear to affect the
stiffness of the gels, though it should be noted that the volumes were 6X greater
than those used for TE L/T preparation but the seeding density was maintained at
100,000cells/mL. The purpose of seeding the cells, was to determine if they would
secrete matrix degrading enzymes in response to the fibrin gel stiffness that would
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alter its mechanical strength.
Reducing thrombin to fibrinogen ratio showed no effect on fibrin fibre
diameter but increased porosity
Characterisation of the fibrin hydrogels showed that there were no significant dif-
ferences in fibrin fibre diameters, with increasing stiffness (Section 5.3.4.3). This
was surprising as increasing fibrin gel stiffness has been attributed to larger fibre
diameters and increased porosity (Shen et al., 1974; Wolberg and Campbell, 2008).
Reasons for this, may have been due to processing methods such as ethanol dehy-
dration and critical point drying, used in preparing the gels for SEM. Additionally,
in vivo, concentrations of thrombin fluctuate, which affect the structure of the fibrin
clot (Shen et al., 1974) along with other variables such as pH, ionic strength and cal-
cium concentration (Mosesson, 2005). SEM images of cryo-fractured gels, suggested
that at lower thrombin concentrations, 0.313UT/mgF showed larger variation in pore
structure with clusters of small pores surrounding some larger ones. The amount of
solid fibrin matter present in the gels 2.46 ± 0.05%, was consistent with estimated
fibrin fibre volume fractions determined using equations 5.1 and 5.2 of 2.61%.
It is important to note, studies on purified fibrin are likely to differ from plasma fibrin
due to their structural differences (Weisel, 2004). In addition, the effects of plasmin,
an enzyme synthesized in the liver which more readily digests fibrin clots, may differ
from MMPs and consequently the degradation of fibrin gels produced in vitro.
Stiffness enhances cell alignment and proliferation
Morphological evaluation showed that increasing stiffness increased CTF cell prolifer-
ation in TE ligament and tendon (Figure 5.19). This is likely due to higher percentage
fibrin gel areas with increasing stiffness, resulting in greater scaffold availability. A
study by Cox et al. (2004), showed similar results with their formulations 6 and
9 at 0.2UT/mgF and 1.68UT/mgF (closest to UT/mgF shown here) resulting in
higher and lower proliferation, respectively. On contraction impeded gels, light mi-
croscopy and fluorescent imaging of calcein-AM stained gels showed that the stiffest
gels (0.313UT/mgF) had a mixture of rounded and spread cells. This was contrary
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to literature, where increasing stiffness has been shown to improve cell attachment
and result in a spread morphology of the cells (Discher et al., 2005; Solon et al.,
2007; Mason et al., 2012; Wells, 2008). However, cells seeded on the stiffer gels of
0.313UT/mgF stained with calcein-AM appeared to align themselves in a particular
direction (Figure 5.18). This was possibly due to higher tensions occurring in the gel
due to cell contractile forces, which were likely greater in the stiffer gels than in the
control and 2.5UT/mgF groups.
H&E staining of 5 week sinews confirmed that the increase in fibrin gel stiffness to
0.313UT/mgF was not limiting to cell migration, proliferation or construct formation
as cells were present throughout the length and breadth of the constructs. In addition,
the images also showed that sinews of the stiffest gel also formed using the rolling
mechanism previously shown in Chapter 4 and by Paxton et al. (2012) (Appendix
D). More individual cells were present within the the 0.313UT/mgF sinews, greater
cell densities and alignment occurring mostly in the folds, whereas control sinews had
a greater extent of cell alignment throughout the constructs.
Increasing stiffness did not increase sinew collagen content or sinew tensile
strength
Although increase in fibrin gel stiffness increased CTF cell proliferation, this did not
result in significant increases in collagen content (Figure 5.21). This demonstrated
that collagen synthesis is not proportional to cell number or gel stiffness but depen-
dent on other factors, particularly the presence of chemical cues such as AA+P as
shown by Paxton et al. (2010a, 2012). As there was not a significant increase in
collagen content seen between the sinews, tensile strength (load in mN) also showed
no major differences, with statistical significance (p<0.05) only occurring between
constructs 2.5UT/mgF (softest) and 0.313UT/mgF (stiffest) (Figure 5.22). Sinews
of smaller geometry experienced greater stress or load per unit area, therefore as
the sinews showed varying widths, comparing the maximum loads withstood by the
constructs conferred fairer comparisons.
Factors leading to variability in fibrin gels
Owing to variations observed between fibrin gel mechanical behaviour of incuba-
tor gelled and rheometer gelled samples as well as contraction of control constructs
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shown in previous chapters, factors that may have led to variation in the fibrin gel
mechanical properties were evaluated. Fibrinogen sterilisation methods and freeze-
thaw cycles up to 8 cycles showed no significant effect on the varying rates of fibrin
gel contraction and construct maximum and minimum widths. However, fibrinogen
powder dissolution time did, the optimum being >3 hours. In addition, the number
of thrombin freeze thaw cycles affected contraction, as greater numbers of freeze-thaw
cycles were shown to lower fibrin gel mechanical strength. These results are shown
in Appendix C.
5.5 Conclusion
These results demonstrated that both fibrin gel volume and fibrin gel stiffness could
be used to control the rates of fibrin gel contraction and its extent. Fibrin rates of
contraction and its extent appeared to be largely dependent on the amount of fibrin
or volume fraction of fibrin fibres present within the gel or its stiffness in terms of
thrombin to fibrinogen ratios. Unexpectedly, increasing fibrin gel stiffness did not
increase construct collagen content or improve tensile strength. This was perhaps
testament to the importance of AA in collagen synthesis.
Characterisation into fibrin fibre diameters and porosity confirmed that enhancing
fibrin fibre volume fraction reduced extent of contraction as no differences were ob-
served in fibre diameters, their quantity must have increased. This chapter also
quantitatively demonstrated that the G’ of 0.313UT/mgF gels was twice that of
1.25UT/mgF and 6-fold that of the 2.5UT/mgF at low strains or low angular fre-
quencies. In addition, gels were generally stable at low strains <5% and exhibited
frequency independence, which was in line with the literature regarding the mechan-
ical behaviour of biopolymers. Differences between construct contraction at constant
UT/mgF, using the standard control gel formulation of 1.25UT/mgF must depend
largely on the cells and cell mediated processes.
Chapter 6
Optimisation of ascorbic acid +
proline treated constructs
6.1 Introduction
Chapter 4 showed that AA+P resulted in enhanced contraction of the fibrin gel as
well as upregulation of MMP-2. Increasing the stiffness of the fibrin gel in Chapter
5 reduced the extent of fibrin gel contraction and constructs were wider although no
AA+P supplementation was used.
In this chapter, it was therefore of interest to establish if supplementation of con-
structs prepared using the stiffest 0.313UT/mgF fibrin gel formulation with AA+P
would result in constructs that were wider that also had a similar or higher col-
lagen content compared to supplemented constructs prepared using the standard
1.25UT/mgF fibrin gels. Since, AA+P treatment enhanced MMP-2 expression, treat-
ment with protease inhibitors would likely be necessary. Normally, ε-aminohexanoic
acid (AH) and aprotinin (AP) are added to thrombin in sDMEM during fibrin gel
preparation (see Chapter 3 section 3.2.4). Both these enzyme inhibitors have been
shown to reduce fibrinolysis (Krishnan et al., 2003). As a result, this chapter inves-
tigated the effect of adding AH and AP directly to growth medium to determine if
this reduced fibrin gel contraction rates. Cross-linking of collagen would likely make
it more resistant to degradation (Even-Ram and Yamada, 2005). Lysyl oxidases are
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responsible for collagen cross-linking and require Zn2+ and Cu2+ as cofactors, whilst
Mn2+ is a cofactor necessary for collagen glycosylation and is involved in collagen
fibril formation (Leccia, 1996). The effects of Zn2+ and Mn2+ metal ions on con-
traction, construct collagen content and tensile strength, in combination with AA+P
supplementation, were also evaluated.
6.2 Materials and Methods
6.2.1 Construct preparation
For AP/AH and EDTA MMP inhibition studies as well as supplementation with
ZnSO4 and MnSO4, constructs were prepared using the standard fibrin gel formula-
tion of 1.25UT/mgF as described in Chapter 3 section 3.2.
Where the stiffest fibrin gel formulation of 0.313UT/mgF was used, this was prepared
by spreading 270µL of enzymes (Thrombin, AP and AH) in sDMEM on a 35mm well
and adding 431µL fibrinogen to initiate the polymerisation process. After gelling for
1 hour in an incubator at 37◦C, CTF cells were seeded on top of the gels at a density
of 100,000 cells/mL.
In all instances, CTF cells were used.
6.2.2 Construct supplementation
6.2.2.1 Combined AH and AP treatment
Fibrin gels were prepared as previously described. Groups were divided as control
or AH + AP treated groups. When cells were seeded onto gels, 2µL/mL of each
of the 200mM aminohexanoic Acid (AH) and 10mg/mL Aprotinin (AP) solutions
were added to the media. Constructs were incubated for three days, after which
supplementation with AH and AP was suspended and constructs were fed only with
sDMEM, as with the control group.
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6.2.2.2 Supplementation with AH, AP or EDTA
Constructs were prepared to be either non-treated controls or supplemented with AH,
AP (quantities as above) or 1mM EDTA at 1µL/mL of medium. Supplementation
was performed every 2 to 3 days on feeding with DMEM.
6.2.2.3 Supplementation with ZnSO4 and MnSO4
1mM of ZnSO4 (102994, Analar) and MnSO4 (Fluka) solution were prepared in PBS
solution. Constructs were prepared as previously described and received either no
treatment or were supplemented with either ZnSO4 and AA+P, MnSO4 and AA+P
or AA+P only on feeding with sDMEM every 2 to 3 days.
All constructs were imaged and percentage gel areas and widths quantified as previ-
ously described in Chapter 3 section 3.3.
6.2.3 Collagen quantification
Procedure was detailed in Chapter 3 section 3.4.
6.2.4 Histology
Samples were prepared for histology as decribed in Chapter 3 section 3.9.
6.2.5 Confocal microscopy
Constructs were prepared as described in Chapter 3 and left overnight (≥ 18 hours)
for cells to attach. The following day, the constructs were fixed in 4% formaldehyde
in PBS solution for 1 hour. Thereafter, samples were incubated in 0.1% Triton-X
for 15 minutes. A 1% BSA in PBS solution was prepared and 5µL phalloidin stain
(Alexa Fluor 4888, Life Technologies) was added to 200µL of the PBS solution. The
stain was added to the samples and incubated at 37◦C for 1.5 hours. After washing
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in PBS, the samples were counter-stained in DAPI (D1306, Life Technologies), as de-
cribed in Chapter 3 section 3.7.1. Samples were imaged using a confocal fluorescence
microscope (Leica DM 2500).
6.2.6 RT-PCR
Generally, cells were detached from the matrix as detailed in Chapter 3 section 3.6.2
and RT-PCR was performed as detailed in section 3.10. The mRNAs investigated in
this chapter are referred to according to the genes they regulate and/or the proteins
encoded for by those genes.
6.2.7 Interface strength testing
The tensile testing system set up as shown in Chapter 3 was used. Constructs were cut
in half and each half of the TE soft tissue was glued between two pieces of waterproof
sandpaper such that only the interface was visible (Figure 6.1). The brushite cement
anchor was not removed but gripped in the bottom of the water bath. The TE soft
tissue was attached to the top grip. The mechanical tester (Instron 5800) was fitted
with a 10N load cell (Instron) and set at an extension rate of 0.4mm/s.
6.3 Results
6.3.1 Use of MMP inhibitors to reduce rates of matrix degra-
dation
AP and AH are normally added to the fibrin reagents prior to gelation as they inhibit
the action of MMPs and slow the degradation of the fibrin hydrogel.
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Figure 6.1: Method for tensile testing construct interface strength.
6.3.1.1 Supplementation with both AH and AP
To determine if supplementation of the medium with MMP inhibitors retarded initial
contraction, AP and AH were added to the medium at construct preparation only
(day 0). Addition of AP and AH in combination to sDMEM resulted in an increased
rate of contraction of the fibrin gel in the first two days (Figure 6.2). From day
3, when supplementation was withdrawn, control and AP-AH treated constructs
appeared almost identical in width and percentage gel areas showed no significant
difference from each other.
6.3.1.2 Supplementation with AH, AP or EDTA
In the above section, AH and AP were added to the culture medium on seeding and
then withdrawn. It was therefore necessary to determine the effects of prolonged
supplementation. The effects of EDTA on delaying fibrin gel contraction was also
investigated due to its ability to inhibit MMPs. Measurements were taken from day
7 where the control and AP supplemented percentage fibrin gel areas were greater
and differed significantly from AH and EDTA supplemented groups as well as each
other (Figure 6.3A).













































































































































































































Figure 6.2: Contraction inhibition using AP and AH in combination. Addition
of AP and AH to growth medium on seeding day did not retard the initial rates of
fibrin gel contraction. A)– C) fibrin percentage gel areas and widths of AP and AH
treated constructs were smaller that non-treated controls on day 3. Withdrawal
of AP-AH treatment resulted in fibrin percentage gel areas and widths matching
those of the controls.
































































































































































































































































































*, # p<0.05 compared to other group 
max/ min widths, respectively.
§ p<0.05 between compared groups.
¥ p<0.05 compared to EDTA max width.
Figure 6.3: Effect of MMP inhibitors on contraction and sinew mechanics. A)
Supplementation with AP, AH or EDTA resulted in increased rates of contraction
from week 2 to week 5, compared to control constructs. B) As a results, widths
of control constructs were wider than of treated constructs. C) Collagen content
did not differ significantly although average values of AP and AH supplemented
constructs were slightly higher. D) & E) Maximum loads were not affected by
supplementation.
From the 2nd to 5th week of culture, the control group had significantly greater widths
than all other groups (Figure 6.3B). AH and AP group maximum widths were thinner
than control and also differed significantly from the EDTA group at week 5. Although
the percentage gel areas and widths of the supplemented groups were smaller than of
the control group, average collagen content between the groups did not differ greatly
(Figure 6.3C). The average values for AP and AH were slightly higher than for the
control at 17.34 ± 3.88%, 17.65 ± 3.37% and 14.78 ± 3.10%, respectively, however,
differences were not statistically significant. Yet, this was still interesting because, it
suggested that inhibiting MMPs did increase construct collagen content. Tensile tests
indicated that the constructs resembled each other in mechanical strength (Figure
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6.3D and E).
These results and those in section 6.3.1.1 further suggested that fibrin contraction
and fibrinolysis were two separate mechanisms that do not necessarily have to occur
together. However, considering that MMPs may not have been completely inhibited,
if the concentrations of the inhibitors were insufficient, then an alternative hypothesis
would be that reducing rates of fibrinolysis resulted in increased rates of contraction
as a compensatory means of remodelling the matrix.
6.3.2 Effect of collagen cross-linkers on contraction and col-
lagen synthesis
As previously mentioned, zinc and manganese are cofactors required during collagen
synthesis. Zinc and manganese are present in medium specifically designed for chick
cells such as MCDB-201 as well as in Ham’s F12 (see Appendix C on comparisons of
media components used for chick fibroblast cell culture).
To evaluate the effects of Zn2+ and Mn2+ on fibrin gel contraction and collagen
synthesis, they were added in sulfate form to growth medium.
MnSO4 + AA+PControl AA+P ZnSO4 + AA+P
Figure 6.4: Images of constructs treated with combinations of ZnSO4, MnSO4
and AA+P on Day 35. Control constructs were widest whilst AA+P only treated
constructs were thinnest. Combined treatment of ZnSO4 or MnSO4 with AA+P
resulted in constructs whose widths were somewhere in between that of the control
and AA+P only constructs.
Figure 6.4 shows that supplementation with ZnSO4 or MnSO4 in combination with
AA+P reduced the extent of fibrin contraction and degradation as these constructs
were wider than those treated with AA+P alone.
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6.3.2.1 Fibrin percentage gel areas and widths
Percentage fibrin gel areas of the control and AA+P only supplemented groups dif-
fered significantly (p<0.05) from each other as well as from groups treated with
ZnSO4 or MnSO4 in combination with AA+P (Figure 6.5A). On day 35, percentage
gel areas of the control, AA+P only, ZnSO4 and MnSO4 groups were 2.81 ± 0.12%,
1.38 ± 0.33%, 2.23 ± 0.38% and 2.09 ± 0.20%, respectively. In the first 3 weeks
of culture, maximum and minimum widths of the control (non-treated) group were
broadest and differed significantly from all groups (p<0.05), (Figure 6.5B). Widths
of the ZnSO4 and MnSO4 groups were also significantly greater than of constructs
treated with only AA+P. Day 35 widths of the control group were 2.86 ± 0.20mm for
the maximum and 1.87 ± 0.27mm for the minimum. Of the supplemented groups,
ZnSO4 constructs were broadest with max/min widths of 2.43 ± 0.46mm and 1.54 ±
0.28mm, followed by the MnSO4 with widths of 2.23 ± 0.19mm and 1.41 ± 0.15mm.
The AA+P constructs were thinnest with max/min widths of 1.32 ± 0.34mm/ 0.95
± 0.12mm.
6.3.2.2 Construct collagen content and tensile strength
Mechanical testing showed that there were no differences in the maximum loads with-
stood by the constructs (Figure 6.5C). Although the maximum loads did not vary
between the groups, constructs treated with AA+P only had the highest average
collagen content of 34.12 ± 13.00% (Figure 6.5D). The group with the second high-
est average collagen content was ZnSO4 of 29.26 ± 9.84%. Both the AA+P only
and ZnSO4 AA+P groups showed statistical significant difference from the control
group with 14.44 ± 4.67% (p=0.000, for both instances). The MnSO4 AA+P group
with 21.79 ± 3.65% collagen only differed from constructs treated with AA+P only
(p=0.001 and p=0.079, p=0.071 when Mn group was compared to AA+P only, con-
trol and Zn groups, respectively). AA+P only constructs were significantly stiffer
than all other groups (Figure 6.5E).
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Figure 6.5: Effects of ZnSO4 and MnSO4 on fibrin contraction and construct
mechanical properties. A) Percentage gel area of the control and AA+P only sup-
plemented groups differed significantly from ZnSO4 and MnSO4 treated constructs
and this was similarly reflected in the construct widths (B). Maximum loads were
similar for all groups (C) although collagen content showed variation (D). AA+P
















Figure 6.6: Histological staining of constructs treated with ZnSO4 and MnSO4. a) & b) H&E staining of control constructs
showing folds and cell alignment in direction of tension. c) Massons trichrome staining showed fibre alignment but no significant
collagen content. H&E staining of ZnSO4 (d & e) and MnSO4 treated constructs showed fibres to be aligned across rather than
along construct. f) Masson’s Trichrome of MnSO4 showed greater presence of collagen in comparison to the control.
Chapter 6. Optimisation 172
6.3.2.3 Construct morphology
Longitudinal sections of the control ZnSO4 and MnSO4 groups were stained with
H&E or Massons Trichrome (Figure 6.6). The control constructs had one main
central fold along the length of the construct. Where formation was not disrupted
by further folding, cells were seen to align along fibres aligned in the direction of
tension/ length of tissue (Figure 6.6a and b). In ZnSO4 or MnSO4 the fibres seemed
to extend cross-wise from the centre of the constructs (Figure 6.6e and g). Masson’s
staining for collagen did not reveal significant collagen presence in control constructs
(Figure 6.6) compared to MnSO4 supplemented constructs, which were significantly
darker and had large quantities of collagen in the main middle fold (Figure 6.6h).
6.3.3 Effect of Ascorbic Acid + Proline treatment on con-
structs prepared on stiffest gel formulation
6.3.3.1 Tensile strength and collagen content
In Chapter 5 section 5.3.4 it was shown that fibrin gels of the stiffest formulation
0.313UT/mgF did not contract to the same extent as control gels of 1.25UT/mgF
and were significantly broader in width. It was also demonstrated that AA+P supple-
mentation of constructs of a 1.25UT/mgF fibrin gel formulation produced constructs
that were very thin but with increased collagen content in comparison to controls
receiving no supplementation in Chapter 4. Here, the 0.313UT/mgF gel formulation
was supplemented with AA+P to determine if the extent of fibrin contraction after
5 weeks would be reduced in comparison to 1.25UT/mgF AA+P constructs. An
additional aim was to optimise construct collagen content and tensile strength.
AA+P supplementation of constructs prepared from 0.313UT/mgF fibrin gels re-
sulted in constructs that were visibly wider than constructs prepared using the
standard formulation of 1.25UT/mgF and supplemented with AA+P (Figure 6.7A).
The maximum load of 0.313UT/mgF AA+P constructs was double that of all other
groups at 218 ± 84mN (Figure 6.7B and C). Control constructs had a maximum
load of 113 ± 17mN, AA+P treated maximum load was 110 ± 30mN and untreated
Chapter 6. Optimisation 173
0.313UT/mgF was 88 ± 3mN. AA+P supplementation resulted in constructs that
were stiffer, achieving lower strains than non-treated groups (Figure 6.7D).
Average collagen content of the control, AA+P, 0.313UT/mgF and 0.313UT/mgF
AA+P constructs were 16.97 ± 2.08%, 25.64 ± 3.25%, 20.99 ± 1.74% and 35.57
± 10.61%, respectively (Figure 6.7E). The collagen content of 0.313UT/mgF AA+P
constructs was the highest and differed significantly from all groups (p <0.05). AA+P
treated constructs differed significantly from controls 1.25UT/mgF (p=0.001) but not
from 0.313UT/mgF (p=0.207). The 0.313UT/mgF group only differed significantly
from 0.313UT/mgF AA+P (p=0.000).
6.3.3.2 Construct morphology
Histological staining of constructs revealed variations in morphology due to supple-
mentation and fibrin gel stiffness. One large central fold between two halves was
visible in the H&E stained control sections along with other visible contraction fold
in each half (Figure 6.8a and b). The rolling mechanism of AA+P treated constructs
was clearly visible in Figure 6.8d and e. Stratified fibres were visible along the pe-
riphery and middle section of AA+P treated constructs. Rolling formation was also
apparent in 0.313UT/mgF (Figure 6.8g). It was also clear that 0.313UT/mgF AA+P
constructs were composed of two main folds (Figure 6.8j).
Masson’s Trichrome staining revealed patchiness of pink and red in the controls,
with red occurring mostly on the outer edges and inside construct folds (Figure 6.8c
and i). AA+P treated constructs were darker in colour than the controls. AA+P
constructs of the softer gel formulation showed collagen to be largely concentration
around the edges of the construct (Figure 6.8f). 0.313UT/mgF AA+P constructs
were darker in colour than the AA+P group. Longer strands of collagen running
across the construct were detected (Figure 6.8l).










































































* p <0.05 compared to control
** p<0.05 compared to AA+P
# p<0.05 compared to AA+P and 0.313 AA+P
Figure 6.7: AA+P supplementation of constructs prepared using the stiffest gel
formulation. A) 0.313UT/mgF AA+P constructs appeared significantly broader
than AA+P only treatment. B) & C) There was an increase in the maximum loads
of the constructs compared to non-treated and AA+P only constructs. D) However,
both AA+P treated groups were stiffer than their controls. E) 0.313UT/mgF
























Figure 6.8: Histological staining of construct cross-sections prepared using the stiffest gel formulation and treated with AA+P.
H&E staining showed presence of cells throughout cross-sections of control (a & b), AA+P (d & e), 0.313UT/mgF control (g &
h) and 0.313UT/mgF AA+P (j & k) constructs. Masson’s Trichrome stained 0.313UT/mgF AA+P constructs (l) significantly
darker than all other groups (c, f & i) and collagen fibres were detected. Some of the control, AA+P and 0.313UT/mgF images
were shown in previous chapters and are repeated here for clarity.
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Masson’s Trichrome staining of construct longitudinal sections also showed that cells
were aligned along fibres on the length of the constructs (Figure 6.9). Most of the
collagen present in control constructs was located on the edges (Figure 6.9a) although
small quantities were also present in the mid-section of the constructs (Figure 6.9b).
The darker staining in 0.313UT/mgF AA+P constructs was likely due to the higher
collagen content (Figures 6.9d and e). Closer magnification of 0.313UT/mgF AA+P
constructs revealed extensive collagen “threads” within the constructs (Figure 6.9).
These were likely collagen fibrils as their appearance differed from the “specks” or
collagen subunits seen in Chapter 4.
6.3.3.3 Confocal microscopy
Actin staining for stress fibres showed that cells in the 0.313UT/mgF AA+P group
expressed greater amount of actin than the control and 0.313UT/mgF groups (Figures
6.10).
6.3.3.4 RT-PCR detection of transcripted mRNAs
The expression of 9 target mRNAs was evaluated using RT-PCR (Figure 6.11). At
weeks 2 and 3 no target mRNAs were detected and these results are for constructs at
week 4. Comparisons between the AA+P and control groups were previously shown
Chapter 4 section 4.3.8 and are repeated here for clarity. The results indicated that
COL1A1 expression in 0.313UT/mgF AA+P constructs was 32% higher than in stan-
dard AA+P constructs and ACTA expression was 38% higher, which supported the
results in Figure 6.7E and Figure 6.10. MMP-2 expression was highest in AA+P
treated constructs and MnSO4 AA+P constructs also expressed higher quantities of
MMP-2 than the control group. Constructs were AA+P was included also expressed
higher amounts of RhoA, when compared with both unsupplemented control groups.
MMP-3 and MMP-9 were highest in 0.313UT/mgF AA+P constructs, although ex-
pression of both their mRNAs fell below GAPDH. MMP-1 expression was highest
in the control and MnSO4 AA+P group. Tenascin-C expression was highest in the
AA+P group and lowest in the control group.







Figure 6.9: Histological staining of construct long-sections prepared using the
stiffest gel formulation and treated with AA+P. a) Collagen was mainly located
on the edges of control constructs although a few collagen strands were present
towards the middle (b). 0.313UT/mgF AA+P had significant amounts of collagen
(c & d) and small strands within the sinew (d) proximal to cells.
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Figure 6.10: Actin staining of constructs treated with AA+P. A greater con-
centration of actin filaments (green) were seen in cells on the 0.313UT/mgF gels
supplemented with AA+P.
6.3.3.5 Interface mechanical strength
The strength of the interface was tested for control, AA+P and 0.313UT/mgF AA+P
treated groups (Figure 6.13). On average, complete detachment of the TE soft tissue
from the brushite anchor required about 15s. Figure 6.13A suggests that control
constructs had the weakest interface as they detached first. Surprisingly, the loads
required to initiate interface detachment were significantly lower for the control and





































Figure 6.11: RT-PCR results showing mRNA expressions of constructs treated
with AA+P. Compared to AA+P only constructs, the 0.313UT/mgF AA+P group
expressed higher levels of ACTA2, COL1A1, MMP-3 and MMP-9. However, MMP-
2, RhoA and Ten-C were downregulated. Interestingly, treatment with MnSO4 also
enhanced COL1A1 expression, higher than AA+P only and 0.313UT/mgF AA+P
groups.
0.313UT/mgF AA+P groups at 0.08mN and 0.052mN, respectively, than for the
AA+P group (5.4mN). However, after 10s, control and AA+P interfaces had com-
pletely detached whereas the 0.313UT/mgF AA+P required longer to reach ultimate
failure. These preliminary results suggest that interface attachment improved with
increasing gel stiffness and AA+P treatment (Figure 6.13B and C) although differ-
ences were not statistically significant.
6.4 Discussion
At concentrations used, AH, AP and EDTA increased rate of fibrin gel
contraction and moderately enhanced average collagen content
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Figure 6.12: Interface tensile strength of AA+P treated constructs. A) Extension
to failure loads of control and AA+P treated constructs over 15 seconds. B) Load-
extension curves of data shown in (A). The results indicated that the interface
of AA+P constructs remained attached for longer than controls. In addition,
0.313UT/mgF AA+P construct interfaces also attached for longer than those of
the AA+P only group. C) Maximum loads of 0.313UT/mgF AA+P construct
differed considerably from each other. (n ≥ 4).
Aminohexanoic acid (ε-aminocaproic acid) inhibits plasmin degradation of fibrin and
its addition to growth medium has been shown to decrease the rate of fibrin degra-
dation in a concentration dependent manner (Grassl et al., 2002). Results by Grassl
et al. (2002) went further to show that at high concentrations of aminohexanoic acid
construct collagen content decreased. Aprotinin is considered an inhibitor of a wide
range of MMPs (Kupcsik et al., 2008). In section 6.3.1, combined supplementation
of Aminohexanoic acid (AH) and Aprotinin (AP) increased the rate of fibrin contrac-
tion and constructs were smaller in width than the controls, though results were not
statistically significant. Individual supplementation with AH, AP as well as EDTA,
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which is an MMP inhibitor (Ashcroft et al., 1997), expressed similar results, though
average collagen content with AH and AP treatment was slightly higher (Figure 6.3).
Treatment with AA+P would still be required to enhance construct collagen con-
tent. These findings suggest that MMP inhibition could be further optimised either
through determining the optimum concentrations for AH and/or AP supplementing
regimes or exploration of alternative MMP inhibitors such galardin (GM6001), which
has shown efficacy in preventing fibrin degradation (Ahmed et al., 2007).
Moreover, this data presents fascinating parallels when compared to findings in Chap-
ter 4 where inhibiting collagen synthesis did not stop but actually slightly increased
the initial rates of contraction. The results shown here and in Chapter 4 suggested
that contraction was a separate phenomenon that does not have to occur with col-
lagen matrix deposition or fibrinolysis although these phenomena can occur simul-
taneously. Why increased initial rates of contraction are observed is unclear but
may have been due to cells using contraction to compensate for impeded proteolysis.
Martin-Martin et al. (2011) studied the effects of GM6001 on contraction of collagen
matrices of varying stiffness using fibroblasts from different parts of the human body
as well as mouse fibroblasts. They found that fibroblasts used two different modes to
remodel the collagen matrices, namely, contraction and proteolysis and that this de-
pended on intrinsic cell properties. In addition, high concentrations of GM6001 also
showed varying efficacy in inhibiting contraction and could not overcome intrinsic
cell contractile properties. Interestingly, their results also showed that the presence
or absence of serum in growth medium affected rates of contraction (see Appendix
C).
To further support the hypothesis that contraction and MMP degradation can act
independently of one another, Phillips et al. (2003) demonstrated that inhibition of
MMPs with garlardin did not alter cell generated contraction forces, when compared
to the uninhibited group and similar to results by Martin-Martin et al. (2011) extent
of inhibition by galardin varied by cell type.
These findings support results in thesis regarding the influence of matrix stiffness, cell
type and growth medium on contraction and emphasize the necessity in determining
factors that impact cell contraction and/or MMP mediated remodelling on formation
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Primary Rat 
Dermal Fibroblasts
Figure 6.13: Effect of 100µM galardin on inhibiting contraction in matrices
of differing stiffness or employing different cell types. A) Extent of contraction
differed depending on the stiffness of the collagen matrix (triangle = softest,
squares=stiffest) (Martin-Martin et al., 2011). Similarly, Phillips et al. (2003)
showed that galardin significantly reduced extent of contraction of collagen matrix
by B) HeLa cells, though increasing concentrations reduced extent of inhibition
whereas C) rat dermal fibroblasts showed higher rates of contraction than HeLa
cells. In all cases, inhibtion of MMPs by galardin did not completely stop contrac-
tion. Images used with permission.
of engineered (L/T) tissue.
Supplementation with ZnSO4 and MnSO4 in combination with AA+P
decreased extent of fibrin gel contraction and ZnSO4 maintained collagen
content similar to AA+P only supplementation.
Supplementation with ZnSO4 and MnSO4 along with AA+P decreased the rate of
fibrin contraction and construct average collagen content in comparison to AA+P
only treated constructs (Figure 6.5). Histological images confirmed a higher collagen
content in Zn and Mn supplemented constructs compared with non-treated sinews
(Figure 6.6). The catalytic active site of MMPs contains Zn2+ (Lansdown et al., 2007)
and surprisingly, this did not increase the rate of fibrin degradation and no differences
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in collagen content were observed in comparison to AA+P only constructs (Figure
6.5D), suggesting that there were other cell processes dependent on the zinc supple-
mentation. Mn supplementation however, resulted in a significantly lower collagen
content when compared to AA+P only constructs. This may be due to additional
requirements of manganese by mitochondria and antioxidant enzymes that control
cell superoxide free radical levels (Craven et al., 2001) and may explain why contrac-
tion and degradation of the fibrin gel was decreased. Nevertheless, RT-PCR results
indicated that MnSO4 treatment resulted in the highest expression of collagen of the
groups investigated, however, the collagen amino acid may not have been in a form
detectable by the test (Figure 6.11).
Supplementation of stiff gels (0.313UT/mgF) with AA+P significantly
increased construct widths and collagen content compared to AA+P only
treatment
In Chapter 5 section 5.3.4, it was shown that fibrin gels of the formulation 0.313UT/mgF
were significantly stiffer and wider than the control fibrin gels of 1.25UT/mgF, how-
ever, no statistically significant differences were observed in the average collagen
content or maximum loads withstood (Figures 5.21 and 5.22). As 0.313UT/mgF con-
structs were wider than 1.25UT/mgF control constructs, it was investigated whether
supplementation with AA+P would lead to constructs that were broader and with
higher collagen content than AA+P constructs prepared using the standard gel for-
mulation 1.25UT/mgF.
The stiffest gels had a similar yet magnified response to AA+P treatment. 0.313UT/mgF
AA+P constructs appeared significantly broader than AA+P constructs (Figure 6.7).
The average collagen content of the 0.313UT/mgF AA+P group was about 10%
greater than for AA+P and the maximum loads withstood by 0.313UT/mgF AA+P
was 2-fold that of AA+P constructs (Figure 6.7C and E). Masson’s Trichrome stain-
ing indicated a significantly darker extent of blue colouring in the 0.313UT/mgF
AA+P group (Figure 6.8f and l). At higher magnification, threads or thin strands
of collagen were detected throughout the 0.313UT/mgF AA+P constructs (Figure
6.9e). Because the increase in collagen content and maximum loads withstood by the
0.313UT/mgF AA+P group only occurred when both the stiffness was increased and
constructs were supplemented with AA+P, the results suggest that construct
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collagen content can be optimised by altering the scaffold matrix stiffness
whilst administering the necessary chemical cues.
Supplementation of 0.313UT/mgF constructs with AA+P also altered the expression
of targeted mRNAs when compared to 1.25UT/mgF AA+P constructs. 0.313UT/mgF
AA+P expressed greater amounts of actin, as shown by confocal fluorescence im-
ages in Figure 6.10C. This was confirmed by RT-PCR results, which indicated that
ACTA2 expression was over 30% higher in 0.313UT/mgF AA+P constructs than
in the AA+P group (Figure 6.11). Alpha smooth muscle actin is a marker for the
myofibroblast cell type; fibroblast differentiation to myofibroblast requires tension,
which activates RhoA, which in-turn is involved in the organization of cytoskeletal
actin and its contraction (Hinz and Gabbiani, 2003b). However, RhoA expression
in the 0.313UT/mgF AA+P was 35% lower than in AA+P constructs. Perhaps
this was an experimental anomaly. Alternatively, the results suggest lower matrix
tension in 0.313UT/mgF AA+P constructs. Possibly, reduced extent of contraction
caused lower tension in the matrix and as a result Tenascin-C expression, a marker
for tendons was 31% lower in 0.313UT/mgF AA+P than AA+P constructs. How-
ever, Tenascin-C expression was still 72% greater in 0.313UT/mgF AA+P than in
controls.
MMP-1 is known to degrade collagen type I and its expression was higher in control
constructs than in both AA+P supplemented groups. On the other hand, MMP-
2 is implicated in collagen I matrix degradation and indirectly to fibrin through
MT1-MMP, which degrades fibrin and activates MMP-2. Unfortunately, MT1-MMP
was not evaluated at this stage, but due to its importance in connective tissue re-
modelling (Page-McCaw et al., 2007), its expression will need to be determined in
future work. MMP-2 in the stiffer gel constructs was significantly downregulated and
MMPs 3 and 9 were upregulated in comparison to AA+P constructs. This is likely
why 0.313UT/mgF AA+P exhibited reduced extents of fibrin contraction and higher
collagen content, when compared to AA+P, where MMP-2 was upregulated. MMP2,
MT1-MMP and Rho have been shown to depend on each other as MMP-2 is also
activated/deactivate by RhoGTPases (Zhuge and Xu, 2001). Using cardiac fibrob-
lasts (Schram et al., 2011) demonstrated that inhibition of Rho attenuated MMP-2
expression.
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MMP-2 and MMP-9 are also involved in activating TGF-β (Egeblad and Werb, 2002),
which is a growth factor involved in wound healing and collagen type I production
by fibroblasts (Clark et al., 1995) as well as other ECM components (Roberts et al.,
1992). This suggests that in the stiffer gels supplemented with AA+P, TGF-beta may
have been upregulated along with the mRNA expression of other ECM proteins. A
study by Kim et al. (2004) showed that TGF-β stimulated the expression of MMP-3
and MMP-9 in corneal epithelial cells, in a TGF-β concentration dependent manner,
however, TGF-β showed no such effect on MMP-2 expression.
0.313UT/mgF AA+P treatment may increase cement-tissue interface strength
The interface strength of the constructs was tested and no statistical differences were
seen in the maximum loads withstood (Figure 6.13). However, 0.313UT/mgF AA+P
constructs remained attached for longer than AA+P, which were also attached longer
than control constructs. The results suggest that supplementation of 0.313UT/mgF
constructs with AA+P may improve interface duration of attachment. Duration of
attachment is equally as important as strength because time dependent behaviour is
a key component of viscoelastic materials such as ligament and tendons (Provenzano
et al., 2001).
6.5 Conclusion
AA+P enhanced contractility by increasing actin expression due to increased ten-
sion in the matrix, in both AA+P and 0.313UT/mgF AA+P groups. Increasing gel
stiffness in combination with AA+P supplementation significantly raised construct
collagen content, whilst retaining width. RT-PCR investigation also suggested that
MMP-2 and possibly MT1-MMP were responsible for matrix degradation of con-
structs prepared using the softer standard gel formulation 1.25UT/mgF and AA+P
treatment as MMP-2 was downregulated in stiffer gel constructs. Possibly, TGF-beta
expression may have been upregulated in 0.313UT/mgF AA+P, which will need to be
investigated further. The brushite cement anchor to TE L/T interface strength was
tested and although the results showed no statistical significance, the findings suggest
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that 0.313UT/mgF AA+P improved attachment in comparison to AA+P and con-
trol constructs. Attempts to use MMP inhibitors to reduce the extent of contraction
were unsuccessful at the concentrations of AP, AH and EDTA used. However, the
results suggested that collagen degradation may be reduced. It would be interesting
to investigate the use of MMP inhibitors along with AA+P treatment on stiffer fib-
rin gel constructs to determine if this would lead to yet further increases in collagen
content.
Chapter 7
Influence of cell properties on
sinew formation
7.1 Introduction
Ascorbic acid and proline supplementation was shown to significantly enhance con-
struct collagen content (Chapters 4, 5 and 6) though it led to greater reductions in
the fibrin gel areas. The expression of several targeted mRNAs were upregulated in-
cluding matrix degrading MMPs and mRNAs associated with stress fibre formation.
The internal morphology of control and AA+P supplemented constructs were shown
to be dissimilar. However, direct treatment of acellular fibrin gels with AA+P did not
affect gel mechanical strength. As a result, cell properties and activities had a greater
effect on construct formation, especially with AA+P treatment. Altering fibrin vol-
ume and thrombin to fibrinogen ratios used to prepare fibrin gels, affected rate of
fibrin gel contraction and resultant sinew maximum and minimum widths (Chapter
5). However, sinew collagen content was not enhanced and no differences in tensile
strengths were observed unless supplemented with AA+P (Chapter 6). Since there
were variations in the initial contraction rates of several non-supplemented controls
groups presented in this thesis, other cell factors such as variations in cell passage
number or cell seeding density may have been responsible. These parameters are
important for TE, as reflected by the copious literature investigating their effects on
a number of conditions.
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Cell seeding density has been shown to affect scaffold depletion as well as cell viabil-
ity and formation of engineered tissue (Dvir-Ginzberg et al., 2003; Holy et al., 2000;
Mauck et al., 2002; Wang et al., 2008). Viability of cells is greatly influenced by
molecular diffusion of nutrients and waste through the constructs posing limitations
on construct dimensions and cell seeding densities. For oxygen sensitive cells, diffu-
sion of oxygen dissolved in medium has been shown to be limited to construct outer
layers approximately only 100µm thick (Radisic et al., 2003). Constructs 1 – 5mm
thick seeded with cells at high densities showed a decrease in cell viability within the
initial 4.5 hours by 55%, which was overcome by direct perfusion, reducing loss of
viability to only 20%, (Radisic et al., 2003). Mature tendons and ligaments are com-
posed of few cells and are largely avascular, with oxygen requirements 7.5 times less
than for skeletal muscles (Sharma and Maffulli, 2006). Nutrition is supplied through
diffusion of the synovial fluid rather than blood vessel perfusion (Fenwick et al.,
2002). In contrast, developing ligaments have high cell densities, which originate at
the enthesis (Tozer and Duprez, 2005). Three dimensional culture of tenocytes at
high density is attractive as continuous two dimensional culture results in a loss of
tenocyte characteristics and decreased collagen I production with increasing passages
(Schulze-Tanzil et al., 2004).
Age has been shown to determine L/T morphology as older joints become broader
and stiffer due to increases in collagen content and anatomical changes within the
joints (Carlstedt, 1987; Woo et al., 1986; Feland et al., 2001). Response of human
embryonic fibroblasts to chemical cues of conditioned medium was shown to decline
steadily after passage 25 (Albini et al., 1988). Adult cells taken from donors be-
tween the ages of 10 and 60 years became less responsive to chemoattractants much
earlier, from passage 15 (Albini et al., 1988). Almarza et al. (2008) evaluated the
effect of fibroblast passage number sourced from Long Evans rats on collagen gene
expression and determined that with increasing passage numbers, cells took longer to
reach confluency, cell numbers decreased and from passage 2 collagen expression also
decreased, with additional variation in collagen expression observed between MCL,
ACL and patellar tendon cell sources.
Ge et al. (2005) compared the suitability of rabbit MSCs, ACL and MCL fibroblasts
for ACL tissue engineering and found that due to inherent differences between the
cells types, concluding that MSCs were better suited for ACL tissue engineering than
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ACL or MCL fibroblasts. MSCs proliferated better in vitro, survived longer in vivo
and excreted higher quantities of collagen (Ge et al., 2005). According to Almarza
et al. (2008) MCL fibroblast proliferate better, migrate faster and produce more
ECM than ACL fibroblasts. However, Ge et al. (2005) found that MCL fibroblasts
secreted less ECM than ACL fibroblasts and in contrast to Almarza et al. (2008),
MCL and ACL fibroblasts began to show reduced proliferation, exhibiting morpho-
logical changes such as increased size and irregular shape. These results emphasise
the differences in cell type behaviour sources from different tissue within the same
organism as well as additional variances stemming from organism to organism.
This chapter investigated the influence of cell properties such as passage number and
minor fluctuations in cell seeding density that may have occurred were not previously
investigated as contributing factors on rates and extent of fibrin gel contraction. It
was also of interest to determine whether the TE L/T model was applicable for use
with other cell types.
7.2 Materials and Methods
7.2.1 Construct preparation
Construct fibrin gels were prepared using the standard fibrin gel formulation of
1.25UT/mgF as described in Chapter 3 section 3.2.4.
7.2.1.1 Varying passage number
CTF cells were thawed at various intervals such that cells at passages 2, 3, 4 and 5
were simultaneously available to seed on fibrin hydrogels.
7.2.1.2 Cell seeding density
The cell seeding density of 100,000 cells/mL was halved and doubled so that experi-
mental groups had cell seeding densities of 50,000 cells/mL (50K), 100,000 cells/mL
(100K) and 200,000 cells/mL (200K).
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7.2.1.3 Cell type for construct formation
Fibrin gels were seeded with CTFs (chick), 3T3s (mouse) or PFBs (rat tail tendon)
to determine differences in construct formation due to cell type.
7.2.2 Supplementation
7.2.2.1 Determining effect of ascorbic acid + proline on constructs seeded
with rat tail tendon fibroblasts
Constructs seeded with PFBs were supplemented with AA, P or AA+P or received
no treatment (NT) (Control group). AA was supplemented at a concentration of
250µM and P at 50µM every two to three days on feeding with sDMEM.
7.3 Results
7.3.1 Effect of passage number on rates and extent of fibrin
gel contraction
Chick tendon fibroblast cells between Passages 2 to 5 were used. Contraction due
to passage numbers showed variations in extent of contraction by day 1. However,
percentage gel areas were not statistically significant until day 3, where percentage














Day 0 Day 3 Day 7 Day 14 Day 22 Day 29 
Figure 7.1: Images of constructs prepared using cells at differing passage stages. On day 29, passage 5 constructs had a
greater percentage of original fibrin gel area remaining and were significantly broader in width.
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Percentage gel areas on day 3 were 11.52 ± 3.71%, 17.28 ± 7.61%, 21.47 ± 15.64%
and 30.83 ± 12.78% for passages 2, 3, 4 and 5, in that order, significant difference
occurring between passages 2 and 5 (p=0.029). By day 7, passage 2 and 4 percentage
gel areas of 6.26 ± 1.26% and 5.68 ± 0.73% differed significantly from that of passage
5, which had the highest percentage gel area of all groups at 9.39 ± 3.30% (Figure
7.2B).
On day 12, passage 5 percentage gel area was 6.04 ± 0.92% and this differed signif-
icantly from all groups. Passage 5 continued to differ significantly from all groups
to day 31, the end of the study. Final percentage gel areas on day 31 were 3.05 ±
0.46%, 2.96 ± 0.45%, 3.07 ± 0.42% and 4.92 ± 0.69% for passages 2, 3, 4 and 5,
respectively.
Despite the significant difference in percentage gel areas between passage 2 and pas-
sage 5 constructs on day 3, no differences were observed between all construct maxi-
mum and minimum widths (Figure 7.3A).
Day 7 maximum and minimum widths for passage 5 were 5.31 ± 1.72mm and 4.30 ±
0.92mm and day 14 maximum and minimum widths were 3.87 ± 0.47mm and 3.05 ±
0.51mm, respectively (Figure 7.3B). Passage 5 maximum/minimum widths differed
significantly from passage 2 max/min widths of 3.67 ± 0.63mm/ 3.01 ± 0.68mm and
passage 4 max width of 3.65 ± 0.66mm/ 2.60 ± 0.47mm, on day 7.
On day 14, passage 5 maximum widths were significantly greater than all groups,
whereas the minimum widths of passages 2 and 4 were significantly smaller than
passage 5 minimum widths only. Towards the remainder of the study, passage 5
max/min widths were broadest and differed significantly from all groups.
7.3.2 Effect of cell seeding density on fibrin contraction
In the first week, there was a correlation between cell seeding density and extent of
fibrin gel contraction as the 50K cell group showed the least amount of contraction
and the 200K contracted the most (Figure 7.4A). The percentage original fibrin gel
areas of the 50K group expressed statistically significant difference from the 100K
and 200K groups in the first seven days (Figure 7.5A).
































































































Passage 2 Passage 3
Passage 4 Passage 5
Figure 7.2: Effect of CTF cell passage number on fibrin gel contraction. (A) In
the first week, passage 2 differed significantly from passage 5 on day 3. (B) From
day 12 Passage 5 differed significantly from all other groups until the end of the
study on day 31 (C).

























































































































































































































































































Figure 7.3: Effect of CTF cell passage number on sinew maximum and minimum
widths. There were no significant differences in construct widths on day 3 (A).
Passage 2 and 4 had significantly smaller maximum and minimum widths when
compared to passage 5 on day 7. Thereafter passage 5 maximum width was broader
those than all other groups (p<0.05). Significant difference denoted by * for max
widths and # for min width.
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Figure 7.4: Effect of cell seeding density on fibrin gel contraction. Contraction
of the 50K group was slow in the first week, though no visible differences were
apparent between 100K and 200K on day 7 (A). By 29, the 50K group constructs
were significantly thinner in width than both 100 and 200K groups.
Day 7 percentage areas were 5.65 ± 0.93%, 3.27 ± 0.28% and 3.36 ± 0.53% for 50K,
100K and 200K, respectively (Figure 7.5B). On day 14, percentage gel areas of all
groups were almost identical at 2.71 ± 0.23% for 50K, 2.53 ± 0.26% for 100K and
2.70 ± 0.36% for 200K. This indicated an increased rate in fibrin gel contraction in
constructs with a 50K cell density between the 1st and 2nd week. The maximum
and minimum widths of the 50K group reflected percentage gel area results seen
on day 7 at 5.30 ± 0.84mm (max) and 3.19 ± 0.58mm (min), which were greater
than max/min widths of group 100K of 3.26 ± 0.70mm/ 1.82 ± 0.13mm and 3.20 ±
0.77mm/ 1.95 ± 0.33mm for 200K (Figure 7.6).
The changes in fibrin gel percentages areas from day 14 to day 29 continued to be
small for 100K and 200K, with final values of 2.13 ± 0.18% and 2.14 ± 0.19%,
respectively, on day 29. The 50K group continued to contract the fibrin gel and had

































































































Figure 7.5: Contraction of fibrin gels due to cell seeding density. Halving the
cell seeding density to 50K had a greater effect on contraction than doubling it
to 200K. 50K constructs had higher percentage gel areas up to day10 (A & B).
From day 15, the contraction rate of the 50K group rapidly increased, resulting
in the greatest reduction of original fibrin gel area compared to 100K and 200K
constructs (p<0.05). Groups 100K and 200K were not significantly different.
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a percentage gel area of 1.75 ± 0.08% on day 29 (p<0.05) (Figures 7.4B & 7.5C).
Day 29 max/min widths further supported fibrin percentage gel areas and were 1.56
± 0.09mm/ 1.26 ± 0.12mm, 2.01 ± 0.20mm/ 1.32 ± 0.09mm and 2.01 ± 0.18mm/
1.36 ± 0.19mm for 50K, 100K and 200K, in that order. With prolonged culture,
over 4 weeks, a low cell density of 50K cells actually increased the extent of fibrin gel
contraction observed.
7.3.3 Suitability of different cell sources for TE L/T
To determine if the TE L/T model could be used with varying sources of fibroblast
cells, constructs were seeded with 3T3 cells, CTFs or PFBs. Constructs seeded with
PFBs contracted the most in the first 3 days (Figure 7.7).



























































































































































































Figure 7.6: Effect of cell seeding density on maximum and minimum widths.
Max/min widths of the 50K constructs were significantly broader than those of
groups 100K and 200K in the first week. The opposite was true by day 29, as
the 50K constructs were significantly thinner than all other groups. Significant























Figure 7.7: Images showing contraction of fibrin due to different cell types. 3T3s did not contract very well around the
anchors and the fibrin gel had completely disappeared after the second week. PFBs initially contracted the fibrin gel faster
than CTF constructs though from the second week contraction appeared to have halted. PFB constructs also appeared more
translucent than CTF constructs.
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3T3s did not contract the gel uniformly between the anchors and after the first week
exhibited a rapid rate of fibrin gel contraction. After the second week, 3T3 cells
had completely degraded the fibrin matrix. PFBs formed sinews in between the
two anchors, as with CTF cells, though they appeared more translucent than CTF
constructs. After day 11, PFB constructs showed slower rates of fibrin gel contraction

































































































Figure 7.8: Rate of fibrin contraction dependent on cell type. (A) PFB constructs
showed a greater extent of fibrin contraction in the first 4 days, which then remained
constant and decreased only slightly on day 11 (B) and plateaued once more (B
& C). PFB constructs had higher percentage gel areas than CTF constrcts. 3T3s
had completely degraded the matrix by day 17 (B).
The percentage gel area of the 3T3s was 3.01 ± 0.91% on day 10. This was about
60% less than the percentage gel areas of PFB constructs 7.13 ± 0.54% and the CTF
group 7.44 ± 0.87%. Maximum and minimum widths of 3T3 constructs were also
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significantly smaller at 2.13 ± 1.46mm/ 0.35 ± 0.12mm than for PFBs at 4.77 ±
0.38mm/ 3.79 ± 0.36mm and for CTFs 4.48 ± 0.36mm/ 3.79 ± 0.62mm.
It is worth noting that on day 10 maximum and minimum widths of PFB and CTF
constructs were near identical. By the next day, day 11, 3T3 percentage gel areas
had further reduced by 40% to 1.76 ± 0.39% whereas PFB were 7.15± 0.52% and
CTF were 6.33 ± 0.88%. PFB constructs continued to have higher percentage gel
areas than CTF until day 36, with values of 3.75 ± 0.51% and 2.73 ± 0.18%, in order
mentioned. Maximum and minimum widths of PFB sinews of 3.32 ± 0.33mm and
2.28 ± 0.29mm were also significantly greater than CTFs of 1.76 ± 0.13mm and 1.40
± 0.12mm.
7.3.4 Effect of ascorbic acid and proline on contraction of
PFB seeded constructs
Figure 7.10A shows contraction of PFB seeded constructs over 29 days. During the
first two days, the control group contracted the least and differed significantly from
AA and AA+P treated groups, which had the lowest percentage gel areas but not
from Proline treated group. The P only group differed significantly from the most
contracted AA group.
From day 3 to day 16 no significant differences were observed between the percentage
gel areas of the groups (Figure 7.10B & C). No clear trend was seen between the
maximum and minimum widths of the sinews though the proline group max width of
5.05 ± 0.23mm were smaller than those of the controls of 6.23 ± 0.98mm (p<0.05) on
day 7 (Figure 7.10E). On day 17, the AA+P group differed from AA (p=0.029) and
P (p=0.042) as it had the largest percentage gel area of 5.00 ± 0.58%. The control
group had contracted to 4.48 ± 1.27% whereas AA was at 3.62 ± 0.77% and P at 3.57
± 0.53%. From day 24 to day 29, AA+P treatment resulted in significant difference
when compared with all other groups as it exhibited a lesser extent of contraction.
The percentage gel area of the AA+P group was 4.27 ± 0.41% on day 29. For the
control group this was 2.84 ± 1.19%, 2.98 ± 0.83% for AA and 2.81 ± 0.49% for P.
The proline group had the smallest minimum width of 1.86 ± 0.38mm, which differed


























































































































































Figure 7.9: Maximum and minimum widths of constructs of varying cell type.
PFB maximum and minimum widths were significantly smaller than other groups
on day 3. From the third week in culture, PFB max/min widths were significantly
broader than CTF construct widths.















































































































































































































































































































































* p<0.05 when compared to PFB Control Max
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# p<0.05 when compared to PFB AA+P Max
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Ұ p<0.05 when compared to PFB AA+P Min





Figure 7.10: Contraction of PFB seeded constructs due to AA/P treatment. (A)
Images showing contraction due to supplementation. AA+P treatment resulted in
constructs that were visibly broader than other constructs, whilst P constructs were
smallest in width. (B) and (C) The control group percentage gel areas differed from
AA & AA+P treated in the first two days but from day 3 to 16 all constructs showed
no significant differences. (D) By the end of the study, AA+P had contracted the
fibrin gel the least. (E) Generally, P group max/min widths were significantly
smaller than AA+P treated constructs.
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significantly from that of the AA+P group, which had the broadest minimum width
of 3.06 ± 0.43mm, on day 29.
During culture it was observed that AA only treatment resulted in fissures within the




AA P Control 
Figure 7.11: Digestion of fibrin matrix due to AA treatment. Fissures were
apparent within the AA treated sinews likely due to enhanced fibrin degradation,
a separate phenomenon from contraction.
These fissures were not present in sinews of the other groups though AA+P treated
constructs had areas of greater thinness and translucence within.
7.3.5 Effect of ascorbic acid + proline on chick and rat fi-
broblast cell proliferation
Both treated and non-treated CTF constructs exhibited a lesser extent of proliferation
than the PFB groups. The CTF control and AA+P treated groups had 3.6× 105 ±
1.0× 105 cells and 2.6× 105 ± 3.7× 101 cells, respectively, on day 3, which differed
significantly from PFB control with 9.5× 105 ± 2.4× 102 cells and PFB AA+P with
1.6× 106 ± 5.8× 105 cells (Figure 7.12).
AA+P treatment appeared to have opposing effects on CTF and PFB cells as CTFs
treated with AA+P had the lowest live cell number, whilst PFB supplemented with







































































































* p<0.05 when compared to PFB Control 
and PFB AA+P
** p<0.05 when compared to CTF Control





Figure 7.12: Proliferation of constructs supplemented with AA/P. CTFs showed
a lesser extent of proliferation than both AA+P treated and control PFB groups.
AA+P had the greatest number of live cells about 6-fold that of the CTF AA+P
group. On day 14, both CTF cell group live cell numbers were significantly less when
compared to the PFB groups. In addition, the CTF AA+P group had a significantly
reduced number of live cells, 2.9× 105 ± 9.9× 101 cells, in comparison to the control
group with 5.2× 105 ± 8.8× 101 cells.
7.3.6 Morphology of rat tail PFB cells on fibrin gels
To determine if supplementation altered gel properties and cell morphology, contrac-
tion impeded gels seeded with cells were stained with calcein-AM and propidium
iodide (Figure 7.13). Day 3 results supported the proliferation study (Figure 7.12),
indicating that PFB cells receiving no treatment proliferated to a lesser extent than
AA+P treated PFB cells (Figure 7.13A). Similarly, AA only treatment of PFB cells
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resulted in greater proliferation than P only supplementation. For the CTF cells, P
only supplementation appeared to retard proliferation. Supplementation with AA or
AA+P resulted in cell alignment.
CTF
PFB
Control AA+P AA PA




Figure 7.13: Variation in cell proliferation between CTF and PFB cells over 7
days. Live/dead staining of gels seeded with CTFs or PFBs on days 3 (A) and day
7 (B). On day 3, CTFs treated with P did not appear to have proliferated well. AA
and AA+P resulted in alignment of the CTF cells. AA and AA+P supplementation
also increased PFB cell proliferation. By day 7, all CTF groups exhibited profound
proliferation whereas the morphology of PFBs appeared altered. Scale bars are
100µm.
By day 7, all CTF cell groups showed no distinguishable difference in proliferation.
This was also in agreement with results from Figure 7.12, which showed no differ-
ences in live cell numbers between CTF control and CTF AA+P. The morphology of
PFB cells appeared drastically altered by day 7, having formed thin vastly intercon-
nected clustered networks (Figure 7.13B). AA treatment of PFB cells also appeared
to enhance digestion of the matrix.
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7.3.7 Construct collagen content and tensile strength
7.3.7.1 Comparison of CTF and PFB construct collagen content
The collagen content of experimental groups in this chapter was evaluated. After 5
weeks of culture, average percentage collagen of passage 2, 3, 4 and 5 constructs were
13.15 ± 5.23%, 6.85 ± 2.17%, 12.34 ± 2.59% and 8.81 ± 2.45%, in order mentioned
(Figure 7.14A). Passage 3 constructs had the least amount of collagen, which differed
significantly from passage 2. Cell seeding density did not have an effect on the amount
of collagen present (Figure 7.14B).
Figure 7.14: Collagen content of constructs due to cell properties. (A) Passage 3
had the lowest % collagen, whilst passage 2 cells expressed the highest amount. (B)
Cell seeding density did not affect sinew collagen content. (C) PFB cells produced
significantly less collagen than CTF cells. (D) Supplementation resulted in CTF
AA constructs, containing the highest amount of collagen, which differed from
all groups. CTF AA+P collagen content was significantly greater than all PFB
groups. Again PFB control collagen differed from CTF control and also from PFB
P.
These constructs where cell seeding density was varied were prepared using cells at
passage number 5, however, the average % collagen differed significantly from passage
number experiments. Generally, CTF cells expressed higher quantities of collagen
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than PFB cells (Figure 7.14C). Here, CTF constructs treated with AA only had a
collagen content of 57.67 ± 17.79%, which differed significantly from all other groups
(Figure 7.14D). Supplementation of CTF cells with AA+P resulted in a significant
difference between CTF AA+P (25.19 ± 2.60%) and all treated and non-treated PFB
groups, which all contained an average percentage collagen less than 10%.
7.3.7.2 Comparison of CTF and PFB construct tensile strength
The tensile test curves for constructs of varying cell passage number, cell seeding
density and cell type with/without supplementation are shown in Figure 7.15A–D.
For passage 3, the load vs extension curve differed from those of passages 2, 4 and
5 and had the lowest maximum load of 131 ± 21mN (Figure 7.15A). Out of the
passages investigated, passage 3 constructs possessed the least amount of collagen
(section 7.3.7). Passage 2, 4 and 5 had similar maximum loads of 244 ± 31mN, 232
± 42mN and 237 ± 72mN, in that order. Passage 5 constructs were stiffest although
they did not contain the highest collagen content, with highest Young’s Modulus
of 37.13 ± 8.28kPa. This differed significantly from passages 3 and 4 of Young’s
Modulus 12.21 ± 2.94kPa and 17.35 ± 6.38kPa, respectively.
Despite 100K and 200K cell seeding densities having 2-fold and 4-fold the initial
number of cells of the 50K group, this did not affect the total amount of collagen
present in the constructs but resulted in the 50K group having smallest percentage
of original fibrin gel area on day 29. The 50K group also had lowest tensile strength,
withstanding only 52 ± 18mN (p<0.05) (Figure 7.15B and E). The 100K group had
a maximum load of 110 ± 42mN, whilst the 200K load had a maximum load of 120
± 30mN. Increasing the cell seeding density from 100K to 200K, did not appear to
affect construct tensile strength.
PFB constructs were weaker than CTF constructs and achieved maximum loads
<80mN. The PFB control and PFB P groups had similar maximum loads of 73 ±
17mN and 71 ± 18mN, respectively. Groups PFB AA+P and PFB AA had lower
maximum loads of 46 ± 15mN and 42 ± 25mN, respectively. Supplementation did
not affect collagen synthesis as no differences were observed between the PFB groups,
however, tensile tests indicate that AA+P and AA supplemented PFB constructs









































































































































































































































































































Figure 7.15: Construct tensile test results. Load to strain curves of constructs
at different CTF passage number (A), CTF cell seeding density (B), supplemented
PFB constructs (C) and supplemented CTF constructs (D). (E) shows sinew max-
imum loads and (F) the corresponding strains at maximum loads. (G) Young’s
modulus of constructs. Symbols represent significance at p<0.05. In (E) # is
when compared to all PFB groups.
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were more fragile than the non-treated or proline only supplemented constructs, fail-
ing at lower strains. Similarly, supplementation with AA+P/AA resulted in CTF
constructs that were more brittle, the maximum load and failure strains occurring at
very low strains <1.0 strain (Figure 7.15D, E and F). This was further reflected in
the Young’s Modulus of CTF AA+P of 57 ± 40kPa, which was significantly larger
than CTF control, PFB control and PFB AA+P, with values of 16 ± 7.0kPa, 3.4 ±
1.3kPa and 2.5 ± 0.8kPa, in order mentioned. Although CTF AA had the highest
percentage collagen, differences in the maximum loads of the CTF constructs were
not significant. CTF Control and CTF P maximum loads of 143 ± 29mN and 163 ±
30mN, respectively, did vary from all the proline groups.
7.4 Discussion
Increasing cell passage numbers and cell history affect fibrin gel contrac-
tion and resulting sinew mechanical strength
Cells at passage number 5 exhibited decreased fibrin gel contractility and were gen-
erally wider in width than passage 2 and 4 in the first weeks and then significantly
different from all groups by the end of the study. This indicated that increasing
passage numbers decreased cell responsiveness to the matrix and affected cell medi-
ated contraction. This was not surprising but it was unexpected that the decrease in
contractility would be observed at such an early passage. With age, fibroblasts from
the human skin become quiescent, have endoplasmic reticulum that is not well devel-
oped and are less responsive to the matrix and chemotactic signals (Ashcroft et al.,
2002). Foetal and adult fibroblasts have been been shown to vary in their capacity
to contract wounds during healing, with in vivo and in vitro results varying between
cell types/sources and experimental protocols (Moulin and Plamondon, 2002).
The effects of experimental protocols or cell history were further demonstrated by
the behavior of passage 3 constructs, which did not differ significantly from passage
5 in the first three weeks, despite being “younger”. The cells used for the passage 3
group, were thawed from a different batch of cells, frozen at a different time point.
Passage 3 expressed the least amount of collagen and had a load-extension curve that
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varied from the other passage numbers. Chang et al. (2002) investigated genome
expressions of human fibroblasts sourced from 10 different parts of the body such as
the arm, scalp, toe, gum, to name a few, from 16 different donors, looking at both
foetal and adult cells and determined that fibroblasts should be considered a class of
distinct differentiated cell types. They determined that the fibroblasts from different
body locations and passages maintained their distinct phenotypes and expressed gene
related to their origin, an important characteristic for tissue engineering cell sourcing.
In a lung undergoing tissue repair and remodelling, several distinct types of fibroblasts
have been identified within the same lung (Phan, 2008).
Low seeding density increases extent of fibrin contraction and may pro-
mote differentiation into myofibroblasts
The ability of fibroblasts to contract the fibrin matrix is due to complex cell-matrix
interactions and environmental cues that lead to the expression of smooth muscle
actin (α-sma) mRNA (see Chapter 2, section 2.3.1.2). Adult differentiated fibrob-
last are quiescent, with slow rates of proliferation, matrix turnover and absent actin
filaments (Ashcroft et al., 2002; Gabbiani, 2003). During wound healing, fibroblasts
differentiate into myofibroblasts, which have two-fold the contractile capacity of fi-
broblasts and are able produce de novo extracellular matrix (Hinz et al., 2007). The
expression of α-sma by myofibroblasts is said to be dependent on mechanical stress
such as matrix rigidity, the presence of particular ECM proteins and the TGF-β
growth factor, which is often released during wound healing as it also promotes colla-
gen type I synthesis (Gabbiani, 2003; Hinz et al., 2007). In vivo, once fibroblasts have
differentiated into myofibroblasts tissue remodeling will continue until the wound is
healed, after which α-sma expression ceases due to ERK pathway downregulation,
leading to cell apoptosis (Desmouliere, 1995; Hinz, 2007; Grinnell, 2000). Other fac-
tors are likely to be involved in wound contraction as some open wounds have been
shown to spontaneously contract suggesting that granulation tissue and myofibrob-
lasts may not be the only requirements for contraction(Grinnell, 2000; Gross et al.,
1995; Tomasek et al., 2002). Masur et al. (1996) demonstrated that fibroblasts dif-
ferentiation into myofibroblasts was also dependent on cell density. Plating corneal
fibroblasts at low cell seeding density impeded cell to cell contacts resulting in 70-
80% differentiation into myofibroblasts whereas at high cell seeding densities, only a
Chapter 7. Cell properties 212
5-10% conversion was achieved (Masur et al., 1996). Further, passaging of corneal
myofibroblasts at high density resulted in a loss of α-sma expression, the marker
for myofibroblasts. The results from Masur et al. (1996) may explain why increased
contraction of the fibrin gel was observed at the low seeding density of 50K cell-
s/mL. Alternatively, seeding at low density may have enhanced proliferation as the
cells strived to increase cell-cell contacts, which may also have increased collective
contractile forces or increased cumulative MMPs present. In vitro, human articular
chondrocytes seeded at low densities redifferentiated more readily and had a 3-fold
greater extent of proliferation than cells seeded at higher densities (Gagne et al.,
2000).
Fibroblasts from varying sources respond differently to AA+P treatment
Although cell mediated contraction of the fibrin gel has been focused on thus far, cell-
matrix interactions also involved enzymatic digestion of the fibrin gel by cell secreted
MMPs, which contributed to reduction in percentage fibrin gel areas, sinew widths
and final collagen content. The complete depletion of the fibrin gel by murine 3T3
cells suggested that distinct fibroblast cell types express varying levels of MMPs that
digest the fibrin gel and possibly any synthesized collagen. The stiffness of the fibrin
gel may have been unfavourable for 3T3s as different cell types have been shown to
prefer matrices of different stiffness (Discher et al., 2005), with the optimum stiffness
for fibroblast dendritic morphology being about 10kPa (Solon et al., 2007). Selection
of cell and scaffold type need to be considered for the tissue to be engineered (Dado
and Levenberg, 2009) and these results suggest that several L/T TE models may
need to be developed for different individuals or age groups.
Although PFB cells contracted to form ligament-like tissues, they remained fairly
translucent in comparison to CTF constructs which appeared denser (Figure 7.8),
which suggested that less collagen was deposited. Upon handling, PFB constructs
were flimsy and not as robust as CTF constructs (data not shown). The tensile tests
and collagen content results supported these statements as TE PFB control sinews
had significantly less collagen and a lower maximum load strength than CTF control
sinews (Figures 7.14 and 7.15).
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Supplementation of PFB constructs with AA+P led to surprising results as sup-
plementation did not significantly increase collagen content and actually resulted in
sinews of lower mechanical strength than non-treated sinews. Treatment with AA
enhanced fibrin degradation rather than fibrin contraction as fissures appeared within
AA treated sinews (Figure 7.11). Arrigoni and De Tullio (2000) state that AA’s roles
extend past its function as an anti-/pro-oxidant or as a cofactor for collagen synthesis
because AA is required for the expression of several genes and it cofactors many other
enzymes. A study by Esteban et al. (2010) investigating the reprogramming of mouse
and human fibroblasts into induced pluripotent stem cells (iPSCs) highlights such ad-
ditional functions of AA. Fibroblast become quiescent during in vitro culture, partly
due to the increase in reactive oxygen species (ROS), which Esteban et al. (2010)
found also increased during the reprogramming of mouse fibroblasts. They explored
the use of several antioxidants to reduce ROS but only treatment with AA resulted in
a significant improvement in reprogramming efficiency, a result they concluded was
not solely due to AA’s antioxidant capacity as similarly active antioxidants showed
no such effect (Esteban et al., 2010). The researchers noted that AA reduced cell
idleness though they were unclear about the exact mechanism, which could have been
due to AA’s involvement with collagen proly hydroxylases, HIF-prolyl hydroxylases,
and histone dimethylases (Esteban et al., 2010). Further research on the extensive
functions of AA on biological systems are much needed.
Growth medium type affects fibrin gel mechanics, construct collagen con-
tent and tensile strength
Because PFB cells do not grow well when cultured in DMEM, Ham’s F12 medium
was used instead. As a result, this was an additional variable between CTF and PFB
constructs. Acellular fibrin gels prepared using either DMEM or Ham’s F12 Ham,
suggested that Ham’s F12 led to the formation of stiffer fibrin gels. To evaluate
this further, CTF cells were seeded on gels prepared using Ham’s F12 media and
PFB’s were seeded on fibrin gels containing DMEM. Constructs were fed with the
medium corresponding to that making up the fibrin gels, with or without AA+P
supplementation. After 5 weeks of culture, CTF constructs fed with Ham’s F12
had a significantly higher collagen content and greater tensile strength. The results
suggested that the culture medium used had an effect on cell collagen synthesis.
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Medium formulations differ and to optimise protein synthesis, separate or additional
factors need to be considered as, in this thesis, enhanced collagen synthesis is equally
important as maintaining cell proliferation and viability. For example, some media
contain proline, hydroxyproline or ascorbic acid as well as differing concentrations of
calcium, which could contribute to varying the stiffness of the fibrin gel or altering the
amount of collagen produced. These results and the various formulation of growth
media used for chick fibroblast cells are are shown in Appendix C.
7.5 Conclusion
What is clear from these results is that there are several cell specific parameters that
affect cell mediated contraction and remodelling of the fibrin hydrogel scaffold and
consequently the dimensions and mechanics of the TE L/T. Alterations to the model
or several models may need to be developed for tissue engineering various ligaments
and tendons for different people/ animals.
Chapter 8
Conclusions and Future Work
8.1 Conclusions
The results presented in this thesis have quantitatively demonstrated the effects of
AA+P supplementation and effects of fibrin hydrogel stiffness on cell mediated scaf-
fold contraction and the resultant TE tissue dimensions. In addition, possible modes
of action behind AA+P supplementation have been elucidated. It was also shown that
scaffold stiffness and supplementation in combination could be exploited to control
construct widths, whilst increasing collagen content and improving the mechanical
strength of the TE tissue as well as prolonging attachment at the brushite cement
interface. The main findings from chapters in this thesis are described below.
Proline reduced initial rates of contraction.
In Chapter 4 it was shown that proline supplementation had a dominant effect on
contraction rates and that initial rates of contraction of the AA+P group were largely
dependent on the presence of P. It was also shown that the rates of AA contraction
were largely similar to the control group over the course of the study. Altering the
concentrations of either AA or P whilst maintaining one or the other constant revealed
that P had no significant effects on construct collagen content, however, increasing
AA increased collagen significantly. AA and P clearly had different modes of action.
Further, constructs with enhanced collagen content also had higher rates of fibrin gel
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contraction and smaller widths suggesting a correlation between construct collagen
content and contraction rates.
Control constructs had collagen subunits with less fibril formation and
lacked organisation. AA+P treatment led to extensive remodelling due
to the upregulated collagen synthesis, contraction and MMP-2 expression.
Biological characterisation using histological, microscopy and RT-PCR techniques
in Chapter 4 offered further insight into the differences between control and AA+P
treated constructs. Histology and TEM images indicated that although control con-
structs sythesize collagen precursors, formation of collagen fibrils was limited. AA+P
led to greater extent of fibrin gel remodelling, resulting in a dense matrix with col-
lagen fibrils. Cells were seen to be actively involved in protein synthesis as they had
prominent endoplasmic reticula. RT-PCR confirmed the upregulation of collagen
type I in AA+P supplemented constructs as well as stress fibre activator RhoA and
contractile actin. MMP-2, a gelatinase that degrades degraded collagen I (gelatin)
and is linked to fibrin degradation, was also upregulated.
Fibrin fibre volume fraction can be used to control rates of contraction
and construct widths
Fibrin gel stiffness was increased in Chapter 5 to determine if collagen content would
be enhanced either due to the increased collagen gene expression or due to delayed
fibrin contraction rates, which would increase cell number and therefore possibly
collagen. Additionally, if contraction was delayed this would result in constructs
that were broader in width. Indeed, increasing fibrin gel properties such as volume
and stiffness, reduced the rates of fibrin gel contraction and constructs were broader.
Increases in volume and/or stiffness did not limit construct formation and cells were
seen to align along the direction of tension. However, comparisons of contraction
data revealed that increasing fibrin volume or increasing fibrin stiffness produced
constructs with similar fibrin percentage gel areas and widths.
As a result, fibrin total volume, stiffness or fibre volume fraction are parameters
that can be used to control construct dimensions such as width. The findings also
showed that increasing the scaffold volume or stiffness was insufficient in raising
collagen content. Thereby emphasising the necessity of collagen cofactors or other
stimulatory agents.
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Reducing thrombin to fibrinogen ratios to 0.313UT/mgF doubled fibrin
gel stiffness (G’). No difference was observed in fibre diameters although
porosity increased suggesting increase in stiffness was due to greater quan-
tity of fibrin fibres.
The structure and mechanical performance of the fibrin gels used in Chapter 5 were
characterised. No difference was observed in fibrin fibre diameters of varying stiffness
though 0.313UT/mgF gels had larger pores not seen in the other formulations. In-
creasing fibrin total volume also increased stiffness though to a more moderate extent
than altering thrombin to fibrinogen ratio, likely due to increased number of fibres.
Gelling kinetics were also observed and fibrin gels polymerised in-situ, on the rheome-
ter, showed strain stiffening behaviour, which was not observed in gels pre-gelled in
the incubator before testing.
There is an optimum stiffness required for collagen sythesis and only in
combination with AA+P supplementation
Because constructs of the stiffest gel formulation 0.313UT/mgF were broader than
constructs of the control gels of 1.25UT/mgF, the effect of stiffness combined with
AA+P treatment was investigated in Chapter 6. As expected, 0.313UT/mgF AA+P
constructs were broader than AA+P constructs prepared using the control gel for-
mulation. In addition, collagen content and sinew mechanical strength increased
dramatically. Attachment at the interface was prolonged in comparison to AA+P
only and the control constructs. The results suggested that there is an optimum
stiffness at which AA+P collagen production is most efficient.
Distinct models may need to be developed for different cell types. Growth
medium may affect gel stiffness and consequently construct collagen con-
tent when supplemented with AA+P.
Chapter 7 investigated the use of different cell sources and their potential to form TE
L/T. The results showed that fibroblast cells have an inherent affinity for fibrin that
varies between cell types. 3T3s completely degraded the fibrin gel within 2 weeks.
Supplementation of PFB constructs with AA/P or AA+P had the opposite effect
to that observed using CTF cells. AA and AA+P reduced extent of PFB construct
contraction whilst no treatment and P supplementation increased it. In addition,
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PFB constructs generally contained significantly lower quantities of collagen than
CTF constructs.
The compositions of various media including DMEM and Ham’s F12 were detailed in
Appendix C. Because PFB and CTF constructs were cultured using different media
this presented an additional variable. Stiffness of the fibrin gels was shown to be
affected by the type of medium used (Ham’s F12 or DMEM), suggesting medium
choice to be a factor determining construct collagen content.
8.2 Recommendations for future work
8.2.1 Increasing fibrin fibre volume fraction
The results presented in this thesis have shown that fibrin contraction rates were sig-
nificantly reduced by increasing fibrinogen volume or fibrin stiffness (Figure 8.1). The
fibre volume fraction can be increased by raising the concentration of the thrombin
and fibrinogen stock solutions. Fibrin fibre diameters and pore spaces will need to be
evaluated to ensure they do not become limiting. Optimum fibrin gels are those that
balance fibre lengths, diameters, quantity and extent of branching without extremes
in one parameter (Weisel, 2007). In some instances, cell encapsulation within the
firbin gel, will assist cell permeation as opposed to cell seeding on the gel surface. In
addition, cell encapsulation would assist the formation of 3D TE L/T with improved
attachment to the brushite cement anchors. This will likely eliminate the rolling
mechanism observed in this thesis and promote uniform formation with fewer folds,
which may have limited construct strength.
8.2.2 Optimising fibrin gel stiffness with AA+P supplemen-
tation
The results in this thesis showed that increasing stiffness together with AA+P sup-
plementation increased final fibrin gel percentage areas, constructs widths, collagen
content and maximum loads. Using DOE software (Design Expert, Stat Ease), Figure
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Figure 8.1: Multiple factor comparison of percentage gel areas.
8.2 was produced. From data presented in this thesis, the optimum condition at the
stiffnesses investigated was to use the stiffest formulation 0.313UT/mgF with supple-
mentation (where 1 = treated, 0= non-treated) in order to maximize the responses:
fibrin percentage gel area, maximum load and collagen content.
Increasing concentrations of the stock solutions will allow the stiffness of the gels to
be increased further whilst adjusting thrombin to fibrinogen ratios. And it would
be of interest to evaluate the effects of varying concentrations of AA and P and the
stiffer gels on construct morphology and mechanical properties.
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Figure 8.2: Effect of fibrin UT:mgF ratio and supplementation on maximizing
construct properties. Conditions were set to optimise construct percentage gel
areas, maximum load and collagen content.
8.2.3 Cross-linking fibrin
In the body, fibrin clots are cross-linked by the enzyme transglutaminase or Factor
XIIIa, which reduces the degradative effects of MMPs (Janmey et al., 2009a). Addi-
tion of CaCl2 to fibrinogen has been shown to increase fibrin stiffness by allowing the
formation of cross-links (Shen et al., 1974). Use of cross-linked fibrin hydrogels may
help reduce the rates of fibrin gel contraction. Increasing the rigidity by cross-linking
whilst supplementing with AA+P may further improve construct collagen content.
8.2.4 Quantifying degraded fibrin
Although MMP-2 upregulation suggested degradation of both newly formed collagen
and fibrin, through the action of MT1-MMP (MMP-14) the amount of fibrin actually
degraded will need to be quantified in order to determine if differences between the
control and AA+P supplemented constructs are due to enhanced contraction and
not enhanced proteolytic activity. Fibrin degradation products (FDPs) are produced
during fibrinolysis and can be measured using biological assays. Hoelzel Diagnostika
supply Bovine Fibrinogen Degradation Product ELISA kits for the cost of 576 Euros
each (price January 2013).
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8.2.5 Interface
In this thesis one of the aims was to improve interface strength and attachment
by enhancing properties of TE soft tissue. Further work needs to be conducted in
characterising the effects of fibrin gel stiffness with AA+P treatment on the interface
strength. In addition, as stated in Chapter 2 strategies for regenerating the enthesis
include co-culture (Lu et al., 2010) of cells capable of forming bone, cartilage and the
TE soft tissue.
8.2.6 Mechanical loading
Mechanical loading implementing intermittent stretch regimes has also been shown
to enhance collagen content and improve the strength of the interface (Paxton et al.,
2011). It would be of interest to determine whether increased fibrin gel stiffness
along with AA+P supplementation and stretching would further enhance construct
collagen content and mechanical strength, as well as the strength of the interface.
8.2.7 RT-PCR
Preliminary RT-PCR results indicated the upregulation of several MMPs. No scler-
axis was detected, which is a marker for tendons, highly expressed by fibroblasts and
even more so by myofibroblasts. Myofibroblasts are known to be highly contractile,
which makes the absence of scleraxis questionable as RhoA and actin were upreg-
ulated, whilst Tenascin-C expression was higher in supplemented constructs than
non-treated controls. Reasons for the lack of scleraxis detection may have been due
to a low signal from low cDNA concentrations. As a result, further work needs to
be conducted to investigate scleraxis expression. Further, the results implied that
constructs prepared on 0.313UT/mgF gels and supplemented with AA+P expressed
other small GTPase proteins such as Ras and that TGF-β expression may also have
been upregulated. Additional work needs to be conducted to determine the upregu-
lation of these proteins. Although MMP-2 was seen to be upregulated or downreg-
ulated for AA+P or 0.313UT/mgF AA+P, respectively, as MMP-2 is activated by
MT1-MMP, the expression of MT1-MMP itself will need to be explored.
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8.2.8 Studying contraction
To better study the influence of supplementation or fibrin gel stiffness on cell contrac-
tile activities, future work could implement time lapse microscopy with microbeads
to quantify actual cell forces generated, observe migratory processes and physical
mechanisms of remodelling the matrix. Dikovsky (2008) used such a system, incor-
porating microbeads in a PEGylated-Fibrin gel to study the effects of matrix stiffness
on cell morphology and proteolytic activity. Techniques such as AFM could also be
used to measure cell-matrix adhesion strength. Work was begun aimed at exploring
contractile behaviour of cells on matrices of differing stiffness, with or without sup-
plementation using micropost arrays as per protocol developed by Yang et al. (2011).
Unfortunately, due to time constraints it was not possible to measure cell contractile
forces using this method in this thesis. However, work on fabricating the pillars was
begun and we were supplied with the Matlab code relating to their protocol, therefore
this study should be continued in future work.
8.2.9 Supplementation
AA, P, ZnSO4 or MnSO4 supplements were used in this thesis. Combined treatment
of ZnSO4 or MnSO4 with AA+P reduced the extent of fibrin gel contraction. Zinc
(Kaplan et al., 2004) and manganese are cofactors for enzymes involved in collagen
synthesis (Leccia, 1996). RT-PCR results showed that supplementation with MnSO4
and AA+P upregulated collagen expression to a higher extent than both AA+P
only and 0.313UT/mgF AA+P constructs, however, the assay for testing collagen
content suggested collagen content of MnSO4 AA+P was below that of AA+P or
0.313UT/mgF AA+P. The mechanism behind the mode of action of Zn2+ and Mn2+
on collagen synthesis therefore needs to be further evaluated.
There may be room to further optimize AA+P supplement concentrations. Using
the DOE software and data from Chapter 4 where AA or P were varied whilst main-
taining one of them constant, a suggested supplementation regime to enhance fibrin
percentage gel area and collagen content, was to increase concentrations of AA and
P in combination to 340µM AA with 185µM P (Figure 8.3A). However, the actual
optimum design, based on the range of concentrations used, would be 316µM AA
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without P (Figure 8.3B). Experiments can be setup in the future to determine the
validity of such models.
The results presented in this thesis suggested that collagen synthesis was not signifi-
cantly increased by raising P concentration at constant AA. Perhaps this is because
a combination of several co-factors may be required to maximize collagen synthesis
such as iron and α-ketoglutaric acid, which along with AA are required for proline
hydroxylation. Iron is already present in cell culture medium (as shown in Appendix
C), however, it may be worth determining optimum concentrations for collagen pro-
duction. In addition, although α-ketoglutaric acid is a product of metabolism, its
inhibition with increasing concentrations of DMOG (Chapter 4) suggested that it is
important for collagen synthesis and fibrin gel contraction. A longer study utiliz-
ing DMOG should be conducted to determine construct fibrin percentage gel areas,
collagen content and tensile strength.
8.2.10 Cell proliferation
This thesis used enzymatic digestion methods to detach cells from the matrix. Quan-
tification using calcein-AM relied on cells remaining viable. Although it was shown
that the reagents did not lead to significant cell apoptosis (see Chapter 3, Figure
3.7), the use of Hoechst Assay would allow quantification of total cell DNA, includ-
ing both live and dead cells thereby offering a more accurate means of determining
cell proliferation within the constructs.
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A
B
Figure 8.3: Optimizing AA+P concentrations. A) When the design was set to
find the optimum maximum concentrations of AA and P in combination, suggested
concentrations were 340µM AA + 185µM P. To increased both fibrin percentage gel
areas and collagen content within the ranges of concentrations used, the suggested
optimum concentrations were B) 316µM AA, without proline. (Note: The position
of the flag (optimum condition) in A moved backwards in B, to zero Proline.)
Appendix A
Example calculations
A.1 Determining UT/mgF of control gels
Fibrinogen stock solution = 20mg/mL
Thrombin stock solution = 200UT/mL
Fibrinogen
Per 35mm petri-dish / well plate:
Fibrinogen = 200µL added
Fibrinogen per petri-dish = (200/1000) mL * 20mg/mL = 4mg
Thrombin
Enzymes: Thrombin and MMP inhibitors AP and AH are added to sDMEM first at
volumes of 50µL Thrombin, 2µL AP and 2µL AH per 1mL of medium.
For example, 20mL would contain 1000µL Thrombin, 40µL AP and 40µL in 18.92mL
sDMEM −→ total 20mL.
500µL of these enzymes are added to each petri dish/ well.
UT in 500µL = 5UT [from: 200UT/mL * (50/1000)mL * (0.5mL/1.0mL) ]
Therefore UT/mgF = 5UT/4mg = 1.25UT/mgF
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A.2 Estimating fibrin gel thickness
petri dish diameter = 35mm
petri dish radius (PDR)=17.5mm
PDR=0.0175 m




Using V=π r2 h
at control V0, h0 = 0.000727565m
h0= 0.73mm
A.3 Estimating fibrin fibre volume fraction
From:
The hydraulic permeability of blood clots as a function of fibrin and platelet density
(Wufsus 2013)
cfbg = fibrinogen concentrations (valid for 1–40mg/mL)
mass density of fibrinogen protein, rho m = 1.4 g/mL = 1400 mg/mL
phi int = internal fibre volume fraction = 0.015 ln(cfbg) + 0.13
overall fibre volume fraction = phi f = cfbg/ (rho m * phi int)
Fibrinogen stock = 20 mg/mL
Units thrombin per well/ petri dish = 5 UT
Fibrinogen Groups
mg Fibrinogen in µL of fibrinogen solution
mg Fibrinogen = volume fibrinogen in mL * stock concentration (20mg/mL)
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Table A.1: mg Fibrinogen in increasing fibrinogen volumes.





Table A.2: mg Fibrinogen in UT/mgF.
UT/mgF µL Fibrinogen mL Fibrinogen mg Fibrinogen
2.5 117 0.12 2.34
(control) 1.25 200 0.20 4.00
0.5 350 0.35 7.00
0.313 431 0.43 8.62
Table A.3: Fibre volume fractions (φf ) of fibrin gels of increasing fibrinogen
volumes or of varying UT/mgF
Fibrinogen mL UT/mg mg/mL (cfbg) phi int phi f phi f %
0.1 2.5 3.34 0.15 0.016 1.61
0.2 1.25 5.71 0.16 0.026 2.61
0.5 0.5 10.00 0.16 0.043 4.34
0.8 0.313 12.31 0.17 0.052 5.25
mg/mL (cfbg) were calculated by dividing mg fibrinogen with total volume in petri-
dish (given that total volume in petri-dish = mL fibrinogen + mL thrombin in sD-
MEM).
For example:
mg/mL fibrinogen (cfbg) for 1.25UT/mgF = 4.00mg / 0.7mL = 5.71mg/mL
mg/mL fibrinogen for 800µL fibrinogen (cfbg) = 16mg / 1.3mL = 12.31mg/mL
Note for changing fibrinogen volumes, thrombin in sDMEM was kept constant at
500µL (or 0.5mL), so total petri-dish volume for 800µL fibrinogen volume group
would be 800µL fibrinogen + 500µL thrombin in sDMEM = 1300µL (1.3mL).
For changing thrombin to fibrinogen ratios, volumes were made up to a total of
700µL. For the 0.313UT/mgF group, mL fibrinogen = 0.43mL, therefore thrombin
in sDMEM was 0.7mL - 0.43mL = 0.27mL.
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A.4 Quantifying collagen from standard curve
From the calibration curve prepared from known hydroxyproline concentrations, the
sample hydroxyproline contents were obtained using their absorbance readings at
550nm (Figure A.1).
µg/mL hydroxyproline (known) = absorbance (known - used to plot curve)
µg/mL hydroxyproline in sample (unknown, X) = absorbance (known from sample
readings)
From best fit line equation: y = mx + c
Sample absorbance (unitless) = (gradient of calibration curve)x + constant
Where x = sample hydroxyproline content
Units check, for sample hydroxyproline:
Using, x =(y - c)/m
x (µg/mL)= (y - constant) * (µg/ mL)
x (µg/mL) = µg/mL
However, of the known hydroxyproline concentrations standards only 50µL was used.
Same for the sample.
So actual amount of hydroxyproline in sample:
0.05mL * x µg/mL = µg/mL * 0.05mL
µg = µg
Therefore using basis that hydroxyproline = 13.4% of total collagen then:
µg hydroxyproline in sample * (100/13.4) = sample µg collagen
sample µg collagen/ sample weight µg * 100
OR as equation shown in Chapter 3:
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Figure A.1: A CTF construct hydroxyproline caliberation curve.

Appendix B
Construct uniformity and anchor
parameters
The results in chapter 4 indicted differences in fibrin gel contraction and maximum and
minimum widths. To fully attribute the difference in contraction to the supplements,
potential sources of error had to be eliminated.
In sections 4.3.1.2 and 4.3.5 maximum and minimum width measurements indicated that
constructs did not form uniformly. The ratio of maximum to minimum width was deter-
mined to better illustrate this and determine if construct irregularity varied significantly in
certain experimental groups and how this difference in construct width differed with culture
duration.
Additionally, anchor positioning is necessary to provide tension required for the formation
of TE sinew, as without them, the extensive contraction and depletion of the fibrin gel
occurs resulting in the formation of small spherical ball.
The distance between the anchors is a parameter that if varied significantly between groups,
would lead to inaccurate comparisons. For example, if the anchors are too close together,
then it is likely that construct widths would be broader. Conversely, if they are too far
apart, this may lead to excessive tension in the middle of the constructs, causing them
to snap and contract around each individual anchor. Distances between the anchors from
section were measured using day 0 images (see Figure B.1) and no significant differences
were observed between the groups. As differences between the percentage gel areas and
max/min widths of the constructs were small, especially after 4 weeks in culture then
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even minor differences in placing the anchors could have affected the results. Thus a truer
measure for comparison was thought to be aspect ratio as this would relate the length and
width of individual constructs.
However, anchor distance was not the only factor that could have affected construct fibrin
gel area and maximum/minimum widths measurements. Fibrin percentage gel area mea-
surements were conducted such that the area of the anchors at the measurement plane
were subtracted from the total area, to give only the area of the fibrin gel (see Chapter
3 section 3.3). As a result, differences in anchor areas could have potentially been the
cause of observed differences between supplemented groups rather than the supplements
themselves.
B.1 Determining construct length to width (as-
pect) ratios
The distance between the anchors was measured and divided by the average width to
give the construct aspect ratios. The average width was taken to be the the mean of the
maximum and minimum width. Measurements and calculations were conducted for each




              
       
     
Control
Construct 1 2 3 4 5 6 7 Average SD
Length 11.68 12.07 10.72 11.85 13.40 11.92 12.51 12.02 0.81
AA+P
Construct 1 2 3 4 5 6 7 Average SD
Length 12.59 13.16 11.65 12.79 12.22 11.62 12.34 12.34 0.57
AA
Construct 1 2 3 4 5 6 7 Average SD
Length 11.87 11.03 11.21 11.01 12.87 12.30 11.94 11.75 0.70
P
Construct 1 2 3 4 5 6 7 Average SD
Length 12.26 13.20 11.94 12.06 11.54 12.88 10.92 12.11 0.77
 𝑣 𝑟    
(max+ min)
2
Figure B.1: Dimensions measured for aspect ratio and initial distances (lengths)
between anchors. The lengths shown are of constructs in Sections 4.3.1 and 4.3.1.2.
B.2 Construct anchor area measurements
Areas of the anchors (Ai) were calculated using Image J as described in Chapter 3 for fibrin
gel percentage areas. Average areas and standard deviations were determined per group as
per equations in Figure B.2.
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Anchor area at visible plane
𝐴1 𝐴2
𝐴𝑇𝑜𝑡𝑎𝑙1 = 𝐴1 + 𝐴2






 (𝑥−  𝑥)
2
𝑛−1
Figure B.2: Determination of anchor surface area at visible plane.
B.3 Ratio of maximum to minimum widths
To allow comparison of construct uniformity in terms of widths, the ratios of their maxi-
mum to minimum widths were calculated (Figure B.3A). All constructs had maximum to
minimum width ratios greater than 1, indicating the non-uniform formation of the con-
structs and differences were not statistically significant. However, during the first week
supplementation with AA+P and AA only resulted in constructs with the lowest ratios of
1.30 ± 0.29 and 1.23 ± 0.16, respectively, suggesting greater uniformity as their average
values tended towards 1. The ratio of the control group was 1.74 ± 0.93 and that of the P
only group was 1.49 ± 0.34 on day 7. Over the course of the study, supplementation ap-
peared to influence construct widths as treated constructs showed less variability in widths
than control constructs. On day 52, the control constructs had the greatest max to min
ratio of 1.97 ± 1.31 and showed the greatest variation in width between constructs. Ratios
of AA+P, AA and P were 1.64 ± 0.30, 1.53 ± 0.57 and 1.53 ± 0.39, respectively.
B.4 Aspect ratio
To determine the effect of anchor distance on construct widths, the aspect (length to width)
ratios were calculated and are shown in Figure B.3B. However, no statistically significant
differences were observed between the groups. Construct lengths between the anchors
remained constant during the study and as expected the average widths of the constructs
contributed to the greatest difference between the groups.
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A
B
Figure B.3: Comparison of construct dimensions. A) Ratio of maximum to mini-
mum widths. A greater tendency towards 1 suggests greater uniformity in construct
widths. B) Construct aspect ratio, the relationship between anchor distance and
construct width.
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B.5 Effect of anchor planar surface area
Figure B.4 shows that there were no significant difference between visible anchor surface
areas within individual experiments. Between experiment comparisons indicated that an-
chors of the initial study, supplementing with AA/ P or AA+P, differed significantly from





























* Compared to experimental groups were AA conc 
was varied, P conc was varied and experiment utilising 
DMOG.
** compared to experiment were P conc was varied 
and were DMOG was administered.
Figure B.4: Comparison of average anchor surface areas at visible plane. 2D




Influence of extrinsic factors on
fibrin gel contraction
Cells cultured in vitro require the supply of nutrients for growth, which are provided in
the form of artificial growth media. According to Freshney (2005), the development of
cell culture media began with the use of serum and lymph fluids until Eagle’s Minimal
Essential Medium (EMEM) was developed in the 1959. Different cell types have varying
nutritional needs resulting in the demand for media with compositions that vary. EMEM
was developed from the nutritional requirements of mouse L-strain fibroblasts and human
uterine carcinoma (HeLa) cells, which required 12/13 similar amino acids and 7 vitamins
for survival and growth (Eagle, 1955). EMEM was modified by Dulbecco et al. to DMEM,
containing greater amounts of vitamins and glucose. DMEM is considered a general cell
culture medium and it also has higher quantities of amino acid and vitamins than the F12
Ham medium (Freshney, 2005). Early research using embryonic chick heart and fibroblast
cells for a period of 4 to 5 weeks led to the synthesis of Medium 199 by (Morgan et al., 1950),
intended for cell culture without serum. Morgan’s analysis of cell culture media available
at the time concluded that Medium 199 was suitable for chick fibroblast cell survival rather
than growth as significant cell growth was seen only when serum was combined with media
such as investigations by Eagle et al. (Morgan, 1958). Due to experimental variability posed
by the use of serum, (Ham, 1965) also sought to produce serum free synthetic medium in the
form of Ham’s medium to culture CHO cells as well as human fibroblasts and chick embryo
fibroblasts (Shipley and Ham, 1981). Medium MCDB-201, was specifically developed for
chicken fibroblast cells (McKeehan and Ham (1976) as cited by Ham and McKeehan (1978)).
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Apart from medium and serum, preparation methods such UV sterilisation affect biopoly-
mer structure and reduce cell adhesion (Fischbach et al., 2001) and freeze-thaw cycles have
also been shown to lead to protein degradation and loss of protein activity (Cao et al., 2003;
Pikal-Cleland et al., 2000).
Chapter 5 investigated the effects of the fibrin gel mechanics and cell properties such as
cell seeding density, passage number and cell type on the rates and extent of contraction of
the fibrin hydrogel, collagen content and mechanics of the sinews. These properties were
intrinsic to the formation of the TE L/T. This Appendix demonstrates external factors,
which do not directly become a physical part of the TE L/T itself affect fibrin contraction.
Factors that were investigated include the choice in growth culture medium, which as
mentioned above, could affect the activities of the cells; the selection and preparation
methods used for fibrinogen, thrombin and serum reagents; and whether duration of TE
L/T culture affects sinew mechanics.
C.1 Effect of fibrin reagents and preparation meth-
ods
Fibrinogen is purchased in powder form and is dissolved in F12K medium, swirling inter-
mittently, in a water bath at 37◦C. It was noted that dissolution time of the fibrin powder
can vary. In addition, two types of sterilisation methods were used for fibrinogen, namely,
syringe filtration and overnight UV sterilisation. To determine if fibrinogen powder dissolu-
tion time at 37◦C and sterilization using UV irradiation affected fibrin gel contraction, the
percentage gel areas and maximum and minimum widths of the constructs were measured
at intervals during the first week. Further, the fibrinogen solutions for UV sterilisation were
prepared from fibrinogen powders left to dissolve for 1 hour in the waterbath before leaving
to sterilise under UV, whilst the dissolution time fibrinogens were syringe filtered, thereby
allowing a comparison of sterilisation methods
C.1.1 Fibrin gel contraction
A fibrinogen powder dissolution time of only 1 hour resulted in the fastest rate of fibrin gel
contraction, in comparison to the 3 hour and 6 hour groups. By day 4, the 1 hour constructs
had a percentage gel area of 12.62 ± 1.74% whereas the 3 hour and 6 hour group constructs
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had contract to 28.98 ± 7.66% (p=0.000, compared to 1hr) and 25.83 ± 8.93% (p=0.002),
respectively (Figure C.1A). Constructs prepared from UV treated fibrinogen showed the
greatest extent of contraction. Day 4, percentage gel areas were 6.41 ± 0.62%, 7.09 ± 1.18%
and 8.94 ± 5.55%, in that order. Interestingly, the 1 hour fibrinogen dissolution group did
not differ significantly from the UV sterilisation groups on day 4, although dissolution
groups of 3 and 6 hours did. By day 6, no significant differences were observed between
the percentage gel areas of the groups. Maximum and minimum widths on days 4, 6 and 8
also showed no statistically significant differences from each other (Figure C.1B).
As proteins are known to be denatured by repeated freeze-thaw (FT) cycles, the effect
of fibrinogen freeze-thaw cycles on fibrin gel contraction was investigated. Percentage gel
areas of fibronogen that had undergone 1, 2, 5 and 8 FT cycles were 17.96 ± 3.21%, 15.30
± 5.10%, 16.32 ± 4.47% and 14.23 ± 7.37%, respectively, on day 3 (Figure C.1C). A 5- to
6-fold reduction in fibrin gel areas occured between days 3 and 8 to 2.90 ± 0.40%, 2.75 ±
0.22%, 3.19 ± 0.37% and 2.24 ± 1.30% for FTs 1,2,5 and 8, in that order. Differences in
percentage gel areas of the groups were not statistically relevant and neither were differences
in the maximum and minimum widths (Figure C.1D).
C.1.2 Rheology of fibrin gels due to FT cycles and UV ster-
ilisation
The stiffness of fibrin gels from section C.1.1 were quantified to determine if there were dif-
ferences in stiffness either due to fibrinogen freeze thaw cycles or fibrinogen UV sterilisation
times. Fibrin gel stiffness due to thrombin freeze thaw cycles was also evaluated.
C.1.2.1 Fibrin gel mechanical response due to FT cycles or UV sterilisa-
tion
At low strains, there were large variation in the G’ of all gels signified by the large standard
deviations (Figure C.2a and d).
At 1% strain, G’ was 6.76 ± 2.35Pa for 1 FT, 12.91 ± 7.06Pa for 5 FT, 23.26 ± 7.63Pa for
overnight UV sterilisation, 27.53 ± 6.62Pa for 5 hours UV treatment and 22.90 ± 16.05Pa
for 7 hours under UV light. No statistically significant differences were seen between the
groups at 1% or 10% strain (Table C.1).






































































































































































































































































































































































































































































































































Figure C.1: Effect of fibrinogen powder dissolution time, sterilisation method
and freeze-thaw cycles on fibrin gel contraction. (A) Percentage gel areas due to
fibrinogen preparation methods varied greatly before day 6. However, by day 8,
no significant differences were observed between percentage gel areas or max/min
widths (B). The investigated freeze-thaw cycles also did not affect construct per-
centage gel areas (C) or max/min widths (D). Note: UV(a), UV(b) and UV(c),
represent overnight UV sterilisation, 5 hours UV and 7 hours UV, respectively.
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Table C.1: G’ values at low strain and low frequency.
1 FT 5 FT UV Overnight UV 5.0hrs UV 7.0 hrs
1% Strain 6.76 ± 2.35 12.91 ± 7.06 23.26 ± 7.63 27.53 ± 6.62 22.90 ± 16.05
10% Strain 6.45 ± 2.45 10.71 ± 4.89 21.29 ± 8.14 20.36 ± 4.99 17.83 ± 13.02
Frequency 1 rad/s 6.98 ± 2.58 11.98 ± 6.29 23.07 ± 7.54 28.26 ± 5.94 23.36 ± 16.60




























Figure C.2: Rheology of fibrin gels of differing freeze thaw cycles and UV sterilisation times. a) Strain sweeps: fibrin gels
had a linear response up to 10% strain, b) Freeze -thaw cycles 1–5 did not appear to adversely affect fibrin gel robustness and
gels were showed frequency independence, particularly at >50rad/s (c). Fibrin gels sterilised under UV were within the LVR
at strains <10% (d). Gels were also robust over the frequency range 0.1–50rad/s (d & e).
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Frequency sweeps showed that the gels were frequency independent as no statistical dif-
ferences were seen at 1rad/s or at 10rad/s for all groups (Table C.1). The freeze-thaw
cycles and time under UV irradiation investigated did not appear to affect gel mechanical
strength. However, the fibrinogens for freeze thaw cycles experiments were sterilised by
syringe filtration from the same stock solutions that were used to prepared fibrinogens for
UV sterilisation.
C.1.2.2 Thrombin
Figure C.3A shows the time sweep profiles of gels prepared from varying thrombin freeze-
thaw cycles. There was a relationship between the number of thrombin FT cycles and
gel storage modulus following gelation for 1 hour as G’ was 95.19Pa for 1FT, 76.14Pa for
5FTs and 61.80Pa for 8FTs cycles. In-situ strain sweeps showed the gels exhibited strain
hardening behavior. The 5FT strain curve varied from those of 1FT and 8FT, peaking at a
G’ of 128.6Pa and a lower strain of 15.15% whereas 1FT had a maximum G’ at 206Pa and
24.71% strain and 8FT’s maximum G’ was 143.4Pa and 24.7% strain (Figure C.3B). The
gels were also frequency dependent at low frequencies, however, 1FT and 5FT did not differ
significantly from each other and were fairly linear between 10-50 rad/s (Figure C.3C). The
8FT gels were not as strong as FT1 and FT5 gels over the frequency range investigated.
C.2 Effect of culture medium type
CTF and PFB constructs in Chapter 7 were fed with different types of media – F12Ham
for PFB cells and DMEM for CTFs. As a result, additional variations, apart from that due
to cell type, may have occured due to the type of growth medium used to prepare the gels
and feed the constructs. To determine if culture medium type affected construct fibrin gel
contraction, widths, collagen content and tensile strength, PFB and CTF constructs were
prepared using DMEM or F12Ham, for each cell type. In addition, the shear modulus of
acellular gels was measured.
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AA+P
Thrombin FT cycle 1 G'
Thrombin FT cycle 1 G"
Thrombin FT cycle 5 G'
Thrombin FT cycle 5 G"
Thrombin FT cycle 8 G'






Figure C.3: Effect of thrombin FT on fibrin gel mechanical strength. A) Thombin
gelation profiles over 1 hour. Increasing freeze-thaw cycles, reduced gel stiffness.
B) Strain stiffening non-linear behaviour observed in the gels. C) Gels were fairly
robust over frequency range investigated.
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C.2.1 Fibrin gel contraction
CTF constructs cultured in either DMEM or F12 Ham appeared denser than PFB con-
structs (Figure C.4A). PFB constructs did not form well in DMEM and were visibly weaker
and more transluscent.
C.2.1.1 Fibrin percentage gel areas
On day 3, no contraction of the fibrin gel was observed for CTF constructs whereas PFB
DMEM had contracted the fibrin gel to 17.65 ± 8.55% of its original area and PFB F12 Ham
gel areas had reduced to 23.78 ± 9.52%. By day 5, no statistically significant differences
were observed in the fibrin gel areas of all groups.
The percentage gel areas of the PFB DMEM group were significantly different from all other
groups on day 26 (Figure C.4B) at 1.89 ± 0.28% and 1.13 ± 0.40% on day 28 (p=0.000
in all instances). Fibrin percentage gel areas of groups PFB F12Ham, CTF F12 Ham and
CTF DMEM were 3.41 ± 0.38%, 3.52 ± 0.35% and 3.16 ± 0.20% on day 26 and 2.51 ±
0.23%, 2.75 ± 0.22% and 2.34 ± 0.19%, respectively.
C.2.1.2 Maximum and minimum widths
The maximum width of the PFB DMEM group was 2.42 ± 0.38mm on day 26 and this
differed only from the CTF F12 Ham group, which had a maximum width of 3.30 ± 0.57mm
(p=0.020) (Figure C.4C). PFB DMEM maximum widths of 2.28± 0.36mm on day 28 also
differed significantly from the maximum widths of PFB F12 Ham and CTF F12 Ham of
3.00 ± 0.40mm (p=0.026) and 3.12 ± 4 0.46mm (p=0.009). Similarly on day 35, PFB
DMEM max width of 2.19 ± 0.34mm was the smallest of groups, differing from the F12
Ham fed groups with maximum widths of 2.90 ± 0.34mm (PFB, p=0.020) and 3.00 ±
0.44mm (CTF, p=0.007).
C.2.2 Sinew collagen content and mechanical strength
Analysis of collagen content in the sinews at 5 weeks revealed that the PFB DMEM group
had the lowest collagen content of 4.95 ± 3.01% (Figure C.5). This was 3-fold lower than
PFB constructs cultured in F12 Ham, which had an collagen quantity of 15.09 ± 5.56%.

























































































































































































































































































































Figure C.4: Effect of medium. A) shows images of constructs cultured in DMEM
or F12 Ham. B) Percentage gel areas of PFB constructs cultred in DMEM were
lowest in week 4. CTF cells grew well in both F12 Ham and DMEM. C) PBF
DMEM constructs max/min widths were significantly smaller than for constructs
cultured in F12 Ham.
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Interestingly, feeding CTF constructs with F12 Ham increased the collagen content from
12.79 ± 3.21% (DMEM) to 17.34 ± 3.76% (p=0.006).
* # * Significantly lower collagen content
# Significantly lower maximum load
Figure C.5: Effect of medium type on construct collagen content and maximum
loads. CTF constructs cultured in F12 Ham had a significantly higher collagen
content. The maximum load of CTF F12 Ham constructs was also greater than
for other groups.
Tensile test results showed PFB DMEM to be weakest, likely due to the low collagen
content, as the average maximum load endured by the sinews was only 27 ± 9mN (Figure
C.5). The PFB F12 Ham had a maximum load of 97 ± 16mN. The maximum loads of CTF
DMEM and CTF F12 Ham were 119 ± 35mN and 178 ± 37mN (p <0.05), respectively.
C.2.3 Rheology of fibrin gels prepared using different media
As the fibrin gels were prepared using different media, it was of interest to determine
whether the medium affected the mechanics of the fibrin gel. Strain sweep results indicated
that fibrin gels prepared using DMEM were fairly robust at strains <10%, although both
DMEM and F12 gels generally exhibited non-linear responses to strain over the range inves-
tigated (Figure C.6A and B). G’ and G” of gels prepared using F12 Ham were significantly
greater than those of the DMEM group. At 1% strain F12 Ham gels had a G’ of 36.03 ±
9.31Pa and for DMEM gels G’ was 17.4 ± 5.50Pa.
At low frequencies <10rad/s, both gels showed frequency dependent stiffening although
differences in G’ between data points per group were not statistically significant. At 1
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A B 
C D 
Figure C.6: Effect of medium - mechanical performance of gels. (A) shows G’
over 0.1 - 120% strain. At low strains <10%, the gels were fairly robust and had
a linear response (B). Low freequency dependene was observed, which stabilised
after 10 rad/s (C & D).
rad/s, the results wer in correlation with those seen at 1% strain. G’ of the F12 Ham fibrin
gels was 33.01 ± 9.97Pa and for the DMEM gels G’ was 17.85% ± 5.60Pa.
C.2.4 DMEM and Ham’s F12 media composition
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Table C.2: DMEM and F12 Ham media composition.
Component DMEM (Sigma D6546) DMEM (Sigma D5796) F12 Ham (Sigma N4888)
g/L g/L g/L
Inorganic Salts
Calcium Chloride (CaCl2) 0.2 0.2 0.0333
Fe(NO3)3 • 9H2O 0.0001 0.0001 ----
MgSO4 0.09767 0.09767 ----
KCl 0.4 0.4 0.224
NaHCO3 3.7 3.7 1.176
NaCl 6.4 6.4 7.599
NaH2PO4 0.109 0.109 0.14204
Cupric Sulfate • 5H2O 0.0000025
Ferrous Sulfate • 7H2O 0.000834
Magnesium Chloride 0.0576
Zinc Sulfate • 7H2O 0.000863
Amino Acids
L-Alanyl-L-Glutamine ---- ---- ----
L-Arginine • HCl 0.084 0.084 0.211
L-Cysteine • 2HCl 0.0626 0.0626 ----
L-Glutamine ---- ---- 0.146
Glycine 0.03 0.03 0.00751
L-Histidine • HCl • H2O 0.042 0.042 ----
L-Isoleucine 0.105 0.105 0.00394
L-Leucine 0.105 0.105 0.0131
L-Lysine • HCl 0.146 0.146 0.0365
L-Methionine 0.03 0.03 0.00448
L-Phenylalanine 0.066 0.066 0.00496
L-Serine 0.042 0.042 0.0105
L-Threonine 0.095 0.095 0.0119
L-Tryptophan 0.016 0.016 0.00204
L-Tyrosine • 2Na • 2H2O 0.10379 0.10379 0.00778
L-Tyrosine ---- ---- ----
L-Valine 0.094 0.094 0.0117
L-Alanine 0.009
L-Asparagine • H2O 0.01501
L-Aspartic Acid 0.0133
L-Cysteine • HCl • H2O 0.035
L-Glutamic Acid 0.0147
L-Histidine • 3HCl • H2O 0.02096
L-Proline 0.0345
Vitamins
Choline Chloride 0.004 0.004 0.01396
Folic Acid 0.004 0.004 0.00132
myo-Inositol 0.0072 0.0072 0.018
Niacinamide 0.004 0.004 0.000037
D-Pantothenic Acid • ½Ca 0.004 0.004 0.00048
Pyridoxal • HCl ---- ---- ----
Pyridoxine • HCl 0.004 0.00404 0.000062
Riboflavin 0.0004 0.0004 0.000038




D-Glucose 4.5 4.5 1.802
HEPES ---- ---- ----
Phenol Red • Na 0.0159 0.0159 0.0013
Pyruvic Acid • Na 0.11 ---- 0.11
Hypoxanthine 0.00408
Linoleic Acid 0.000084




NaHCO3 ---- ---- ----
L-Glutamine 0.584 ---- ----


























C.2.5 Evaluation of media used during chick fibroblast cell culture
Table C.3: Media used during culture of embryonic chick cells.
Cell type Medium Serum Reference
CTF DMEM 10% New born bovine serum Gunn and Ehrlich (2012)
CEF DMEM 10% New born bovine serum Hazard et al. (2011)
CEF EMEM with Earle’s Salts 10% FBS Hernandez and Brown (2010)
CTF DMEM 10% Fetal calf serum Kapacee et al. (2008)
CSF DMEM 10% Fetal calf serum Chiquet et al. (2004)
CEF MEM or RPI 1640 Medium 10% Fetal calf serum Hornemann et al. (2003)
CEF DMEM 8% Fetal calf serum + 2% chick serum Edom-Vovard et al. (2002)
CEF Medium 199 2% calf serum + 1% chick serum Yang and Hawkes (1992)
CEF EMEM 10% FBS Rifkin et al. (1979)
CEF F12 Ham Fetal calf serum Conrad et al. (1977)
CHC EMEM 15% FBS Schneider et al. (1965)
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C.2.6 Composition of different types of media used for chick
fibroblast cell culture
Medium 199, RPMI-1640 and MCDB-201 all contain L-Proline, Medium 199 also includes
ascorbic acid, RPMI-1640 has L-hydroxyproline and MCDB contains cupric, manganese and
zinc sulfates and several other trace elements. In terms of medium costs, Medium 199 is
slightly more expensive than DMEM, though RPMI-1640 and MCDB-201 work out slightly
cheaper (Table C.5), which suggests medium choice to be performance based although there
are few studies to support this.
C.3 Serum sensitivity of CTF cells and effects on
fibrin gel contraction
Due to reported contamination of the regular serum brand used during previous TE L/T,
it was necessary to find an alternative serum brand. Three types of serum were evaluated
blind as serum 1, serum 2 and serum 3 and the fibrin contraction results were compared to
the control group of previously published data (see Chapter 4 and Appendix D) and controls
of two other experiments (reported as UNW-X, where X refers to experiment number).
All three serum types contracted the fibrin gel at similar rates though serum 3 constructs
appeared denser than the other two types (Figure C.7A).
C.3.0.1 Fibrin percentage gel areas
When fibrin gel contraction data were compared, there was variation in the initial rates
of contraction, not solely attributable to serum (Figure C.7B). Day 7 percentage gel areas
were 14.83 ± 2.31%, 15.67 ± 1.86%, 12.57 ± 3.44% and 12.36 ± 5.64% for serum 1, serum
2, serum 3 and unw-3 control group, respectively. Percentage gel areas of serum 1-3 and
unw-3 published data showed no statistically significant differences on days 7 and 9.
C.3.0.2 Maximum and minimum widths
Maximum widths of the unw-3 control group were 11.41 ± 3.12mm and minimum widths
were 7.93 ± 3.39mm, which were significantly lower than for serum 1, 2 and 3, whose
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Table C.4: Comparison media used during culture of chick embryo cells.
Medium 199 RPMI-1640 MCDB-201 
Component  Sigma M2154 Component  Sigma R0883 Component Sigma M6770
g/L g/L g/L
Inorganic Salts Inorganic Salts Inorganic Salts
CaCl2 • 2H2O 0.2 Ca(NO3)2 • 4H2O 0.1 Ammonium Metavanadate 0.000000006
Fe(NO3)3 • 9H2O 0.00072 MgSO4 (anhydrous) 0.04884 Calcium Chloride(anhydrous) 0.2219
MgSO4 (anhydrous) 0.09767 KCl 0.4 Cupric Sulfate•5H2O 0.00000025
KCl 0.4 NaHCO3 2 Ferrous Sulfate•7H2O 0.001668
KH2PO4 --- NaCl 6 Magnesium Sulfate (anhydrous) 0.18057
Na • Acetate (anhydrous) 0.05 Na2HPO4 (Anhydrous) 0.8 Manganese Sulfate 0.000000075
NaHCO3 --- Molybdic Acid•4H2O (ammonium) 0.000000618
NaCl 6 Nickel Chloride•6H2O 0.0000000012
Na2HPO4 ---- Potassium Chloride 0.22365
NaH2PO4 (anhydrous) 0.122 Sodium Chloride 7.599
Sodium Metasilicate•9H2O 0.000142
Sodium Phosphate Dibasic (anhydrous) 0.07099
Sodium Selenite 0.000000865
Zinc Sulfate•7H2O 0.000028744
Amino Acids Amino Acids Amino Acids
L-Alanine 0.025 L-Alanyl-L-Glutamine ---- L-Alanine 0.00891
L-Arginine • HCl 0.7 L-Arginine • HCl 0.2 L-Arginine•HCl 0.0632
L-Aspartic Acid 0.03 L-Asparagine • H2O  ---- L-Asparagine•H2O 0.15
L-Cystine • HCl • H2O 0.00011 L-Asparagine  0.05 L-Aspartic Acid 0.01331
L-Cysteine • 2HCl 0.026 L-Aspartic Acid 0.02 L-Cysteine•HCl•H2O 0.03513
L-Glutamic Acid 0.0668 L-Cystine • 2HCl • H2O 0.0652 L-Glutamic Acid 0.01471
L-Glutamine 0.1 L-Glutamic Acid 0.02 L-Glutamine 0.14615
Glycine 0.05 L-Glutamine ---- Glycine 0.00751
L-Histidine • HCl • H2O 0.02188 Glycine 0.01 L-Histidine•HCl•H2O 0.02097
Hydroxy-L-Proline 0.01 L-Histidine • HCl • H2O 0.015 L-Isoleucine 0.01312
L-Isoleucine 0.02 Hydroxy-L-Proline 0.02 L-Leucine 0.03935
L-Leucine 0.06 L-Isoleucine 0.05 L-Lysine•HCl 0.03654
L-Lysine • HCl 0.07 L-Leucine 0.05 L-Methionine 0.00448
L-Methionine 0.015 L-Lysine • HCl 0.04 L-Phenylalanine 0.00496
L-Phenylalanine 0.025 L-Methionine 0.015 L-Proline 0.00576
L-Proline 0.04 L-Phenylalanine 0.015 L-Serine 0.03153
L-Serine 0.025 L-Proline 0.02 L-Threonine 0.03574
L-Threonine 0.03 L-Serine 0.03 L-Tryptophan 0.00613
L-Tryptophan 0.01 L-Threonine 0.02 L-Tyrosine•2Na•2H2O 0.01135
L-Tyrosine • 2Na • 2H2O 0.05766 L-Tryptophan 0.005 L-Valine 0.03513




Ascorbic Acid • Na 0.0000566 D-Biotin 0.0002 D-Biotin 0.00000733
D-Biotin 0.00001 Choline Chloride  0.003 Choline Chloride 0.01396
Calciferol 0.0001 Folic Acid 0.001 Folinic Acid (calcium) 0.00000512
Choline Chloride 0.0005 myo-Inositol 0.035 myo-Inositol 0.01802
Folic Acid 0.00001 Niacinamide 0.001 Niacinamide 0.00611
Menadione (sodium bisulfite) 0.000016 p-Aminobenzoic Acid 0.001 D-Pantothenic Acid (hemicalcium) 0.000477
myo-Inositol 0.00005 D-Pantothenic Acid • ½Ca 0.00025 Pyridoxine•HCl 0.0000617
Niacinamide 0.000025 Pyridoxine • HCl 0.001 Riboflavin 0.000113
Nicotinic Acid 0.000025 Riboflavin 0.0002 Thiamine•HCl 0.000337
p-Amino Benzoic Acid 0.00005 Thiamine • HCl 0.001 Vitamin B-12 0.000136
D-Pantothenic Acid • ½Ca 0.00001 Vitamin B12 0.000005
Pyridoxal • HCl 0.000025
Pyridoxine • HCl 0.000025
Retinol Acetate 0.00014
Riboflavin 0.00001
DL-a-Tocopherol Phosphate • Na 0.00001
Thiamine • HCl 0.00001
Other Other Other
Adenine Sulfate 0.01 D-Glucose 2 Adenine•HCl 0.000172
Adenosine Triphosphate • 2Na 0.001 Glutathione (reduced) 0.001 D-Glucose 1.441
Adenosine Monophosphate • Na 0.0002385 Phenol Red • Na 0.0053 Linoleic Acid 0.0000841
Cholesterol 0.0002 Putrescine•2HCl 0.000000161
Deoxyribose 0.0005 HEPES 7.149
Glucose 1 Phenol Red•Na 0.001242
Glutathione (reduced) 0.00005 Pyruvic Acid•Na 0.055
Guanine • HCl 0.0003 Thioctic Acid 0.00000206
HEPES ---- Thymidine 0.0000727
Hypoxanthine 0.0003





Xanthine • Na 0.000344
ADD ADD ADD
L-Glutamine 0.1 L-Glutamine 0.3 Required supplements
Sodium Bicarbonate ---- NaHCO3 ---- -----
Serum for long-term culture Required supplements
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Table C.5: Comparison of tissue culture medium costs.
Cat. No. Medium Cost (£)
per 500mL bottle
D6546 DMEM (without L-Glutamine and pyruvate) 21.00
D5796 DMEM (with L-Glutamine) 18.10
M2154 Medium 199 with Earle's salts 28.30













































































































































































Figure C.7: Serum type effects on contraction. (A) Images of constructs fed
with media containing different types of serum. (B) Variation in percentage gel
areas in the first 4 days did not appear to be related to serum as groups UNW-3,
UNW-4 and UNW-9 were prepared using the same type. No statistically significant
differences were observed. (C) Max/min widths of constructs fed with serum 1, 2
and 3, diiffered from that of published data on day 3 and 7 for the min width.
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average maximum widths were all about 24 ± 2mm on day 3 (Figure C.7C). On day 7, all
maximum widths were not significantly different from each other.
C.4 Effect of temperature
Generally, constructs were maintained in an incubator at 37◦C and reagents/media were
pre-warmed to this temperature before use. Care was taken to avoid drastic drops in
temperature. However, it was of interest to determine how minor temperature fluctuations
would affect fibrin gel mechanical strength.
At 25◦C, the gels were stiffer with a G’ of 15.14 ± 3.24Pa. With increasing temperature,
G’ fell to 13.58 ± 2.57Pa at 28◦C, 10.74 ± 1.53Pa at 28◦C, 10.74 ± 1.53Pa at 35◦C, 9.47
± 1.47Pa at 37◦C and 8.97 ± 1.40Pa at 38◦C. Between 35◦C and 38◦C, differences in G’






Figure C.8: Effect of temperature fluctuations of fibrin gel mechanics. (A) Gel
stiffness fell with increasing temperature. (B) G’ at 25◦C differed signifcantly with
G’ between 35◦C and 38◦C.
C.5 Effect of culture duration on construct me-
chanical strength
Generally, constructs for contraction studies were maintained in culture for a period of 5
weeks. However, to determine if duration of culture affected construct mechanical strength,
particularly at weeks 4 or 5, tensile tests of NT constructs were conducted.
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Generally, maximum loads withstood by the sinews increased with increasing culture dura-
tion. Week 3 maximum loads were 99 ± 54mN, week 4 maximum loads were 112 ± 45mN
and 120 ± 27mN at week 5, however, increases in load were not statistically significant
(Figures C.9A). Sinew stiffness did increase with culture time as average strains at the
maximum load at week 5 were lower at 2.39 ± 1.12 than at week 3 at 2.94 ± 0.69, p >0.05,
(Figure C.9B). Young’s Modulus values reflected this, with values of 15 ± 10kPa, 25 ±
11kPa and 31 ± 23kPa for weeks 3, 4 and 5, respectively (Figure C.9C). The duration of
culture had a significant effect on collagen content in the sinews (Figure C.9D). Week 5
construsts had the highest collagen content of 15.60 ± 4.28%, which varied considerably



















































































Figure C.9: Effect of culture time on construct mechanics. No significant differ-
ences were observed in the maximum loads achieved by 3, 4 or 5 week old sinews
although at week 5, constructs were slightly stiffer (B) and (C). Week 5 had a




D.1 Monitoring Sinew Contraction During For-
mation of Tissue-Engineered Fibrin-Based Lig-
ament Constructs
Original Article
Monitoring Sinew Contraction During Formation
of Tissue-Engineered Fibrin-Based Ligament Constructs
Jennifer Z. Paxton, Ph.D.,1 Uchena N.G. Wudebwe, M.Eng.,1 Anqi Wang, Ph.D.,1,2
Daniel Woods, Ph.D.,3 and Liam M. Grover, Ph.D.1
The ability to study the gross morphological changes occurring during tissue formation is vital to producing tissue-
engineered structures of clinically relevant dimensions in vitro. Here, we have used nondestructive methods of
digital imaging and optical coherence tomography to monitor the early-stage formation and subsequent matu-
ration of fibrin-based tissue-engineered ligament constructs. In addition, the effect of supplementation with es-
sential promoters of collagen synthesis, ascorbic acid (AA) and proline (P), has been assessed. Contraction of the
cell-seeded fibrin gel occurs unevenly within the first 5 days of culture around two fixed anchor points before
forming a longitudinal ligament-like construct. AA + P supplementation accelerates gel contraction in the matu-
ration phase of development, producing ligament-like constructs with a higher collagen content and distinct
morphology to that of unsupplemented constructs. These studies highlight the importance of being able to control
the methods of tissue formation and maturation in vitro to enable the production of tissue-engineered constructs
with suitable replacement tissue characteristics for repair of clinical soft-tissue injuries.
Introduction
In vitro engineering of connective tissues for surgicalimplantation is an active field of research. In particular,
the manufacture of suitable artificial tissues for replacement
of the anterior cruciate ligament (ACL) is receiving much
interest, as each year an estimated 80,000 to 100,000 ACL
ruptures occur in the United States alone.1 The majority of
these injuries occur in young, active individuals,2 and failure
to repair the injured tissue will result in joint instability,3
pain,1 injury to other structures within the knee joint,3
muscle weakness,4 and the subsequent development of os-
teoarthritis.5,6 While attempts have been made to repair the
ACL with synthetic graft replacements (e.g., Gore-tex, Da-
cron, and carbon fibers), problems resulting from the me-
chanical breakdown of the grafts mean that transplantation
of an autograft to the injured site remains the most successful
method of ACL repair. However, because of problems such
as pain,7,8 muscle weakness,4 patellar tendonitis,9 and donor-
site morbidity10 after autograft treatment, tissue-engineered
constructs are now being investigated for implantation.
We have recently shown that complete bone-ligament-
bone constructs for potential implantation and repair of the
ACL can be formed in vitro using brushite anchors and a cell-
seeded fibrin gel.11 However, little attention has been given
to the three-dimensional (3D) morphology of the soft-tissue
portion of the graft during construct formation and the ef-
fects of anabolic supplementation on morphology. Such in-
formation is desirable to predict the long-term size and shape
of construct grafts for implantation. While conventional im-
aging techniques, such as histology, usually allow only vi-
sualization of the tissue using destructive methods, we have
used the nondestructive optical coherence tomography
(OCT) imaging technology alongside conventional digital
imaging to visualize the morphology of constructs during
their formation and maturation phases.
OCT is an emerging imaging technology for the biological
and medical sciences. It enables imaging of 1–2-mm inside
opaque tissue without any special preparation, making it an
ideal nondestructive adjunct to histology. Also, the use of
low-power infrared light means that OCT is also noncontact,
noninvasive, and capable of providing high-resolution im-
ages at a video rate. OCT works by focusing a beam of light
inside a sample, and the depth positions of multiple sub-
surface structures are then determined by performing
frequency-domain time-of-flight measurements on the back-
scattered light, resulting in a tomographic depth-reflectivity
profile (A-scan). One- and two-dimensional (2D) scanning of
1School of Chemical Engineering, College of Physical Sciences and Engineering, University of Birmingham, Edgbaston, Birmingham,
United Kingdom.
2School of Dentistry, College of Medical and Dental Sciences, University of Birmingham, St Chad’s Queensway, Birmingham,
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3Michelsons Diagnostics, Orpington, Kent, United Kingdom.
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the focused beam can then be used to make 2D and 3D
images of the sample. Recently, OCT has been used within
many different fields of research from cancer biology12,13 and
development14–16 to clinically within cardiology17 and oph-
thalmology18–20 owing to the nondestructive nature of the
technique and the ability to visualize inside tissues and or-
ganisms. Furthermore, it has also received great attention
within the tissue engineering field, having been described as
a technique with great promise for visualizing engineered
tissues.21 Many groups have utilized this imaging technique
to study scaffold morphologies,21–26 collagen gel remodel-
ing,27 and collagen fiber alignment.28
The aim of this study was to investigate the morphological
changes occurring during the early-stage formation and
maturation of tissue-engineered bone-to-bone ligament-like
constructs manufactured from fibroblast-seeded fibrin gels.
Digital imaging, OCT, and histological techniques were used
to evaluate construct development over time.
Materials and Methods
b-Tricalcium phosphate manufacture
The b-tricalcium phosphate (b-TCP; Ca3(PO4)2) was manu-
factured by reactive sintering of a powder containing CaHPO4
(Mallinckdrodt-Baker) and CaCO3 (Merck), with a theoretical
calcium to phosphate molar ratio of 1.5. The powder mixture
was suspended in absolute ethanol and mixed for 12 h. After
this, the suspension was filtered and the resulting cake heated
in an alumina crucible to 1400C for 12 h and 1000C for 6 h
before quenching in a dessicator in ambient conditions. The
resulting sinter cake was then crushed using a pestle and a
mortar, and was passed through a 125-mm sieve.
Brushite cement formation
The brushite cement was made by incrementally com-
bining b-TCP (Ca3(PO4)2) with 3.5 M orthophosphoric acid
(H3PO4; Sigma-Aldrich) at a ratio of 3.5 mg/mL to form a
paste. Citric acid (200 mM; Sigma-Aldrich) and sodium py-
rophosphate (200 mM; Sigma-Aldrich) were added to the
H3PO4 before combination with b-TCP. The paste was con-
solidated into a custom-made silicone mold,29 and mold-
filling was improved with the use of a vibrating platform
(Denstar 500; National Dental Supplies) for 60 s. Stainless
steel insect pins (0.2-mm diameter; Fine Science Tools) were
inserted into each anchor before setting occurred, and ce-
ment anchors were left to set within their molds overnight at
37C. Final cement anchors were trapezoidal in shape,
measuring *4 · 4 mm at the widest points and 3 mm in
height as described previously.11,29
Ligament-like construct formation
Thirty-five-millimeter Petri dishes were coated with
1.5 mL of Sylgard (type 184 silicone elastomer; Dow Corning
Corporation) and left to polymerize for at least a week before
use. Cement anchors were removed from their molds and
pinned to the sylgard layer *12 mm apart, and the anchors
and plate were sterilized by soaking in 70% ethanol for
20 min. The Sylgard layer was used to allow immobilization
of the cement anchors and to provide a non-cell-adhesive
surface underneath the fibrin gel. Five hundred microliters of
the Dulbecco’s modified Eagle’s medium (DMEM; Invitro-
gen) supplemented with 10% fetal bovine serum (FBS; Bio-
sera), 1% penicillin/streptomycin (P/S; Invitrogen), 50 U/
mL thrombin (Calbiochem), 400 mM aminohexanoic acid
(Sigma-Aldrich, UK), and 20 mg/mL aprotinin (Roche) solu-
tion was used to coat the Sylgard layer. Two hundred mi-
croliters of 20 mg/mL fibrinogen (Sigma-Aldrich) was then
added dropwise, and the fibrin gel was left to polymerize at
37C for 1 h. Embryonic chick tendon fibroblasts were iso-
lated from the flexor tendons of 13.5-day-old chick embryos
by a 1.5-h digestion in the collagenase type-II solution (in
serum- and antibiotic-free DMEM) at 37C. After digestion,
the solution was passed through a 100-mm cell strainer (BD
Biosciences) to remove any insoluble material. The cell so-
lution was spun at 2500 rpm for 3 min. The resulting cell
pellet was suspended in the DMEM supplemented with 10%
FBS and 1% P/S (Invitrogen). Chick tendon fibroblasts were
cultured and split routinely, and used between passages 2
and 5. Cells were seeded on top of the polymerized fibrin gel
at a concentration of 100,000 cells in 1 mL. The growth me-
dium (DMEM + 10% FBS + 1% P/S) was replenished on day 3
after seeding, and then every 2–3 days for the duration of the
experiments. On day 7 of formation, half the ligament-like
constructs received supplementation with 250mM ascorbic
acid 2-phosphate (AA; Sigma-Aldrich) and 50 mM L-proline
(P; Sigma-Aldrich) added to the growth medium. Day 7 was
chosen, as it was in line with previous work.11,29 This sup-
plementation regime was continued on every day of medium
replenishment in the AA + P-treated samples. Over time, the
fibrin gel contracts around the two brushite cement anchors
to form a cement-cellularized fibrin gel–cement (bone-
ligament-bone) construct.
Optical coherence tomography
Ligament-like constructs were scanned using a high-
resolution EX1301 MultiBeam OCT microscope daily from
day 0 to day 7, followed by day 10, day 14, and then every 7
days until day 35 (n = 16 in each treatment group). The day-0
scans were taken after the addition of cells in the growth
medium. The microscope was equipped with a Santec HSL-
2010 swept-source laser with a spectral range of 150 nm
spectrum centered at 1310 nm. The measured resolution was
< 9 mm axially (depth) and < 7.5 mm laterally. The frequency
of A-scans was at a rate of 10,000/s. Optical B-Scans com-
prising 1188 A-Scans and spanning *5 mm laterally and
1.9 mm in depth (1188 · 460 pixels) were captured showing
cross sections of the ligaments in the longitudinal orienta-
tions. For transverse orientations, B-scans comprised 242–
1118 A-scans depending on the diameter of the construct at
the time of scanning. Multiple parallel B-Scan image sets
with fixed spatial periodicity were also acquired by moving
the sample orthogonally to the B-Scan direction on an au-
tomated translation stage in 4-mm steps. Using this tech-
nique, 3D volumes of ligament-like constructs can be
digitally reconstructed with dimensions up to 5 · 25 · 1.9 mm
for fly-through examination. Constructs were scanned in
their Petri dishes, in the growth medium, with the Petri dish
lid removed. Consequently, each sample could only be used
for one time point per scan. Images of the constructs were
also taken using a digital camera (Optio V10; Pentax Cor-
poration) at the same time points as the scans. Constructs
that have not been assigned for time-point scans were kept in
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the same culture conditions until the 2.5-month time point,
where 3D scans were taken (n = 1 each condition).
Gel contraction analysis
To investigate and quantify the effect of supplementation
with AA + P on gel contraction, constructs were formed and
supplemented with or without AA + P from day 0 of culture
(n = 7 in each group). The decision to supplement from day 0
was to investigate the effect of AA + P on gel contraction
from the beginning of formation, rather than from day 7 as
described earlier. Digital images were taken of each construct
every day until day 15, and then every other day thereafter.
Gel surface areas were quantified using image analysis
software (ImageJ; NIH) to calculate percentage reduction in
gel area over time. Further to this, the maximum and mini-
mum widths of the ligament-like constructs transverse to the
longitudinal length were also measured (n = 7 in each group;
ImageJ; NIH.). All measurements were taken in between the
anchors to ensure consistency.
Histology
The ligament-like constructs were removed from their culture
media at the 5-week and 10-week time points (n = 2) and fixed in
4% formaldehyde buffer in phosphate-buffered saline at 4C for
24 h. Samples were then dehydrated in a series of ethanol solu-
tions from 35% to 100% followed by 100% xylene. The specimen
was then transferred to a 60C paraffin wax bath (HISTO WAX
514409) overnight, and then placed under vacuum (Citadel 1000;
Thermo Shandon) for 4 h to allow wax infiltration. The sample
was later embedded in paraffin wax, and a LEICA RM 2035
microtome was used to cut 5–7-mm sections. The sections were
picked up on glass coverslips (four per slide and two slides per
construct) that were left in a 60C oven for 30 min before they
were stained using hematoxylin and eosin (H&E; SHANDON
Linistain GLX) per the manufacturer’s instructions. Stained
sections were viewed on a light microscope (Inverso 3000, Ceti;
Progen Scientific) and images taken using Image Capture (Ceti;
Progen Scientific).
Collagen content
The collagen content of ligament-like constructs was
measured over time using a hydroxyproline assay, as hy-
droxyproline accounts for *13% of total collagen and is re-
leased after tissue hydrolysis.30,31
Briefly, ligament constructs (n = 4 each time point and
group) were removed from their cement anchors and left to
dehydrate at 37C for at least 72 h. The dry mass of each
sample was then measured, and the dry sample was hy-
drolyzed in 200 mL of 6 M HCl at 130C for 3 h. The liquid
was removed by allowing the HCl to evaporate for 30 min in
a fume hood at 130C. The resulting pellet was re-suspended
in 200 mL of hydroxyproline buffer. Samples were further
diluted 1:8 in hydroxyproline buffer. About 150mL of chlo-
ramine T solution was added to each sample, vortexed,
and left at room temperature for 20 min. About 150mL of
aldehyde–perchloric acid solution was then added to each
tube before the tubes were vortexed and incubated in a
preheated water bath at 60C for 15 min. After incubation,
tubes were left to cool for 10 min, and then samples/stan-
dards were read at 550 nm on a Glomax Multi Detection
System Plate reader (Promega). Hydroxyproline was con-
verted to collagen using a factor of 13.34%.
Statistical analysis
Where appropriate, data are presented as means – standard
error of the mean. Differences in mean values were compared
within groups, and significant differences were determined by
analysis of variance with the post hoc Tukey-Kramer Honestly
Significant Difference test using BrightStat.32 The significance
level was set at p < 0.05. The gel contraction data were analyzed
using independent one-tailed tests (IBM SPSS Statistics 19) on a
day-by-day basis. To determine the effect size of the data,
Pearson’s correlation r was used such that r values < 0.1 re-
presented a small effect; 0.3, a medium effect; and 0.5 or
greater, a large effect. The Cohen’s d method was also used,
with categories being 0.2 is small, 0.5 is medium, and 0.8 is
large. Pearson’s r and Cohen’s d effect sizes are referred to as ES
r and ES d, respectively. Post hoc power analyses were also
conducted (DSS Research Statistical Power Calculator).
Results
Early-stage formation of ligament-like constructs
Over the course of 7 days, the cell-seeded fibrin gel con-
tracted around the two fixed brushite anchor points (Fig. 1).
FIG. 1. Early-stage formation of the
ligament-like constructs. Digital im-
ages of the constructs were taken each
day from day 0 (D0) to day 7 (D7) after
cell seeding. The outer edges of the
fibrin gel have been marked for clarity
(white-dashed line). Over the course of
the 7 days, the fibrin gel contracts
unevenly around the two fixed anchor
points. Constructs are formed in
35-mm Petri dishes.
SINEW FORMATION IN VITRO 3
The fibrin gel began to contract rapidly and unevenly within
5 days after cell seeding, continuing rapid contraction until
day 5, when the contraction rate noticeably reduced (Fig. 1).
The OCT scans demonstrate the method of gel contraction
in the ligament constructs. Folds of the fibrin gel can be seen
in the transverse scans from day 1 onward (Fig. 2, arrows),
becoming clearly evident at day 3 (Fig. 2). The uneven nature
of gel contraction demonstrated in Figure 1 can also be ob-
served in Figure 2. By day 7, both sides of the fibrin gel have
contracted around the anchor points evenly, and the folds
have coalesced into a single solid mass (Figs. 1 and 2).
Maturation of ligament-like constructs
Contraction of the ligament constructs continues over
several weeks of maturation (Fig. 3). Supplementation of the
FIG. 2. Optical coherence tomography
(OCT) scans in the longitudinal and
transverse orientations during early-stage
formation of the ligament-like constructs.
OCT scans were performed daily. Fibrin
gel contraction is evident from day 1 after
cell seeding and continues over the course
of the week. Folds in the fibrin gel are
marked with arrows. Scale bar represents
1 mm in all images. Schematic diagrams
depict the scanning direction in both
orientations.
FIG. 3. Maturation of the
ligament-like constructs.
Digital images of the ligament-
like constructs over a 5-week
period in unsupplemented
and supplemented groups
(250mM ascorbic acid 2-phos-
phate [AA] + 50mM proline
[P]). Supplementation causes
increased contraction from
week 2 (2W) onward.
Constructs are formed in
35-mm Petri dishes. NT, no
treatment.
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culture medium with AA + P has a marked effect on con-
traction of the constructs, with supplemented constructs
continuing to contract beyond the boundaries of the cement
anchors as seen in the unsupplemented group (Fig. 3). No-
tably, in both the unsupplemented and supplemented
groups, the constructs became white and appeared to in-
crease in opacity over time, which is indicative of increased
matrix deposition in the samples (Fig. 3). To confirm this, the
hydroxyproline content constructs were measured at each
time point (Fig. 4). As anticipated, the supplemented group
continued to produce collagen, with the collagen content
rising significantly from 4.16% – 1.42% at 1 week to
15.45% – 0.49% per construct after 5 weeks of culture
( p > 0.00). In the unsupplemented samples, however, the
collagen content stayed relatively constant, with no signifi-
cant difference observed between week 1 and week 5 of
culture at any time point measured ( p > 0.05 at all time
points). Furthermore, the dry weights of the constructs do
not significantly differ at any time point measured (Fig. 4B).
Figure 5A displays the longitudinal scans of the constructs
using OCT in the maturation phase of development. Over
the course of 5 weeks, the constructs became thinner and
more opaque, markedly so in the AA + P-treated samples
(Fig. 5A). The transverse scans of the constructs clearly
demonstrated gross morphological changes occurring during
construct maturation (Fig. 5B). In both the AA + P-treated
samples and the unsupplemented group, the constructs
display a rolled-up appearance after 1 week of formation.
Gradually, the two sides of the construct contracted and
joined to form a tubular structure by week 2 (Fig. 5B). No-
tably, this occurred faster in the AA + P-treated group (Fig.
5B). Cross-sectional areas of the transverse OCT scans were
measured and plotted against time (Fig. 5C). At all time
points after 14 days, unsupplemented samples possess a
larger cross-sectional area than supplemented constructs
(Fig. 5C), reaching significance on day 14 ( p = 0.001), day 28
( p = 0.01), and day 35 ( p = 0.0001). Over the course of the
following weeks, constructs in both groups contracted fur-
ther, became more opaque, and displayed a more uniform
tissue distribution. Continued culture of the ligament-like
constructs for several months in culture maintains this gross
morphology as shown in the 3D reconstructions of constructs
with dense constructs with distinct morphologies produced
(Fig. 6). As shown previously in the digital images (Fig. 3),
constructs in the AA + P-treated group underwent significant
contraction, becoming < 2 mm in width by 4 weeks of cul-
ture. To investigate the effect of supplementation of AA + P
on the contraction of cell-seeded fibrin gels, constructs were
photographed every day after cell seeding for 2 weeks and
then every other day for the duration of the experiment. Gel
areas were then calculated using digital imaging software
(ImageJ; NIH). The percentage reduction in the gel area is
displayed in Figure 7. Overall, it appears that supplemen-
tation has no prominent effect on gel contraction. However,
to allow for better comparison of the gel contraction,
percentage area reductions were plotted for specific time
periods of the experiment—the early-stage contraction pe-
riod (0–7 days, Fig. 7B), maturation of the ligament-like
constructs (7–35 days, Fig. 7C), and late-stage maturation
(35–52 days, Fig. 7D). Figure 7B demonstrates that at the
initial stage of gel contraction, unsupplemented constructs
contract faster than supplemented, reaching a similar gel
area by 7 days. Unsupplemented constructs contract to
40.83% – 4.12% of their original area in the first 24 h after
seeding (Fig. 7B) compared to AA + P-supplemented reduc-
tion to 45.52% – 4.95%. Conversely, as contraction continues
after day 7, AA + P-supplemented constructs display a faster
rate of contraction with the difference between groups sta-
bilizing at around day 14 (Fig. 7C). The most noticeable
difference between groups is observed in the late-stage for-
mation of ligament-like constructs, where from day 33 to day
36, AA + P-supplemented constructs contract more and then
exhibit a smaller area at the remaining time points, with
values of 2.72% – 0.11% and 3.41% – 0.47%, respectively (Fig.
7D). Statistical analysis revealed that while this difference
was not significant ( p > 0.05), it represented a large effect size
(an indication of the strength of the relationship between the
groups).33,34
To further quantify the differences observed between the
constructs, the maximum and minimum transversal widths
were measured. As with the construct gel area measure-
ments, the largest change in widths was observed between
day 0 and day 1 (Fig. 8). The no treatment (NT) group ex-
hibited a greater extent of contraction in comparison to the
AA + P group. The maximum width of the NT constructs
reduced from 35 to 13.98 – 4.45 mm, and the maximum width
of the AA + P supplemented maximum width reduced to
FIG. 4. Collagen content of ligament-like constructs. (A)
AA + P causes a significant increase in the collagen content
when compared to unsupplemented samples at all time
points from 14 days. *p < 0.05 when compared to the un-
supplemented group. n = 6 in all groups. (B) Dry mass of
constructs does not significantly differ between supple-
mented and unsupplemented groups. n = 6 in all groups.
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22.23 – 5.49 mm ( p = 0.0045, ES r = 0.67, ES d = 1.78). The
minimum widths for NT and AA + P were 10.41 – 4.46 mm
and 17.36 – 7.41 mm, respectively ( p = 0.0275, ES r = 0.52, ES
d = 1.22). From day 33 to day 52, the average maximum and
minimum widths of the NT group were almost double than
those of the AA + P group, with the NT group widths being
*1.6 times larger than the AA + P-treated widths (Fig. 8 and
Table 1). For example, on day 52, the maximum widths were
2.41 – 0.48 mm for NT and 1.48 – 0.15 mm for AA + P,
( p = 0.012, ES r = 0.82, ES d = 1.63), while the minimum widths
for NT and AA + P were 1.47 – 0.51 mm and 0.91 – 0.1 mm,
respectively (Fig. 8). All the maximum widths were found to
be significant between days 33 and 52 ( p < 0.05); however,
the minimum widths were not. The effect–size statistics,
FIG. 5. OCT scans of ligament-like construct maturation: (A) longitudinal and (B) transverse orientations of the constructs.
The difference in the construct morphology on addition of AA + P is evident in the transverse OCT scans. Scale bar represents
1 mm in all images. (C) Cross-sectional measurements of ligament-like constructs as measured by ImageJ software. Data are
represented as mean – standard deviation of three measurements per individual scan. *p < 0.05.
FIG. 6. Three-dimensional reconstruc-
tions of the ligament constructs after 2.5
months in culture, with and without
AA + P supplementation.
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which is an indication of the strength of the relationship
between the groups, was calculated using Cohen’s d and
Pearson’s Correlation Coefficient r. Both methods resulted in
large effect–size statistical values on day 1 and in the period
between days 33 and 52, meaning that although the mini-
mum widths failed to give significant results, there was
strong separation between means due to the AA + P treat-
ment (Fig. 8C, D).
The transversal maximum-to-minimum width ratios
within each group were also determined to observe if there
were any extremes in the construct dimensions (Table 2).
Although the magnitude of contraction differed between the
groups, the maximum-to-minimum width ratios of the con-
structs were almost identical by day 52, at 1.64 and 1.62 for
NT and AA + P-supplemented, respectively (Table 2). Using
the average widths, the aspect ratio of the constructs was
calculated (Table 3). The final aspect ratio of the constructs
treated with AA + P was larger, at *10, than for those un-
supplemented with an aspect ratio of about 6 (Table 3), again
indicating that AA + P changes the final dimensions of the
ligament-like constructs.
Histological sections of supplemented ligament-like con-
structs were taken after 5 and 10 weeks of culture (Fig. 9).
H&E staining of the sections shows that in cross section, the
folds of the fibrin gel can be seen in the center of the con-
struct (Fig. 9A, small arrows) and where the fibrin gel at-
taches to the cement anchor (Fig. 9B). Furthermore, a cell
layer can be seen on the outside of the tubular structure (Fig.
9A, large arrows) with limited cells visible in the inside of the
structure. However, in longitudinal sections at 10 weeks in
culture, cells are present throughout the ligament-like con-
struct, and the tissue displayed a fiber-like appearance (Fig.
9C, D). Figure 9C and D also revealed a thick layer on the
outer edges of the scaffold, in line with the cortex layer that
can be observed in the 3D reconstructions in the AA + P-
treated group (Fig. 6).
Discussion
In this study, we have examined the morphological
changes occurring during early-stage formation and matu-
ration of tissue-engineered bone-to-bone ligament-like con-
structs. We have used conventional digital imaging
alongside OCT imaging with anticipation that by combining
these techniques, we could gain an understanding of con-
struct formation and matrix deposition by nondestructive
means, improving our understanding of how these tissues
form and develop in vitro. Furthermore, we have combined
the OCT scans with the digital image analysis of the con-
structs to study the effect of AA + P supplementation on
FIG. 7. Quantification of contraction of ligament-like constructs. (A) Global percentage reduction in the fibrin gel area over
time. (B) Early-stage formation of ligament constructs (0–7 days), (C) maturation stage (7–35 days), and (D) late-stage
maturation (35–52 days). n = 7 for each time point and group.
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fibrin gel contraction and tissue-engineered ligament con-
struct formation.
Although the standard histological analysis of tissue-
engineered constructs has advantages, such as the ability to
determine matrix components and determine cell distribu-
tion within tissues, it also has several drawbacks. First, a
histological analysis can require the fixation and freezing of
tissue constructs. Both these procedures can damage the
specimen and therefore may not provide a true represen-
tation of tissue morphology. Second, owing to the limita-
tions of light microscopy, constructs need to be sectioned
into slices of several micron thicknesses, and therefore it
remains difficult to obtain a 3D view of the specimen. This
can be problematic if, as is the case here, the gross mor-
phology during formation is of interest. In this study, OCT
has allowed an in-depth view of the tissue morphology in
both the transverse and the longitudinal orientations that is
not possible using digital imaging alone. The use of OCT
allowed visualization of the gross cross-sectional morphol-
ogy of the ligament-like constructs during formation and
has permitted a far better understanding of the mode of
construct formation. However, it is also apparent that the
use of OCT to determine matrix composition by images
alone is not ideal and requires further analysis. Some re-
searchers have demonstrated the use of polarization-
sensitive OCT to visualize collagen fiber alignment within
tendon,35 cartilage,36 and tissue-engineered structures.28 By
this method, the polarization of backscattered light is
measured after it has passed though the sample, and this
can be directly related to the alignment of the collagen
fibers. Such an analysis should be performed on the
ligament-like construct samples to confirm an increase in
FIG. 8. Transversal maximum and minimum widths of the ligament-like constructs. (A) Maximum widths for no treatment
(NT) and AA + P constructs over time. (B) Maximum widths from 33 to 52 days. (C) Minimum widths for NT and AA + P
constructs over time. (D) Minimum widths from 33 to 52 days. n = 7 for each time point and group. *p < 0.05 between groups.
Table 1. Ratio of NT-to-AA + P Maximum and Minimum Widths of Ligament-Like Constructs Over 33–52 Days
Day
Description Ratio 33 36 38 40 43 45 47 50 52
Max. width NT:AA + P 1.63 2.05 1.90 1.67 1.61 1.63 1.75 1.61 1.63
Min. width NT:AA + P 1.18 1.62 1.62 1.65 1.49 1.38 1.44 1.55 1.61
NT, no treatment; AA + P, ascorbic acid and proline.
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collagen deposition and alignment in the samples over an
extended culture period.
The transverse OCT scans clearly demonstrate the manner
in which the fibrin gel contracts around the two anchor
points and rolls into a tubular structure (Figs. 2 and 5B).
Eventually, the two sides of the construct come into contact
and fuse together to form a single longitudinal ligament-like
structure by approximately week 2 of culture (Fig. 5B). An-
other research group has recently reported the formation of
tendon-like constructs using a similar method, although they
embedded the ACL cells into the fibrin gel before polymer-
ization.37 It would also be interesting to compare the meth-
ods of formation of those constructs using OCT, to establish
their mode of formation. Furthermore, it seems likely that the
two modes of formation could result in a distinct mechanical
behavior between the two and may provide evidence to es-
tablish which method is conducive to forming engineered
tissues with greater mechanical integrity.
The decision to supplement the ligament-like constructs
with AA + P was made through our previous work that
demonstrates that the addition of AA + P to the culture me-
dia of the constructs resulted in an increased deposition of
collagen within the fibrin matrix after only 1 week of sup-
plementation.11 As expected, the supplementation of AA + P
over the 5-week culture period resulted in a continuous in-
crease in the collagen content of the constructs (Fig. 4A). AA
is an essential cofactor for prolyl-4-hydroxylase, and its
presence is required for the hydroxylation of collagen chains
during collagen fibril assembly.38 In addition, as proline is a
major constituent of the collagen protein, it is not surprising
that increasing both AA and proline availability augments
collagen production. Here, we have also demonstrated the
effect that AA + P supplementation has on contraction of the
ligament-like constructs, with supplemented groups dis-
playing increased contraction in the digital images (Fig. 3),
OCT scans (Fig. 5B), and the evaluation of contraction by
digital imaging (Figs. 7 and 8). Although there were no sta-
tistically significant differences between the gel areas of the
NT- and AA + P-supplemented constructs, the maximum
widths of the constructs differed significantly between the
groups between days 33 and 52 (Fig. 8B). The ratios calcu-
lated from the results (Table 1) do show that there is some
inherent pattern in the formation of the constructs with re-
gard to the maximum and minimum widths achieved. The
ratios of the maximum-to-minimum width of the supple-
mented group appeared to stabilize from day 33 onward, at
a value of about 1.6. The max/min ratio for the NT group is
not as consistent, but reaches a similar value of 1.64 on day
52. A possible explanation for the stability seen in the max/
min ratio of the AA + P group, in the final stages of the study,
could be that treatment with AA + P causes a more uniform
and controlled type of contraction of the gel as a result of
increased deposition of collagen matrix (Fig. 4A).
However, it must also be noted that with the digital im-
ages and resulting contraction data, the area measured does
not take the depth of the construct into account. As observed
in the transverse OCT scans, AA + P-supplemented con-
structs display distinct cross-sectional areas (Fig. 5B) with
unsupplemented constructs remaining broad and flat and
AA + P-supplemented constructs becoming thin and round.
Cross-sectional area was less in supplemented constructs
than in unsupplemented constructs from day 14 onward
(Fig. 5C) reaching values of 0.132 and 0.9 mm,2 respectively
at the 35-day time point (Fig. 5C). Native ligaments are
typically described as broad, flat tissues; in particular, the
ACL has an average length and width range in humans from
22 to 41 mm and 7 to 12 mm, respectively.39 Based on this
information, although collagen content improves, the in-
creased contraction observed on addition of AA + P is not
ideal for our intended application, as it results in the pro-
duction of thin, tubular structures, vastly different from the
native ligament tissue morphology. The fact that supple-
mented constructs display greater contraction is not unex-
pected, since AA addition has been shown to increase
wound contraction in mouse40 and guinea pig models.41–43 It
is important to note that even though the AA + P constructs
contract to a greater degree, the dry weight of the constructs
does not significantly differ at any time point (Fig. 4B).
Furthermore, it is critical to mention that while the cross-
sectional area of the construct was measured, these measures
were made at only one point in the graft. In hindsight, since
the constructs are not completely uniform, it would have
been beneficial to obtain several scans along the full length of
the construct. Future work should focus on obtaining a
Table 2. Ratio of Maximum-to-Minimum Widths of Ligament-Like Constructs
in NT- and AA + P-Treated Samples Over 33–52 Days
Day
Group Ratio 33 36 38 40 43 45 47 50 52
NT Max:min 2.22 1.96 1.88 1.62 1.79 1.99 2.05 1.69 1.64
AA + P Max:min 1.60 1.54 1.60 1.61 1.66 1.69 1.69 1.62 1.62
Table 3. Ratio of Length to Width of Ligament-Like Constructs in NT and AA + P Samples Over 33–52 Days
Day
Group Ratio 33 36 38 40 43 45 47 50 52
NT Length:width 4.79 5.03 5.25 5.84 6.01 6.40 6.06 6.22 6.20
AA + P Length:width 7.18 9.71 9.64 9.96 9.66 10.08 10.18 10.13 10.32
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complete scan along the length of the construct, since the
morphological tapering evident in the digital images (Fig. 3)
and the 3D reconstructions (Fig. 6) was not taken into ac-
count when the scans were collected. This inaccuracy in
obtaining scans likely explains the variability of the cross-
sectional area data and the large increase in the cross-
sectional area at the 4-week time point in the unsupplemented
group (Fig. 5C).
The mechanism for increased contraction in the ligament-
like constructs on addition of AA + P could be multifaceted.
As mentioned, exogenous addition of both AA + P lead to
improved collagen accumulation; therefore, it is possible that
by increasing the collagen content, collagen fibrils act to
contract the fibrin matrix further as they crosslink with one
another under control of the enzyme lysyl oxidase. However,
contrary to this, a 1-mM dose of AA has been shown to have
an inhibitory effect on lysyl oxidase activity in vitro,44 al-
though the authors performed no further experiments to
establish the inhibitory ranges of AA concentrations. Fur-
thermore, AA has been shown to have positive and negative
effects on cellular proliferation depending on cell type. One
reason for increased contraction could be an increase in cell
number and therefore faster cell-mediated enzymatic diges-
tion of the initial fibrin matrix. We have previously shown
that 1 week of 50mM AA + P supplementation increases the
embryonic chick tendon fibroblasts cell number within the
constructs.11 Conversely, AA may act to transdifferentiate
fibroblasts into a contractile myofibroblastic phenotype, with
cells rich in a-smooth muscle actin as reported in smooth
muscle cells45,46 and bone mesenchymal stem cells.47 This
has been previously been reported to occur in fibroblasts on
addition of transforming growth factor-b,48 a growth factor
pivotal to the collagen fibrillogenesis pathway, so it is pos-
sible that a related effect is occurring within our system. In
two dimensions, addition of 250 mM AA + 50 mM P to our
fibroblast culture resulted in no significant change in the cell
number (data not shown); however, since the attachment to
the external environment in 2D is very different from that in
3D,49 no conclusions can be drawn without further analysis
within this tissue-engineered ligament system.
The histological analysis shows that cells populate the
entire scaffold and align in the direction of tension (Fig. 9).
Also, taken with the 3D scans of the ligament constructs, the
formation of a dense, outer cortex can be seen (Figs. 6 and 8).
Another research group has used immunohistochemical
techniques to investigate the deposition of extracellular ma-
trix (ECM) using ACL cells in this fibrin gel system.37 In-
terestingly, they showed that a cortex of collagen type I was
formed with mainly collagen type XII in the core of the
construct.37 Our hydroxyproline content assay does not
distinguish between types of collagen, so we are currently
undertaking work to give a full immunohistochemical anal-
ysis of the ECM deposited over the culture period. It may be
that the mechanical environment predisposes the production
of different types of collagen, and it is important to establish
what these matrix proteins are within this system.
FIG. 9. Histological sections of AA + P-treated ligament-like constructs. (A) Transverse section from the midpoint of an
AA + P-treated sample after 5 weeks in culture. The folds of the fibrin can be seen clearly (small arrows). Also, a cell layer is
present on the outside of the tubular scaffold (large arrows). Stained with hematoxylin and eosin. (B) Transverse section of an
AA + P-treated sample after 5 weeks in culture taken from the end of the construct near the cement anchor point. The
midpoints of the construct have not joined together, probably due to the mechanical barrier of the cement anchor. (C, D)
Longitudinal section of an AA + P-treated construct after 10 weeks in culture. Cell nuclei (blue) are distributed throughout the
fibrous scaffold (pink), although are seen to be more prominent on the outer layers, creating a thick, dense layer on either side
of the construct. Cells appear to align in the direction of tension. Color images available online at www.liebertonline.com/tea
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It is also likely that addition of AA + P affects matrix me-
talloproteinase (MMP) activity. MMPs are a family of zinc-
dependent proteases that degrade components of the ECM.50,51
Also, members of the A disintegrin and metalloproteinases
with the thrombospondin motif (ADAMTS) family, known as
the aggrecanases, act to degrade proteoglycans within the
ECM,52 and the enzymatic activity of both MMPs and
ADAMTS is central to the control of matrix remodeling. Also,
the tissue inhibitors of MMPs act to inhibit the degradative
functions of MMPs in an effort to maintain homeostasis within
the ECM.27,53 Although the expression of quantification of
MMP was not performed in the current study, the effect of
AA + P on control of MMP activity remains an important factor
to understand with regard to formation and contraction of the
ligament-like constructs. Analysis of MMP will form part of our
future work on this system.
Conclusions
This study has used digital imaging techniques, OCT, and
histology to monitor the early-stage formation and maturation
of tissue-engineered ligament-like constructs. OCT has allowed
a complete cross-sectional view of the constructs during for-
mation and the gross contraction of the fibrin-based cultures. It
has also been shown that although AA + P supplementation
continues to significantly improve collagen production over a
5-week period, it also causes excessive contraction of the con-
structs, producing a thin, round cross-sectional morphology
rather than broad, flat ligament-like tissues that could prove
problematic for our intended application as ACL replacement.
Further analysis of effect of supplementation on the contraction
method is crucial for the future development of tissue-en-
gineered ligaments with clinically relevant morphological
characteristics for implantation.
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drogel fibers for acl prosthesis: Design and mechanical evaluation of pva and pva/uhmwpe
fiber constructs. Journal of biomechanics.
Badylak, S. F., Freytes, D. O., and Gilbert, T. W. (2009). Extracellular matrix as a
biological scaffold material: structure and function. Acta biomaterialia, 5(1):1–13.
References 272
Balakrishnan, B. and Banerjee, R. (2011). Biopolymer-based hydrogels for cartilage tissue
engineering. Chemical Reviews, 111(8):4453–4474.
Ballestrem, C., Wehrle-Haller, B., Hinz, B., and Imhof, B. A. (2000). Actin-dependent
lamellipodia formation and microtubule-dependent tail retraction control-directed cell
migration. Molecular biology of the cell, 11(9):2999–3012.
Bayer, M. L., Yeung, C.-Y. C., Kadler, K. E., Qvortrup, K., Baar, K., Svensson, R. B.,
Peter Magnusson, S., Krogsgaard, M., Koch, M., and Kjaer, M. (2010). The initiation of
embryonic-like collagen fibrillogenesis by adult human tendon fibroblasts when cultured
under tension. Biomaterials, 31(18):4889–4897.
Benjamin, M. and McGonagle, D. (2009). Entheses: tendon and ligament attachment sites.
Scandinavian journal of medicine & science in sports, 19(4):520–527.
Benjamin, M. and Ralphs, J. (1998). Fibrocartilage in tendons and ligaments—an adapta-
tion to compressive load. Journal of anatomy, 193(4):481–494.
Benjamin, M. and Ralphs, J. R. (1997). Tendons and ligaments–an overview. Histol
Histopathol, 12(4):1135–44. Benjamin, M Ralphs, J R Review Spain Histology and
histopathology Histol Histopathol. 1997 Oct;12(4):1135-44.
Benjamin, M., Toumi, H., Ralphs, J. R., Bydder, G., Best, T. M., and Milz, S. (2006).
Where tendons and ligaments meet bone: attachment sites (’entheses’) in relation to
exercise and/or mechanical load. J Anat, 208(4):471–90. Benjamin, M Toumi, H Ralphs,
J R Bydder, G Best, T M Milz, S Review England Journal of anatomy J Anat. 2006
Apr;208(4):471-90.
Berrier, A. L. and Yamada, K. M. (2007). Cell-matrix adhesion. J Cell Physiol, 213(3):565–
73. Berrier, Allison L Yamada, Kenneth M Research Support, N.I.H., Extramural Re-
search Support, N.I.H., Intramural Review United States Journal of cellular physiology
J Cell Physiol. 2007 Dec;213(3):565-73.
Bhandari, R. N., Riccalton, L. A., Lewis, A. L., Fry, J. R., Hammond, A. H., Tendler, S. J.,
and Shakesheff, K. M. (2001). Liver tissue engineering: a role for co-culture systems in
modifying hepatocyte function and viability. Tissue engineering, 7(3):345–357.
Bhattacharjee, A. and Bansal, M. (2005). Collagen structure: the madras triple helix and
the current scenario. Iubmb Life, 57(3):161–172.
Bonassar, L. J. and Vacanti, C. A. (1998). Tissue engineering: the first decade and beyond.
Journal of Cellular Biochemistry, 72(S30–31):297–303.
Breidenbach, A. P., Gilday, S. D., Lalley, A. L., Dyment, N. A., Gooch, C., Shearn, J. T.,
and Butler, D. L. (2013). Functional tissue engineering of tendon: Establishing biological
success criteria for improving tendon repair. Journal of biomechanics.
Brodsky, B. and Ramshaw, J. A. (1997). The collagen triple-helix structure. Matrix Biology,
15(8):545–554.
Brooks, R. (1976). Regulation of the fibroblast cell cycle by serum.
Brown, J. P., Finley, V. G., and Kuo, C. K. (2014). Embryonic mechanical and soluble cues
regulate tendon progenitor cell gene expression as a function of developmental stage and
anatomical origin. Journal of biomechanics, 47(1):214–222.
Bryant, S. J. and Anseth, K. S. (2001). The effects of scaffold thickness on tissue engineered
cartilage in photocrosslinked poly (ethylene oxide) hydrogels. Biomaterials, 22(6):619–
626.
Butler, D. L., Juncosa-Melvin, N., Boivin, G. P., Galloway, M. T., Shearn, J. T., Gooch, C.,
and Awad, H. (2008). Functional tissue engineering for tendon repair: A multidisciplinary
References 273
strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation. Journal
of Orthopaedic Research, 26(1):1–9.
Buxboim, A., Rajagopal, K., Andre’EX, B., and Discher, D. E. (2010). How deeply cells
feel: methods for thin gels. Journal of Physics: Condensed Matter, 22(19):194116.
Caliari, S. R. and Harley, B. A. (2011). The effect of anisotropic collagen-gag scaffolds and
growth factor supplementation on tendon cell recruitment, alignment, and metabolic
activity. Biomaterials, 32(23):5330–5340.
Caliari, S. R. and Harley, B. A. (2013). Composite growth factor supplementation strategies
to enhance tenocyte bioactivity in aligned collagen-gag scaffolds. Tissue Engineering Part
A, 19(9-10):1100–1112.
Caliari, S. R., Ramirez, M. A., and Harley, B. A. (2011). The development of collagen-gag
scaffold-membrane composites for tendon tissue engineering. Biomaterials, 32(34):8990–
8998.
Calve, S., Dennis, R. G., Kosnik, P. E., Baar, K., Grosh, K., and Arruda, E. M. (2004).
Engineering of functional tendon. Tissue engineering, 10(5-6):755–761.
Canty, E. and Kadler, K. (2002). Collagen fibril biosynthesis in tendon: a review and recent
insights. Comparative Biochemistry and Physiology Part A: Molecular & Integrative
Physiology, 133(4):979–985.
Cao, E., Chen, Y., Cui, Z., and Foster, P. R. (2003). Effect of freezing and thawing rates
on denaturation of proteins in aqueous solutions. Biotechnology and bioengineering,
82(6):684–690.
Carlstedt, C. A. (1987). Mechanical and chemical factors in tendon healing: effects of
indomethacin and surgery in the rabbit. Acta Orthopaedica, 58(S224):1–75.
Chambard, J.-C., Lefloch, R., Pouysségur, J., and Lenormand, P. (2007). Erk implication
in cell cycle regulation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research,
1773(8):1299 – 1310.
Chang, H. Y., Chi, J.-T., Dudoit, S., Bondre, C., van de Rijn, M., Botstein, D., and Brown,
P. O. (2002). Diversity, topographic differentiation, and positional memory in human
fibroblasts. Proceedings of the National Academy of Sciences, 99(20):12877–12882.
Chen, F. M., Zhang, M., and Wu, Z. F. (2010). Toward delivery of multiple growth factors
in tissue engineering. Biomaterials, 31(24):6279–308.
Chen, G., Okamura, A., Sugiyama, K., Wozniak, M. J., Kawazoe, N., Sato, S., and Tateishi,
T. (2009). Surface modification of porous scaffolds with nanothick collagen layer by
centrifugation and freeze-drying. J Biomed Mater Res B Appl Biomater, 90(2):864–72.
Chen, G., Sato, T., Ushida, T., Hirochika, R., Shirasaki, Y., Ochiai, N., and Tateishi, T.
(2003). The use of a novel plga fiber/collagen composite web as a scaffold for engineering
of articular cartilage tissue with adjustable thickness. Journal of Biomedical Materials
Research Part A, 67(4):1170–1180.
Chen, G. P., Ushida, T., and Tateishi, T. (2002). Scaffold design for tissue engineer-
ing. Macromolecular Bioscience, 2(2):67–77. 533MD Times Cited:130 Cited References
Count:107.
Chen, Q., Kinch, M. S., Lin, T. H., Burridge, K., and Juliano, R. (1994). Integrin-mediated
cell adhesion activates mitogen-activated protein kinases. Journal of Biological Chem-
istry, 269(43):26602–26605.
Cheng, C. W., Solorio, L. D., and Alsberg, E. (2014). Decellularized tissue and cell-derived
References 274
extracellular matrices as scaffolds for orthopaedic tissue engineering. Biotechnology ad-
vances.
Chiarugi, P. and Giannoni, E. (2008). ¡ i¿ anoikis¡/i¿: A necessary death program for
anchorage-dependent cells. Biochemical pharmacology, 76(11):1352–1364.
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Kemençe, N. and Bölgen, N. (2013). Gelatin-and hydroxyapatite-based cryogels for bone
tissue engineering: synthesis, characterization, in vitro and in vivo biocompatibility.
Journal of tissue engineering and regenerative medicine.
Kemler, R. (1993). From cadherins to catenins: cytoplasmic protein interactions and reg-
ulation of cell adhesion. Trends in Genetics, 9(9):317–321.
Kew, S., Gwynne, J., Enea, D., Abu-Rub, M., Pandit, A., Zeugolis, D., Brooks, R., Rush-
ton, N., Best, S., and Cameron, R. (2011). Regeneration and repair of tendon and
ligament tissue using collagen fibre biomaterials. Acta biomaterialia, 7(9):3237–3247.
Kim, H.-S., Shang, T., Chen, Z., Pflugfelder, S. C., and Li, D.-Q. (2004). Tgf-β1 stimulates
production of gelatinase (mmp-9), collagenases (mmp-1,-13) and stromelysins (mmp-3,-
10,-11) by human corneal epithelial cells. Experimental eye research, 79(2):263–274.
Kim, W. S., Mooney, D. J., Arany, P. R., Lee, K., Huebsch, N., and Kim, J. (2012). Adipose
tissue engineering using injectable, oxidized alginate hydrogels. Tissue Engineering Part
A, 18(7-8):737–743.
Kinoh, H., Sato, H., Tsunezuka, Y., Takino, T., Kawashima, A., Okada, Y., and Seiki,
M. (1996). Mt-mmp, the cell surface activator of prommp-2 (pro-gelatinase a), is ex-
pressed with its substrate in mouse tissue during embryogenesis. Journal of cell science,
References 282
109(5):953–959.
Klammert, U., Reuther, T., Blank, M., Reske, I., Barralet, J. E., Grover, L. M., Kübler,
A. C., and Gbureck, U. (2010). Phase composition, mechanical performance and in
vitro biocompatibility of hydraulic setting calcium magnesium phosphate cement. Acta
biomaterialia, 6(4):1529–1535.
Klein-Nulend, J., Roelofsen, J., Sterck, J. G., Semeins, C. M., and Burger, E. H. (1995).
Mechanical loading stimulates the release of transforming growth factor-β activity by
cultured mouse calvariae and periosteal cells. Journal of cellular physiology, 163(1):115–
119.
Knoblich, J. A. (2008). Mechanisms of asymmetric stem cell division. Cell, 132(4):583–597.
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Zinc in wound healing: theoretical, experimental, and clinical aspects. Wound repair
and regeneration, 15(1):2–16.
Lanza, R., Langer, R., and Vacanti, J. P. (2011). Principles of tissue engineering. Academic
press.
Laurencin, C. T., Ambrosio, A. M., Borden, M. D., and Cooper, J. A., J. (1999). Tissue
engineering: orthopedic applications. Annu Rev Biomed Eng, 1:19–46.
Laurencin, C. T. and Freeman, J. W. (2005). Ligament tissue engineering: An evolutionary
materials science approach. Biomaterials, 26(36):7530–7536.
Leccia, M. (1996). Pharmacological uses of zinc and other trace elements in dermatology.
In Therapeutic Uses of Trace Elements, pages 213–217. Springer.
Lecuit, T. and Lenne, P.-F. (2007). Cell surface mechanics and the control of cell shape,
tissue patterns and morphogenesis. Nature Reviews Molecular Cell Biology, 8(8):633–644.
References 283
Lee, D. J., Rosenfeldt, H., and Grinnell, F. (2000). Activation of erk and p38 map kinases
in human fibroblasts during collagen matrix contraction. Experimental cell research,
257(1):190–197.
Leong, N. L., Petrigliano, F. A., and McAllister, D. R. (2013). Current tissue engineering
strategies in anterior cruciate ligament reconstruction. Journal of Biomedical Materials
Research Part A.
Lin, T. W., Cardenas, L., and Soslowsky, L. J. (2004). Biomechanics of tendon injury and
repair. Journal of biomechanics, 37(6):865–877.
Lin, Y.-C., Tambe, D. T., Park, C. Y., Wasserman, M. R., Trepat, X., Krishnan, R.,
Lenormand, G., Fredberg, J. J., and Butler, J. P. (2010). Mechanosensing of substrate
thickness. Physical Review E, 82(4):041918.
Linhardt, R. J. and Toida, T. (2004). Role of glycosaminoglycans in cellular communication.
Accounts of chemical research, 37(7):431–438.
Little, D., Guilak, F., and Ruch, D. S. (2010). Ligament-derived matrix stimulates a
ligamentous phenotype in human adipose-derived stem cells. Tissue Engineering Part
A, 16(7):2307–2319.
Lo, C.-M., Wang, H.-B., Dembo, M., and Wang, Y.-l. (2000). Cell movement is guided by
the rigidity of the substrate. Biophysical journal, 79(1):144–152.
Lo, K. W.-H., Jiang, T., Gagnon, K. A., Nelson, C., and Laurencin, C. T. (2014). Small-
molecule based musculoskeletal regenerative engineering. Trends in biotechnology.
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